<!DOCTYPE html><html  lang="en" data-capo=""><head><meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1">
<title>Frontiers | Research progress of multimodal biomarkers in the early diagnosis of mild cognitive impairment in Parkinsonâ€™s disease</title>
<link rel="stylesheet" href="/ap-2024/_nuxt/entry.G8Gc_r9x.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/vue-core.D28fhFCU.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/explainer.CMppEa5M.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleDetails.B93eTAmx.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleLayoutHeader.CKWUz2Al.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/AnnouncementCard.Db7nmstV.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/FloatingButtons.xuP8gC33.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleEvent.D0PaxIW7.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/SimilarArticles.BMee4Fk4.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleTemplateBanner.CXmOJ7NH.css">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BlX2Cz3M.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/B674Mi_H.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BXedFy5e.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/eQMj-Fph.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/l0jHfajE.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BUyL5Z_3.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/DYN1s-Xq.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/DHv8pTSw.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BHPWSuhB.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/x5HZk7Le.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CNJXQ6ZR.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Dss5ciUI.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CD4qBbFY.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Dts-EAXz.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/eXUaRzJx.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Bo9_K6z3.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/DHM6nMTY.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/B1fFwJGS.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Di9znkJ7.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CPZN2_Bm.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/DtIx_aOo.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/B2VEUP4r.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Dv5mmZXs.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/DHe6lDGB.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BCjFX_1y.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/wJAsf1xy.js">
<link rel="prefetch" as="style" crossorigin href="/ap-2024/_nuxt/ArticleHubLayout.q6CU8_bN.css">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/DNDUX-8l.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/I7IeNEc2.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/GWtHKqLR.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/CGD7YFzg.js">
<meta name="theme-color" content="#0C4DED">
<meta name="mobile-web-app-capable" content="yes">
<meta name="apple-mobile-web-app-capable" content="yes">
<script type="text/javascript" data-hid="4cd079c">window.NREUM||(NREUM={});NREUM.info = {"agent":"","beacon":"bam.nr-data.net","errorBeacon":"bam.nr-data.net","licenseKey":"598a124f17","applicationID":"586843029","agentToken":null,"applicationTime":4.223324,"transactionName":"MQcDMkECCkNSW0YMWghNLwlBDgVcWkJXAWAUC04MXBYWXlJUQUpbAxcTCV8MA0kcWUARXAUOBBUcSUtWXV1HFxtUUlNTHVJSBQELBV0aABcNCg==","queueTime":0,"ttGuid":"3f638d536beb3dcd"}; (window.NREUM||(NREUM={})).init={privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]},distributed_tracing:{enabled:true}};(window.NREUM||(NREUM={})).loader_config={agentID:"594460232",accountID:"230385",trustKey:"230385",xpid:"VgUHUl5WGwYIUllWBAEFXw==",licenseKey:"598a124f17",applicationID:"586843029"};;/*! For license information please see nr-loader-spa-1.299.0.min.js.LICENSE.txt */
(()=>{var e,t,r={8122:(e,t,r)=>{"use strict";r.d(t,{a:()=>i});var n=r(944);function i(e,t){try{if(!e||"object"!=typeof e)return(0,n.R)(3);if(!t||"object"!=typeof t)return(0,n.R)(4);const r=Object.create(Object.getPrototypeOf(t),Object.getOwnPropertyDescriptors(t)),o=0===Object.keys(r).length?e:r;for(let a in o)if(void 0!==e[a])try{if(null===e[a]){r[a]=null;continue}Array.isArray(e[a])&&Array.isArray(t[a])?r[a]=Array.from(new Set([...e[a],...t[a]])):"object"==typeof e[a]&&"object"==typeof t[a]?r[a]=i(e[a],t[a]):r[a]=e[a]}catch(e){r[a]||(0,n.R)(1,e)}return r}catch(e){(0,n.R)(2,e)}}},2555:(e,t,r)=>{"use strict";r.d(t,{D:()=>s,f:()=>a});var n=r(384),i=r(8122);const o={beacon:n.NT.beacon,errorBeacon:n.NT.errorBeacon,licenseKey:void 0,applicationID:void 0,sa:void 0,queueTime:void 0,applicationTime:void 0,ttGuid:void 0,user:void 0,account:void 0,product:void 0,extra:void 0,jsAttributes:{},userAttributes:void 0,atts:void 0,transactionName:void 0,tNamePlain:void 0};function a(e){try{return!!e.licenseKey&&!!e.errorBeacon&&!!e.applicationID}catch(e){return!1}}const s=e=>(0,i.a)(e,o)},7699:(e,t,r)=>{"use strict";r.d(t,{It:()=>i,No:()=>n,qh:()=>a,uh:()=>o});const n=16e3,i=1e6,o="NR_CONTAINER_AGENT",a="SESSION_ERROR"},9324:(e,t,r)=>{"use strict";r.d(t,{F3:()=>i,Xs:()=>o,Yq:()=>a,xv:()=>n});const n="1.299.0",i="PROD",o="CDN",a="^2.0.0-alpha.18"},6154:(e,t,r)=>{"use strict";r.d(t,{A4:()=>s,OF:()=>d,RI:()=>i,WN:()=>h,bv:()=>o,gm:()=>a,lR:()=>f,m:()=>u,mw:()=>c,sb:()=>l});var n=r(1863);const i="undefined"!=typeof window&&!!window.document,o="undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self.navigator instanceof WorkerNavigator||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis.navigator instanceof WorkerNavigator),a=i?window:"undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis),s="complete"===a?.document?.readyState,c=Boolean("hidden"===a?.document?.visibilityState),u=""+a?.location,d=/iPad|iPhone|iPod/.test(a.navigator?.userAgent),l=d&&"undefined"==typeof SharedWorker,f=(()=>{const e=a.navigator?.userAgent?.match(/Firefox[/\s](\d+\.\d+)/);return Array.isArray(e)&&e.length>=2?+e[1]:0})(),h=Date.now()-(0,n.t)()},7295:(e,t,r)=>{"use strict";r.d(t,{Xv:()=>a,gX:()=>i,iW:()=>o});var n=[];function i(e){if(!e||o(e))return!1;if(0===n.length)return!0;for(var t=0;t<n.length;t++){var r=n[t];if("*"===r.hostname)return!1;if(s(r.hostname,e.hostname)&&c(r.pathname,e.pathname))return!1}return!0}function o(e){return void 0===e.hostname}function a(e){if(n=[],e&&e.length)for(var t=0;t<e.length;t++){let r=e[t];if(!r)continue;0===r.indexOf("http://")?r=r.substring(7):0===r.indexOf("https://")&&(r=r.substring(8));const i=r.indexOf("/");let o,a;i>0?(o=r.substring(0,i),a=r.substring(i)):(o=r,a="");let[s]=o.split(":");n.push({hostname:s,pathname:a})}}function s(e,t){return!(e.length>t.length)&&t.indexOf(e)===t.length-e.length}function c(e,t){return 0===e.indexOf("/")&&(e=e.substring(1)),0===t.indexOf("/")&&(t=t.substring(1)),""===e||e===t}},3241:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(6154);const i="newrelic";function o(e={}){try{n.gm.dispatchEvent(new CustomEvent(i,{detail:e}))}catch(e){}}},1687:(e,t,r)=>{"use strict";r.d(t,{Ak:()=>u,Ze:()=>f,x3:()=>d});var n=r(3241),i=r(7836),o=r(3606),a=r(860),s=r(2646);const c={};function u(e,t){const r={staged:!1,priority:a.P3[t]||0};l(e),c[e].get(t)||c[e].set(t,r)}function d(e,t){e&&c[e]&&(c[e].get(t)&&c[e].delete(t),p(e,t,!1),c[e].size&&h(e))}function l(e){if(!e)throw new Error("agentIdentifier required");c[e]||(c[e]=new Map)}function f(e="",t="feature",r=!1){if(l(e),!e||!c[e].get(t)||r)return p(e,t);c[e].get(t).staged=!0,h(e)}function h(e){const t=Array.from(c[e]);t.every((([e,t])=>t.staged))&&(t.sort(((e,t)=>e[1].priority-t[1].priority)),t.forEach((([t])=>{c[e].delete(t),p(e,t)})))}function p(e,t,r=!0){const a=e?i.ee.get(e):i.ee,c=o.i.handlers;if(!a.aborted&&a.backlog&&c){if((0,n.W)({agentIdentifier:e,type:"lifecycle",name:"drain",feature:t}),r){const e=a.backlog[t],r=c[t];if(r){for(let t=0;e&&t<e.length;++t)g(e[t],r);Object.entries(r).forEach((([e,t])=>{Object.values(t||{}).forEach((t=>{t[0]?.on&&t[0]?.context()instanceof s.y&&t[0].on(e,t[1])}))}))}}a.isolatedBacklog||delete c[t],a.backlog[t]=null,a.emit("drain-"+t,[])}}function g(e,t){var r=e[1];Object.values(t[r]||{}).forEach((t=>{var r=e[0];if(t[0]===r){var n=t[1],i=e[3],o=e[2];n.apply(i,o)}}))}},7836:(e,t,r)=>{"use strict";r.d(t,{P:()=>s,ee:()=>c});var n=r(384),i=r(8990),o=r(2646),a=r(5607);const s="nr@context:".concat(a.W),c=function e(t,r){var n={},a={},d={},l=!1;try{l=16===r.length&&u.initializedAgents?.[r]?.runtime.isolatedBacklog}catch(e){}var f={on:p,addEventListener:p,removeEventListener:function(e,t){var r=n[e];if(!r)return;for(var i=0;i<r.length;i++)r[i]===t&&r.splice(i,1)},emit:function(e,r,n,i,o){!1!==o&&(o=!0);if(c.aborted&&!i)return;t&&o&&t.emit(e,r,n);var s=h(n);g(e).forEach((e=>{e.apply(s,r)}));var u=v()[a[e]];u&&u.push([f,e,r,s]);return s},get:m,listeners:g,context:h,buffer:function(e,t){const r=v();if(t=t||"feature",f.aborted)return;Object.entries(e||{}).forEach((([e,n])=>{a[n]=t,t in r||(r[t]=[])}))},abort:function(){f._aborted=!0,Object.keys(f.backlog).forEach((e=>{delete f.backlog[e]}))},isBuffering:function(e){return!!v()[a[e]]},debugId:r,backlog:l?{}:t&&"object"==typeof t.backlog?t.backlog:{},isolatedBacklog:l};return Object.defineProperty(f,"aborted",{get:()=>{let e=f._aborted||!1;return e||(t&&(e=t.aborted),e)}}),f;function h(e){return e&&e instanceof o.y?e:e?(0,i.I)(e,s,(()=>new o.y(s))):new o.y(s)}function p(e,t){n[e]=g(e).concat(t)}function g(e){return n[e]||[]}function m(t){return d[t]=d[t]||e(f,t)}function v(){return f.backlog}}(void 0,"globalEE"),u=(0,n.Zm)();u.ee||(u.ee=c)},2646:(e,t,r)=>{"use strict";r.d(t,{y:()=>n});class n{constructor(e){this.contextId=e}}},9908:(e,t,r)=>{"use strict";r.d(t,{d:()=>n,p:()=>i});var n=r(7836).ee.get("handle");function i(e,t,r,i,o){o?(o.buffer([e],i),o.emit(e,t,r)):(n.buffer([e],i),n.emit(e,t,r))}},3606:(e,t,r)=>{"use strict";r.d(t,{i:()=>o});var n=r(9908);o.on=a;var i=o.handlers={};function o(e,t,r,o){a(o||n.d,i,e,t,r)}function a(e,t,r,i,o){o||(o="feature"),e||(e=n.d);var a=t[o]=t[o]||{};(a[r]=a[r]||[]).push([e,i])}},3878:(e,t,r)=>{"use strict";function n(e,t){return{capture:e,passive:!1,signal:t}}function i(e,t,r=!1,i){window.addEventListener(e,t,n(r,i))}function o(e,t,r=!1,i){document.addEventListener(e,t,n(r,i))}r.d(t,{DD:()=>o,jT:()=>n,sp:()=>i})},5607:(e,t,r)=>{"use strict";r.d(t,{W:()=>n});const n=(0,r(9566).bz)()},9566:(e,t,r)=>{"use strict";r.d(t,{LA:()=>s,ZF:()=>c,bz:()=>a,el:()=>u});var n=r(6154);const i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx";function o(e,t){return e?15&e[t]:16*Math.random()|0}function a(){const e=n.gm?.crypto||n.gm?.msCrypto;let t,r=0;return e&&e.getRandomValues&&(t=e.getRandomValues(new Uint8Array(30))),i.split("").map((e=>"x"===e?o(t,r++).toString(16):"y"===e?(3&o()|8).toString(16):e)).join("")}function s(e){const t=n.gm?.crypto||n.gm?.msCrypto;let r,i=0;t&&t.getRandomValues&&(r=t.getRandomValues(new Uint8Array(e)));const a=[];for(var s=0;s<e;s++)a.push(o(r,i++).toString(16));return a.join("")}function c(){return s(16)}function u(){return s(32)}},2614:(e,t,r)=>{"use strict";r.d(t,{BB:()=>a,H3:()=>n,g:()=>u,iL:()=>c,tS:()=>s,uh:()=>i,wk:()=>o});const n="NRBA",i="SESSION",o=144e5,a=18e5,s={STARTED:"session-started",PAUSE:"session-pause",RESET:"session-reset",RESUME:"session-resume",UPDATE:"session-update"},c={SAME_TAB:"same-tab",CROSS_TAB:"cross-tab"},u={OFF:0,FULL:1,ERROR:2}},1863:(e,t,r)=>{"use strict";function n(){return Math.floor(performance.now())}r.d(t,{t:()=>n})},7485:(e,t,r)=>{"use strict";r.d(t,{D:()=>i});var n=r(6154);function i(e){if(0===(e||"").indexOf("data:"))return{protocol:"data"};try{const t=new URL(e,location.href),r={port:t.port,hostname:t.hostname,pathname:t.pathname,search:t.search,protocol:t.protocol.slice(0,t.protocol.indexOf(":")),sameOrigin:t.protocol===n.gm?.location?.protocol&&t.host===n.gm?.location?.host};return r.port&&""!==r.port||("http:"===t.protocol&&(r.port="80"),"https:"===t.protocol&&(r.port="443")),r.pathname&&""!==r.pathname?r.pathname.startsWith("/")||(r.pathname="/".concat(r.pathname)):r.pathname="/",r}catch(e){return{}}}},944:(e,t,r)=>{"use strict";r.d(t,{R:()=>i});var n=r(3241);function i(e,t){"function"==typeof console.debug&&(console.debug("New Relic Warning: https://github.com/newrelic/newrelic-browser-agent/blob/main/docs/warning-codes.md#".concat(e),t),(0,n.W)({agentIdentifier:null,drained:null,type:"data",name:"warn",feature:"warn",data:{code:e,secondary:t}}))}},5701:(e,t,r)=>{"use strict";r.d(t,{B:()=>o,t:()=>a});var n=r(3241);const i=new Set,o={};function a(e,t){const r=t.agentIdentifier;o[r]??={},e&&"object"==typeof e&&(i.has(r)||(t.ee.emit("rumresp",[e]),o[r]=e,i.add(r),(0,n.W)({agentIdentifier:r,loaded:!0,drained:!0,type:"lifecycle",name:"load",feature:void 0,data:e})))}},8990:(e,t,r)=>{"use strict";r.d(t,{I:()=>i});var n=Object.prototype.hasOwnProperty;function i(e,t,r){if(n.call(e,t))return e[t];var i=r();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,t,{value:i,writable:!0,enumerable:!1}),i}catch(e){}return e[t]=i,i}},6389:(e,t,r)=>{"use strict";function n(e,t=500,r={}){const n=r?.leading||!1;let i;return(...r)=>{n&&void 0===i&&(e.apply(this,r),i=setTimeout((()=>{i=clearTimeout(i)}),t)),n||(clearTimeout(i),i=setTimeout((()=>{e.apply(this,r)}),t))}}function i(e){let t=!1;return(...r)=>{t||(t=!0,e.apply(this,r))}}r.d(t,{J:()=>i,s:()=>n})},1910:(e,t,r)=>{"use strict";r.d(t,{i:()=>o});var n=r(944);const i=new Map;function o(...e){return e.every((e=>{if(i.has(e))return i.get(e);const t="function"==typeof e&&e.toString().includes("[native code]");return t||(0,n.R)(64,e?.name||e?.toString()),i.set(e,t),t}))}},3304:(e,t,r)=>{"use strict";r.d(t,{A:()=>o});var n=r(7836);const i=()=>{const e=new WeakSet;return(t,r)=>{if("object"==typeof r&&null!==r){if(e.has(r))return;e.add(r)}return r}};function o(e){try{return JSON.stringify(e,i())??""}catch(e){try{n.ee.emit("internal-error",[e])}catch(e){}return""}}},3496:(e,t,r)=>{"use strict";function n(e){return!e||!(!e.licenseKey||!e.applicationID)}function i(e,t){return!e||e.licenseKey===t.info.licenseKey&&e.applicationID===t.info.applicationID}r.d(t,{A:()=>i,I:()=>n})},5289:(e,t,r)=>{"use strict";r.d(t,{GG:()=>o,Qr:()=>s,sB:()=>a});var n=r(3878);function i(){return"undefined"==typeof document||"complete"===document.readyState}function o(e,t){if(i())return e();(0,n.sp)("load",e,t)}function a(e){if(i())return e();(0,n.DD)("DOMContentLoaded",e)}function s(e){if(i())return e();(0,n.sp)("popstate",e)}},384:(e,t,r)=>{"use strict";r.d(t,{NT:()=>a,US:()=>d,Zm:()=>s,bQ:()=>u,dV:()=>c,pV:()=>l});var n=r(6154),i=r(1863),o=r(1910);const a={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net"};function s(){return n.gm.NREUM||(n.gm.NREUM={}),void 0===n.gm.newrelic&&(n.gm.newrelic=n.gm.NREUM),n.gm.NREUM}function c(){let e=s();return e.o||(e.o={ST:n.gm.setTimeout,SI:n.gm.setImmediate||n.gm.setInterval,CT:n.gm.clearTimeout,XHR:n.gm.XMLHttpRequest,REQ:n.gm.Request,EV:n.gm.Event,PR:n.gm.Promise,MO:n.gm.MutationObserver,FETCH:n.gm.fetch,WS:n.gm.WebSocket},(0,o.i)(...Object.values(e.o))),e}function u(e,t){let r=s();r.initializedAgents??={},t.initializedAt={ms:(0,i.t)(),date:new Date},r.initializedAgents[e]=t}function d(e,t){s()[e]=t}function l(){return function(){let e=s();const t=e.info||{};e.info={beacon:a.beacon,errorBeacon:a.errorBeacon,...t}}(),function(){let e=s();const t=e.init||{};e.init={...t}}(),c(),function(){let e=s();const t=e.loader_config||{};e.loader_config={...t}}(),s()}},2843:(e,t,r)=>{"use strict";r.d(t,{u:()=>i});var n=r(3878);function i(e,t=!1,r,i){(0,n.DD)("visibilitychange",(function(){if(t)return void("hidden"===document.visibilityState&&e());e(document.visibilityState)}),r,i)}},8139:(e,t,r)=>{"use strict";r.d(t,{u:()=>f});var n=r(7836),i=r(3434),o=r(8990),a=r(6154);const s={},c=a.gm.XMLHttpRequest,u="addEventListener",d="removeEventListener",l="nr@wrapped:".concat(n.P);function f(e){var t=function(e){return(e||n.ee).get("events")}(e);if(s[t.debugId]++)return t;s[t.debugId]=1;var r=(0,i.YM)(t,!0);function f(e){r.inPlace(e,[u,d],"-",p)}function p(e,t){return e[1]}return"getPrototypeOf"in Object&&(a.RI&&h(document,f),c&&h(c.prototype,f),h(a.gm,f)),t.on(u+"-start",(function(e,t){var n=e[1];if(null!==n&&("function"==typeof n||"object"==typeof n)&&"newrelic"!==e[0]){var i=(0,o.I)(n,l,(function(){var e={object:function(){if("function"!=typeof n.handleEvent)return;return n.handleEvent.apply(n,arguments)},function:n}[typeof n];return e?r(e,"fn-",null,e.name||"anonymous"):n}));this.wrapped=e[1]=i}})),t.on(d+"-start",(function(e){e[1]=this.wrapped||e[1]})),t}function h(e,t,...r){let n=e;for(;"object"==typeof n&&!Object.prototype.hasOwnProperty.call(n,u);)n=Object.getPrototypeOf(n);n&&t(n,...r)}},3434:(e,t,r)=>{"use strict";r.d(t,{Jt:()=>o,YM:()=>u});var n=r(7836),i=r(5607);const o="nr@original:".concat(i.W),a=50;var s=Object.prototype.hasOwnProperty,c=!1;function u(e,t){return e||(e=n.ee),r.inPlace=function(e,t,n,i,o){n||(n="");const a="-"===n.charAt(0);for(let s=0;s<t.length;s++){const c=t[s],u=e[c];l(u)||(e[c]=r(u,a?c+n:n,i,c,o))}},r.flag=o,r;function r(t,r,n,c,u){return l(t)?t:(r||(r=""),nrWrapper[o]=t,function(e,t,r){if(Object.defineProperty&&Object.keys)try{return Object.keys(e).forEach((function(r){Object.defineProperty(t,r,{get:function(){return e[r]},set:function(t){return e[r]=t,t}})})),t}catch(e){d([e],r)}for(var n in e)s.call(e,n)&&(t[n]=e[n])}(t,nrWrapper,e),nrWrapper);function nrWrapper(){var o,s,l,f;let h;try{s=this,o=[...arguments],l="function"==typeof n?n(o,s):n||{}}catch(t){d([t,"",[o,s,c],l],e)}i(r+"start",[o,s,c],l,u);const p=performance.now();let g;try{return f=t.apply(s,o),g=performance.now(),f}catch(e){throw g=performance.now(),i(r+"err",[o,s,e],l,u),h=e,h}finally{const e=g-p,t={start:p,end:g,duration:e,isLongTask:e>=a,methodName:c,thrownError:h};t.isLongTask&&i("long-task",[t,s],l,u),i(r+"end",[o,s,f],l,u)}}}function i(r,n,i,o){if(!c||t){var a=c;c=!0;try{e.emit(r,n,i,t,o)}catch(t){d([t,r,n,i],e)}c=a}}}function d(e,t){t||(t=n.ee);try{t.emit("internal-error",e)}catch(e){}}function l(e){return!(e&&"function"==typeof e&&e.apply&&!e[o])}},9300:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.ajax},3333:(e,t,r)=>{"use strict";r.d(t,{$v:()=>d,TZ:()=>n,Xh:()=>c,Zp:()=>i,kd:()=>u,mq:()=>s,nf:()=>a,qN:()=>o});const n=r(860).K7.genericEvents,i=["auxclick","click","copy","keydown","paste","scrollend"],o=["focus","blur"],a=4,s=1e3,c=2e3,u=["PageAction","UserAction","BrowserPerformance"],d={MARKS:"experimental.marks",MEASURES:"experimental.measures",RESOURCES:"experimental.resources"}},6774:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.jserrors},993:(e,t,r)=>{"use strict";r.d(t,{A$:()=>o,ET:()=>a,TZ:()=>s,p_:()=>i});var n=r(860);const i={ERROR:"ERROR",WARN:"WARN",INFO:"INFO",DEBUG:"DEBUG",TRACE:"TRACE"},o={OFF:0,ERROR:1,WARN:2,INFO:3,DEBUG:4,TRACE:5},a="log",s=n.K7.logging},3785:(e,t,r)=>{"use strict";r.d(t,{R:()=>c,b:()=>u});var n=r(9908),i=r(1863),o=r(860),a=r(8154),s=r(993);function c(e,t,r={},c=s.p_.INFO,u,d=(0,i.t)()){(0,n.p)(a.xV,["API/logging/".concat(c.toLowerCase(),"/called")],void 0,o.K7.metrics,e),(0,n.p)(s.ET,[d,t,r,c,u],void 0,o.K7.logging,e)}function u(e){return"string"==typeof e&&Object.values(s.p_).some((t=>t===e.toUpperCase().trim()))}},8154:(e,t,r)=>{"use strict";r.d(t,{z_:()=>o,XG:()=>s,TZ:()=>n,rs:()=>i,xV:()=>a});r(6154),r(9566),r(384);const n=r(860).K7.metrics,i="sm",o="cm",a="storeSupportabilityMetrics",s="storeEventMetrics"},6630:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.pageViewEvent},782:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.pageViewTiming},6344:(e,t,r)=>{"use strict";r.d(t,{BB:()=>d,G4:()=>o,Qb:()=>l,TZ:()=>i,Ug:()=>a,_s:()=>s,bc:()=>u,yP:()=>c});var n=r(2614);const i=r(860).K7.sessionReplay,o={RECORD:"recordReplay",PAUSE:"pauseReplay",ERROR_DURING_REPLAY:"errorDuringReplay"},a=.12,s={DomContentLoaded:0,Load:1,FullSnapshot:2,IncrementalSnapshot:3,Meta:4,Custom:5},c={[n.g.ERROR]:15e3,[n.g.FULL]:3e5,[n.g.OFF]:0},u={RESET:{message:"Session was reset",sm:"Reset"},IMPORT:{message:"Recorder failed to import",sm:"Import"},TOO_MANY:{message:"429: Too Many Requests",sm:"Too-Many"},TOO_BIG:{message:"Payload was too large",sm:"Too-Big"},CROSS_TAB:{message:"Session Entity was set to OFF on another tab",sm:"Cross-Tab"},ENTITLEMENTS:{message:"Session Replay is not allowed and will not be started",sm:"Entitlement"}},d=5e3,l={API:"api",RESUME:"resume",SWITCH_TO_FULL:"switchToFull",INITIALIZE:"initialize",PRELOAD:"preload"}},5270:(e,t,r)=>{"use strict";r.d(t,{Aw:()=>a,SR:()=>o,rF:()=>s});var n=r(384),i=r(7767);function o(e){return!!(0,n.dV)().o.MO&&(0,i.V)(e)&&!0===e?.session_trace.enabled}function a(e){return!0===e?.session_replay.preload&&o(e)}function s(e,t){try{if("string"==typeof t?.type){if("password"===t.type.toLowerCase())return"*".repeat(e?.length||0);if(void 0!==t?.dataset?.nrUnmask||t?.classList?.contains("nr-unmask"))return e}}catch(e){}return"string"==typeof e?e.replace(/[\S]/g,"*"):"*".repeat(e?.length||0)}},3738:(e,t,r)=>{"use strict";r.d(t,{He:()=>i,Kp:()=>s,Lc:()=>u,Rz:()=>d,TZ:()=>n,bD:()=>o,d3:()=>a,jx:()=>l,sl:()=>f,uP:()=>c});const n=r(860).K7.sessionTrace,i="bstResource",o="resource",a="-start",s="-end",c="fn"+a,u="fn"+s,d="pushState",l=1e3,f=3e4},3962:(e,t,r)=>{"use strict";r.d(t,{AM:()=>a,O2:()=>l,OV:()=>o,Qu:()=>f,TZ:()=>c,ih:()=>h,pP:()=>s,t1:()=>d,tC:()=>i,wD:()=>u});var n=r(860);const i=["click","keydown","submit"],o="popstate",a="api",s="initialPageLoad",c=n.K7.softNav,u=5e3,d=500,l={INITIAL_PAGE_LOAD:"",ROUTE_CHANGE:1,UNSPECIFIED:2},f={INTERACTION:1,AJAX:2,CUSTOM_END:3,CUSTOM_TRACER:4},h={IP:"in progress",PF:"pending finish",FIN:"finished",CAN:"cancelled"}},7378:(e,t,r)=>{"use strict";r.d(t,{$p:()=>x,BR:()=>b,Kp:()=>R,L3:()=>y,Lc:()=>c,NC:()=>o,SG:()=>d,TZ:()=>i,U6:()=>p,UT:()=>m,d3:()=>w,dT:()=>f,e5:()=>E,gx:()=>v,l9:()=>l,oW:()=>h,op:()=>g,rw:()=>u,tH:()=>A,uP:()=>s,wW:()=>T,xq:()=>a});var n=r(384);const i=r(860).K7.spa,o=["click","submit","keypress","keydown","keyup","change"],a=999,s="fn-start",c="fn-end",u="cb-start",d="api-ixn-",l="remaining",f="interaction",h="spaNode",p="jsonpNode",g="fetch-start",m="fetch-done",v="fetch-body-",b="jsonp-end",y=(0,n.dV)().o.ST,w="-start",R="-end",x="-body",T="cb"+R,E="jsTime",A="fetch"},4234:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(7836),i=r(1687);class o{constructor(e,t){this.agentIdentifier=e,this.ee=n.ee.get(e),this.featureName=t,this.blocked=!1}deregisterDrain(){(0,i.x3)(this.agentIdentifier,this.featureName)}}},7767:(e,t,r)=>{"use strict";r.d(t,{V:()=>i});var n=r(6154);const i=e=>n.RI&&!0===e?.privacy.cookies_enabled},1741:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(944),i=r(4261);class o{#e(e,...t){if(this[e]!==o.prototype[e])return this[e](...t);(0,n.R)(35,e)}addPageAction(e,t){return this.#e(i.hG,e,t)}register(e){return this.#e(i.eY,e)}recordCustomEvent(e,t){return this.#e(i.fF,e,t)}setPageViewName(e,t){return this.#e(i.Fw,e,t)}setCustomAttribute(e,t,r){return this.#e(i.cD,e,t,r)}noticeError(e,t){return this.#e(i.o5,e,t)}setUserId(e){return this.#e(i.Dl,e)}setApplicationVersion(e){return this.#e(i.nb,e)}setErrorHandler(e){return this.#e(i.bt,e)}addRelease(e,t){return this.#e(i.k6,e,t)}log(e,t){return this.#e(i.$9,e,t)}start(){return this.#e(i.d3)}finished(e){return this.#e(i.BL,e)}recordReplay(){return this.#e(i.CH)}pauseReplay(){return this.#e(i.Tb)}addToTrace(e){return this.#e(i.U2,e)}setCurrentRouteName(e){return this.#e(i.PA,e)}interaction(){return this.#e(i.dT)}wrapLogger(e,t,r){return this.#e(i.Wb,e,t,r)}measure(e,t){return this.#e(i.V1,e,t)}}},4261:(e,t,r)=>{"use strict";r.d(t,{$9:()=>d,BL:()=>c,CH:()=>p,Dl:()=>R,Fw:()=>w,PA:()=>v,Pl:()=>n,Tb:()=>f,U2:()=>a,V1:()=>E,Wb:()=>T,bt:()=>y,cD:()=>b,d3:()=>x,dT:()=>u,eY:()=>g,fF:()=>h,hG:()=>o,hw:()=>i,k6:()=>s,nb:()=>m,o5:()=>l});const n="api-",i=n+"ixn-",o="addPageAction",a="addToTrace",s="addRelease",c="finished",u="interaction",d="log",l="noticeError",f="pauseReplay",h="recordCustomEvent",p="recordReplay",g="register",m="setApplicationVersion",v="setCurrentRouteName",b="setCustomAttribute",y="setErrorHandler",w="setPageViewName",R="setUserId",x="start",T="wrapLogger",E="measure"},5205:(e,t,r)=>{"use strict";r.d(t,{j:()=>S});var n=r(384),i=r(1741);var o=r(2555),a=r(3333);const s=e=>{if(!e||"string"!=typeof e)return!1;try{document.createDocumentFragment().querySelector(e)}catch{return!1}return!0};var c=r(2614),u=r(944),d=r(8122);const l="[data-nr-mask]",f=e=>(0,d.a)(e,(()=>{const e={feature_flags:[],experimental:{marks:!1,measures:!1,resources:!1},mask_selector:"*",block_selector:"[data-nr-block]",mask_input_options:{color:!1,date:!1,"datetime-local":!1,email:!1,month:!1,number:!1,range:!1,search:!1,tel:!1,text:!1,time:!1,url:!1,week:!1,textarea:!1,select:!1,password:!0}};return{ajax:{deny_list:void 0,block_internal:!0,enabled:!0,autoStart:!0},api:{allow_registered_children:!0,duplicate_registered_data:!1},distributed_tracing:{enabled:void 0,exclude_newrelic_header:void 0,cors_use_newrelic_header:void 0,cors_use_tracecontext_headers:void 0,allowed_origins:void 0},get feature_flags(){return e.feature_flags},set feature_flags(t){e.feature_flags=t},generic_events:{enabled:!0,autoStart:!0},harvest:{interval:30},jserrors:{enabled:!0,autoStart:!0},logging:{enabled:!0,autoStart:!0},metrics:{enabled:!0,autoStart:!0},obfuscate:void 0,page_action:{enabled:!0},page_view_event:{enabled:!0,autoStart:!0},page_view_timing:{enabled:!0,autoStart:!0},performance:{get capture_marks(){return e.feature_flags.includes(a.$v.MARKS)||e.experimental.marks},set capture_marks(t){e.experimental.marks=t},get capture_measures(){return e.feature_flags.includes(a.$v.MEASURES)||e.experimental.measures},set capture_measures(t){e.experimental.measures=t},capture_detail:!0,resources:{get enabled(){return e.feature_flags.includes(a.$v.RESOURCES)||e.experimental.resources},set enabled(t){e.experimental.resources=t},asset_types:[],first_party_domains:[],ignore_newrelic:!0}},privacy:{cookies_enabled:!0},proxy:{assets:void 0,beacon:void 0},session:{expiresMs:c.wk,inactiveMs:c.BB},session_replay:{autoStart:!0,enabled:!1,preload:!1,sampling_rate:10,error_sampling_rate:100,collect_fonts:!1,inline_images:!1,fix_stylesheets:!0,mask_all_inputs:!0,get mask_text_selector(){return e.mask_selector},set mask_text_selector(t){s(t)?e.mask_selector="".concat(t,",").concat(l):""===t||null===t?e.mask_selector=l:(0,u.R)(5,t)},get block_class(){return"nr-block"},get ignore_class(){return"nr-ignore"},get mask_text_class(){return"nr-mask"},get block_selector(){return e.block_selector},set block_selector(t){s(t)?e.block_selector+=",".concat(t):""!==t&&(0,u.R)(6,t)},get mask_input_options(){return e.mask_input_options},set mask_input_options(t){t&&"object"==typeof t?e.mask_input_options={...t,password:!0}:(0,u.R)(7,t)}},session_trace:{enabled:!0,autoStart:!0},soft_navigations:{enabled:!0,autoStart:!0},spa:{enabled:!0,autoStart:!0},ssl:void 0,user_actions:{enabled:!0,elementAttributes:["id","className","tagName","type"]}}})());var h=r(6154),p=r(9324);let g=0;const m={buildEnv:p.F3,distMethod:p.Xs,version:p.xv,originTime:h.WN},v={appMetadata:{},customTransaction:void 0,denyList:void 0,disabled:!1,entityManager:void 0,harvester:void 0,isolatedBacklog:!1,isRecording:!1,loaderType:void 0,maxBytes:3e4,obfuscator:void 0,onerror:void 0,ptid:void 0,releaseIds:{},session:void 0,timeKeeper:void 0,jsAttributesMetadata:{bytes:0},get harvestCount(){return++g}},b=e=>{const t=(0,d.a)(e,v),r=Object.keys(m).reduce(((e,t)=>(e[t]={value:m[t],writable:!1,configurable:!0,enumerable:!0},e)),{});return Object.defineProperties(t,r)};var y=r(5701);const w=e=>{const t=e.startsWith("http");e+="/",r.p=t?e:"https://"+e};var R=r(7836),x=r(3241);const T={accountID:void 0,trustKey:void 0,agentID:void 0,licenseKey:void 0,applicationID:void 0,xpid:void 0},E=e=>(0,d.a)(e,T),A=new Set;function S(e,t={},r,a){let{init:s,info:c,loader_config:u,runtime:d={},exposed:l=!0}=t;if(!c){const e=(0,n.pV)();s=e.init,c=e.info,u=e.loader_config}e.init=f(s||{}),e.loader_config=E(u||{}),c.jsAttributes??={},h.bv&&(c.jsAttributes.isWorker=!0),e.info=(0,o.D)(c);const p=e.init,g=[c.beacon,c.errorBeacon];A.has(e.agentIdentifier)||(p.proxy.assets&&(w(p.proxy.assets),g.push(p.proxy.assets)),p.proxy.beacon&&g.push(p.proxy.beacon),e.beacons=[...g],function(e){const t=(0,n.pV)();Object.getOwnPropertyNames(i.W.prototype).forEach((r=>{const n=i.W.prototype[r];if("function"!=typeof n||"constructor"===n)return;let o=t[r];e[r]&&!1!==e.exposed&&"micro-agent"!==e.runtime?.loaderType&&(t[r]=(...t)=>{const n=e[r](...t);return o?o(...t):n})}))}(e),(0,n.US)("activatedFeatures",y.B),e.runSoftNavOverSpa&&=!0===p.soft_navigations.enabled&&p.feature_flags.includes("soft_nav")),d.denyList=[...p.ajax.deny_list||[],...p.ajax.block_internal?g:[]],d.ptid=e.agentIdentifier,d.loaderType=r,e.runtime=b(d),A.has(e.agentIdentifier)||(e.ee=R.ee.get(e.agentIdentifier),e.exposed=l,(0,x.W)({agentIdentifier:e.agentIdentifier,drained:!!y.B?.[e.agentIdentifier],type:"lifecycle",name:"initialize",feature:void 0,data:e.config})),A.add(e.agentIdentifier)}},8374:(e,t,r)=>{r.nc=(()=>{try{return document?.currentScript?.nonce}catch(e){}return""})()},860:(e,t,r)=>{"use strict";r.d(t,{$J:()=>d,K7:()=>c,P3:()=>u,XX:()=>i,Yy:()=>s,df:()=>o,qY:()=>n,v4:()=>a});const n="events",i="jserrors",o="browser/blobs",a="rum",s="browser/logs",c={ajax:"ajax",genericEvents:"generic_events",jserrors:i,logging:"logging",metrics:"metrics",pageAction:"page_action",pageViewEvent:"page_view_event",pageViewTiming:"page_view_timing",sessionReplay:"session_replay",sessionTrace:"session_trace",softNav:"soft_navigations",spa:"spa"},u={[c.pageViewEvent]:1,[c.pageViewTiming]:2,[c.metrics]:3,[c.jserrors]:4,[c.spa]:5,[c.ajax]:6,[c.sessionTrace]:7,[c.softNav]:8,[c.sessionReplay]:9,[c.logging]:10,[c.genericEvents]:11},d={[c.pageViewEvent]:a,[c.pageViewTiming]:n,[c.ajax]:n,[c.spa]:n,[c.softNav]:n,[c.metrics]:i,[c.jserrors]:i,[c.sessionTrace]:o,[c.sessionReplay]:o,[c.logging]:s,[c.genericEvents]:"ins"}}},n={};function i(e){var t=n[e];if(void 0!==t)return t.exports;var o=n[e]={exports:{}};return r[e](o,o.exports,i),o.exports}i.m=r,i.d=(e,t)=>{for(var r in t)i.o(t,r)&&!i.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},i.f={},i.e=e=>Promise.all(Object.keys(i.f).reduce(((t,r)=>(i.f[r](e,t),t)),[])),i.u=e=>({212:"nr-spa-compressor",249:"nr-spa-recorder",478:"nr-spa"}[e]+"-1.299.0.min.js"),i.o=(e,t)=>Object.prototype.hasOwnProperty.call(e,t),e={},t="NRBA-1.299.0.PROD:",i.l=(r,n,o,a)=>{if(e[r])e[r].push(n);else{var s,c;if(void 0!==o)for(var u=document.getElementsByTagName("script"),d=0;d<u.length;d++){var l=u[d];if(l.getAttribute("src")==r||l.getAttribute("data-webpack")==t+o){s=l;break}}if(!s){c=!0;var f={478:"sha512-yFJXofnEnG8GVm9Qz5bow499gEH4SUOHqCjdkgsEOCxDOsZoo6GAo0XOXkpDWCr8r/qh/17K3wtEjY+UStuwyw==",249:"sha512-3rG4bEt0s/aK1DXD9BmVuktPkzvPXiB21q2yBNlhxwh6FzcavxvecMtedf3aoJl9CNoyGK6ELRA9yaR0cXbgrQ==",212:"sha512-vjMr4Qq4Ot5S5x5z8QHtNerncpBJSI4ZG0LtBk34EJW4Qtauz9/kg4PFIxMbgq9NSWQyPfCLMnjuTBIHagA1aQ=="};(s=document.createElement("script")).charset="utf-8",s.timeout=120,i.nc&&s.setAttribute("nonce",i.nc),s.setAttribute("data-webpack",t+o),s.src=r,0!==s.src.indexOf(window.location.origin+"/")&&(s.crossOrigin="anonymous"),f[a]&&(s.integrity=f[a])}e[r]=[n];var h=(t,n)=>{s.onerror=s.onload=null,clearTimeout(p);var i=e[r];if(delete e[r],s.parentNode&&s.parentNode.removeChild(s),i&&i.forEach((e=>e(n))),t)return t(n)},p=setTimeout(h.bind(null,void 0,{type:"timeout",target:s}),12e4);s.onerror=h.bind(null,s.onerror),s.onload=h.bind(null,s.onload),c&&document.head.appendChild(s)}},i.r=e=>{"undefined"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},i.p="https://js-agent.newrelic.com/",(()=>{var e={38:0,788:0};i.f.j=(t,r)=>{var n=i.o(e,t)?e[t]:void 0;if(0!==n)if(n)r.push(n[2]);else{var o=new Promise(((r,i)=>n=e[t]=[r,i]));r.push(n[2]=o);var a=i.p+i.u(t),s=new Error;i.l(a,(r=>{if(i.o(e,t)&&(0!==(n=e[t])&&(e[t]=void 0),n)){var o=r&&("load"===r.type?"missing":r.type),a=r&&r.target&&r.target.src;s.message="Loading chunk "+t+" failed.\n("+o+": "+a+")",s.name="ChunkLoadError",s.type=o,s.request=a,n[1](s)}}),"chunk-"+t,t)}};var t=(t,r)=>{var n,o,[a,s,c]=r,u=0;if(a.some((t=>0!==e[t]))){for(n in s)i.o(s,n)&&(i.m[n]=s[n]);if(c)c(i)}for(t&&t(r);u<a.length;u++)o=a[u],i.o(e,o)&&e[o]&&e[o][0](),e[o]=0},r=self["webpackChunk:NRBA-1.299.0.PROD"]=self["webpackChunk:NRBA-1.299.0.PROD"]||[];r.forEach(t.bind(null,0)),r.push=t.bind(null,r.push.bind(r))})(),(()=>{"use strict";i(8374);var e=i(9566),t=i(1741);class r extends t.W{agentIdentifier=(0,e.LA)(16)}var n=i(860);const o=Object.values(n.K7);var a=i(5205);var s=i(9908),c=i(1863),u=i(4261),d=i(3241),l=i(944),f=i(5701),h=i(8154);function p(e,t,i,o){const a=o||i;!a||a[e]&&a[e]!==r.prototype[e]||(a[e]=function(){(0,s.p)(h.xV,["API/"+e+"/called"],void 0,n.K7.metrics,i.ee),(0,d.W)({agentIdentifier:i.agentIdentifier,drained:!!f.B?.[i.agentIdentifier],type:"data",name:"api",feature:u.Pl+e,data:{}});try{return t.apply(this,arguments)}catch(e){(0,l.R)(23,e)}})}function g(e,t,r,n,i){const o=e.info;null===r?delete o.jsAttributes[t]:o.jsAttributes[t]=r,(i||null===r)&&(0,s.p)(u.Pl+n,[(0,c.t)(),t,r],void 0,"session",e.ee)}var m=i(1687),v=i(4234),b=i(5289),y=i(6154),w=i(5270),R=i(7767),x=i(6389),T=i(7699);class E extends v.W{constructor(e,t){super(e.agentIdentifier,t),this.agentRef=e,this.abortHandler=void 0,this.featAggregate=void 0,this.onAggregateImported=void 0,this.deferred=Promise.resolve(),!1===e.init[this.featureName].autoStart?this.deferred=new Promise(((t,r)=>{this.ee.on("manual-start-all",(0,x.J)((()=>{(0,m.Ak)(e.agentIdentifier,this.featureName),t()})))})):(0,m.Ak)(e.agentIdentifier,t)}importAggregator(e,t,r={}){if(this.featAggregate)return;let n;this.onAggregateImported=new Promise((e=>{n=e}));const o=async()=>{let o;await this.deferred;try{if((0,R.V)(e.init)){const{setupAgentSession:t}=await i.e(478).then(i.bind(i,8766));o=t(e)}}catch(e){(0,l.R)(20,e),this.ee.emit("internal-error",[e]),(0,s.p)(T.qh,[e],void 0,this.featureName,this.ee)}try{if(!this.#t(this.featureName,o,e.init))return(0,m.Ze)(this.agentIdentifier,this.featureName),void n(!1);const{Aggregate:i}=await t();this.featAggregate=new i(e,r),e.runtime.harvester.initializedAggregates.push(this.featAggregate),n(!0)}catch(e){(0,l.R)(34,e),this.abortHandler?.(),(0,m.Ze)(this.agentIdentifier,this.featureName,!0),n(!1),this.ee&&this.ee.abort()}};y.RI?(0,b.GG)((()=>o()),!0):o()}#t(e,t,r){if(this.blocked)return!1;switch(e){case n.K7.sessionReplay:return(0,w.SR)(r)&&!!t;case n.K7.sessionTrace:return!!t;default:return!0}}}var A=i(6630),S=i(2614);class O extends E{static featureName=A.T;constructor(e){var t;super(e,A.T),this.setupInspectionEvents(e.agentIdentifier),t=e,p(u.Fw,(function(e,r){"string"==typeof e&&("/"!==e.charAt(0)&&(e="/"+e),t.runtime.customTransaction=(r||"http://custom.transaction")+e,(0,s.p)(u.Pl+u.Fw,[(0,c.t)()],void 0,void 0,t.ee))}),t),this.ee.on("api-send-rum",((e,t)=>(0,s.p)("send-rum",[e,t],void 0,this.featureName,this.ee))),this.importAggregator(e,(()=>i.e(478).then(i.bind(i,1983))))}setupInspectionEvents(e){const t=(t,r)=>{t&&(0,d.W)({agentIdentifier:e,timeStamp:t.timeStamp,loaded:"complete"===t.target.readyState,type:"window",name:r,data:t.target.location+""})};(0,b.sB)((e=>{t(e,"DOMContentLoaded")})),(0,b.GG)((e=>{t(e,"load")})),(0,b.Qr)((e=>{t(e,"navigate")})),this.ee.on(S.tS.UPDATE,((t,r)=>{(0,d.W)({agentIdentifier:e,type:"lifecycle",name:"session",data:r})}))}}var _=i(384);var N=i(2843),I=i(3878),P=i(782);class j extends E{static featureName=P.T;constructor(e){super(e,P.T),y.RI&&((0,N.u)((()=>(0,s.p)("docHidden",[(0,c.t)()],void 0,P.T,this.ee)),!0),(0,I.sp)("pagehide",(()=>(0,s.p)("winPagehide",[(0,c.t)()],void 0,P.T,this.ee))),this.importAggregator(e,(()=>i.e(478).then(i.bind(i,9917)))))}}class k extends E{static featureName=h.TZ;constructor(e){super(e,h.TZ),y.RI&&document.addEventListener("securitypolicyviolation",(e=>{(0,s.p)(h.xV,["Generic/CSPViolation/Detected"],void 0,this.featureName,this.ee)})),this.importAggregator(e,(()=>i.e(478).then(i.bind(i,6555))))}}var C=i(6774),L=i(3304);class M{constructor(e,t,r,n,i){this.name="UncaughtError",this.message="string"==typeof e?e:(0,L.A)(e),this.sourceURL=t,this.line=r,this.column=n,this.__newrelic=i}}function H(e){return U(e)?e:new M(void 0!==e?.message?e.message:e,e?.filename||e?.sourceURL,e?.lineno||e?.line,e?.colno||e?.col,e?.__newrelic,e?.cause)}function D(e){const t="Unhandled Promise Rejection: ";if(!e?.reason)return;if(U(e.reason)){try{e.reason.message.startsWith(t)||(e.reason.message=t+e.reason.message)}catch(e){}return H(e.reason)}const r=H(e.reason);return(r.message||"").startsWith(t)||(r.message=t+r.message),r}function K(e){if(e.error instanceof SyntaxError&&!/:\d+$/.test(e.error.stack?.trim())){const t=new M(e.message,e.filename,e.lineno,e.colno,e.error.__newrelic,e.cause);return t.name=SyntaxError.name,t}return U(e.error)?e.error:H(e)}function U(e){return e instanceof Error&&!!e.stack}function F(e,t,r,i,o=(0,c.t)()){"string"==typeof e&&(e=new Error(e)),(0,s.p)("err",[e,o,!1,t,r.runtime.isRecording,void 0,i],void 0,n.K7.jserrors,r.ee),(0,s.p)("uaErr",[],void 0,n.K7.genericEvents,r.ee)}var W=i(3496),B=i(993),G=i(3785);function V(e,{customAttributes:t={},level:r=B.p_.INFO}={},n,i,o=(0,c.t)()){(0,G.R)(n.ee,e,t,r,i,o)}function z(e,t,r,i,o=(0,c.t)()){(0,s.p)(u.Pl+u.hG,[o,e,t,i],void 0,n.K7.genericEvents,r.ee)}function Z(e){p(u.eY,(function(t){return function(e,t){const r={};let i,o;(0,l.R)(54,"newrelic.register"),e.init.api.allow_registered_children||(i=()=>(0,l.R)(55));t&&(0,W.I)(t)||(i=()=>(0,l.R)(48,t));const a={addPageAction:(n,i={})=>{u(z,[n,{...r,...i},e],t)},log:(n,i={})=>{u(V,[n,{...i,customAttributes:{...r,...i.customAttributes||{}}},e],t)},noticeError:(n,i={})=>{u(F,[n,{...r,...i},e],t)},setApplicationVersion:e=>{r["application.version"]=e},setCustomAttribute:(e,t)=>{r[e]=t},setUserId:e=>{r["enduser.id"]=e},metadata:{customAttributes:r,target:t,get connected(){return o||Promise.reject(new Error("Failed to connect"))}}};i?i():o=new Promise(((n,i)=>{try{const o=e.runtime?.entityManager;let s=!!o?.get().entityGuid,c=o?.getEntityGuidFor(t.licenseKey,t.applicationID),u=!!c;if(s&&u)t.entityGuid=c,n(a);else{const d=setTimeout((()=>i(new Error("Failed to connect - Timeout"))),15e3);function l(r){(0,W.A)(r,e)?s||=!0:t.licenseKey===r.licenseKey&&t.applicationID===r.applicationID&&(u=!0,t.entityGuid=r.entityGuid),s&&u&&(clearTimeout(d),e.ee.removeEventListener("entity-added",l),n(a))}e.ee.emit("api-send-rum",[r,t]),e.ee.on("entity-added",l)}}catch(f){i(f)}}));const u=async(t,r,a)=>{if(i)return i();const u=(0,c.t)();(0,s.p)(h.xV,["API/register/".concat(t.name,"/called")],void 0,n.K7.metrics,e.ee);try{await o;const n=e.init.api.duplicate_registered_data;(!0===n||Array.isArray(n)&&n.includes(a.entityGuid))&&t(...r,void 0,u),t(...r,a.entityGuid,u)}catch(e){(0,l.R)(50,e)}};return a}(e,t)}),e)}class q extends E{static featureName=C.T;constructor(e){var t;super(e,C.T),t=e,p(u.o5,((e,r)=>F(e,r,t)),t),function(e){p(u.bt,(function(t){e.runtime.onerror=t}),e)}(e),function(e){let t=0;p(u.k6,(function(e,r){++t>10||(this.runtime.releaseIds[e.slice(-200)]=(""+r).slice(-200))}),e)}(e),Z(e);try{this.removeOnAbort=new AbortController}catch(e){}this.ee.on("internal-error",((t,r)=>{this.abortHandler&&(0,s.p)("ierr",[H(t),(0,c.t)(),!0,{},e.runtime.isRecording,r],void 0,this.featureName,this.ee)})),y.gm.addEventListener("unhandledrejection",(t=>{this.abortHandler&&(0,s.p)("err",[D(t),(0,c.t)(),!1,{unhandledPromiseRejection:1},e.runtime.isRecording],void 0,this.featureName,this.ee)}),(0,I.jT)(!1,this.removeOnAbort?.signal)),y.gm.addEventListener("error",(t=>{this.abortHandler&&(0,s.p)("err",[K(t),(0,c.t)(),!1,{},e.runtime.isRecording],void 0,this.featureName,this.ee)}),(0,I.jT)(!1,this.removeOnAbort?.signal)),this.abortHandler=this.#r,this.importAggregator(e,(()=>i.e(478).then(i.bind(i,2176))))}#r(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}var X=i(8990);let Y=1;function Q(e){const t=typeof e;return!e||"object"!==t&&"function"!==t?-1:e===y.gm?0:(0,X.I)(e,"nr@id",(function(){return Y++}))}function J(e){if("string"==typeof e&&e.length)return e.length;if("object"==typeof e){if("undefined"!=typeof ArrayBuffer&&e instanceof ArrayBuffer&&e.byteLength)return e.byteLength;if("undefined"!=typeof Blob&&e instanceof Blob&&e.size)return e.size;if(!("undefined"!=typeof FormData&&e instanceof FormData))try{return(0,L.A)(e).length}catch(e){return}}}var ee=i(8139),te=i(7836),re=i(3434);const ne={},ie=["open","send"];function oe(e){var t=e||te.ee;const r=function(e){return(e||te.ee).get("xhr")}(t);if(void 0===y.gm.XMLHttpRequest)return r;if(ne[r.debugId]++)return r;ne[r.debugId]=1,(0,ee.u)(t);var n=(0,re.YM)(r),i=y.gm.XMLHttpRequest,o=y.gm.MutationObserver,a=y.gm.Promise,s=y.gm.setInterval,c="readystatechange",u=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],d=[],f=y.gm.XMLHttpRequest=function(e){const t=new i(e),o=r.context(t);try{r.emit("new-xhr",[t],o),t.addEventListener(c,(a=o,function(){var e=this;e.readyState>3&&!a.resolved&&(a.resolved=!0,r.emit("xhr-resolved",[],e)),n.inPlace(e,u,"fn-",b)}),(0,I.jT)(!1))}catch(e){(0,l.R)(15,e);try{r.emit("internal-error",[e])}catch(e){}}var a;return t};function h(e,t){n.inPlace(t,["onreadystatechange"],"fn-",b)}if(function(e,t){for(var r in e)t[r]=e[r]}(i,f),f.prototype=i.prototype,n.inPlace(f.prototype,ie,"-xhr-",b),r.on("send-xhr-start",(function(e,t){h(e,t),function(e){d.push(e),o&&(p?p.then(v):s?s(v):(g=-g,m.data=g))}(t)})),r.on("open-xhr-start",h),o){var p=a&&a.resolve();if(!s&&!a){var g=1,m=document.createTextNode(g);new o(v).observe(m,{characterData:!0})}}else t.on("fn-end",(function(e){e[0]&&e[0].type===c||v()}));function v(){for(var e=0;e<d.length;e++)h(0,d[e]);d.length&&(d=[])}function b(e,t){return t}return r}var ae="fetch-",se=ae+"body-",ce=["arrayBuffer","blob","json","text","formData"],ue=y.gm.Request,de=y.gm.Response,le="prototype";const fe={};function he(e){const t=function(e){return(e||te.ee).get("fetch")}(e);if(!(ue&&de&&y.gm.fetch))return t;if(fe[t.debugId]++)return t;function r(e,r,n){var i=e[r];"function"==typeof i&&(e[r]=function(){var e,r=[...arguments],o={};t.emit(n+"before-start",[r],o),o[te.P]&&o[te.P].dt&&(e=o[te.P].dt);var a=i.apply(this,r);return t.emit(n+"start",[r,e],a),a.then((function(e){return t.emit(n+"end",[null,e],a),e}),(function(e){throw t.emit(n+"end",[e],a),e}))})}return fe[t.debugId]=1,ce.forEach((e=>{r(ue[le],e,se),r(de[le],e,se)})),r(y.gm,"fetch",ae),t.on(ae+"end",(function(e,r){var n=this;if(r){var i=r.headers.get("content-length");null!==i&&(n.rxSize=i),t.emit(ae+"done",[null,r],n)}else t.emit(ae+"done",[e],n)})),t}var pe=i(7485);class ge{constructor(e){this.agentRef=e}generateTracePayload(t){const r=this.agentRef.loader_config;if(!this.shouldGenerateTrace(t)||!r)return null;var n=(r.accountID||"").toString()||null,i=(r.agentID||"").toString()||null,o=(r.trustKey||"").toString()||null;if(!n||!i)return null;var a=(0,e.ZF)(),s=(0,e.el)(),c=Date.now(),u={spanId:a,traceId:s,timestamp:c};return(t.sameOrigin||this.isAllowedOrigin(t)&&this.useTraceContextHeadersForCors())&&(u.traceContextParentHeader=this.generateTraceContextParentHeader(a,s),u.traceContextStateHeader=this.generateTraceContextStateHeader(a,c,n,i,o)),(t.sameOrigin&&!this.excludeNewrelicHeader()||!t.sameOrigin&&this.isAllowedOrigin(t)&&this.useNewrelicHeaderForCors())&&(u.newrelicHeader=this.generateTraceHeader(a,s,c,n,i,o)),u}generateTraceContextParentHeader(e,t){return"00-"+t+"-"+e+"-01"}generateTraceContextStateHeader(e,t,r,n,i){return i+"@nr=0-1-"+r+"-"+n+"-"+e+"----"+t}generateTraceHeader(e,t,r,n,i,o){if(!("function"==typeof y.gm?.btoa))return null;var a={v:[0,1],d:{ty:"Browser",ac:n,ap:i,id:e,tr:t,ti:r}};return o&&n!==o&&(a.d.tk=o),btoa((0,L.A)(a))}shouldGenerateTrace(e){return this.agentRef.init?.distributed_tracing?.enabled&&this.isAllowedOrigin(e)}isAllowedOrigin(e){var t=!1;const r=this.agentRef.init?.distributed_tracing;if(e.sameOrigin)t=!0;else if(r?.allowed_origins instanceof Array)for(var n=0;n<r.allowed_origins.length;n++){var i=(0,pe.D)(r.allowed_origins[n]);if(e.hostname===i.hostname&&e.protocol===i.protocol&&e.port===i.port){t=!0;break}}return t}excludeNewrelicHeader(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!!e.exclude_newrelic_header}useNewrelicHeaderForCors(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!1!==e.cors_use_newrelic_header}useTraceContextHeadersForCors(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!!e.cors_use_tracecontext_headers}}var me=i(9300),ve=i(7295);function be(e){return"string"==typeof e?e:e instanceof(0,_.dV)().o.REQ?e.url:y.gm?.URL&&e instanceof URL?e.href:void 0}var ye=["load","error","abort","timeout"],we=ye.length,Re=(0,_.dV)().o.REQ,xe=(0,_.dV)().o.XHR;const Te="X-NewRelic-App-Data";class Ee extends E{static featureName=me.T;constructor(e){super(e,me.T),this.dt=new ge(e),this.handler=(e,t,r,n)=>(0,s.p)(e,t,r,n,this.ee);try{const e={xmlhttprequest:"xhr",fetch:"fetch",beacon:"beacon"};y.gm?.performance?.getEntriesByType("resource").forEach((t=>{if(t.initiatorType in e&&0!==t.responseStatus){const r={status:t.responseStatus},i={rxSize:t.transferSize,duration:Math.floor(t.duration),cbTime:0};Ae(r,t.name),this.handler("xhr",[r,i,t.startTime,t.responseEnd,e[t.initiatorType]],void 0,n.K7.ajax)}}))}catch(e){}he(this.ee),oe(this.ee),function(e,t,r,i){function o(e){var t=this;t.totalCbs=0,t.called=0,t.cbTime=0,t.end=E,t.ended=!1,t.xhrGuids={},t.lastSize=null,t.loadCaptureCalled=!1,t.params=this.params||{},t.metrics=this.metrics||{},t.latestLongtaskEnd=0,e.addEventListener("load",(function(r){A(t,e)}),(0,I.jT)(!1)),y.lR||e.addEventListener("progress",(function(e){t.lastSize=e.loaded}),(0,I.jT)(!1))}function a(e){this.params={method:e[0]},Ae(this,e[1]),this.metrics={}}function u(t,r){e.loader_config.xpid&&this.sameOrigin&&r.setRequestHeader("X-NewRelic-ID",e.loader_config.xpid);var n=i.generateTracePayload(this.parsedOrigin);if(n){var o=!1;n.newrelicHeader&&(r.setRequestHeader("newrelic",n.newrelicHeader),o=!0),n.traceContextParentHeader&&(r.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&r.setRequestHeader("tracestate",n.traceContextStateHeader),o=!0),o&&(this.dt=n)}}function d(e,r){var n=this.metrics,i=e[0],o=this;if(n&&i){var a=J(i);a&&(n.txSize=a)}this.startTime=(0,c.t)(),this.body=i,this.listener=function(e){try{"abort"!==e.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==e.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof r.onload)&&"function"==typeof o.end)&&o.end(r)}catch(e){try{t.emit("internal-error",[e])}catch(e){}}};for(var s=0;s<we;s++)r.addEventListener(ye[s],this.listener,(0,I.jT)(!1))}function l(e,t,r){this.cbTime+=e,t?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof r.onload||"function"!=typeof this.end||this.end(r)}function f(e,t){var r=""+Q(e)+!!t;this.xhrGuids&&!this.xhrGuids[r]&&(this.xhrGuids[r]=!0,this.totalCbs+=1)}function p(e,t){var r=""+Q(e)+!!t;this.xhrGuids&&this.xhrGuids[r]&&(delete this.xhrGuids[r],this.totalCbs-=1)}function g(){this.endTime=(0,c.t)()}function m(e,r){r instanceof xe&&"load"===e[0]&&t.emit("xhr-load-added",[e[1],e[2]],r)}function v(e,r){r instanceof xe&&"load"===e[0]&&t.emit("xhr-load-removed",[e[1],e[2]],r)}function b(e,t,r){t instanceof xe&&("onload"===r&&(this.onload=!0),("load"===(e[0]&&e[0].type)||this.onload)&&(this.xhrCbStart=(0,c.t)()))}function w(e,r){this.xhrCbStart&&t.emit("xhr-cb-time",[(0,c.t)()-this.xhrCbStart,this.onload,r],r)}function R(e){var t,r=e[1]||{};if("string"==typeof e[0]?0===(t=e[0]).length&&y.RI&&(t=""+y.gm.location.href):e[0]&&e[0].url?t=e[0].url:y.gm?.URL&&e[0]&&e[0]instanceof URL?t=e[0].href:"function"==typeof e[0].toString&&(t=e[0].toString()),"string"==typeof t&&0!==t.length){t&&(this.parsedOrigin=(0,pe.D)(t),this.sameOrigin=this.parsedOrigin.sameOrigin);var n=i.generateTracePayload(this.parsedOrigin);if(n&&(n.newrelicHeader||n.traceContextParentHeader))if(e[0]&&e[0].headers)s(e[0].headers,n)&&(this.dt=n);else{var o={};for(var a in r)o[a]=r[a];o.headers=new Headers(r.headers||{}),s(o.headers,n)&&(this.dt=n),e.length>1?e[1]=o:e.push(o)}}function s(e,t){var r=!1;return t.newrelicHeader&&(e.set("newrelic",t.newrelicHeader),r=!0),t.traceContextParentHeader&&(e.set("traceparent",t.traceContextParentHeader),t.traceContextStateHeader&&e.set("tracestate",t.traceContextStateHeader),r=!0),r}}function x(e,t){this.params={},this.metrics={},this.startTime=(0,c.t)(),this.dt=t,e.length>=1&&(this.target=e[0]),e.length>=2&&(this.opts=e[1]);var r=this.opts||{},n=this.target;Ae(this,be(n));var i=(""+(n&&n instanceof Re&&n.method||r.method||"GET")).toUpperCase();this.params.method=i,this.body=r.body,this.txSize=J(r.body)||0}function T(e,t){if(this.endTime=(0,c.t)(),this.params||(this.params={}),(0,ve.iW)(this.params))return;let i;this.params.status=t?t.status:0,"string"==typeof this.rxSize&&this.rxSize.length>0&&(i=+this.rxSize);const o={txSize:this.txSize,rxSize:i,duration:(0,c.t)()-this.startTime};r("xhr",[this.params,o,this.startTime,this.endTime,"fetch"],this,n.K7.ajax)}function E(e){const t=this.params,i=this.metrics;if(!this.ended){this.ended=!0;for(let t=0;t<we;t++)e.removeEventListener(ye[t],this.listener,!1);t.aborted||(0,ve.iW)(t)||(i.duration=(0,c.t)()-this.startTime,this.loadCaptureCalled||4!==e.readyState?null==t.status&&(t.status=0):A(this,e),i.cbTime=this.cbTime,r("xhr",[t,i,this.startTime,this.endTime,"xhr"],this,n.K7.ajax))}}function A(e,r){e.params.status=r.status;var i=function(e,t){var r=e.responseType;return"json"===r&&null!==t?t:"arraybuffer"===r||"blob"===r||"json"===r?J(e.response):"text"===r||""===r||void 0===r?J(e.responseText):void 0}(r,e.lastSize);if(i&&(e.metrics.rxSize=i),e.sameOrigin&&r.getAllResponseHeaders().indexOf(Te)>=0){var o=r.getResponseHeader(Te);o&&((0,s.p)(h.rs,["Ajax/CrossApplicationTracing/Header/Seen"],void 0,n.K7.metrics,t),e.params.cat=o.split(", ").pop())}e.loadCaptureCalled=!0}t.on("new-xhr",o),t.on("open-xhr-start",a),t.on("open-xhr-end",u),t.on("send-xhr-start",d),t.on("xhr-cb-time",l),t.on("xhr-load-added",f),t.on("xhr-load-removed",p),t.on("xhr-resolved",g),t.on("addEventListener-end",m),t.on("removeEventListener-end",v),t.on("fn-end",w),t.on("fetch-before-start",R),t.on("fetch-start",x),t.on("fn-start",b),t.on("fetch-done",T)}(e,this.ee,this.handler,this.dt),this.importAggregator(e,(()=>i.e(478).then(i.bind(i,3845))))}}function Ae(e,t){var r=(0,pe.D)(t),n=e.params||e;n.hostname=r.hostname,n.port=r.port,n.protocol=r.protocol,n.host=r.hostname+":"+r.port,n.pathname=r.pathname,e.parsedOrigin=r,e.sameOrigin=r.sameOrigin}const Se={},Oe=["pushState","replaceState"];function _e(e){const t=function(e){return(e||te.ee).get("history")}(e);return!y.RI||Se[t.debugId]++||(Se[t.debugId]=1,(0,re.YM)(t).inPlace(window.history,Oe,"-")),t}var Ne=i(3738);function Ie(e){p(u.BL,(function(t=Date.now()){const r=t-y.WN;r<0&&(0,l.R)(62,t),(0,s.p)(h.XG,[u.BL,{time:r}],void 0,n.K7.metrics,e.ee),e.addToTrace({name:u.BL,start:t,origin:"nr"}),(0,s.p)(u.Pl+u.hG,[r,u.BL],void 0,n.K7.genericEvents,e.ee)}),e)}const{He:Pe,bD:je,d3:ke,Kp:Ce,TZ:Le,Lc:Me,uP:He,Rz:De}=Ne;class Ke extends E{static featureName=Le;constructor(e){var t;super(e,Le),t=e,p(u.U2,(function(e){if(!(e&&"object"==typeof e&&e.name&&e.start))return;const r={n:e.name,s:e.start-y.WN,e:(e.end||e.start)-y.WN,o:e.origin||"",t:"api"};r.s<0||r.e<0||r.e<r.s?(0,l.R)(61,{start:r.s,end:r.e}):(0,s.p)("bstApi",[r],void 0,n.K7.sessionTrace,t.ee)}),t),Ie(e);if(!(0,R.V)(e.init))return void this.deregisterDrain();const r=this.ee;let o;_e(r),this.eventsEE=(0,ee.u)(r),this.eventsEE.on(He,(function(e,t){this.bstStart=(0,c.t)()})),this.eventsEE.on(Me,(function(e,t){(0,s.p)("bst",[e[0],t,this.bstStart,(0,c.t)()],void 0,n.K7.sessionTrace,r)})),r.on(De+ke,(function(e){this.time=(0,c.t)(),this.startPath=location.pathname+location.hash})),r.on(De+Ce,(function(e){(0,s.p)("bstHist",[location.pathname+location.hash,this.startPath,this.time],void 0,n.K7.sessionTrace,r)}));try{o=new PerformanceObserver((e=>{const t=e.getEntries();(0,s.p)(Pe,[t],void 0,n.K7.sessionTrace,r)})),o.observe({type:je,buffered:!0})}catch(e){}this.importAggregator(e,(()=>i.e(478).then(i.bind(i,6974))),{resourceObserver:o})}}var Ue=i(6344);class Fe extends E{static featureName=Ue.TZ;#n;recorder;constructor(e){var t;let r;super(e,Ue.TZ),t=e,p(u.CH,(function(){(0,s.p)(u.CH,[],void 0,n.K7.sessionReplay,t.ee)}),t),function(e){p(u.Tb,(function(){(0,s.p)(u.Tb,[],void 0,n.K7.sessionReplay,e.ee)}),e)}(e);try{r=JSON.parse(localStorage.getItem("".concat(S.H3,"_").concat(S.uh)))}catch(e){}(0,w.SR)(e.init)&&this.ee.on(Ue.G4.RECORD,(()=>this.#i())),this.#o(r)&&this.importRecorder().then((e=>{e.startRecording(Ue.Qb.PRELOAD,r?.sessionReplayMode)})),this.importAggregator(this.agentRef,(()=>i.e(478).then(i.bind(i,6167))),this),this.ee.on("err",(e=>{this.blocked||this.agentRef.runtime.isRecording&&(this.errorNoticed=!0,(0,s.p)(Ue.G4.ERROR_DURING_REPLAY,[e],void 0,this.featureName,this.ee))}))}#o(e){return e&&(e.sessionReplayMode===S.g.FULL||e.sessionReplayMode===S.g.ERROR)||(0,w.Aw)(this.agentRef.init)}importRecorder(){return this.recorder?Promise.resolve(this.recorder):(this.#n??=Promise.all([i.e(478),i.e(249)]).then(i.bind(i,8589)).then((({Recorder:e})=>(this.recorder=new e(this),this.recorder))).catch((e=>{throw this.ee.emit("internal-error",[e]),this.blocked=!0,e})),this.#n)}#i(){this.blocked||(this.featAggregate?this.featAggregate.mode!==S.g.FULL&&this.featAggregate.initializeRecording(S.g.FULL,!0,Ue.Qb.API):this.importRecorder().then((()=>{this.recorder.startRecording(Ue.Qb.API,S.g.FULL)})))}}var We=i(3962);function Be(e){const t=e.ee.get("tracer");function r(){}p(u.dT,(function(e){return(new r).get("object"==typeof e?e:{})}),e);const i=r.prototype={createTracer:function(r,i){var o={},a=this,d="function"==typeof i;return(0,s.p)(h.xV,["API/createTracer/called"],void 0,n.K7.metrics,e.ee),e.runSoftNavOverSpa||(0,s.p)(u.hw+"tracer",[(0,c.t)(),r,o],a,n.K7.spa,e.ee),function(){if(t.emit((d?"":"no-")+"fn-start",[(0,c.t)(),a,d],o),d)try{return i.apply(this,arguments)}catch(e){const r="string"==typeof e?new Error(e):e;throw t.emit("fn-err",[arguments,this,r],o),r}finally{t.emit("fn-end",[(0,c.t)()],o)}}}};["actionText","setName","setAttribute","save","ignore","onEnd","getContext","end","get"].forEach((t=>{p.apply(this,[t,function(){return(0,s.p)(u.hw+t,[(0,c.t)(),...arguments],this,e.runSoftNavOverSpa?n.K7.softNav:n.K7.spa,e.ee),this},e,i])})),p(u.PA,(function(){e.runSoftNavOverSpa?(0,s.p)(u.hw+"routeName",[performance.now(),...arguments],void 0,n.K7.softNav,e.ee):(0,s.p)(u.Pl+"routeName",[(0,c.t)(),...arguments],this,n.K7.spa,e.ee)}),e)}class Ge extends E{static featureName=We.TZ;constructor(e){if(super(e,We.TZ),Be(e),!y.RI||!(0,_.dV)().o.MO)return;const t=_e(this.ee);try{this.removeOnAbort=new AbortController}catch(e){}We.tC.forEach((e=>{(0,I.sp)(e,(e=>{a(e)}),!0,this.removeOnAbort?.signal)}));const r=()=>(0,s.p)("newURL",[(0,c.t)(),""+window.location],void 0,this.featureName,this.ee);t.on("pushState-end",r),t.on("replaceState-end",r),(0,I.sp)(We.OV,(e=>{a(e),(0,s.p)("newURL",[e.timeStamp,""+window.location],void 0,this.featureName,this.ee)}),!0,this.removeOnAbort?.signal);let n=!1;const o=new((0,_.dV)().o.MO)(((e,t)=>{n||(n=!0,requestAnimationFrame((()=>{(0,s.p)("newDom",[(0,c.t)()],void 0,this.featureName,this.ee),n=!1})))})),a=(0,x.s)((e=>{(0,s.p)("newUIEvent",[e],void 0,this.featureName,this.ee),o.observe(document.body,{attributes:!0,childList:!0,subtree:!0,characterData:!0})}),100,{leading:!0});this.abortHandler=function(){this.removeOnAbort?.abort(),o.disconnect(),this.abortHandler=void 0},this.importAggregator(e,(()=>i.e(478).then(i.bind(i,4393))),{domObserver:o})}}var Ve=i(7378);const ze={},Ze=["appendChild","insertBefore","replaceChild"];function qe(e){const t=function(e){return(e||te.ee).get("jsonp")}(e);if(!y.RI||ze[t.debugId])return t;ze[t.debugId]=!0;var r=(0,re.YM)(t),n=/[?&](?:callback|cb)=([^&#]+)/,i=/(.*)\.([^.]+)/,o=/^(\w+)(\.|$)(.*)$/;function a(e,t){if(!e)return t;const r=e.match(o),n=r[1];return a(r[3],t[n])}return r.inPlace(Node.prototype,Ze,"dom-"),t.on("dom-start",(function(e){!function(e){if(!e||"string"!=typeof e.nodeName||"script"!==e.nodeName.toLowerCase())return;if("function"!=typeof e.addEventListener)return;var o=(s=e.src,c=s.match(n),c?c[1]:null);var s,c;if(!o)return;var u=function(e){var t=e.match(i);if(t&&t.length>=3)return{key:t[2],parent:a(t[1],window)};return{key:e,parent:window}}(o);if("function"!=typeof u.parent[u.key])return;var d={};function l(){t.emit("jsonp-end",[],d),e.removeEventListener("load",l,(0,I.jT)(!1)),e.removeEventListener("error",f,(0,I.jT)(!1))}function f(){t.emit("jsonp-error",[],d),t.emit("jsonp-end",[],d),e.removeEventListener("load",l,(0,I.jT)(!1)),e.removeEventListener("error",f,(0,I.jT)(!1))}r.inPlace(u.parent,[u.key],"cb-",d),e.addEventListener("load",l,(0,I.jT)(!1)),e.addEventListener("error",f,(0,I.jT)(!1)),t.emit("new-jsonp",[e.src],d)}(e[0])})),t}const Xe={};function Ye(e){const t=function(e){return(e||te.ee).get("promise")}(e);if(Xe[t.debugId])return t;Xe[t.debugId]=!0;var r=t.context,n=(0,re.YM)(t),i=y.gm.Promise;return i&&function(){function e(r){var o=t.context(),a=n(r,"executor-",o,null,!1);const s=Reflect.construct(i,[a],e);return t.context(s).getCtx=function(){return o},s}y.gm.Promise=e,Object.defineProperty(e,"name",{value:"Promise"}),e.toString=function(){return i.toString()},Object.setPrototypeOf(e,i),["all","race"].forEach((function(r){const n=i[r];e[r]=function(e){let i=!1;[...e||[]].forEach((e=>{this.resolve(e).then(a("all"===r),a(!1))}));const o=n.apply(this,arguments);return o;function a(e){return function(){t.emit("propagate",[null,!i],o,!1,!1),i=i||!e}}}})),["resolve","reject"].forEach((function(r){const n=i[r];e[r]=function(e){const r=n.apply(this,arguments);return e!==r&&t.emit("propagate",[e,!0],r,!1,!1),r}})),e.prototype=i.prototype;const o=i.prototype.then;i.prototype.then=function(...e){var i=this,a=r(i);a.promise=i,e[0]=n(e[0],"cb-",a,null,!1),e[1]=n(e[1],"cb-",a,null,!1);const s=o.apply(this,e);return a.nextPromise=s,t.emit("propagate",[i,!0],s,!1,!1),s},i.prototype.then[re.Jt]=o,t.on("executor-start",(function(e){e[0]=n(e[0],"resolve-",this,null,!1),e[1]=n(e[1],"resolve-",this,null,!1)})),t.on("executor-err",(function(e,t,r){e[1](r)})),t.on("cb-end",(function(e,r,n){t.emit("propagate",[n,!0],this.nextPromise,!1,!1)})),t.on("propagate",(function(e,r,n){this.getCtx&&!r||(this.getCtx=function(){if(e instanceof Promise)var r=t.context(e);return r&&r.getCtx?r.getCtx():this})}))}(),t}const $e={},Qe="setTimeout",Je="setInterval",et="clearTimeout",tt="-start",rt=[Qe,"setImmediate",Je,et,"clearImmediate"];function nt(e){const t=function(e){return(e||te.ee).get("timer")}(e);if($e[t.debugId]++)return t;$e[t.debugId]=1;var r=(0,re.YM)(t);return r.inPlace(y.gm,rt.slice(0,2),Qe+"-"),r.inPlace(y.gm,rt.slice(2,3),Je+"-"),r.inPlace(y.gm,rt.slice(3),et+"-"),t.on(Je+tt,(function(e,t,n){e[0]=r(e[0],"fn-",null,n)})),t.on(Qe+tt,(function(e,t,n){this.method=n,this.timerDuration=isNaN(e[1])?0:+e[1],e[0]=r(e[0],"fn-",this,n)})),t}const it={};function ot(e){const t=function(e){return(e||te.ee).get("mutation")}(e);if(!y.RI||it[t.debugId])return t;it[t.debugId]=!0;var r=(0,re.YM)(t),n=y.gm.MutationObserver;return n&&(window.MutationObserver=function(e){return this instanceof n?new n(r(e,"fn-")):n.apply(this,arguments)},MutationObserver.prototype=n.prototype),t}const{TZ:at,d3:st,Kp:ct,$p:ut,wW:dt,e5:lt,tH:ft,uP:ht,rw:pt,Lc:gt}=Ve;class mt extends E{static featureName=at;constructor(e){if(super(e,at),Be(e),!y.RI)return;try{this.removeOnAbort=new AbortController}catch(e){}let t,r=0;const n=this.ee.get("tracer"),o=qe(this.ee),a=Ye(this.ee),u=nt(this.ee),d=oe(this.ee),l=this.ee.get("events"),f=he(this.ee),h=_e(this.ee),p=ot(this.ee);function g(e,t){h.emit("newURL",[""+window.location,t])}function m(){r++,t=window.location.hash,this[ht]=(0,c.t)()}function v(){r--,window.location.hash!==t&&g(0,!0);var e=(0,c.t)();this[lt]=~~this[lt]+e-this[ht],this[gt]=e}function b(e,t){e.on(t,(function(){this[t]=(0,c.t)()}))}this.ee.on(ht,m),a.on(pt,m),o.on(pt,m),this.ee.on(gt,v),a.on(dt,v),o.on(dt,v),this.ee.on("fn-err",((...t)=>{t[2]?.__newrelic?.[e.agentIdentifier]||(0,s.p)("function-err",[...t],void 0,this.featureName,this.ee)})),this.ee.buffer([ht,gt,"xhr-resolved"],this.featureName),l.buffer([ht],this.featureName),u.buffer(["setTimeout"+ct,"clearTimeout"+st,ht],this.featureName),d.buffer([ht,"new-xhr","send-xhr"+st],this.featureName),f.buffer([ft+st,ft+"-done",ft+ut+st,ft+ut+ct],this.featureName),h.buffer(["newURL"],this.featureName),p.buffer([ht],this.featureName),a.buffer(["propagate",pt,dt,"executor-err","resolve"+st],this.featureName),n.buffer([ht,"no-"+ht],this.featureName),o.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"],this.featureName),b(f,ft+st),b(f,ft+"-done"),b(o,"new-jsonp"),b(o,"jsonp-end"),b(o,"cb-start"),h.on("pushState-end",g),h.on("replaceState-end",g),window.addEventListener("hashchange",g,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("load",g,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",(function(){g(0,r>1)}),(0,I.jT)(!0,this.removeOnAbort?.signal)),this.abortHandler=this.#r,this.importAggregator(e,(()=>i.e(478).then(i.bind(i,5592))))}#r(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}var vt=i(3333);class bt extends E{static featureName=vt.TZ;constructor(e){super(e,vt.TZ);const t=[e.init.page_action.enabled,e.init.performance.capture_marks,e.init.performance.capture_measures,e.init.user_actions.enabled,e.init.performance.resources.enabled];var r;if(r=e,p(u.hG,((e,t)=>z(e,t,r)),r),function(e){p(u.fF,(function(){(0,s.p)(u.Pl+u.fF,[(0,c.t)(),...arguments],void 0,n.K7.genericEvents,e.ee)}),e)}(e),Ie(e),Z(e),function(e){p(u.V1,(function(t,r){const i=(0,c.t)(),{start:o,end:a,customAttributes:d}=r||{},f={customAttributes:d||{}};if("object"!=typeof f.customAttributes||"string"!=typeof t||0===t.length)return void(0,l.R)(57);const h=(e,t)=>null==e?t:"number"==typeof e?e:e instanceof PerformanceMark?e.startTime:Number.NaN;if(f.start=h(o,0),f.end=h(a,i),Number.isNaN(f.start)||Number.isNaN(f.end))(0,l.R)(57);else{if(f.duration=f.end-f.start,!(f.duration<0))return(0,s.p)(u.Pl+u.V1,[f,t],void 0,n.K7.genericEvents,e.ee),f;(0,l.R)(58)}}),e)}(e),y.RI){if(e.init.user_actions.enabled&&(vt.Zp.forEach((e=>(0,I.sp)(e,(e=>(0,s.p)("ua",[e],void 0,this.featureName,this.ee)),!0))),vt.qN.forEach((e=>{const t=(0,x.s)((e=>{(0,s.p)("ua",[e],void 0,this.featureName,this.ee)}),500,{leading:!0});(0,I.sp)(e,t)}))),e.init.performance.resources.enabled&&y.gm.PerformanceObserver?.supportedEntryTypes.includes("resource")){new PerformanceObserver((e=>{e.getEntries().forEach((e=>{(0,s.p)("browserPerformance.resource",[e],void 0,this.featureName,this.ee)}))})).observe({type:"resource",buffered:!0})}const a=_e(this.ee);function d(){a.emit("navChange")}a.on("pushState-end",d),a.on("replaceState-end",d),window.addEventListener("hashchange",d,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",d,(0,I.jT)(!0,this.removeOnAbort?.signal))}try{this.removeOnAbort=new AbortController}catch(f){}function o(t){const r=(0,pe.D)(t);return e.beacons.includes(r.hostname+":"+r.port)}this.abortHandler=()=>{this.removeOnAbort?.abort(),this.abortHandler=void 0},y.gm.addEventListener("error",(()=>{(0,s.p)("uaErr",[],void 0,n.K7.genericEvents,this.ee)}),(0,I.jT)(!1,this.removeOnAbort?.signal)),he(this.ee),oe(this.ee),this.ee.on("open-xhr-start",((e,t)=>{o(e[1])||t.addEventListener("readystatechange",(()=>{2===t.readyState&&(0,s.p)("uaXhr",[],void 0,n.K7.genericEvents,this.ee)}))})),this.ee.on("fetch-start",(e=>{e.length>=1&&!o(be(e[0]))&&(0,s.p)("uaXhr",[],void 0,n.K7.genericEvents,this.ee)})),t.some((e=>e))?this.importAggregator(e,(()=>i.e(478).then(i.bind(i,8019)))):this.deregisterDrain()}}var yt=i(2646);const wt=new Map;function Rt(e,t,r,n){if("object"!=typeof t||!t||"string"!=typeof r||!r||"function"!=typeof t[r])return(0,l.R)(29);const i=function(e){return(e||te.ee).get("logger")}(e),o=(0,re.YM)(i),a=new yt.y(te.P);a.level=n.level,a.customAttributes=n.customAttributes;const s=t[r]?.[re.Jt]||t[r];return wt.set(s,a),o.inPlace(t,[r],"wrap-logger-",(()=>wt.get(s))),i}var xt=i(1910);class Tt extends E{static featureName=B.TZ;constructor(e){var t;super(e,B.TZ),t=e,p(u.$9,((e,r)=>V(e,r,t)),t),function(e){p(u.Wb,((t,r,{customAttributes:n={},level:i=B.p_.INFO}={})=>{Rt(e.ee,t,r,{customAttributes:n,level:i})}),e)}(e),Z(e);const r=this.ee;["log","error","warn","info","debug","trace"].forEach((e=>{(0,xt.i)(y.gm.console[e]),Rt(r,y.gm.console,e,{level:"log"===e?"info":e})})),this.ee.on("wrap-logger-end",(function([e]){const{level:t,customAttributes:n}=this;(0,G.R)(r,e,n,t)})),this.importAggregator(e,(()=>i.e(478).then(i.bind(i,5288))))}}new class extends r{constructor(e){var t;(super(),y.gm)?(this.features={},(0,_.bQ)(this.agentIdentifier,this),this.desiredFeatures=new Set(e.features||[]),this.desiredFeatures.add(O),this.runSoftNavOverSpa=[...this.desiredFeatures].some((e=>e.featureName===n.K7.softNav)),(0,a.j)(this,e,e.loaderType||"agent"),t=this,p(u.cD,(function(e,r,n=!1){if("string"==typeof e){if(["string","number","boolean"].includes(typeof r)||null===r)return g(t,e,r,u.cD,n);(0,l.R)(40,typeof r)}else(0,l.R)(39,typeof e)}),t),function(e){p(u.Dl,(function(t){if("string"==typeof t||null===t)return g(e,"enduser.id",t,u.Dl,!0);(0,l.R)(41,typeof t)}),e)}(this),function(e){p(u.nb,(function(t){if("string"==typeof t||null===t)return g(e,"application.version",t,u.nb,!1);(0,l.R)(42,typeof t)}),e)}(this),function(e){p(u.d3,(function(){e.ee.emit("manual-start-all")}),e)}(this),this.run()):(0,l.R)(21)}get config(){return{info:this.info,init:this.init,loader_config:this.loader_config,runtime:this.runtime}}get api(){return this}run(){try{const e=function(e){const t={};return o.forEach((r=>{t[r]=!!e[r]?.enabled})),t}(this.init),t=[...this.desiredFeatures];t.sort(((e,t)=>n.P3[e.featureName]-n.P3[t.featureName])),t.forEach((t=>{if(!e[t.featureName]&&t.featureName!==n.K7.pageViewEvent)return;if(this.runSoftNavOverSpa&&t.featureName===n.K7.spa)return;if(!this.runSoftNavOverSpa&&t.featureName===n.K7.softNav)return;const r=function(e){switch(e){case n.K7.ajax:return[n.K7.jserrors];case n.K7.sessionTrace:return[n.K7.ajax,n.K7.pageViewEvent];case n.K7.sessionReplay:return[n.K7.sessionTrace];case n.K7.pageViewTiming:return[n.K7.pageViewEvent];default:return[]}}(t.featureName).filter((e=>!(e in this.features)));r.length>0&&(0,l.R)(36,{targetFeature:t.featureName,missingDependencies:r}),this.features[t.featureName]=new t(this)}))}catch(e){(0,l.R)(22,e);for(const e in this.features)this.features[e].abortHandler?.();const t=(0,_.Zm)();delete t.initializedAgents[this.agentIdentifier]?.features,delete this.sharedAggregator;return t.ee.get(this.agentIdentifier).abort(),!1}}}({features:[Ee,O,j,Ke,Fe,k,q,bt,Tt,Ge,mt],loaderType:"spa"})})()})();</script>
<link rel="icon" type="image/png" sizes="16x16" href="https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_16-tenantFavicon-Frontiers.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_32-tenantFavicon-Frontiers.png">
<meta name="apple-mobile-web-app-title" content="Frontiers | Articles">
<link rel="manifest" href="/manifest.json">
<link rel="canonical" href="https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1652378/full">
<meta property="description" name="description" content="Parkinsonâ€™s disease (PD), as a common neurodegenerative disorder, its associated mild cognitive impairment (PD-mild cognitive impairment, PD-MCI) is a key pr...">
<meta property="og:title" name="title" content="Frontiers | Research progress of multimodal biomarkers in the early diagnosis of mild cognitive impairment in Parkinsonâ€™s disease">
<meta property="og:description" name="description" content="Parkinsonâ€™s disease (PD), as a common neurodegenerative disorder, its associated mild cognitive impairment (PD-mild cognitive impairment, PD-MCI) is a key pr...">
<meta name="keywords" content="review,early diagnosis,machine learning algorithm,multimodal biomarkers,Parkinsonâ€™s disease-mild cognitive impairment">
<meta property="og:site_name" name="site_name" content="Frontiers">
<meta property="og:image" name="image" content="https://images-provider.frontiersin.org/api/ipx/w=1200&f=png/https://www.frontiersin.org/files/Articles/1652378/fneur-16-1652378-HTML/image_m/fneur-16-1652378-g001.jpg">
<meta property="og:type" name="type" content="article">
<meta property="og:url" name="url" content="https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1652378/full">
<meta name="twitter:card" content="summary_large_image">
<meta name="citation_volume" content="16">
<meta name="citation_journal_title" content="Frontiers in Neurology">
<meta name="citation_publisher" content="Frontiers">
<meta name="citation_journal_abbrev" content="Front. Neurol.">
<meta name="citation_issn" content="1664-2295">
<meta name="citation_doi" content="10.3389/fneur.2025.1652378">
<meta name="citation_firstpage" content="1652378">
<meta name="citation_language" content="English">
<meta name="citation_title" content="Research progress of multimodal biomarkers in the early diagnosis of mild cognitive impairment in Parkinsonâ€™s disease">
<meta name="citation_keywords" content="review; early diagnosis; machine learning algorithm; multimodal biomarkers; Parkinsonâ€™s disease-mild cognitive impairment">
<meta name="citation_abstract" content="Parkinsonâ€™s disease (PD), as a common neurodegenerative disorder, its associated mild cognitive impairment (PD-mild cognitive impairment, PD-MCI) is a key prodromal stage in the progression to PD-dementia (PDD). Cognitive dysfunction seriously affects the quality of life of patients. Early diagnosis of PD-MCI is crucial for the prognosis of the disease. At present, traditional clinical diagnosis mainly relies on neuropsychological tests, but it has limitations such as low sensitivity and being easily interfered by subjective factors. It is difficult to achieve early and accurate identification of PD-MCI, which greatly affects the intervention timing and prognosis of the disease. This article summarizes the research progress of multimodal biomarkers in the early diagnosis of PD-MCI, mainly including the comprehensive application of neuroimaging biomarkers, humoral biomarkers, genetic and molecular biomarkers, digital biomarkers, and clinical assessment, providing new theoretical basis and technical paths for promoting the early diagnosis of PD-MCI. It is of great clinical significance and social value to assist in the formulation of individualized intervention strategies, delay the progression of diseases to dementia, improve the quality of life of patients, and reduce the medical burden on families and society.">
<meta name="citation_article_type" content="Mini Review">
<meta name="citation_pdf_url" content="https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1652378/pdf">
<meta name="citation_xml_url" content="https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1652378/xml">
<meta name="citation_fulltext_world_readable" content="yes">
<meta name="citation_online_date" content="2025/08/01">
<meta name="citation_publication_date" content="2025/08/29">
<meta name="citation_author" content="Guo, Huiping ">
<meta name="citation_author_institution" content="Department of Encephalopathy, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, China">
<meta name="citation_author" content="Shen, Xiaoming ">
<meta name="citation_author_institution" content="Department of Encephalopathy, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, China">
<meta name="citation_author" content="Lyu, Mengke ">
<meta name="citation_author_institution" content="Department of Encephalopathy, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, China">
<meta name="citation_author" content="Zhou, Guangsheng ">
<meta name="citation_author_institution" content="Department of Encephalopathy, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, China">
<meta name="citation_author" content="Chen, Chongchong ">
<meta name="citation_author_institution" content="Department of Encephalopathy, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, China">
<meta name="citation_author" content="Xing, Baofu ">
<meta name="citation_author_institution" content="Department of Encephalopathy, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, China">
<meta name="citation_author" content="Xie, Yanming ">
<meta name="citation_author_institution" content="Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, China">
<meta name="dc.identifier" content="doi:10.3389/fneur.2025.1652378">
<script type="application/ld+json">{"@context":"https://schema.org","@type":"ScholarlyArticle","headline":"Research progress of multimodal biomarkers in the early diagnosis of mild cognitive impairment in Parkinsonâ€™s disease","author":[{"@type":"Person","name":"Huiping Guo","affiliation":["Department of Encephalopathy, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, China","The First Clinical Medical College, Henan University of Chinese Medicine, China"]},{"@type":"Person","name":"Xiaoming Shen","affiliation":["Department of Encephalopathy, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, China"]},{"@type":"Person","name":"Mengke Lyu","affiliation":["Department of Encephalopathy, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, China","The First Clinical Medical College, Henan University of Chinese Medicine, China"]},{"@type":"Person","name":"Guangsheng Zhou","affiliation":["Department of Encephalopathy, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, China","The First Clinical Medical College, Henan University of Chinese Medicine, China"]},{"@type":"Person","name":"Chongchong Chen","affiliation":["Department of Encephalopathy, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, China","The First Clinical Medical College, Henan University of Chinese Medicine, China"]},{"@type":"Person","name":"Baofu Xing","affiliation":["Department of Encephalopathy, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, China","The First Clinical Medical College, Henan University of Chinese Medicine, China"]},{"@type":"Person","name":"Yanming Xie","affiliation":["Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, China"]}],"datePublished":"2025-08-29","dateModified":"2025-10-12","publisher":{"@type":"Organization","name":"Frontiers"},"isPartOf":{"@type":"PublicationIssue","datePublished":"2025","isPartOf":{"@type":"PublicationVolume","volumeNumber":"16","isPartOf":{"@type":"Periodical","name":"Frontiers in Neurology"}}},"citation":["https://doi.org/10.3389/fneur.2025.1652378"],"inLanguage":"en"}</script>
<script type="module" src="/ap-2024/_nuxt/BlX2Cz3M.js" crossorigin></script>
<script id="unhead:payload" type="application/json">{"title":"Frontiers | Articles"}</script></head><body  class="body--v3"><div id="__nuxt"><!--[--><!----><div theme="cyan"><nav class="Ibar"><div class="Ibar__main"><div class="Ibar__wrapper"><button class="Ibar__burger" aria-label="Open Menu" data-event="iBar-btn-openMenu"></button><div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg class="Ibar__logo__svg" viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg"><path class="Ibar__logo__text" d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF"></path><path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path><path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path><path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path><path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path><path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path><path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path><path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path><path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path><path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div><a href="//www.frontiersin.org/journals/neurology" class="Ibar__journalName" data-event="iBar-a-journalHome"><div class="Ibar__journalName__container" logoclass="Ibar__logo--mixed"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Neurology</span></div></div></a><div class="Ibar__dropdown--aboutUs" parent-data-event="iBar"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About us</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About us</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Who we are</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/mission" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Mission and values</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/history" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">History</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/leadership" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Leadership</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/awards" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Awards</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Impact and progress</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/impact" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Frontiers&#39; impact</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/annual-reports" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Our annual reports</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Publishing model</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">How we publish</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Open access</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/peer-review" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Peer review</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-integrity" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research integrity</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-topics" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research Topics</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fair-data-management" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">FAIRÂ² Data Management</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Fee policy</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Services</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://publishingpartnerships.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_3-a_services">Societies</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/open-access-agreements/consortia" target="_self" data-event="iBar-aboutUs_3-a_services">National consortia</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access-agreements" target="_self" data-event="iBar-aboutUs_3-a_services">Institutional partnerships</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/collaborators" target="_self" data-event="iBar-aboutUs_3-a_services">Collaborators</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">More from Frontiers</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://forum.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Forum</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/frontiers-planet-prize" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Planet Prize</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://pressoffice.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Press office</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/sustainability" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Sustainability</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://careers.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Career opportunities</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Contact us</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><!--[--><a class="Ibar__link" href="https://www.frontiersin.org/journals" data-event="iBar-a-allJournals">All journals</a><a class="Ibar__link" href="https://www.frontiersin.org/articles" data-event="iBar-a-allArticles">All articles</a><!--]--><a class="Ibar__button Ibar__submit" href="https://www.frontiersin.org/submission/submit?domainid=2&amp;fieldid=54&amp;specialtyid=0&amp;entitytype=2&amp;entityid=141" data-event="iBar-a-submit">Submit your research</a><div class="Ibar__spacer"></div><a class="Ibar__icon Ibar__icon--search" href="//www.frontiersin.org/search" aria-label="Search" target="_self" data-event="iBar-a-search"><span>Search</span></a><!----><!----><!----><div class="Ibar__userArea"></div></div></div><div><div class="Ibar__menu Ibar__menu--journal"><div class="Ibar__menu__header"><div class="Ibar__logo"><div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg class="Ibar__logo__svg" viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg"><path class="Ibar__logo__text" d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF"></path><path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path><path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path><path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path><path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path><path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path><path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path><path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path><path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path><path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div></div><button class="Ibar__close" aria-label="Close Menu" data-event="iBarMenu-btn-closeMenu"></button></div><div class="Ibar__menu__wrapper"><div class="Ibar__menu__journal"><a href="//www.frontiersin.org/journals/neurology" data-event="iBarMenu-a-journalHome"><div class="Ibar__journalName__container"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Neurology</span></div></div></a><div parent-data-event="iBarMenu"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">Sections</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><ul class="Ibar__dropdown__sections"><!--[--><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/applied-neuroimaging" data-event="iBarJournal-sections-a_id_156">Applied Neuroimaging</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/artificial-intelligence-in-neurology" data-event="iBarJournal-sections-a_id_3712">Artificial Intelligence in Neurology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/autonomic-disorders" data-event="iBarJournal-sections-a_id_3023">Autonomic Disorders</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/cognitive-and-behavioral-neurology" data-event="iBarJournal-sections-a_id_3740">Cognitive and Behavioral Neurology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/dementia-and-neurodegenerative-diseases" data-event="iBarJournal-sections-a_id_1439">Dementia and Neurodegenerative Diseases</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/diagnostic-neuropathology" data-event="iBarJournal-sections-a_id_2038">Diagnostic Neuropathology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/endovascular-and-interventional-neurology" data-event="iBarJournal-sections-a_id_143">Endovascular and Interventional Neurology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/epilepsy" data-event="iBarJournal-sections-a_id_144">Epilepsy</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/experimental-therapeutics" data-event="iBarJournal-sections-a_id_1784">Experimental Therapeutics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/headache-and-neurogenic-pain" data-event="iBarJournal-sections-a_id_153">Headache and Neurogenic Pain</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/movement-disorders" data-event="iBarJournal-sections-a_id_145">Movement Disorders</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/multiple-sclerosis-and-neuroimmunology" data-event="iBarJournal-sections-a_id_147">Multiple Sclerosis and Neuroimmunology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neuro-oncology-and-neurosurgical-oncology" data-event="iBarJournal-sections-a_id_150">Neuro-Oncology and Neurosurgical Oncology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neuro-ophthalmology" data-event="iBarJournal-sections-a_id_154">Neuro-Ophthalmology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neuro-otology" data-event="iBarJournal-sections-a_id_155">Neuro-Otology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neurocritical-and-neurohospitalist-care" data-event="iBarJournal-sections-a_id_159">Neurocritical and Neurohospitalist Care</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neuroepidemiology" data-event="iBarJournal-sections-a_id_1339">Neuroepidemiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neurogenetics" data-event="iBarJournal-sections-a_id_160">Neurogenetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neuroinfectious-diseases" data-event="iBarJournal-sections-a_id_1334">Neuroinfectious Diseases</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neurological-biomarkers" data-event="iBarJournal-sections-a_id_2345">Neurological Biomarkers</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neuromuscular-disorders-and-peripheral-neuropathies" data-event="iBarJournal-sections-a_id_146">Neuromuscular Disorders and Peripheral Neuropathies</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neurorehabilitation" data-event="iBarJournal-sections-a_id_547">Neurorehabilitation</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neurotechnology" data-event="iBarJournal-sections-a_id_3418">Neurotechnology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neurotrauma" data-event="iBarJournal-sections-a_id_163">Neurotrauma</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/pediatric-neurology" data-event="iBarJournal-sections-a_id_161">Pediatric Neurology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/sleep-disorders" data-event="iBarJournal-sections-a_id_151">Sleep Disorders</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/stroke" data-event="iBarJournal-sections-a_id_142">Stroke</a></li><!--]--></ul><!--]--></div></div></div><!--[--><a class="Ibar__link" href="//www.frontiersin.org/journals/neurology/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.frontiersin.org/journals/neurology/research-topics" target="_self" data-event="iBar-a-researchTopics">Research Topics</a><a class="Ibar__link" href="//www.frontiersin.org/journals/neurology/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><!--]--><div parent-data-event="iBarMenu"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_fieldChiefEditors">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/about#about-submission" target="_self" data-event="iBar-aboutJournal_3-a_journalSections">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_quality">Quality</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_2-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_editorGuidelines">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_4-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_5-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_6-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div></div><div class="Ibar__dropdown--aboutUs" parent-data-event="iBarMenu"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About us</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About us</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Who we are</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/mission" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Mission and values</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/history" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">History</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/leadership" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Leadership</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/awards" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Awards</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Impact and progress</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/impact" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Frontiers&#39; impact</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/annual-reports" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Our annual reports</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Publishing model</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">How we publish</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Open access</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/peer-review" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Peer review</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-integrity" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research integrity</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-topics" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research Topics</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fair-data-management" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">FAIRÂ² Data Management</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Fee policy</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Services</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://publishingpartnerships.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_3-a_services">Societies</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/open-access-agreements/consortia" target="_self" data-event="iBar-aboutUs_3-a_services">National consortia</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access-agreements" target="_self" data-event="iBar-aboutUs_3-a_services">Institutional partnerships</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/collaborators" target="_self" data-event="iBar-aboutUs_3-a_services">Collaborators</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">More from Frontiers</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://forum.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Forum</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/frontiers-planet-prize" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Planet Prize</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://pressoffice.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Press office</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/sustainability" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Sustainability</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://careers.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Career opportunities</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Contact us</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><!--[--><a class="Ibar__link" href="https://www.frontiersin.org/journals" data-event="iBar-a-allJournals">All journals</a><a class="Ibar__link" href="https://www.frontiersin.org/articles" data-event="iBar-a-allArticles">All articles</a><!--]--><!----><!----><!----><a class="Ibar__button Ibar__submit" href="https://www.frontiersin.org/submission/submit?domainid=2&amp;fieldid=54&amp;specialtyid=0&amp;entitytype=2&amp;entityid=141" data-event="iBarMenu-a-submit">Submit your research</a></div></div></div><!--[--><div class="Ibar__journal Ibar__journal--main"><div class="Ibar__wrapper Ibar__wrapper--journal"><a href="//www.frontiersin.org/journals/neurology" class="Ibar__journalName" data-event="iBarJournal-a-journalHome"><div class="Ibar__journalName__container"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Neurology</span></div></div></a><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">Sections</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><ul class="Ibar__dropdown__sections"><!--[--><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/applied-neuroimaging" data-event="iBarJournal-sections-a_id_156">Applied Neuroimaging</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/artificial-intelligence-in-neurology" data-event="iBarJournal-sections-a_id_3712">Artificial Intelligence in Neurology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/autonomic-disorders" data-event="iBarJournal-sections-a_id_3023">Autonomic Disorders</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/cognitive-and-behavioral-neurology" data-event="iBarJournal-sections-a_id_3740">Cognitive and Behavioral Neurology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/dementia-and-neurodegenerative-diseases" data-event="iBarJournal-sections-a_id_1439">Dementia and Neurodegenerative Diseases</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/diagnostic-neuropathology" data-event="iBarJournal-sections-a_id_2038">Diagnostic Neuropathology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/endovascular-and-interventional-neurology" data-event="iBarJournal-sections-a_id_143">Endovascular and Interventional Neurology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/epilepsy" data-event="iBarJournal-sections-a_id_144">Epilepsy</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/experimental-therapeutics" data-event="iBarJournal-sections-a_id_1784">Experimental Therapeutics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/headache-and-neurogenic-pain" data-event="iBarJournal-sections-a_id_153">Headache and Neurogenic Pain</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/movement-disorders" data-event="iBarJournal-sections-a_id_145">Movement Disorders</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/multiple-sclerosis-and-neuroimmunology" data-event="iBarJournal-sections-a_id_147">Multiple Sclerosis and Neuroimmunology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neuro-oncology-and-neurosurgical-oncology" data-event="iBarJournal-sections-a_id_150">Neuro-Oncology and Neurosurgical Oncology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neuro-ophthalmology" data-event="iBarJournal-sections-a_id_154">Neuro-Ophthalmology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neuro-otology" data-event="iBarJournal-sections-a_id_155">Neuro-Otology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neurocritical-and-neurohospitalist-care" data-event="iBarJournal-sections-a_id_159">Neurocritical and Neurohospitalist Care</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neuroepidemiology" data-event="iBarJournal-sections-a_id_1339">Neuroepidemiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neurogenetics" data-event="iBarJournal-sections-a_id_160">Neurogenetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neuroinfectious-diseases" data-event="iBarJournal-sections-a_id_1334">Neuroinfectious Diseases</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neurological-biomarkers" data-event="iBarJournal-sections-a_id_2345">Neurological Biomarkers</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neuromuscular-disorders-and-peripheral-neuropathies" data-event="iBarJournal-sections-a_id_146">Neuromuscular Disorders and Peripheral Neuropathies</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neurorehabilitation" data-event="iBarJournal-sections-a_id_547">Neurorehabilitation</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neurotechnology" data-event="iBarJournal-sections-a_id_3418">Neurotechnology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neurotrauma" data-event="iBarJournal-sections-a_id_163">Neurotrauma</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/pediatric-neurology" data-event="iBarJournal-sections-a_id_161">Pediatric Neurology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/sleep-disorders" data-event="iBarJournal-sections-a_id_151">Sleep Disorders</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/stroke" data-event="iBarJournal-sections-a_id_142">Stroke</a></li><!--]--></ul><!--]--></div></div></div><!--[--><a class="Ibar__link" href="//www.frontiersin.org/journals/neurology/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.frontiersin.org/journals/neurology/research-topics" target="_self" data-event="iBar-a-researchTopics">Research Topics</a><a class="Ibar__link" href="//www.frontiersin.org/journals/neurology/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><!--]--><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_fieldChiefEditors">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/about#about-submission" target="_self" data-event="iBar-aboutJournal_3-a_journalSections">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_quality">Quality</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_2-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_editorGuidelines">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_4-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_5-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_6-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><div class="Ibar__spacer"></div></div></div><div class="Ibar__journal Ibar__journal--mix"><div class="Ibar__wrapper Ibar__wrapper--journal"><div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg class="Ibar__logo__svg" viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg"><path class="Ibar__logo__text" d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF"></path><path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path><path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path><path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path><path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path><path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path><path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path><path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path><path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path><path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div><a href="//www.frontiersin.org/journals/neurology" class="Ibar__journalName" data-event="iBarJournal-a-journalHome"><div class="Ibar__journalName__container" logoclass="Ibar__logo--mixed"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Neurology</span></div></div></a><div class="Ibar__spacer"></div><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">Sections</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><ul class="Ibar__dropdown__sections"><!--[--><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/applied-neuroimaging" data-event="iBarJournal-sections-a_id_156">Applied Neuroimaging</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/artificial-intelligence-in-neurology" data-event="iBarJournal-sections-a_id_3712">Artificial Intelligence in Neurology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/autonomic-disorders" data-event="iBarJournal-sections-a_id_3023">Autonomic Disorders</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/cognitive-and-behavioral-neurology" data-event="iBarJournal-sections-a_id_3740">Cognitive and Behavioral Neurology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/dementia-and-neurodegenerative-diseases" data-event="iBarJournal-sections-a_id_1439">Dementia and Neurodegenerative Diseases</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/diagnostic-neuropathology" data-event="iBarJournal-sections-a_id_2038">Diagnostic Neuropathology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/endovascular-and-interventional-neurology" data-event="iBarJournal-sections-a_id_143">Endovascular and Interventional Neurology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/epilepsy" data-event="iBarJournal-sections-a_id_144">Epilepsy</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/experimental-therapeutics" data-event="iBarJournal-sections-a_id_1784">Experimental Therapeutics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/headache-and-neurogenic-pain" data-event="iBarJournal-sections-a_id_153">Headache and Neurogenic Pain</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/movement-disorders" data-event="iBarJournal-sections-a_id_145">Movement Disorders</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/multiple-sclerosis-and-neuroimmunology" data-event="iBarJournal-sections-a_id_147">Multiple Sclerosis and Neuroimmunology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neuro-oncology-and-neurosurgical-oncology" data-event="iBarJournal-sections-a_id_150">Neuro-Oncology and Neurosurgical Oncology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neuro-ophthalmology" data-event="iBarJournal-sections-a_id_154">Neuro-Ophthalmology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neuro-otology" data-event="iBarJournal-sections-a_id_155">Neuro-Otology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neurocritical-and-neurohospitalist-care" data-event="iBarJournal-sections-a_id_159">Neurocritical and Neurohospitalist Care</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neuroepidemiology" data-event="iBarJournal-sections-a_id_1339">Neuroepidemiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neurogenetics" data-event="iBarJournal-sections-a_id_160">Neurogenetics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neuroinfectious-diseases" data-event="iBarJournal-sections-a_id_1334">Neuroinfectious Diseases</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neurological-biomarkers" data-event="iBarJournal-sections-a_id_2345">Neurological Biomarkers</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neuromuscular-disorders-and-peripheral-neuropathies" data-event="iBarJournal-sections-a_id_146">Neuromuscular Disorders and Peripheral Neuropathies</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neurorehabilitation" data-event="iBarJournal-sections-a_id_547">Neurorehabilitation</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neurotechnology" data-event="iBarJournal-sections-a_id_3418">Neurotechnology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/neurotrauma" data-event="iBarJournal-sections-a_id_163">Neurotrauma</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/pediatric-neurology" data-event="iBarJournal-sections-a_id_161">Pediatric Neurology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/sleep-disorders" data-event="iBarJournal-sections-a_id_151">Sleep Disorders</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/neurology/sections/stroke" data-event="iBarJournal-sections-a_id_142">Stroke</a></li><!--]--></ul><!--]--></div></div></div><!--[--><a class="Ibar__link" href="//www.frontiersin.org/journals/neurology/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.frontiersin.org/journals/neurology/research-topics" target="_self" data-event="iBar-a-researchTopics">Research Topics</a><a class="Ibar__link" href="//www.frontiersin.org/journals/neurology/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><!--]--><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_fieldChiefEditors">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/about#about-submission" target="_self" data-event="iBar-aboutJournal_3-a_journalSections">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_quality">Quality</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_2-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_editorGuidelines">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_4-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_5-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/neurology/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_6-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><div class="Ibar__spacer"></div><a class="Ibar__button Ibar__submit" href="https://www.frontiersin.org/submission/submit?domainid=2&amp;fieldid=54&amp;specialtyid=0&amp;entitytype=2&amp;entityid=141" data-event="iBarJournal-a-submit"><span>Submit</span><span>Â your research</span></a><a class="Ibar__icon Ibar__icon--search" href="//www.frontiersin.org/search" aria-label="Search" target="_self" data-event="iBar-a-search"><span>Search</span></a><!----><!----><!----><div class="Ibar__userArea"></div></div></div><!--]--></nav><div class="ArticlePage"><!--[--><div class="Layout Layout--withAside Layout--withIbarMix"><div class="Alert Alert--info Alert--noInfo ArticleTemplateBanner"><div class="Alert__icon"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" width="24px" class="FeedbackIcon"><path fill="#fff" d="M10 10h28v28H10z"></path><path fill="var(--blue50)" d="M24 2.88a21.12 21.12 0 1 0 0 42.24 21.12 21.12 0 0 0 0-42.24ZM22.08 13.4a.96.96 0 0 1 .96-.96h1.92a.96.96 0 0 1 .96.96v1.92a.96.96 0 0 1-.96.96h-1.92a.96.96 0 0 1-.96-.96V13.4Zm5.76 21.2a.96.96 0 0 1-.96.97h-5.76a.96.96 0 0 1-.96-.96v-1.92a.96.96 0 0 1 .96-.96h.96v-7.68h-.96a.96.96 0 0 1-.96-.96v-1.92a.96.96 0 0 1 .96-.96h3.84a.96.96 0 0 1 .96.96v10.56h.96a.96.96 0 0 1 .96.96v1.92Z"></path></svg></div><div class="Alert__main"><p class="Alert__message">Your new experience awaits. Try the new design now and help us make it even better</p><!--[--><button type="button" class="Button Button--outline Button--grey80 Button--small ArticleTemplateBanner__switchButton" data-event="btn-action"><span>Switch to the new experience</span></button><!--]--><!----></div><ol class="Alert__info"><!--[--><!--]--></ol></div><!----><main class="Layout__main"><!----><div class="ArticleDetails"><div class="ArticleLayoutHeader"><div class="ArticleLayoutHeader__info"><p class="ArticleLayoutHeader__info__title">MINI REVIEW article</p><p class="ArticleLayoutHeader__info__journalDate"><span>Front. Neurol.</span><span>, 29 August 2025</span></p><p class="ArticleLayoutHeader__info__journalDate"> Sec. Neurological Biomarkers</p><p class="ArticleLayoutHeader__info__doiVolume"><span>Volume 16 - 2025 | </span><a class="ArticleLayoutHeader__info__doi" href="https://doi.org/10.3389/fneur.2025.1652378">https://doi.org/10.3389/fneur.2025.1652378</a></p><!----></div><!----><p class="ArticleLayoutHeader__isPartOfRT"><span class="ArticleLayoutHeader__isPartOfRT__label">This article is part of the Research Topic</span><span class="ArticleLayoutHeader__isPartOfRT__title">Identification of Neurological Biomarkers for Neurodegenerative Disorders</span><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--chevronRight Link--right" aria-label="View all 4 articles" href="https://www.frontiersin.org/research-topics/71456/identification-of-neurological-biomarkers-for-neurodegenerative-disorders/articles" target="_self" data-event="customLink-linkType-a_viewAll4Articles"><span>View all 4 articles</span></a></span></p></div><div class="ArticleDetails__main__content"><div class="ArticleDetails__main__content__main ArticleDetails__main__content__main--fullArticle"><div class="JournalAbstract"><div class="JournalAbstract__titleWrapper"><h1>Research progress of multimodal biomarkers in the early diagnosis of mild cognitive impairment in Parkinson&#x2019;s disease</h1><!----></div><!----></div><div class="JournalFullText"><div class="JournalAbstract"> <a id="h1" name="h1"></a>
 <div class="authors"><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/2023989" class="user-id-2023989"><img class="pr5" src="https://loop.frontiersin.org/images/profile/2023989/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Huiping Guo,">Huiping Guo</a><sup>1,2</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Xiaoming Shen&#xA;" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Xiaoming Shen<sup>1</sup><sup>&#x0002A;</sup></span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/1249698" class="user-id-1249698"><img class="pr5" src="https://loop.frontiersin.org/images/profile/1249698/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Mengke Lyu,">Mengke Lyu</a><sup>1,2</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Guangsheng Zhou," onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Guangsheng Zhou<sup>1,2</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Chongchong Chen," onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Chongchong Chen<sup>1,2</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Baofu Xing," onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Baofu Xing<sup>1,2</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Yanming Xie" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Yanming Xie<sup>3</sup></span></div> <ul class="notes"> <li><span><sup>1</sup></span>Department of Encephalopathy, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, China</li> <li><span><sup>2</sup></span>The First Clinical Medical College, Henan University of Chinese Medicine, Zhengzhou, China</li> <li><span><sup>3</sup></span>Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China</li> </ul>
<p>Parkinson&#x2019;s disease (PD), as a common neurodegenerative disorder, its associated mild cognitive impairment (PD-mild cognitive impairment, PD-MCI) is a key prodromal stage in the progression to PD-dementia (PDD). Cognitive dysfunction seriously affects the quality of life of patients. Early diagnosis of PD-MCI is crucial for the prognosis of the disease. At present, traditional clinical diagnosis mainly relies on neuropsychological tests, but it has limitations such as low sensitivity and being easily interfered by subjective factors. It is difficult to achieve early and accurate identification of PD-MCI, which greatly affects the intervention timing and prognosis of the disease. This article summarizes the research progress of multimodal biomarkers in the early diagnosis of PD-MCI, mainly including the comprehensive application of neuroimaging biomarkers, humoral biomarkers, genetic and molecular biomarkers, digital biomarkers, and clinical assessment, providing new theoretical basis and technical paths for promoting the early diagnosis of PD-MCI. It is of great clinical significance and social value to assist in the formulation of individualized intervention strategies, delay the progression of diseases to dementia, improve the quality of life of patients, and reduce the medical burden on families and society.</p> <div class="clear"></div> </div> <div class="JournalFullText"> <a id="h2" name="h2"></a>
<h2>1 Introduction</h2>
<p class="mb0">Mild cognitive impairment (PD-mild cognitive impairment, PD-MCI) in Parkinson&#x2019;s disease is the prodromal stage of PD-dementia (PDD), and its diagnosis and treatment are crucial for improving the prognosis of patients. Relevant epidemiological research shows that over 80% of PD patients have cognitive function changes, and approximately 30% of them will eventually develop into PDD (<a href="#ref1">1</a>). Between 20 and 33% of patients have PD-MCI at the time of diagnosis of PD, and as many as 57% of PD patients develop PD-MCI successively within 5&#x202F;years after the first diagnosis (<a href="#ref2">2</a>, <a href="#ref3">3</a>). In recent years, with the rapid development of big data, artificial intelligence and machine learning technologies, the application of multimodal biomarkers has increasingly gained favor in clinical research, providing powerful tools for the early diagnosis and prognosis of diseases. By aggregating and integrating multi-dimensional data such as neuroimaging, humoral biomarkers, genetics, digital phenotypes, and clinical assessment tools, the pathophysiological changes of PD-MCI can be reflected from different perspectives, providing support for conducting high-quality clinical research and precise diagnosis and treatment. The realization of precise identification of risk factors for PD-MCI, early intervention of the disease and improvement of prognosis provides evidence-based medical evidence, which is conducive to the formulation of effective prevention and treatment strategies in clinical practice. This article reviews the application of multimodal biomarkers in the diagnosis of PD-MCI, explores their different roles in clinical diagnosis, and looks forward to their potential value in the assessment of PD-MCI, aiming to provide a more comprehensive diagnostic strategy for clinical practice and offer references for future research directions (<a href="#fig1">Figure 1</a>).</p>
<div class="DottedLine"></div> <div class="Imageheaders">Figure 1</div> <div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/1652378/fneur-16-1652378-HTML/image_m/fneur-16-1652378-g001.jpg" name="figure1" target="_blank">
  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1652378/fneur-16-1652378-HTML/image_m/fneur-16-1652378-g001.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1652378/fneur-16-1652378-HTML/image_m/fneur-16-1652378-g001.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1652378/fneur-16-1652378-HTML/image_m/fneur-16-1652378-g001.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1652378/fneur-16-1652378-HTML/image_m/fneur-16-1652378-g001.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/1652378/fneur-16-1652378-HTML/image_m/fneur-16-1652378-g001.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/1652378/fneur-16-1652378-HTML/image_m/fneur-16-1652378-g001.jpg" alt="Flowchart illustrating the multimodal biomarker classification for early prediction of PD-MCI. It includes categories: neuroimaging, body fluid, genetics and molecular, digital, and clinical assessment. Each category lists specific methods and associated factors like gray/white matter, blood markers, gene mutations, speech analysis, and clinical scales." id="fig1" loading="lazy">
  </picture>
</a>
<p><b>Figure 1</b>. Classification and techniques of multimodal biomarkers.</p></div> <div class="clear"></div> <div class="DottedLine"></div> <a id="h3" name="h3"></a>
<h2>2 Neuroimaging biomarkers</h2>
<p class="mb0">Imaging plays a crucial role in the early diagnosis of PD-MCI (Parkinson&#x2019;s Disease with Mild Cognitive Impairment). Through imaging techniques such as Structural Magnetic Resonance Imaging (sMRI), Functional Magnetic Resonance Imaging (fMRI), Single Photon Emission Computed Tomography (SPECT), and Positron Emission Tomography (PET), researchers can identify structural and functional changes associated with PD-MCI. For instance, MRI can reveal atrophy in brain regions related to motor control, while PET is used to detect changes in dopamine transporter activity in the brain. These imaging biomarkers are not only helpful for early diagnosis but also provide key evidence for monitoring disease progression. Studies have shown that imaging-related indicators, such as changes in the basal ganglia, are closely correlated with the severity of clinical symptoms, making imaging an important tool for assessing PD-MCI patients (<a href="#ref4">4</a>).</p>
<h3>2.1 Structural magnetic resonance imaging</h3>
<p class="mb0">Structural Magnetic Resonance Imaging (sMRI), utilizing surface-based morphometry (SBM) techniques, quantifies parameters such as cortical thickness, surface area, volume, and curvature, revealing the characteristic gray matter atrophy and white matter damage in PD-MCI patients. Changes in these parameters are closely related to dysfunction in specific cognitive domains, as reflected by abnormal striatal volume alterations in PD-MCI patients. A multicenter study found that cortical thickness in the frontal lobe (dorsolateral prefrontal cortex, DLPFC) and parietal lobe (inferior parietal cortex) of PD-MCI patients was significantly reduced compared to healthy controls, with the degree of atrophy positively correlating with declines in executive function (e.g., Stroop test) and working memory scores (<a href="#ref5">5</a>). A longitudinal cohort study showed that volume reduction in the temporal lobe (parahippocampal gyrus, entorhinal cortex) independently predicts episodic memory impairment in PD-MCI patients, with an atrophy rate 1.5 times faster than in PD patients without cognitive impairment (<a href="#ref6">6</a>). Compared to early PD patients without MCI, the PD-MCI group exhibited more pronounced white matter microstructural abnormalities. sMRI evidence indicated widespread reductions in white matter fiber tract integrity, along with significantly increased volumes of white matter hyperintensity lesions in periventricular and deep brain regions. Moreover, expansion of white matter hyperintensities in the left frontal and temporal lobes was significantly associated with worsening performance on free recall tests, suggesting that white matter damage in specific brain regions may underlie PD-MCI pathology (<a href="#ref7">7</a>&#x2013;<a href="#ref10">10</a>).</p>
<h3>2.2 Functional magnetic resonance imaging</h3>
<p class="mb0">Resting-state fMRI studies have shown (<a href="#ref11">11</a>) that PD-MCI patients exhibit significant weakening in the functional connectivity (FC) of the default mode network (DMN) between the hippocampus-inferior frontal gyrus, posterior cingulate cortex-posterior parietal lobe, anterior temporal lobe-inferior frontal gyrus, and middle frontal gyrus-middle temporal gyrus. Compared to controls, PD-MCI patients show markedly reduced bilateral prefrontal cortex intra-FC, characterized by decreased connectivity strength between the caudate nucleus and precuneus (<a href="#ref12">12</a>). Besides widespread FC reduction, studies have reported abnormal increases in FC between the midbrain-posterior cingulate cortex and left hippocampus-right cerebellar hemisphere in PD-MCI patients (<a href="#ref13">13</a>, <a href="#ref14">14</a>). Apart from FC, local consistency (ReHo) values within the DMN positively correlate with cognitive function in PD and continuously decline with disease progression (<a href="#ref15">15</a>). The dynamic FC changes in the DMN, frontoparietal network (FPN), and salience network are more sensitive than structural imaging, with continuous alterations in the salience network showing the strongest association with PD cognitive impairment (PD-CI). Multiple task-based fMRI studies have found (<a href="#ref16">16</a>, <a href="#ref17">17</a>) that during working memory tasks, PD-MCI patients exhibit significantly reduced activation in bilateral caudate nuclei, right putamen, and dorsolateral/ventrolateral prefrontal cortex, indicating dopaminergic-cortical circuit dysfunction. Additionally, cerebellar functional activity is generally weakened, suggesting damage to cerebello-cortical pathways or their involvement in cognitive regulation.</p>
<h3>2.3 Dopaminergic system imaging</h3>
<p class="mb0">Dopamine transporter (DAT) single-photon emission computed tomography (SPECT) demonstrates early dopaminergic dysfunction and its association with cognitive impairment in PD-MCI patients by detecting dopaminergic nerve terminal density in the striatum. A multicenter study showed that DAT binding in the caudate and posterior putamen of PD-MCI patients was 30&#x2013;40% lower than that of healthy controls, with caudate DAT loss significantly correlated with executive functions (such as Stroop test) and working memory (such as digit span test) scores (<a href="#ref18">18</a>). The B&#x000E4;ckman research team, through longitudinal DAT-SPECT tracking, found that PD patients with an annual striatal DAT binding decline rate exceeding 5% had a 3.2-fold increased risk of progression to MCI within 3&#x202F;years, indicating that DAT loss could serve as an early predictive biomarker of cognitive decline (<a href="#ref19">19</a>). Serotonin (5-HT) positron emission tomography (PET) utilizes tracers (e.g., [11C] DASB, [18F]altanserin) to visualize serotonin transporter (SERT) or receptor distribution, revealing abnormalities in the raphe 5-HT system and its association with attention and emotional regulation deficits in PD-MCI. Studies show that compared to healthy controls, PD-MCI patients exhibit a 45% decrease in raphe SERT binding, which is positively correlated with Conners&#x2019; Continuous Performance Test (CPT) scores. Reduced 5-HT projections from the raphe to the prefrontal cortex may impair attentional control (<a href="#ref20">20</a>). Smith et al.&#x2019;s longitudinal 5-HT PET study indicated that PD patients with an annual raphe SERT binding decline exceeding 8% have a 2.5-fold increased risk of developing MCI within 2&#x202F;years (<a href="#ref21">21</a>). The Ballanger team, using the [18F] MPPF tracer, demonstrated elevated 5-HT1A receptor binding in the anterior cingulate cortex of PD-MCI patients, which is associated with depressive symptoms (e.g., BDI scores) and anxiety, suggesting that compensatory receptor upregulation might exacerbate mood disorders (<a href="#ref22">22</a>).</p>
<h3>2.4 Metabolism and molecular imaging</h3>
<p class="mb0">Fluorodeoxyglucose positron emission tomography (FDG-PET) reveals the distinctive metabolic patterns of PD-MCI (Parkinson&#x2019;s Disease Mild Cognitive Impairment) patients by measuring cerebral glucose metabolism rate, which is associated with impairments in specific cognitive domains. Huang et al.&#x2019;s study demonstrated significantly reduced glucose metabolism in the prefrontal cortex (especially the dorsolateral prefrontal cortex, DLPFC) and the inferior parietal lobule in PD-MCI patients, with the degree of metabolic decline positively correlating with executive function scores (e.g., Stroop test, Digit Symbol Substitution Test) (<a href="#ref23">23</a>). Tau positron emission tomography (Tau-PET), employing specific tracers such as [18F]AV-1451 and [18F]MK-6240, visualizes tau protein deposits, illustrating the spatial characteristics of tau pathology in PD-MCI and their relationship to cognitive decline. Sch&#x000F6;ll et al. found that tau deposition in the midbrain positively correlates with dopaminergic neuron loss assessed by DaT-SPECT, suggesting the involvement of tau pathology in degeneration of the nigrostriatal pathway (<a href="#ref24">24</a>). Ossenkoppele et al. proposed that tau deposition in PD-MCI primarily occurs in the midbrain and limbic system, whereas in Alzheimer&#x2019;s disease (AD) it is predominantly distributed in the temporoparietal lobes and neocortex, supporting specificity in pathological distribution (<a href="#ref25">25</a>).</p> <a id="h4" name="h4"></a>
<h2>3 Fluid biomarkers</h2>
<p class="mb0">Fluid biomarkers are crucial for the early identification of PD-MCI. Specific biochemical substances detected in blood and cerebrospinal fluid, such as neuron-specific enolase (NSE) and neurofilament light chain (NfL), are considered closely related to the degree of neuronal damage and stages of disease progression. The detection of these biochemical markers not only aids in identifying early PD-MCI patients but also serves to monitor disease progression and evaluate therapeutic efficacy (<a href="#ref26">26</a>). Due to their diversity and sensitivity, biochemical biomarkers hold broad application potential in clinical practice. Research on biomarkers continues to advance, and novel biomarkers, such as changes in <math id="M1">
<mi>&#x03B1;</mi>
</math>
-synuclein and tau protein, have been confirmed to be associated with PD-MCI, offering new avenues for early clinical diagnosis (<a href="#ref27">27</a>).</p>
<h3>3.1 Cerebrospinal fluid</h3>
<p class="mb0">In patients with PD-MCI, changes in cerebrospinal fluid (CSF) <math id="M2">
<mi>&#x03B1;</mi>
</math>
-synuclein levels reflect the association between pathological progression and cognitive impairment. Numerous studies have shown that total <math id="M3">
<mi>&#x03B1;</mi>
</math>
-synuclein levels in the CSF of PD-MCI patients are significantly lower than those in healthy controls and PD patients without cognitive impairment. Kang et al. found that decreased CSF <math id="M4">
<mi>&#x03B1;</mi>
</math>
-synuclein levels in PD-MCI patients are related to midbrain atrophy and weakened functional connectivity of the default mode network (DMN), suggesting it may serve as a surrogate marker for neuronal loss (<a href="#ref28">28</a>). Parnetti et al.&#x2019;s review indicates that reduced CSF <math id="M5">
<mi mathvariant="normal">&#x03B1;</mi>
</math>
-synuclein is associated with degenerative changes in the frontostriatal pathway in PD-MCI patients, possibly affecting executive function through synaptic dysfunction (<a href="#ref29">29</a>). Unlike total <math id="M6">
<mi mathvariant="normal">&#x03B1;</mi>
</math>
-synuclein, its oligomeric form (oligomeric <math id="M7">
<mi>&#x03B1;</mi>
</math>
-syn) is significantly elevated in PD-MCI patients and correlates with cognitive deterioration. Shahnawaz et al. developed a novel detection method and found that CSF oligomeric <math id="M8">
<mi mathvariant="normal">&#x03B1;</mi>
</math>
-syn levels in PD-MCI patients are three times higher than those in healthy controls and negatively correlated with Montreal Cognitive Assessment (MoCA) scores (<a href="#ref30">30</a>). Abnormal phosphorylation of Tau protein (such as p-tau181, p-tau231) is a typical marker of Alzheimer&#x2019;s disease (AD), and elevated CSF Tau levels are also observed in PD-MCI patients; however, its pathological distribution and clinical significance differ from those in AD-MCI. Alves et al. found that CSF p-tau181 levels in PD-MCI patients are significantly higher than in PD patients without cognitive impairment, but the increase is less pronounced compared to AD-MCI patients and lacks strong correlation with hippocampal atrophy, suggesting that Tau pathology in PD-MCI may be confined to subcortical regions (such as the brainstem and limbic system) (<a href="#ref31">31</a>). Hall et al. demonstrated through proteomic analysis that the Tau phosphorylation patterns (such as p-tau231) in PD-MCI patients differ from those in AD-MCI and may contribute to synaptic toxicity formation together with <math id="M9">
<mi mathvariant="normal">&#x03B1;</mi>
</math>
-synuclein (<a href="#ref32">32</a>).</p>
<h3>3.2 Blood</h3>
<p class="mb15">The levels of &#x03B1;-synuclein and synaptic proteins such as GAP43 and SNAP25 in blood exosomes change and can serve as non-invasive biomarkers. Abnormal oligomers of &#x03B1;-synuclein can spread between neurons via exosomes, accelerating pathological propagation. Stuendl et al. observed a significant increase of &#x03B1;-synuclein oligomers in the blood exosomes of PD-MCI patients, which positively correlated with oligomer concentrations in cerebrospinal fluid (CSF), indicating it can replace CSF testing (<a href="#ref33">33</a>). Shi et al. used single molecule array (Simoa) technology to show that exosomal &#x03B1;-synuclein oligomer levels were significantly associated with reduced executive function scores (e.g., Stroop test) in PD-MCI patients (<a href="#ref34">34</a>). Mechanistic studies by Chung et al. demonstrated that exosome-mediated &#x03B1;-synuclein propagation triggers microglial inflammatory responses, leading to synaptic loss in the frontal cortex and consequent cognitive impairment (<a href="#ref35">35</a>). Growth-associated protein 43 (GAP43) and synaptosomal-associated protein 25 (SNAP25) are key proteins for synaptic plasticity and neurotransmitter release; changes in their exosomal levels reflect synaptic integrity. Svenningsson et al. reported a 40% decrease in GAP43 content in blood exosomes of PD-MCI patients compared to healthy controls, correlating with hippocampal volume reduction (<a href="#ref36">36</a>). Bacioglu et al. found significantly reduced exosomal SNAP25 in PD-MCI patients, associated with weakened functional connectivity in the default mode network (DMN), indicating decreased synaptic transmission efficiency (<a href="#ref37">37</a>). Chen et al., combining exosomal proteomics with structural MRI, identified that GAP43/SNAP25 levels and frontal cortex thickness together predict the risk of PD-MCI progressing to dementia (<a href="#ref38">38</a>).</p>
<p class="mb0">Neurofilament Light Chain (NfL) is a cytoskeletal protein released following neuronal axonal damage. Elevated plasma <math id="M10">
<mi>NfL</mi>
</math> levels reflect the activity of neurodegeneration. Backstrm and colleagues, after a 5-year follow-up, found that initial plasma NfL levels in PD-MCI patients were higher than in PD patients without cognitive impairment, and <math id="M11">
<mi>NfL</mi>
</math> for each increase of <math id="M12">
<mn>10</mn>
<mspace width="0.25em"></mspace>
<mi>pg</mi>
<mo>/</mo>
<mi>mL</mi>
</math>
, the risk of dementia conversion increased 2.3-fold (<a href="#ref39">39</a>). Byrne et al. demonstrated that combining plasma NfL with midbrain atrophy MRI can predict the rate of cognitive decline in PD-MCI patients (<a href="#ref40">40</a>). The rate of white matter atrophy and ventricular enlargement are also considered key early predictive factors for MCI, further indicating that plasma NfL combined with midbrain atrophy MRI has potential in predicting the rate of cognitive decline in PD-MCI patients. Hansson et al. through autopsy research, found that plasma <math id="M13">
<mi>NfL</mi>
</math> levels positively correlate with the degree of nigral dopaminergic neuron loss and <math id="M14">
<mi mathvariant="normal">&#x03B1;</mi>
</math>
-synuclein pathological burden in the brains of <math id="M15">
<mi>PD</mi>
</math>
-
<math id="M16">
<mi>MCI</mi>
</math> patients (<a href="#ref41">41</a>).</p>
<h3>3.3 Saliva/urine</h3>
<p class="mb0">The amount of salivary &#x03B1;-synuclein is positively correlated with its concentration in CSF (cerebrospinal fluid), demonstrating potential screening value. Vivacqua et al. showed that the content of <math id="M17">
<mi mathvariant="normal">&#x03B1;</mi>
</math>
-synuclein oligomers in the saliva of PD (Parkinson&#x2019;s disease) patients is significantly positively correlated with its concentration in CSF, and that PD-MCI (Parkinson&#x2019;s disease with mild cognitive impairment) patients have higher salivary oligomer levels than PD patients without cognitive impairment (<a href="#ref42">42</a>). Stewart et al. used ultrasensitive single molecule detection technology (Simoa) to prove that the total &#x03B1;-synuclein level in saliva highly matches the total <math id="M18">
<mi mathvariant="normal">&#x03B1;</mi>
</math>
-synuclein concentration in CSF, and that salivary <math id="M19">
<mi mathvariant="normal">&#x03B1;</mi>
</math>
-synuclein is reduced by approximately 30% in PD-MCI patients compared to healthy controls (<a href="#ref43">43</a>). Kang et al.&#x2019;s longitudinal cohort study showed that PD patients with high baseline saliva <math id="M20">
<mi mathvariant="normal">&#x03B1;</mi>
</math>
-synuclein levels are more likely to develop MCI within 2&#x202F;years, demonstrating its predictive role (<a href="#ref44">44</a>). In PD-MCI patients, oxidative stress participates in cognitive decline by damaging neurons and synaptic function; elevated urinary 8-hydroxy-2&#x2032;-deoxyguanosine (8-OHdG) levels can serve as a non-invasive pathological marker. A cross-sectional study reported that urinary 8-OHdG levels are approximately 2.5 times higher in PD-MCI patients than in healthy controls, and are significantly negatively correlated with Montreal Cognitive Assessment (MoCA) scores; patients with high 8-OHdG levels have lower executive function and memory scores (<a href="#ref45">45</a>). A five-year cohort study showed that PD patients with baseline urinary 8-OHdG levels above the median have a 2.8-fold increased risk of progression to MCI, and the rate of increase in 8-OHdG levels positively correlates with the rate of cognitive decline (<a href="#ref46">46</a>). At present, there are relatively few studies on saliva/urine biomarkers of PD-MCI. Subsequently, it is necessary to optimize the detection technology, standardize the research process, and deeply explore its value in the early diagnosis of the disease, disease monitoring and mechanism interpretation.</p>
<h3>3.4 Skin/sweat</h3>
<p class="mb0">
<math id="M21">
<mi mathvariant="normal">&#x03B1;</mi>
</math>
-synuclein abnormal deposition in cutaneous nerve endings and sweat glands is a core pathological feature of PD, and its quantitative detection provides a non-invasive method for early diagnosis of PD-MCI. Donadio et al. found through skin biopsy that the positivity rate of phosphorylated <math id="M22">
<mi mathvariant="normal">&#x03B1;</mi>
</math>
-synuclein (p-
<math id="M23">
<mi mathvariant="normal">&#x03B1;</mi>
</math>
-syn) deposition in the epidermal small nerve fibers of PD patients reached 90%, and the deposition density in PD-MCI patients was significantly higher than that in PD patients without cognitive impairment. The deposition density was negatively correlated with the MoCA score, indicating its association with cognitive decline (<a href="#ref47">47</a>). Gibbons et al. quantitatively analyzed <math id="M24">
<mi mathvariant="normal">&#x03B1;</mi>
</math>
-synuclein aggregates around sweat glands using confocal microscopy and found that the aggregate load in PD-MCI patients was three times that of healthy controls and positively correlated with CSF <math id="M25">
<mi mathvariant="normal">&#x03B1;</mi>
</math>
-synuclein oligomer levels (<a href="#ref48">48</a>). Wang&#x2019;s team multicenter study showed that skin p-&#x03B1;-syn detection distinguished PD-MCI from healthy controls with an AUC of 0.92, outperforming traditional blood biomarkers such as NfL (<a href="#ref49">49</a>).</p> <a id="h5" name="h5"></a>
<h2>4 Genetic biomarkers</h2>
<h3>4.1 Genetics</h3>
<p class="mb0">Cohort studies by Sidransky et al. showed that PD patients carrying the heterozygous GBA N370S mutation have a 2.8-fold increased risk of developing MCI compared to non-carriers, with L444P mutation carriers exhibiting an even higher risk (<a href="#ref50">50</a>). Polymeropoulos et al. found that 80% of PD patients carrying the SNCA A53T mutation progressed to MCI within 3&#x202F;years after diagnosis, significantly higher than non-carriers (<a href="#ref51">51</a>). Kiely et al. reported that the SNCA E46K mutation accelerates <math id="M26">
<mi mathvariant="normal">&#x03B1;</mi>
</math>
-synuclein fibril formation, which is associated with temporal cortical atrophy and memory impairment (<a href="#ref52">52</a>). Irwin et al. found that PD-MCI patients carrying APOE <math id="M27">
<mi>&#x03B5;</mi>
<mn>4</mn>
</math> exhibit significantly elevated cerebrospinal fluid p-tau181 levels, indicating aggravated tau pathology (<a href="#ref53">53</a>). Zhang et al.&#x2019;s fMRI study showed that the Val/Val genotype weakens functional connectivity between the DLPFC and the striatum, exacerbating deficits in cognitive flexibility (<a href="#ref54">54</a>).</p>
<h3>4.2 Epigenetics</h3>
<p class="mb0">Abnormal methylation of genes such as HDAC4 and HOXC5 is present in the peripheral blood of PD-MCI patients and is associated with neuroinflammation and synaptic plasticity. Studies have found hypermethylation in the promoter region of HDAC4 in the peripheral blood of PD-MCI patients, leading to decreased expression, which is also linked to reduced synaptophysin in the frontal cortex. Low expression of HDAC4 impairs synaptic plasticity by inhibiting the BDNF (brain-derived neurotrophic factor) signaling pathway (<a href="#ref55">55</a>). Another study using epigenome-wide association study (EWAS) showed hypomethylation in the gene body of HOXC5 in PD-MCI patients, resulting in increased expression. Overexpression of HOXC5 promotes peripheral monocytes to release IL-6 and TNF-
<math id="M28">
<mi mathvariant="normal">&#x03B1;</mi>
</math>
, exacerbating blood&#x2013;brain barrier permeability and central inflammation (<a href="#ref56">56</a>). Abnormal expression of miR-124 and miR-132 regulates tau phosphorylation and synaptic function. Relevant studies found a 50% reduction of miR-124 levels in the plasma of PD-MCI patients compared with controls, with a negative correlation between its expression and CSF p-tau181. Experimental evidence shows that overexpression of miR-124 can inhibit GSK-3&#x03B2; activity, thereby reducing <math id="M29">
<mi>tau</mi>
</math> phosphorylation (<a href="#ref57">57</a>). Additionally, studies have found significantly reduced miR-132 levels in exosomes from PD-MCI patients, with its expression positively correlated with hippocampal volume and memory scores. Overexpression of miR-132 can rescue synaptic plasticity deficits (<a href="#ref58">58</a>).</p> <a id="h6" name="h6"></a>
<h2>5 Digital biomarkers</h2>
<p class="mb0">Digital biomarkers leverage technologies such as wearable devices, voice analysis, and cognitive task interactions to collect real-time, non-invasive physiological, behavioral, and environmental multidimensional data, greatly enhancing early diagnostic accuracy for PD-MCI. Research shows that digital features based on gait dynamics (such as stride variability) and micro-expression recognition can precisely capture neurodegenerative changes in the prodromal phase of PD-MCI (<a href="#ref59">59</a>). Moreover, smartphone applications (e.g., &#x201C;PD-Brain&#x201D;) can diagnose risks of hippocampal and prefrontal cortex functional decline by real-time monitoring of cognitive-motor dual tasks (<a href="#ref60">60</a>). Longitudinal studies indicate that baseline speech articulation deficits in PD patients (e.g., prolonged consonant-vowel transition time) can predict the risk of developing MCI within 2 years, with sensitivity comparable to hippocampal volume reduction (<a href="#ref61">61</a>). These technological advances overcome the subjective limitations of traditional neuropsychological scales, providing objective and dynamic quantitative tools for precise stratification and intervention in PD-MCI.</p> <a id="h7" name="h7"></a>
<h2>6 Clinical and neuropsychological assessment</h2>
<p class="mb0">Clinical assessment indicators, as a key part of early diagnosis of PD-MCI (Parkinson&#x2019;s Disease Mild Cognitive Impairment), are typically implemented using standardized clinical evaluation tools. These tools include the Unified Parkinson&#x2019;s Disease Rating Scale (UPDRS), Montreal Cognitive Assessment (MoCA), and Stroop Color-Word Test, which effectively assess patients&#x2019; motor function and cognitive status. Research shows that clinical assessment indicators have significant correlations with imaging and biochemical biomarkers, providing critical information on disease progression. For example, integrating UPDRS scores with imaging results can more accurately diagnose patients&#x2019; disease progression and quality of life (<a href="#ref62">62</a>). By combining clinical assessments with other biomarker information, physicians can develop personalized treatment plans better suited to patients&#x2019; needs to improve their quality of life.</p> <a id="h8" name="h8"></a>
<h2>7 Multimodal integration models</h2>
<p class="mb0">The application of machine learning algorithms in the medical field is becoming increasingly widespread, especially in the early prediction of diseases. Common machine learning algorithms include categories such as Support Vector Machine (SVM), Random Forest (RF), Gradient Boosting Tree (GBM), and deep learning models. These algorithms identify biomarkers and potential therapeutic targets of PD-MCI by analyzing different dimensions of the data, and provide new ideas for the comprehensive diagnosis and personalized treatment of PD-MCI. As algorithms continue to be optimized and datasets become increasingly rich, the accuracy and reliability of early machine learning predictions are constantly improving. Machine learning helps identify PD-MCI patients by analyzing specific proteins or molecules in samples such as blood and cerebrospinal fluid. Zhang et al. constructed support vector machine (SVM), decision tree (DT), and logistic regression (LR) models based on multimodal markers of quantitative electroencephalogram (qEEG) and structural magnetic resonance imaging (sMRI). The study found that among 23 pairs of PD-MCI and non-dementia Parkinson&#x2019;s disease (PD-ND) patients matched by propensity scores, qEEG features are superior to sMRI features in terms of prediction accuracy and area under the curve (AUC). Among them, the theta wave in lead P3 of qEEG features has a significant impact on the classification model, suggesting that multimodal &#x201C;composite markers&#x201D; have potential value for individualized diagnosis of PD-MCI (<a href="#ref63">63</a>). Zhu et al. integrated clinical features, plasma markers, functional connectivity of the default mode network and cortical thickness to construct a model and found that the plasma phosphorylated tau181 level and the ratio of phosphorylated tau181/&#x03B2;-amyloid protein 1&#x2013;42 in the PD-MCI group were significantly higher than those in the PD with normal cognition (PD-NC) group. Moreover, in terms of functional connectivity, the connection between the left posterior cingulate cortex and the left parahippocampal gyrus in the PD-MCI group was enhanced (<a href="#ref64">64</a>). Andrew et al. found that by using support vector machine (SVM) to classify clinical data, T1-weighted magnetic resonance imaging (MRI), resting-state functional MRI (Rs-fMRI), and plasma nerve fiber light chain (NfL) and glial fibrillary acidic protein (GFAP) level data, the results showed that The classifier combining clinical data, Rs-fMRI and NfL biomarkers performed the best, highlighting the importance of multimodal data fusion in improving the predictive ability of PD-MCI (<a href="#ref65">65</a>). A study analyzed the cognitive function assessment of MCI patients using machine learning algorithms. The results showed that a multimodal model integrating multi-source data biomarkers such as neuroimaging, humoral biomarkers, and clinical features demonstrated higher sensitivity and specificity in predicting cognitive decline in patients compared to single biomarkers or traditional diagnostic methods. It has laid a solid foundation for achieving precise and early diagnosis of PD-MCI and promoting the implementation of individualized intervention strategies (<a href="#ref66">66</a>).</p> <a id="h9" name="h9"></a>
<h2>8 Conclusion</h2>
<p class="mb15">PD-MCI is an intermediate transformation stage from normal cognition to PDD. As the duration of the disease increases, patients gradually lose their autonomy, increasing the mental and economic burden on society and families. To improve the prognosis of patients with PD-MCI, enhance the quality of life and reduce the social burden, the early identification, diagnosis and treatment of PD-MCI are of vital importance. However, there are still difficulties in the early and accurate identification of PD-MCI. This study integrates multi-dimensional data of multimodal biomarkers, including imaging biomarkers, humoral biomarkers, genetic and molecular biomarkers, digital biomarkers, and clinical evaluations. With the help of machine learning algorithms to mine potential disease patterns, it can more comprehensively assess the patient&#x2019;s condition and improve the sensitivity and specificity of early diagnosis of PD-MCI. Provide quantitative basis for individualized risk stratification.</p>
<p class="mb0">Although multimodal biomarkers have shown great potential in improving the accuracy, efficiency and personalization of the early diagnosis of PD-MCI, there are still many bottlenecks that need to be urgently broken through in their clinical transformation: (1) The cognitive barriers and trust deficits of clinicians toward emerging technologies stem from the insufficient update of interdisciplinary knowledge; (2) The update of clinical practice guidelines lags behind the progress of scientific research, and there is a lack of standardized procedures for interpreting multimodal data. (3) Insufficient allocation of interdisciplinary research resources has restricted the efficiency of large-scale cohort validation and technology transfer. Multimodal biomarkers still need to be further optimized and validated through clinical tests. Future research directions include: improving data quality on the basis of multimodal data fusion, constructing more generalized integrated models based on neurophysiological and pathological mechanisms, building larger-scale multi-center standardized databases, and promoting clinical transformation and precision diagnosis and treatment through industry-university-research collaboration. By continuously promoting the development of multimodal biomarkers in the diagnosis of PD-MCI, it is expected that in the future, through strengthening interdisciplinary cooperation, such as close collaboration among clinicians, data scientists and biomedical researchers, relying on large-scale cohort validation and standardized processes to promote the clinical application of multimodal biomarkers, more accurate diagnosis and more effective treatment can be provided for PD-MCI patients. In addition, with the continuous advancement of technology, the application of artificial intelligence and machine learning will also play a key role in this process. Utilizing artificial intelligence for multimodal data analysis and pattern recognition can accurately identify disease states and patient needs, providing support for the optimization of treatment plans. In conclusion, although there are many challenges at present, with the deepening of research and technological innovation, the application prospects of multimodal biomarkers in the diagnosis of PD-MCI will be very broad.</p> <a id="h10" name="h10"></a>
<h2>Author contributions</h2>
<p class="mb0">HG: Funding acquisition, Writing &#x2013; original draft, Writing &#x2013; review &#x00026; editing. XS: Funding acquisition, Writing &#x2013; review &#x00026; editing. ML: Funding acquisition, Writing &#x2013; original draft. GZ: Funding acquisition, Writing &#x2013; original draft. CC: Funding acquisition, Writing &#x2013; original draft. BX: Funding acquisition, Writing &#x2013; original draft. YX: Funding acquisition, Writing &#x2013; original draft, Writing &#x2013; review &#x00026; editing.</p> <a id="h11" name="h11"></a>
<h2>Funding</h2>
<p class="mb0">The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by the National Natural Science Foundation of China Project (81303011); Key Project jointly supported by the National Health Commission and Provincial Ministries (S BGJ202102187); Henan Province Key Scientific and Technological Tackling Project (242102311250); Henan Province &#x201C;Double First-Class&#x201D; Establishment Engineering Projects (No. HSRP-DFCTCM-2023-8-27, HSRP-DFCTCM-2023-8-44).</p> <a id="h12" name="h12"></a>
<h2>Conflict of interest</h2>
<p class="mb0">The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p> <a id="h13" name="h13"></a>
<h2>Generative AI statement</h2>
<p class="mb15">The authors declare that no Gen AI was used in the creation of this manuscript.</p>
<p class="mb0">Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p> <a id="h14" name="h14"></a>
<h2>Publisher&#x2019;s note</h2>
<p class="mb0">All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p> <a id="h15" name="h15"></a>
<h2>References</h2>
<div class="References">
<p class="ReferencesCopy1"><a name="ref1" id="ref1"></a>1. Monastero, R, Cicero, CE, Baschi, R, Dav&#x000EC;, M, Luca, A, Restivo, V, et al. Mild cogni-tive impairment in Parkinson's disease: the Parkinson's diseasecognitive study(PACOS). <i>J Neurol</i>. (2018) 265:1050&#x2013;8. doi: 10.1007/s00415-018-8800-4 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/29478221" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/s00415-018-8800-4" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=R+Monastero&#x00026;author=CE+Cicero&#x00026;author=R+Baschi&#x00026;author=M+Dav&#x000EC;&#x00026;author=A+Luca&#x00026;author=V+Restivo&#x00026;publication_year=2018&#x00026;title=Mild+cogni-tive+impairment+in+Parkinson's+disease:+the+Parkinson's+diseasecognitive+study(PACOS)&#x00026;journal=J+Neurol&#x00026;volume=265&#x00026;pages=1050-8" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="ref2" id="ref2"></a>2. Lawson, RA, Yarnall, AJ, Duncan, GW, Breen, DP, Khoo, TK, Williams-Gray, CH, et al. Stability of mild cognitiveimpairment in newly diagnosed Parkinson's disease. <i>J Neurol Neurosurg Psychiatry</i>. (2017) 88:648&#x2013;52. doi: 10.1136/jnnp-2016-315099</p>
<p class="ReferencesCopy2"><a href="https://doi.org/10.1136/jnnp-2016-315099" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=RA+Lawson&#x00026;author=AJ+Yarnall&#x00026;author=GW+Duncan&#x00026;author=DP+Breen&#x00026;author=TK+Khoo&#x00026;author=CH+Williams-Gray&#x00026;publication_year=2017&#x00026;title=Stability+of+mild+cognitiveimpairment+in+newly+diagnosed+Parkinson's+disease&#x00026;journal=J+Neurol+Neurosurg+Psychiatry&#x00026;volume=88&#x00026;pages=648-52" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="ref3" id="ref3"></a>3. Goldman, JG, Vernaleo, &#x0412;A, Camicioli, R, Dahodwala, N, Dobkin, RD, Ellis, T, et al. Cognitive impairment inParkinson's disease:a report from a multidisciplinary symposium onunmet needs and future directions to maintain cognitive health. <i>NPJ Parkinsons Dis</i>. (2018) 4:19. doi: 10.1038/s41531-018-0055-3</p>
<p class="ReferencesCopy2"><a href="https://doi.org/10.1038/s41531-018-0055-3" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=JG+Goldman&#x00026;author=&#x0412;A+Vernaleo&#x00026;author=R+Camicioli&#x00026;author=N+Dahodwala&#x00026;author=RD+Dobkin&#x00026;author=T+Ellis&#x00026;publication_year=2018&#x00026;title=Cognitive+impairment+inParkinson's+disease:a+report+from+a+multidisciplinary+symposium+onunmet+needs+and+future+directions+to+maintain+cognitive+health&#x00026;journal=NPJ+Parkinsons+Dis&#x00026;volume=4&#x00026;pages=19" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref4" id="ref4"></a>4. Liang, J, Li, ZW, Sun, ZN, Bi, Y, Cheng, H, Zeng, T, et al. Latent space search based multimodal optimization with personalized edge-network biomarker for multi-purpose early disease prediction. <i>Brief Bioinform</i>. (2023) 24:bbad364. doi: 10.1093/bib/bbad364 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/37833844" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1093/bib/bbad364" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=J+Liang&#x00026;author=ZW+Li&#x00026;author=ZN+Sun&#x00026;author=Y+Bi&#x00026;author=H+Cheng&#x00026;author=T+Zeng&#x00026;publication_year=2023&#x00026;title=Latent+space+search+based+multimodal+optimization+with+personalized+edge-network+biomarker+for+multi-purpose+early+disease+prediction&#x00026;journal=Brief+Bioinform&#x00026;volume=24&#x00026;pages=bbad364" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref5" id="ref5"></a>5. Rong, S, Li, Y, Li, B, Nie, K, Zhang, P, Cai, T, et al. Meynert nucleus-related cortical thinning in Parkinson's disease with mild cognitive impairment. <i>Quant Imaging Med Surg</i>. (2021) 11:1554&#x2013;66. doi: 10.21037/qims-20-444 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/33816191" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.21037/qims-20-444" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=S+Rong&#x00026;author=Y+Li&#x00026;author=B+Li&#x00026;author=K+Nie&#x00026;author=P+Zhang&#x00026;author=T+Cai&#x00026;publication_year=2021&#x00026;title=Meynert+nucleus-related+cortical+thinning+in+Parkinson's+disease+with+mild+cognitive+impairment&#x00026;journal=Quant+Imaging+Med+Surg&#x00026;volume=11&#x00026;pages=1554-66" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref6" id="ref6"></a>6. Xu, H, Liu, Y, Wang, L, Zeng, X, Xu, Y, and Wang, Z. Role of hippocampal subfields in neurodegenerative disease progression analyzed with a multi-scale attention-based network. <i>Neuroimage Clin</i>. (2023) 38:103370. doi: 10.1016/j.nicl.2023.103370 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/36948139" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.nicl.2023.103370" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=H+Xu&#x00026;author=Y+Liu&#x00026;author=L+Wang&#x00026;author=X+Zeng&#x00026;author=Y+Xu&#x00026;author=Z+Wang&#x00026;publication_year=2023&#x00026;title=Role+of+hippocampal+subfields+in+neurodegenerative+disease+progression+analyzed+with+a+multi-scale+attention-based+network&#x00026;journal=Neuroimage+Clin&#x00026;volume=38&#x00026;pages=103370" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="ref7" id="ref7"></a>7. Choi, SA, Evidente, VG, Caviness, JN, Shill, HA, Sabbagh, MN, Connor, DJ, et al. Are there differences in cerebral white matter lesion burdens between Parkinson's disease patients with or without dementia? <i>Acta Neuropathol</i>. (2020) 119:147&#x2013;9. doi: 10.1007/s00401-009-0620-2</p>
<p class="ReferencesCopy2"><a href="https://doi.org/10.1007/s00401-009-0620-2" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=SA+Choi&#x00026;author=VG+Evidente&#x00026;author=JN+Caviness&#x00026;author=HA+Shill&#x00026;author=MN+Sabbagh&#x00026;author=DJ+Connor&#x00026;publication_year=2020&#x00026;title=Are+there+differences+in+cerebral+white+matter+lesion+burdens+between+Parkinson's+disease+patients+with+or+without+dementia?&#x00026;journal=Acta+Neuropathol&#x00026;volume=119&#x00026;pages=147-9" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref8" id="ref8"></a>8. Zhu, Y, Yang, B, Zhou, C, Gao, C, Hu, Y, Yin, WF, et al. Cortical atrophy is associated with cognitive impairment in Parkinson's disease: a combined analysis of cortical thickness and functional connectivity. <i>Brain Imaging Behav</i>. (2022) 16:2586&#x2013;600. doi: 10.1007/s11682-022-00714-w </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/36044168" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/s11682-022-00714-w" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=Y+Zhu&#x00026;author=B+Yang&#x00026;author=C+Zhou&#x00026;author=C+Gao&#x00026;author=Y+Hu&#x00026;author=WF+Yin&#x00026;publication_year=2022&#x00026;title=Cortical+atrophy+is+associated+with+cognitive+impairment+in+Parkinson's+disease:+a+combined+analysis+of+cortical+thickness+and+functional+connectivity&#x00026;journal=Brain+Imaging+Behav&#x00026;volume=16&#x00026;pages=2586-600" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref9" id="ref9"></a>9. Zhao, W, Cheng, B, Zhu, T, Cui, Y, Shen, Y, Fu, X, et al. Effects of white matter hyperintensity on cognitive function in PD patients: a meta-analysis. <i>Front Neurol</i>. (2023) 14:1203311. doi: 10.3389/fneur.2023.1203311 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/37621858" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3389/fneur.2023.1203311" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=W+Zhao&#x00026;author=B+Cheng&#x00026;author=T+Zhu&#x00026;author=Y+Cui&#x00026;author=Y+Shen&#x00026;author=X+Fu&#x00026;publication_year=2023&#x00026;title=Effects+of+white+matter+hyperintensity+on+cognitive+function+in+PD+patients:+a+meta-analysis&#x00026;journal=Front+Neurol&#x00026;volume=14&#x00026;pages=1203311" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref10" id="ref10"></a>10. Pu, W, Shen, X, Huang, M, Li, Z, Zeng, X, Wang, R, et al. Assessment of white matter lesions in Parkinson's disease: voxelbased analysis and tract-based spatial statistics analysis of Parkinson's disease with mild cognitive impairment. <i>Curr Neurovasc Res</i>. (2020) 17:480&#x2013;6. doi: 10.2174/1567202617666200901181842 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/32875986" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.2174/1567202617666200901181842" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=W+Pu&#x00026;author=X+Shen&#x00026;author=M+Huang&#x00026;author=Z+Li&#x00026;author=X+Zeng&#x00026;author=R+Wang&#x00026;publication_year=2020&#x00026;title=Assessment+of+white+matter+lesions+in+Parkinson's+disease:+voxelbased+analysis+and+tract-based+spatial+statistics+analysis+of+Parkinson's+disease+with+mild+cognitive+impairment&#x00026;journal=Curr+Neurovasc+Res&#x00026;volume=17&#x00026;pages=480-6" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref11" id="ref11"></a>11. Hou, Y, Yang, J, Luo, C, Song, W, Ou, R, Liu, W, et al. Dysfunction of the default mode network in drug-na&#x000EF;ve Parkinson's disease with mild cognitive impairments: a resting-state fMRI study. <i>Front Aging Neurosci</i>. (2016) 8:247. doi: 10.3389/fnagi.2016.00247 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/27833548" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3389/fnagi.2016.00247" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=Y+Hou&#x00026;author=J+Yang&#x00026;author=C+Luo&#x00026;author=W+Song&#x00026;author=R+Ou&#x00026;author=W+Liu&#x00026;publication_year=2016&#x00026;title=Dysfunction+of+the+default+mode+network+in+drug-na&#x000EF;ve+Parkinson's+disease+with+mild+cognitive+impairments:+a+resting-state+fMRI+study&#x00026;journal=Front+Aging+Neurosci&#x00026;volume=8&#x00026;pages=247" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref12" id="ref12"></a>12. Amboni, M, Tessitore, A, Esposito, F, Santangelo, G, Picillo, M, Vitale, C, et al. Restingstate functional connectivity associated with mild cognitive impairment in Parkinson's disease. <i>J Neurol</i>. (2015) 262:425&#x2013;34. doi: 10.1007/s00415-014-7591-5 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/25428532" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/s00415-014-7591-5" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=M+Amboni&#x00026;author=A+Tessitore&#x00026;author=F+Esposito&#x00026;author=G+Santangelo&#x00026;author=M+Picillo&#x00026;author=C+Vitale&#x00026;publication_year=2015&#x00026;title=Restingstate+functional+connectivity+associated+with+mild+cognitive+impairment+in+Parkinson's+disease&#x00026;journal=J+Neurol&#x00026;volume=262&#x00026;pages=425-34" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref13" id="ref13"></a>13. Owens-Walton, C, Jakabek, D, Power, BD, Walterfang, M, Hall, S, van Westen, D, et al. Structural and functional neuroimaging changes associated with cognitive impairment and dementia in Parkinson's disease. <i>Psychiatry Res Neuroimaging</i>. (2021) 312:111273. doi: 10.1016/j.pscychresns.2021.111273 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/33892387" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.pscychresns.2021.111273" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=C+Owens-Walton&#x00026;author=D+Jakabek&#x00026;author=BD+Power&#x00026;author=M+Walterfang&#x00026;author=S+Hall&#x00026;author=D+van+Westen&#x00026;publication_year=2021&#x00026;title=Structural+and+functional+neuroimaging+changes+associated+with+cognitive+impairment+and+dementia+in+Parkinson's+disease&#x00026;journal=Psychiatry+Res+Neuroimaging&#x00026;volume=312&#x00026;pages=111273" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref14" id="ref14"></a>14. Lang, S, Yoon, EJ, Kibreab, M, Kathol, I, Cheetham, J, Hammer, T, et al. Mild behavioral impairment in Parkinson's disease is associated with altered corticostriatal connectivity. <i>NeuroImage: Clinical</i>. (2020) 26:102252. doi: 10.1016/j.nicl.2020.102252 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/32279019" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.nicl.2020.102252" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=S+Lang&#x00026;author=EJ+Yoon&#x00026;author=M+Kibreab&#x00026;author=I+Kathol&#x00026;author=J+Cheetham&#x00026;author=T+Hammer&#x00026;publication_year=2020&#x00026;title=Mild+behavioral+impairment+in+Parkinson's+disease+is+associated+with+altered+corticostriatal+connectivity&#x00026;journal=NeuroImage:+Clinical&#x00026;volume=26&#x00026;pages=102252" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="ref15" id="ref15"></a>15. Guo, W, Jin, W, Li, N, Gao, J, Wang, J, Chang, Y, et al. Brain activity alterations in patients with Parkinson's disease with cognitive impairment based on resting-state functional MRI. <i>Neurosci Lett</i>. (2021) 747:135672. doi: 10.1016/j.neulet.2021.135672</p>
<p class="ReferencesCopy2"><a href="https://doi.org/10.1016/j.neulet.2021.135672" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=W+Guo&#x00026;author=W+Jin&#x00026;author=N+Li&#x00026;author=J+Gao&#x00026;author=J+Wang&#x00026;author=Y+Chang&#x00026;publication_year=2021&#x00026;title=Brain+activity+alterations+in+patients+with+Parkinson's+disease+with+cognitive+impairment+based+on+resting-state+functional+MRI&#x00026;journal=Neurosci+Lett&#x00026;volume=747&#x00026;pages=135672" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref16" id="ref16"></a>16. Ay, U, and G&#x000FC;rvit, IH. Alterations in large-scale intrinsic connectivity networks in the Parkinson's diseaseassociated cognitive impairment continuum: a systematic review. <i>Noro Psikiyatr Ars</i>. (2022) 59:S57&#x2013;66. doi: 10.29399/npa.28209 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/36578982" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.29399/npa.28209" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=U+Ay&#x00026;author=IH+G&#x000FC;rvit&#x00026;publication_year=2022&#x00026;title=Alterations+in+large-scale+intrinsic+connectivity+networks+in+the+Parkinson's+diseaseassociated+cognitive+impairment+continuum:+a+systematic+review&#x00026;journal=Noro+Psikiyatr+Ars&#x00026;volume=59&#x00026;pages=S57-66" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref17" id="ref17"></a>17. Putcha, D, Ross, RS, Cronin-Golomb, A, Janes, AC, and Stern, CE. Salience and default mode network coupling predicts cognition in aging and Parkinson's disease. <i>J Int Neuropsychol Soc</i>. (2016) 22:205&#x2013;15. doi: 10.1017/S1355617715000892 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/26888617" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1017/S1355617715000892" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=D+Putcha&#x00026;author=RS+Ross&#x00026;author=A+Cronin-Golomb&#x00026;author=AC+Janes&#x00026;author=CE+Stern&#x00026;publication_year=2016&#x00026;title=Salience+and+default+mode+network+coupling+predicts+cognition+in+aging+and+Parkinson's+disease&#x00026;journal=J+Int+Neuropsychol+Soc&#x00026;volume=22&#x00026;pages=205-15" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref18" id="ref18"></a>18. Demailly, A, Moreau, C, and Devos, D. Effectiveness of continuous dopaminergic therapies in Parkinson's disease: a review of L-DOPA pharmacokinetics/pharmacodynamics. <i>J Parkinsons Dis</i>. (2024) 14:925&#x2013;39. doi: 10.3233/JPD-230372 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/38848195" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3233/JPD-230372" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=A+Demailly&#x00026;author=C+Moreau&#x00026;author=D+Devos&#x00026;publication_year=2024&#x00026;title=Effectiveness+of+continuous+dopaminergic+therapies+in+Parkinson's+disease:+a+review+of+L-DOPA+pharmacokinetics/pharmacodynamics&#x00026;journal=J+Parkinsons+Dis&#x00026;volume=14&#x00026;pages=925-39" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref19" id="ref19"></a>19. Seo, S, Yoon, YJ, Lee, S, Lim, H, Choo, K, Kim, D, et al. Striatal dopamine transporter uptake predicts neuronal hypometabolism and visuospatial function in Parkinson's disease. <i>Eur J Nucl Med Mol Imaging</i>. (2025) 52:2307&#x2013;16. doi: 10.1007/s00259-025-07137-x </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/39951136" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/s00259-025-07137-x" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=S+Seo&#x00026;author=YJ+Yoon&#x00026;author=S+Lee&#x00026;author=H+Lim&#x00026;author=K+Choo&#x00026;author=D+Kim&#x00026;publication_year=2025&#x00026;title=Striatal+dopamine+transporter+uptake+predicts+neuronal+hypometabolism+and+visuospatial+function+in+Parkinson's+disease&#x00026;journal=Eur+J+Nucl+Med+Mol+Imaging&#x00026;volume=52&#x00026;pages=2307-16" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="ref20" id="ref20"></a>20. Lee, Y, Ha, S, Yoo, SW, Joo, HO, Ie, RY, and Joong-Seok, K. Decreased raphe connectivity preceding changes of raphe-regional perfusion and SERT expression in drug na&#x000EF;ve PD patients with depressive mood. <i>J Nucl Med</i>. (2022) 63:2948</p>
<p class="ReferencesCopy2"><a href="http://scholar.google.com/scholar_lookup?author=Y+Lee&#x00026;author=S+Ha&#x00026;author=SW+Yoo&#x00026;author=HO+Joo&#x00026;author=RY+Ie&#x00026;author=K+Joong-Seok&#x00026;publication_year=2022&#x00026;title=Decreased+raphe+connectivity+preceding+changes+of+raphe-regional+perfusion+and+SERT+expression+in+drug+na&#x000EF;ve+PD+patients+with+depressive+mood&#x00026;journal=J+Nucl+Med&#x00026;volume=63&#x00026;pages=2948" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="ref21" id="ref21"></a>21. Frouni, I, Kwan, C, Belliveau, S, and Huot, P. Cognition and serotonin in Parkinson's disease. <i>Prog Brain Res</i>. (2022) 269:373&#x2013;403. doi: 10.1016/bs.pbr.2022.01.013</p>
<p class="ReferencesCopy2"><a href="https://doi.org/10.1016/bs.pbr.2022.01.013" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=I+Frouni&#x00026;author=C+Kwan&#x00026;author=S+Belliveau&#x00026;author=P+Huot&#x00026;publication_year=2022&#x00026;title=Cognition+and+serotonin+in+Parkinson's+disease&#x00026;journal=Prog+Brain+Res&#x00026;volume=269&#x00026;pages=373-403" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref22" id="ref22"></a>22. Smith, GS, Kuwabara, H, Yan, H, Nassery, N, Yoon, M, Kamath, V, et al. Serotonin degeneration and amyloid-&#x03B2; deposition in mild cognitive impairment: relationship to cognitive deficits. <i>J Alzheimer's Dis</i>. (2023) 96:215&#x2013;27. doi: 10.3233/JAD-230570 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/37718818" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3233/JAD-230570" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=GS+Smith&#x00026;author=H+Kuwabara&#x00026;author=H+Yan&#x00026;author=N+Nassery&#x00026;author=M+Yoon&#x00026;author=V+Kamath&#x00026;publication_year=2023&#x00026;title=Serotonin+degeneration+and+amyloid-&#x03B2;+deposition+in+mild+cognitive+impairment:+relationship+to+cognitive+deficits&#x00026;journal=J+Alzheimer's+Dis&#x00026;volume=96&#x00026;pages=215-27" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref23" id="ref23"></a>23. Zhihui, S, Yinghua, L, Hongguang, Z, Yuyin, D, Xiaoxiao, D, Lulu, G, et al. Correlation analysis between 18F-fluorodeoxyglucose positron emission tomography and cognitive function in first diagnosed Parkinson&#x2019;s disease patients. <i>Front Neurol</i>. (2023) 14:1195576. doi: 10.3389/fneur.2023.1195576 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/37384283" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3389/fneur.2023.1195576" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=S+Zhihui&#x00026;author=L+Yinghua&#x00026;author=Z+Hongguang&#x00026;author=D+Yuyin&#x00026;author=D+Xiaoxiao&#x00026;author=G+Lulu&#x00026;publication_year=2023&#x00026;title=Correlation+analysis+between+18F-fluorodeoxyglucose+positron+emission+tomography+and+cognitive+function+in+first+diagnosed+Parkinson&#x2019;s+disease+patients&#x00026;journal=Front+Neurol&#x00026;volume=14&#x00026;pages=1195576" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref24" id="ref24"></a>24. Devignes, Q, Lopes, R, and Dujardin, K. Neuroimaging outcomes associated with mild cognitive impairment subtypes in Parkinson's disease: a systematic review. <i>Parkinsonism Relat Disord</i>. (2022) 95:122&#x2013;37. doi: 10.1016/j.parkreldis.2022.02.006 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/35249807" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.parkreldis.2022.02.006" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=Q+Devignes&#x00026;author=R+Lopes&#x00026;author=K+Dujardin&#x00026;publication_year=2022&#x00026;title=Neuroimaging+outcomes+associated+with+mild+cognitive+impairment+subtypes+in+Parkinson's+disease:+a+systematic+review&#x00026;journal=Parkinsonism+Relat+Disord&#x00026;volume=95&#x00026;pages=122-37" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref25" id="ref25"></a>25. Zhang, J, Jin, J, Su, D, Feng, T, and Zhao, H. Tau-PET imaging in Parkinson's disease: a systematic review and meta-analysis. <i>Front Neurol</i>. (2023) 14:1145939. doi: 10.3389/fneur.2023.1145939 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/37181568" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3389/fneur.2023.1145939" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=J+Zhang&#x00026;author=J+Jin&#x00026;author=D+Su&#x00026;author=T+Feng&#x00026;author=H+Zhao&#x00026;publication_year=2023&#x00026;title=Tau-PET+imaging+in+Parkinson's+disease:+a+systematic+review+and+meta-analysis&#x00026;journal=Front+Neurol&#x00026;volume=14&#x00026;pages=1145939" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref26" id="ref26"></a>26. Park, B, Kim, Y, Park, J, Choi, H, Kim, SE, Ryu, H, et al. Integrating biomarkers from virtual reality and magnetic resonance imaging for the early detection of mild cognitive impairment using a multimodal learning approach: validation study. <i>J Med Internet Res</i>. (2024) 26:e54538. doi: 10.2196/54538 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/38631021" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.2196/54538" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=B+Park&#x00026;author=Y+Kim&#x00026;author=J+Park&#x00026;author=H+Choi&#x00026;author=SE+Kim&#x00026;author=H+Ryu&#x00026;publication_year=2024&#x00026;title=Integrating+biomarkers+from+virtual+reality+and+magnetic+resonance+imaging+for+the+early+detection+of+mild+cognitive+impairment+using+a+multimodal+learning+approach:+validation+study&#x00026;journal=J+Med+Internet+Res&#x00026;volume=26&#x00026;pages=e54538" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref27" id="ref27"></a>27. Galper, J, Dean, NJ, Pickford, R, Lewis, SJG, Halliday, GM, Kim, WS, et al. Lipid pathway dysfunction is prevalent in patients with Parkinson's disease. <i>Brain</i>. (2022) 145:3472&#x2013;87. doi: 10.1093/brain/awac176 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/35551349" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1093/brain/awac176" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=J+Galper&#x00026;author=NJ+Dean&#x00026;author=R+Pickford&#x00026;author=SJG+Lewis&#x00026;author=GM+Halliday&#x00026;author=WS+Kim&#x00026;publication_year=2022&#x00026;title=Lipid+pathway+dysfunction+is+prevalent+in+patients+with+Parkinson's+disease&#x00026;journal=Brain&#x00026;volume=145&#x00026;pages=3472-87" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref28" id="ref28"></a>28. Fan, TS, Liu, SCH, and Wu, RM. Alpha-synuclein and cognitive decline in Parkinson disease. <i>Life</i>. (2021) 11:1239. doi: 10.3390/life11111239 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/34833115" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3390/life11111239" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=TS+Fan&#x00026;author=SCH+Liu&#x00026;author=RM+Wu&#x00026;publication_year=2021&#x00026;title=Alpha-synuclein+and+cognitive+decline+in+Parkinson+disease&#x00026;journal=Life&#x00026;volume=11&#x00026;pages=1239" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref29" id="ref29"></a>29. Papaliagkas, V, Kalinderi, K, Vareltzis, P, Moraitou, D, Papamitsou, T, and Chatzidimitriou, M. CSF biomarkers in the early diagnosis of mild cognitive impairment and Alzheimer&#x2019;s disease. <i>Int J Mol Sci</i>. (2023) 24:8976. doi: 10.3390/ijms24108976 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/37240322" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3390/ijms24108976" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=V+Papaliagkas&#x00026;author=K+Kalinderi&#x00026;author=P+Vareltzis&#x00026;author=D+Moraitou&#x00026;author=T+Papamitsou&#x00026;author=M+Chatzidimitriou&#x00026;publication_year=2023&#x00026;title=CSF+biomarkers+in+the+early+diagnosis+of+mild+cognitive+impairment+and+Alzheimer&#x2019;s+disease&#x00026;journal=Int+J+Mol+Sci&#x00026;volume=24&#x00026;pages=8976" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref30" id="ref30"></a>30. Brockmann, K, Lerche, S, Baiardi, S, Rossi, M, Wurster, I, Quadalti, C, et al. CSF &#x03B1;-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson&#x2019;s disease. <i>NPJ Parkinsons Dis</i>. (2024) 10:24. doi: 10.1038/s41531-023-00627-5 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/38242875" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/s41531-023-00627-5" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=K+Brockmann&#x00026;author=S+Lerche&#x00026;author=S+Baiardi&#x00026;author=M+Rossi&#x00026;author=I+Wurster&#x00026;author=C+Quadalti&#x00026;publication_year=2024&#x00026;title=CSF+&#x03B1;-synuclein+seed+amplification+kinetic+profiles+are+associated+with+cognitive+decline+in+Parkinson&#x2019;s+disease&#x00026;journal=NPJ+Parkinsons+Dis&#x00026;volume=10&#x00026;pages=24" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref31" id="ref31"></a>31. van der Gaag, BL, Deshayes, NAC, Breve, JJP, Bol, JGJM, Jonker, AJ, Hoozemans, JJM, et al. Distinct tau and alpha-synuclein molecular signatures in Alzheimer&#x2019;s disease with and without Lewy bodies and Parkinson&#x2019;s disease with dementia. <i>Acta Neuropathol</i>. (2024) 147:14. doi: 10.1007/s00401-023-02657-y </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/38198008" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/s00401-023-02657-y" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=BL+van+der+Gaag&#x00026;author=NAC+Deshayes&#x00026;author=JJP+Breve&#x00026;author=JGJM+Bol&#x00026;author=AJ+Jonker&#x00026;author=JJM+Hoozemans&#x00026;publication_year=2024&#x00026;title=Distinct+tau+and+alpha-synuclein+molecular+signatures+in+Alzheimer&#x2019;s+disease+with+and+without+Lewy+bodies+and+Parkinson&#x2019;s+disease+with+dementia&#x00026;journal=Acta+Neuropathol&#x00026;volume=147&#x00026;pages=14" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref32" id="ref32"></a>32. Zhang, N, Tang, C, Ma, Q, Wang, W, Shi, M, Zhou, X, et al. Comprehensive serum metabolic and proteomic characterization on cognitive dysfunction in Parkinson&#x2019;s disease. <i>Ann Transl Med</i>. (2021) 9:559&#x2013;9. doi: 10.21037/atm-20-4583 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/33987257" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.21037/atm-20-4583" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=N+Zhang&#x00026;author=C+Tang&#x00026;author=Q+Ma&#x00026;author=W+Wang&#x00026;author=M+Shi&#x00026;author=X+Zhou&#x00026;publication_year=2021&#x00026;title=Comprehensive+serum+metabolic+and+proteomic+characterization+on+cognitive+dysfunction+in+Parkinson&#x2019;s+disease&#x00026;journal=Ann+Transl+Med&#x00026;volume=9&#x00026;pages=559-9" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref33" id="ref33"></a>33. Chung, CC, Chan, L, Chen, JH, Chung, C&#x2010;C, Chen, J&#x2010;H, Bamodu, OA, et al. Plasma extracellular vesicles tau and &#x03B2;-amyloid as biomarkers of cognitive dysfunction of Parkinson's disease. <i>FASEB J</i>. (2021) 35:e21895. doi: 10.1096/fj.202100787R </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/34478572" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1096/fj.202100787R" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=CC+Chung&#x00026;author=L+Chan&#x00026;author=JH+Chen&#x00026;author=C&#x2010;C+Chung&#x00026;author=J&#x2010;H+Chen&#x00026;author=OA+Bamodu&#x00026;publication_year=2021&#x00026;title=Plasma+extracellular+vesicles+tau+and+&#x03B2;-amyloid+as+biomarkers+of+cognitive+dysfunction+of+Parkinson's+disease&#x00026;journal=FASEB+J&#x00026;volume=35&#x00026;pages=e21895" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="ref34" id="ref34"></a>34. Yan, YQ, Pu, JL, Zheng, R, Yan, Y&#x2010;Q, Pu, J&#x2010;L, Fang, Y, et al. Different patterns of exosomal &#x03B1;-synuclein between Parkinson's disease and probable rapid eye movement sleep behavior disorder. <i>Eur J Neurol</i>. (2022) 29:3590&#x2013;9. doi: 10.1111/ene.15537</p>
<p class="ReferencesCopy2"><a href="https://doi.org/10.1111/ene.15537" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=YQ+Yan&#x00026;author=JL+Pu&#x00026;author=R+Zheng&#x00026;author=Y&#x2010;Q+Yan&#x00026;author=J&#x2010;L+Pu&#x00026;author=Y+Fang&#x00026;publication_year=2022&#x00026;title=Different+patterns+of+exosomal+&#x03B1;-synuclein+between+Parkinson's+disease+and+probable+rapid+eye+movement+sleep+behavior+disorder&#x00026;journal=Eur+J+Neurol&#x00026;volume=29&#x00026;pages=3590-9" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="ref35" id="ref35"></a>35. Dai, M, Yan, L, Yu, H, Chen, C, and Xie, Y. TNFRSF10B is involved in motor dysfunction in Parkinson's disease by regulating exosomal &#x03B1;-synuclein secretion from microglia. <i>J Chem Neuroanat</i>. (2023) 129:102249. doi: 10.1016/j.jchemneu.2023.102249</p>
<p class="ReferencesCopy2"><a href="https://doi.org/10.1016/j.jchemneu.2023.102249" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=M+Dai&#x00026;author=L+Yan&#x00026;author=H+Yu&#x00026;author=C+Chen&#x00026;author=Y+Xie&#x00026;publication_year=2023&#x00026;title=TNFRSF10B+is+involved+in+motor+dysfunction+in+Parkinson's+disease+by+regulating+exosomal+&#x03B1;-synuclein+secretion+from+microglia&#x00026;journal=J+Chem+Neuroanat&#x00026;volume=129&#x00026;pages=102249" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="ref36" id="ref36"></a>36. Chen, J, Liang, C, Wang, F, Zhu, Y, Zhu, L, Chen, J, et al. Potential biofluid markers for cognitive impairment in Parkinson&#x2019;s disease. <i>Neural Regen Res</i>. (2025) 21:281&#x2013;95. doi: 10.4103/NRR.NRR-D-24-00592</p>
<p class="ReferencesCopy2"><a href="https://doi.org/10.4103/NRR.NRR-D-24-00592" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=J+Chen&#x00026;author=C+Liang&#x00026;author=F+Wang&#x00026;author=Y+Zhu&#x00026;author=L+Zhu&#x00026;author=J+Chen&#x00026;publication_year=2025&#x00026;title=Potential+biofluid+markers+for+cognitive+impairment+in+Parkinson&#x2019;s+disease&#x00026;journal=Neural+Regen+Res&#x00026;volume=21&#x00026;pages=281-95" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref37" id="ref37"></a>37. Wang, W, Gao, W, Zhang, L, Xia, Z, and Zhao, B. SNAP25 ameliorates postoperative cognitive dysfunction by facilitating PINK1-dependent mitophagy and impeding caspase-3/GSDME-dependent pyroptosis. <i>Exp Neurol</i>. (2023) 367:114463. doi: 10.1016/j.expneurol.2023.114463 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/37295545" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.expneurol.2023.114463" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=W+Wang&#x00026;author=W+Gao&#x00026;author=L+Zhang&#x00026;author=Z+Xia&#x00026;author=B+Zhao&#x00026;publication_year=2023&#x00026;title=SNAP25+ameliorates+postoperative+cognitive+dysfunction+by+facilitating+PINK1-dependent+mitophagy+and+impeding+caspase-3/GSDME-dependent+pyroptosis&#x00026;journal=Exp+Neurol&#x00026;volume=367&#x00026;pages=114463" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="ref38" id="ref38"></a>38. Badr, MY, Amer, RA, Kotait, MA, Shoeib, SM, and Reda, AM. Role of multimodal advanced biomarkers as potential predictors of cognitive and psychiatric aspects of Parkinson's disease. <i>Egypt J Neurol Psychiatr Neurosurg</i>. (2023) 59:58. doi: 10.1186/s41983-023-00662-2</p>
<p class="ReferencesCopy2"><a href="https://doi.org/10.1186/s41983-023-00662-2" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=MY+Badr&#x00026;author=RA+Amer&#x00026;author=MA+Kotait&#x00026;author=SM+Shoeib&#x00026;author=AM+Reda&#x00026;publication_year=2023&#x00026;title=Role+of+multimodal+advanced+biomarkers+as+potential+predictors+of+cognitive+and+psychiatric+aspects+of+Parkinson's+disease&#x00026;journal=Egypt+J+Neurol+Psychiatr+Neurosurg&#x00026;volume=59&#x00026;pages=58" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref39" id="ref39"></a>39. Tang, Y, Han, L, Li, S, Hu, T, Xu, Z, Fan, Y, et al. Plasma GFAP in Parkinson&#x2019;s disease with cognitive impairment and its potential to predict conversion to dementia. <i>NPJ Parkinsons Dis</i>. (2023) 9:23. doi: 10.1038/s41531-023-00447-7 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/36759508" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/s41531-023-00447-7" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=Y+Tang&#x00026;author=L+Han&#x00026;author=S+Li&#x00026;author=T+Hu&#x00026;author=Z+Xu&#x00026;author=Y+Fan&#x00026;publication_year=2023&#x00026;title=Plasma+GFAP+in+Parkinson&#x2019;s+disease+with+cognitive+impairment+and+its+potential+to+predict+conversion+to+dementia&#x00026;journal=NPJ+Parkinsons+Dis&#x00026;volume=9&#x00026;pages=23" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref40" id="ref40"></a>40. Mohammadi, R, Ng, SYE, Tan, JY, Ng, ASL, Deng, X, Choi, X, et al. Machine learning for early detection of cognitive decline in Parkinson's disease using multimodal biomarker and clinical data. <i>Biomedicine</i>. (2024) 12:2758. doi: 10.3390/biomedicines12122758 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/39767666" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3390/biomedicines12122758" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=R+Mohammadi&#x00026;author=SYE+Ng&#x00026;author=JY+Tan&#x00026;author=ASL+Ng&#x00026;author=X+Deng&#x00026;author=X+Choi&#x00026;publication_year=2024&#x00026;title=Machine+learning+for+early+detection+of+cognitive+decline+in+Parkinson's+disease+using+multimodal+biomarker+and+clinical+data&#x00026;journal=Biomedicine&#x00026;volume=12&#x00026;pages=2758" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref41" id="ref41"></a>41. Lin, YS, Lee, WJ, Wang, SJ, and Fuh, JL. Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease. <i>Sci Rep</i>. (2018) 8:17368. doi: 10.1038/s41598-018-35766-w </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/30478269" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/s41598-018-35766-w" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=YS+Lin&#x00026;author=WJ+Lee&#x00026;author=SJ+Wang&#x00026;author=JL+Fuh&#x00026;publication_year=2018&#x00026;title=Levels+of+plasma+neurofilament+light+chain+and+cognitive+function+in+patients+with+Alzheimer+or+Parkinson+disease&#x00026;journal=Sci+Rep&#x00026;volume=8&#x00026;pages=17368" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref42" id="ref42"></a>42. Pawlik, P, and B&#x0142;ochowiak, K. The role of salivary biomarkers in the early diagnosis of Alzheimer&#x2019;s disease and Parkinson&#x2019;s disease. <i>Diagnostics</i>. (2021) 11:371. doi: 10.3390/diagnostics11020371 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/33671562" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3390/diagnostics11020371" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=P+Pawlik&#x00026;author=K+B&#x0142;ochowiak&#x00026;publication_year=2021&#x00026;title=The+role+of+salivary+biomarkers+in+the+early+diagnosis+of+Alzheimer&#x2019;s+disease+and+Parkinson&#x2019;s+disease&#x00026;journal=Diagnostics&#x00026;volume=11&#x00026;pages=371" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref43" id="ref43"></a>43. Kharel, S, Ojha, R, Bist, A, Joshi, SP, Rauniyar, R, and Yadav, JK. Salivary alpha-synuclein as a potential fluid biomarker in Parkinson's disease: a systematic review and meta-analysis. <i>Aging Med</i>. (2022) 5:53&#x2013;62. doi: 10.1002/agm2.12192 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/35309157" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1002/agm2.12192" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=S+Kharel&#x00026;author=R+Ojha&#x00026;author=A+Bist&#x00026;author=SP+Joshi&#x00026;author=R+Rauniyar&#x00026;author=JK+Yadav&#x00026;publication_year=2022&#x00026;title=Salivary+alpha-synuclein+as+a+potential+fluid+biomarker+in+Parkinson's+disease:+a+systematic+review+and+meta-analysis&#x00026;journal=Aging+Med&#x00026;volume=5&#x00026;pages=53-62" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref44" id="ref44"></a>44. Muddaloor, P, Farinango, M, Ansary, A, Dakka, A, Nazir, Z, Shamim, H, et al. Prospect of alpha-Synuclein (A-Syn) isolation from saliva as a promising diagnostic biomarker alternative in Parkinson's disease (PD): a systematic review. <i>Cureus</i>. (2022) 14:e29880. doi: 10.7759/cureus.29880 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/36348879" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.7759/cureus.29880" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=P+Muddaloor&#x00026;author=M+Farinango&#x00026;author=A+Ansary&#x00026;author=A+Dakka&#x00026;author=Z+Nazir&#x00026;author=H+Shamim&#x00026;publication_year=2022&#x00026;title=Prospect+of+alpha-Synuclein+(A-Syn)+isolation+from+saliva+as+a+promising+diagnostic+biomarker+alternative+in+Parkinson's+disease+(PD):+a+systematic+review&#x00026;journal=Cureus&#x00026;volume=14&#x00026;pages=e29880" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref45" id="ref45"></a>45. Ouyang, Q, Xu, L, Zhang, Y, Huang, L, Li, L, and Yu, M. Nonlinear relationship between homocysteine and mild cognitive impairment in early Parkinson&#x2019;s disease: a cross-sectional study. <i>Neuropsychiatr Dis Treat</i>. (2024) 20:913&#x2013;21. doi: 10.2147/NDT.S460938 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/38707522" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.2147/NDT.S460938" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=Q+Ouyang&#x00026;author=L+Xu&#x00026;author=Y+Zhang&#x00026;author=L+Huang&#x00026;author=L+Li&#x00026;author=M+Yu&#x00026;publication_year=2024&#x00026;title=Nonlinear+relationship+between+homocysteine+and+mild+cognitive+impairment+in+early+Parkinson&#x2019;s+disease:+a+cross-sectional+study&#x00026;journal=Neuropsychiatr+Dis+Treat&#x00026;volume=20&#x00026;pages=913-21" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="ref46" id="ref46"></a>46. Margiana, R, Hammid, AT, Ahmad, I, Alsaikhan, F, Jalil, AT, Tursunbaev, F, et al. Current progress in aptasensor for ultra-low level monitoring of Parkinson&#x2019;s disease biomarkers. <i>Crit Rev Anal Chem</i>. (2024) 54:617&#x2013;32. doi: 10.1080/10408347.2022.2091920</p>
<p class="ReferencesCopy2"><a href="https://doi.org/10.1080/10408347.2022.2091920" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=R+Margiana&#x00026;author=AT+Hammid&#x00026;author=I+Ahmad&#x00026;author=F+Alsaikhan&#x00026;author=AT+Jalil&#x00026;author=F+Tursunbaev&#x00026;publication_year=2024&#x00026;title=Current+progress+in+aptasensor+for+ultra-low+level+monitoring+of+Parkinson&#x2019;s+disease+biomarkers&#x00026;journal=Crit+Rev+Anal+Chem&#x00026;volume=54&#x00026;pages=617-32" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="ref47" id="ref47"></a>47. Wang, Z, Becker, K, Donadio, V, Siedlak, S, Yuan, J, Rezaee, M, et al. Skin &#x03B1;-synuclein aggregation seeding activity as a novel biomarker for Parkinson disease. <i>JAMA Neurol</i>. (2021) 78:120. doi: 10.1001/jamaneurol.2020.3311</p>
<p class="ReferencesCopy2"><a href="https://doi.org/10.1001/jamaneurol.2020.3311" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=Z+Wang&#x00026;author=K+Becker&#x00026;author=V+Donadio&#x00026;author=S+Siedlak&#x00026;author=J+Yuan&#x00026;author=M+Rezaee&#x00026;publication_year=2021&#x00026;title=Skin+&#x03B1;-synuclein+aggregation+seeding+activity+as+a+novel+biomarker+for+Parkinson+disease&#x00026;journal=JAMA+Neurol&#x00026;volume=78&#x00026;pages=120" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref48" id="ref48"></a>48. Majbour, N, Aasly, J, Abdi, I, Ghanem, S, Erskine, D, van de Berg, W, et al. Disease-associated &#x03B1;-synuclein aggregates as biomarkers of Parkinson disease clinical stage. <i>Neurology</i>. (2022) 99:e2417&#x2013;27. doi: 10.1212/WNL.0000000000201199 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/36096686" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1212/WNL.0000000000201199" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=N+Majbour&#x00026;author=J+Aasly&#x00026;author=I+Abdi&#x00026;author=S+Ghanem&#x00026;author=D+Erskine&#x00026;author=W+van+de+Berg&#x00026;publication_year=2022&#x00026;title=Disease-associated+&#x03B1;-synuclein+aggregates+as+biomarkers+of+Parkinson+disease+clinical+stage&#x00026;journal=Neurology&#x00026;volume=99&#x00026;pages=e2417-27" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="ref49" id="ref49"></a>49. Zhao, Y, Luan, M, Liu, J, Wang, Q, Deng, J, Wang, Z, et al. Skin &#x03B1;-synuclein assays in diagnosing Parkinson's disease: a systematic review and meta-analysis. <i>J Neurol</i>. (2025) 272:326. doi: 10.1007/s00415-025-12978-5</p>
<p class="ReferencesCopy2"><a href="https://doi.org/10.1007/s00415-025-12978-5" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=Y+Zhao&#x00026;author=M+Luan&#x00026;author=J+Liu&#x00026;author=Q+Wang&#x00026;author=J+Deng&#x00026;author=Z+Wang&#x00026;publication_year=2025&#x00026;title=Skin+&#x03B1;-synuclein+assays+in+diagnosing+Parkinson's+disease:+a+systematic+review+and+meta-analysis&#x00026;journal=J+Neurol&#x00026;volume=272&#x00026;pages=326" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref50" id="ref50"></a>50. Ren, J, Zhou, G, Wang, Y, Zhang, R, Guo, Z, Zhou, H, et al. Association of <i>GBA</i> genotype with motor and cognitive decline in Chinese Parkinson&#x2019;s disease patients. <i>Front Aging Neurosci</i>. (2023) 15:1091919. doi: 10.3389/fnagi.2023.1091919 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/36845659" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3389/fnagi.2023.1091919" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=J+Ren&#x00026;author=G+Zhou&#x00026;author=Y+Wang&#x00026;author=R+Zhang&#x00026;author=Z+Guo&#x00026;author=H+Zhou&#x00026;publication_year=2023&#x00026;title=Association+of+GBA+genotype+with+motor+and+cognitive+decline+in+Chinese+Parkinson&#x2019;s+disease+patients&#x00026;journal=Front+Aging+Neurosci&#x00026;volume=15&#x00026;pages=1091919" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref51" id="ref51"></a>51. Ramezani, M, Mouches, P, Yoon, E, Rajashekar, D, Ruskey, JA, Leveille, E, et al. Investigating the relationship between the SNCA gene and cognitive abilities in idiopathic Parkinson&#x2019;s disease using machine learning. <i>Sci Rep</i>. (2021) 11:4917. doi: 10.1038/s41598-021-84316-4 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/33649398" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/s41598-021-84316-4" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=M+Ramezani&#x00026;author=P+Mouches&#x00026;author=E+Yoon&#x00026;author=D+Rajashekar&#x00026;author=JA+Ruskey&#x00026;author=E+Leveille&#x00026;publication_year=2021&#x00026;title=Investigating+the+relationship+between+the+SNCA+gene+and+cognitive+abilities+in+idiopathic+Parkinson&#x2019;s+disease+using+machine+learning&#x00026;journal=Sci+Rep&#x00026;volume=11&#x00026;pages=4917" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref52" id="ref52"></a>52. Zhao, K, Li, Y, Liu, Z, Long, H, Zhao, C, Luo, F, et al. Parkinson's disease associated mutation E46K of &#x03B1;-synuclein triggers the formation of a distinct fibril structure. <i>Nat Commun</i>. (2020) 11:2643. doi: 10.1038/s41467-020-16386-3 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/32457390" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1038/s41467-020-16386-3" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=K+Zhao&#x00026;author=Y+Li&#x00026;author=Z+Liu&#x00026;author=H+Long&#x00026;author=C+Zhao&#x00026;author=F+Luo&#x00026;publication_year=2020&#x00026;title=Parkinson's+disease+associated+mutation+E46K+of+&#x03B1;-synuclein+triggers+the+formation+of+a+distinct+fibril+structure&#x00026;journal=Nat+Commun&#x00026;volume=11&#x00026;pages=2643" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref53" id="ref53"></a>53. Weigand, AJ, Ortiz, G, Walker, KS, Galasko, DR, Bondi, MW, and Thomas, KR. APOE differentially moderates cerebrospinal fluid and plasma phosphorylated tau181 associations with multi-domain cognition. <i>Neurobiol Aging</i>. (2023) 125:1&#x2013;8. doi: 10.1016/j.neurobiolaging.2022.10.016 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/36780762" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1016/j.neurobiolaging.2022.10.016" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=AJ+Weigand&#x00026;author=G+Ortiz&#x00026;author=KS+Walker&#x00026;author=DR+Galasko&#x00026;author=MW+Bondi&#x00026;author=KR+Thomas&#x00026;publication_year=2023&#x00026;title=APOE+differentially+moderates+cerebrospinal+fluid+and+plasma+phosphorylated+tau181+associations+with+multi-domain+cognition&#x00026;journal=Neurobiol+Aging&#x00026;volume=125&#x00026;pages=1-8" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref54" id="ref54"></a>54. Gordon, EM, Devaney, JM, Bean, S, and Vaidya, CJ. Resting-state striato-frontal functional connectivity is sensitive to DAT1 genotype and predicts executive function. <i>Cereb Cortex</i>. (2015) 25:336&#x2013;45. doi: 10.1093/cercor/bht229 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/23968837" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1093/cercor/bht229" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=EM+Gordon&#x00026;author=JM+Devaney&#x00026;author=S+Bean&#x00026;author=CJ+Vaidya&#x00026;publication_year=2015&#x00026;title=Resting-state+striato-frontal+functional+connectivity+is+sensitive+to+DAT1+genotype+and+predicts+executive+function&#x00026;journal=Cereb+Cortex&#x00026;volume=25&#x00026;pages=336-45" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="ref55" id="ref55"></a>55. Hasani, F, Ahmadi, P, Masrour, M, Khamaki, S, Rahmati, R, and Surguchov, A. Epigenetic alterations of cognition functions in Parkinson's disease (2024). doi: 10.20944/preprints202406.0981.v1,</p>
<p class="ReferencesCopy2"><a href="https://doi.org/10.20944/preprints202406.0981.v1" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=F+Hasani&#x00026;author=P+Ahmadi&#x00026;author=M+Masrour&#x00026;author=S+Khamaki&#x00026;author=R+Rahmati&#x00026;author=A+Surguchov&#x00026;publication_year=2024&#x00026;title=Epigenetic+alterations+of+cognition+functions+in+Parkinson's+disease&#x00026;" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref56" id="ref56"></a>56. Zhang, Y, and Shen, S. Epigenome-wide DNA methylation analysis of late-stage mild cognitive impairment. <i>Front Cell Dev Biol</i>. (2024) 12:1276288. doi: 10.3389/fcell.2024.1276288 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/38298218" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3389/fcell.2024.1276288" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=Y+Zhang&#x00026;author=S+Shen&#x00026;publication_year=2024&#x00026;title=Epigenome-wide+DNA+methylation+analysis+of+late-stage+mild+cognitive+impairment&#x00026;journal=Front+Cell+Dev+Biol&#x00026;volume=12&#x00026;pages=1276288" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref57" id="ref57"></a>57. Jim&#x000E9;nez-Ram&#x000ED;rez, IA, and Casta&#x000F1;o, E. Non-coding RNAs in the pathogenesis of Alzheimer&#x2019;s disease: &#x03B2;-amyloid aggregation, tau phosphorylation and neuroinflammation. <i>Mol Biol Rep</i>. (2025) 52:183. doi: 10.1007/s11033-025-10284-x </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/39890684" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/s11033-025-10284-x" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=IA+Jim&#x000E9;nez-Ram&#x000ED;rez&#x00026;author=E+Casta&#x000F1;o&#x00026;publication_year=2025&#x00026;title=Non-coding+RNAs+in+the+pathogenesis+of+Alzheimer&#x2019;s+disease:+&#x03B2;-amyloid+aggregation+tau+phosphorylation+and+neuroinflammation&#x00026;journal=Mol+Biol+Rep&#x00026;volume=52&#x00026;pages=183" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref58" id="ref58"></a>58. Arya, R, Haque, AKMA, Shakya, H, Billah, MM, Parvin, A, Rahman, M-M, et al. Parkinson&#x2019;s disease: biomarkers for diagnosis and disease progression. <i>Int J Mol Sci</i>. (2024) 25:12379. doi: 10.3390/ijms252212379 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/39596444" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3390/ijms252212379" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=R+Arya&#x00026;author=AKMA+Haque&#x00026;author=H+Shakya&#x00026;author=MM+Billah&#x00026;author=A+Parvin&#x00026;author=M-M+Rahman&#x00026;publication_year=2024&#x00026;title=Parkinson&#x2019;s+disease:+biomarkers+for+diagnosis+and+disease+progression&#x00026;journal=Int+J+Mol+Sci&#x00026;volume=25&#x00026;pages=12379" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref59" id="ref59"></a>59. Geritz, J, Welzel, J, Hansen, C, Maetzler, C, Hobert, MA, Elshehabi, M, et al. Cognitive parameters can predict change of walking performance in advanced Parkinson's disease - chances and limits of early rehabilitation. <i>Front Aging Neurosci</i>. (2022) 14:1070093. doi: 10.3389/fnagi.2022.1070093 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/36620765" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.3389/fnagi.2022.1070093" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=J+Geritz&#x00026;author=J+Welzel&#x00026;author=C+Hansen&#x00026;author=C+Maetzler&#x00026;author=MA+Hobert&#x00026;author=M+Elshehabi&#x00026;publication_year=2022&#x00026;title=Cognitive+parameters+can+predict+change+of+walking+performance+in+advanced+Parkinson's+disease+-+chances+and+limits+of+early+rehabilitation&#x00026;journal=Front+Aging+Neurosci&#x00026;volume=14&#x00026;pages=1070093" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref60" id="ref60"></a>60. Berron, D, Olsson, E, Andersson, F, Janelidze, S, Tideman, P, D&#x000FC;zel, E, et al. Remote and unsupervised digital memory assessments can reliably detect cognitive impairment in Alzheimer's disease. <i>Alzheimers Dement</i>. (2024) 20:4775&#x2013;91. doi: 10.1002/alz.13919 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/38867417" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1002/alz.13919" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=D+Berron&#x00026;author=E+Olsson&#x00026;author=F+Andersson&#x00026;author=S+Janelidze&#x00026;author=P+Tideman&#x00026;author=E+D&#x000FC;zel&#x00026;publication_year=2024&#x00026;title=Remote+and+unsupervised+digital+memory+assessments+can+reliably+detect+cognitive+impairment+in+Alzheimer's+disease&#x00026;journal=Alzheimers+Dement&#x00026;volume=20&#x00026;pages=4775-91" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref61" id="ref61"></a>61. Park, SY, and Schott, N. Which motor-cognitive abilities underlie the digital trail-making test? Decomposing various test scores to detect cognitive impairment in Parkinson's disease-pilot study. <i>Appl Neuropsychol Adult</i>. (2025) 32:60&#x2013;74. doi: 10.1080/23279095.2022.2147837 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/36412487" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1080/23279095.2022.2147837" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=SY+Park&#x00026;author=N+Schott&#x00026;publication_year=2025&#x00026;title=Which+motor-cognitive+abilities+underlie+the+digital+trail-making+test?+Decomposing+various+test+scores+to+detect+cognitive+impairment+in+Parkinson's+disease-pilot+study&#x00026;journal=Appl+Neuropsychol+Adult&#x00026;volume=32&#x00026;pages=60-74" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="ref62" id="ref62"></a>62. Klotz, LV, Casjens, S, Johnen, G, Taeger, D, Brik, A, Eichhorn, F, et al. Combination of calretinin, MALAT1, and GAS5 as a potential prognostic biomarker to predict disease progression in surgically treated mesothelioma patients. <i>Lung Cancer</i>. (2024) 192:107802. doi: 10.1016/j.lungcan.2024.107802</p>
<p class="ReferencesCopy2"><a href="https://doi.org/10.1016/j.lungcan.2024.107802" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=LV+Klotz&#x00026;author=S+Casjens&#x00026;author=G+Johnen&#x00026;author=D+Taeger&#x00026;author=A+Brik&#x00026;author=F+Eichhorn&#x00026;publication_year=2024&#x00026;title=Combination+of+calretinin+MALAT1+and+GAS5+as+a+potential+prognostic+biomarker+to+predict+disease+progression+in+surgically+treated+mesothelioma+patients&#x00026;journal=Lung+Cancer&#x00026;volume=192&#x00026;pages=107802" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref63" id="ref63"></a>63. Zhang, J, Gao, Y, He, X, Feng, S, Hu, J, Zhang, Q, et al. Identifying Parkinson's disease with mild cognitive impairment by using combined MR imaging and electroencephalogram. <i>Eur Radiol</i>. (2021) 31:7386&#x2013;94. doi: 10.1007/s00330-020-07575-1 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/33389038" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1007/s00330-020-07575-1" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=J+Zhang&#x00026;author=Y+Gao&#x00026;author=X+He&#x00026;author=S+Feng&#x00026;author=J+Hu&#x00026;author=Q+Zhang&#x00026;publication_year=2021&#x00026;title=Identifying+Parkinson's+disease+with+mild+cognitive+impairment+by+using+combined+MR+imaging+and+electroencephalogram&#x00026;journal=Eur+Radiol&#x00026;volume=31&#x00026;pages=7386-94" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="ref64" id="ref64"></a>64. Zhu, Y, Wang, F, Ning, P, Zhu, Y, Zhang, L, Li, K, et al. Multimodal neuroimaging-based prediction of Parkinson&#x2019;s disease with mild cognitive impairment using machine learning technique. <i>npj Parkinson's Dis</i>. (2024) 10:218. doi: 10.1038/s41531-024-00828-6</p>
<p class="ReferencesCopy2"><a href="https://doi.org/10.1038/s41531-024-00828-6" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=Y+Zhu&#x00026;author=F+Wang&#x00026;author=P+Ning&#x00026;author=Y+Zhu&#x00026;author=L+Zhang&#x00026;author=K+Li&#x00026;publication_year=2024&#x00026;title=Multimodal+neuroimaging-based+prediction+of+Parkinson&#x2019;s+disease+with+mild+cognitive+impairment+using+machine+learning+technique&#x00026;journal=npj+Parkinson's+Dis&#x00026;volume=10&#x00026;pages=218" target="_blank">Google Scholar</a></p></div>
<div class="References" style="margin-bottom:0.5em;">
<p class="ReferencesCopy1"><a name="ref65" id="ref65"></a>65. Cirincione, A, Lynch, K, Bennett, J, Choupan, J, Varghese, B, Sheikh-Bahaei, N, et al. Prediction of future dementia among patients with mild cognitive impairment (MCI) by integrating multimodal clinical data. <i>Heliyon</i>. (2024) 10:&#x2013;e36728. doi: 10.1016/j.heliyon.2024.e36728</p>
<p class="ReferencesCopy2"><a href="https://doi.org/10.1016/j.heliyon.2024.e36728" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=A+Cirincione&#x00026;author=K+Lynch&#x00026;author=J+Bennett&#x00026;author=J+Choupan&#x00026;author=B+Varghese&#x00026;author=N+Sheikh-Bahaei&#x00026;publication_year=2024&#x00026;title=Prediction+of+future+dementia+among+patients+with+mild+cognitive+impairment+(MCI)+by+integrating+multimodal+clinical+data&#x00026;journal=Heliyon&#x00026;volume=10&#x00026;pages=e36728" target="_blank">Google Scholar</a></p></div>
<div class="References">
<p class="ReferencesCopy1"><a name="ref66" id="ref66"></a>66. Sato, M, Kobayashi, T, Soroida, Y, Tanaka, T, Nakatsuka, T, Nakagawa, H, et al. Development of novel deep multimodal representation learning-based model for the differentiation of liver tumors on B-mode ultrasound images. <i>J Gastroenterol Hepatol</i>. (2022) 37:678&#x2013;84. doi: 10.1111/jgh.15763 </p>
<p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/34911147" target="_blank">PubMed Abstract</a> | <a href="https://doi.org/10.1111/jgh.15763" target="_blank">Crossref Full Text</a> | <a href="http://scholar.google.com/scholar_lookup?author=M+Sato&#x00026;author=T+Kobayashi&#x00026;author=Y+Soroida&#x00026;author=T+Tanaka&#x00026;author=T+Nakatsuka&#x00026;author=H+Nakagawa&#x00026;publication_year=2022&#x00026;title=Development+of+novel+deep+multimodal+representation+learning-based+model+for+the+differentiation+of+liver+tumors+on+B-mode+ultrasound+images&#x00026;journal=J+Gastroenterol+Hepatol&#x00026;volume=37&#x00026;pages=678-84" target="_blank">Google Scholar</a></p></div>
</div> <div class="thinLineM20"></div> <div class="AbstractSummary">
<p><span>Keywords:</span> Parkinson&#x2019;s disease-mild cognitive impairment, multimodal biomarkers, early diagnosis, machine learning algorithm, review</p>
<p><span>Citation:</span> Guo H, Shen X, Lyu M, Zhou G, Chen C, Xing B and Xie Y (2025) Research progress of multimodal biomarkers in the early diagnosis of mild cognitive impairment in Parkinson&#x2019;s disease. <i>Front. Neurol</i>. 16:1652378. doi: 10.3389/fneur.2025.1652378</p>
<p class="timestamps"><span>Received:</span> 23 June 2025; <span>Accepted:</span> 01 August 2025;<br> <span>Published:</span> 29 August 2025.</p> <div>
<p>Edited by:</p> <a href="https://loop.frontiersin.org/people/2991286/overview">Shruti Verma</a>, Symbiosis International University, India</div> <div>
<p>Reviewed by:</p> <a href="https://loop.frontiersin.org/people/451799/overview">Chunchen Xiang</a>, Capital Medical University, China</div>
<p><span>Copyright</span> &#x000A9; 2025 Guo, Shen, Lyu, Zhou, Chen, Xing and Xie. This is an open-access article distributed under the terms of the <a rel="license" href="http://creativecommons.org/licenses/by/4.0/" target="_blank">Creative Commons Attribution License (CC BY)</a>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
<p><span>&#x0002A;Correspondence:</span> Xiaoming Shen, <a id="encmail">c3htZG9jQDE2My5jb20=</a></p> <div class="clear"></div> </div></div></div><p class="AbstractSummary__disclaimer"><span>Disclaimer: </span> All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher. </p></div></div><!----></main><aside class="Layout__aside"><div class="ArticleDetails__wrapper"><div class="ArticleDetails__aside"><div class="ArticleDetails__aside__responsiveButtons"><div class="ActionsDropDown" id="FloatingButtonsEl"><button aria-label="Open dropdown" class="ActionsDropDown__button--type ActionsDropDown__button--icon ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><span class="ActionsDropDown__button__label">Download article</span></button><div class="ActionsDropDown__menuWrapper"><!----><ul class="ActionsDropDown__menu"><!--[--><li><a href="/journals/neurology/articles/10.3389/fneur.2025.1652378/pdf" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-pdf">Download PDF</a></li><li><a href="http://www.readcube.com/articles/10.3389/fneur.2025.1652378" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-readCube">ReadCube</a></li><li><a href="/journals/neurology/articles/10.3389/fneur.2025.1652378/epub" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-epub">epub</a></li><li><a href="/journals/neurology/articles/10.3389/fneur.2025.1652378/xml" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-nlmXml">XML</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div><div class="ArticleDetails__aside__responsiveButtons__items"><span></span><div class="ArticleDetailsShare__responsive"><button class="ArticleDetailsShare__trigger" aria-label="Open share options"></button><div class="ArticleDetailsShare"><p class="ArticleDetailsShare__title">Share on</p><ul class="ArticleDetailsShare__list"><!--[--><li class="ArticleDetailsShare__item"><a href="https://www.twitter.com/share?url=https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1652378/full" target="_blank" class="ArticleDetailsShare__link--x ArticleDetailsShare__link" title="Share on X" aria-label="Share on X"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.linkedin.com/share?url=https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1652378/full" target="_blank" class="ArticleDetailsShare__link--linkedin ArticleDetailsShare__link" title="Share on Linkedin" aria-label="Share on Linkedin"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.facebook.com/sharer/sharer.php?u=https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1652378/full" target="_blank" class="ArticleDetailsShare__link--facebook ArticleDetailsShare__link" title="Share on Facebook" aria-label="Share on Facebook"></a></li><!--]--></ul></div></div><div class="ActionsDropDown"><button aria-label="Open dropdown" class="ActionsDropDown__button--typeIconButton ActionsDropDown__button--iconQuote ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><!----></button><div class="ActionsDropDown__menuWrapper"><div class="ActionsDropDown__mobileTitle">Export citation</div><ul class="ActionsDropDown__menu"><!--[--><li><a href="/journals/neurology/articles/10.3389/fneur.2025.1652378/endNote" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-endNote">EndNote</a></li><li><a href="/journals/neurology/articles/10.3389/fneur.2025.1652378/reference" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-referenceManager">Reference Manager</a></li><li><a href="/journals/neurology/articles/10.3389/fneur.2025.1652378/text" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-simpleTextFile">Simple Text file</a></li><li><a href="/journals/neurology/articles/10.3389/fneur.2025.1652378/bibTex" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-bibTex">BibTex</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div></div></div><div class="TotalViews"><div class="TotalViews__data"><div class="TotalViews__data__metrics"><div class="TotalViews__data__metrics__number">2,261</div><div class="TotalViews__data__metrics__text"><div class="TotalViews__data__metrics__label">Total views</div></div></div><div class="TotalViews__data__metrics"><div class="TotalViews__data__metrics__number">348</div><div class="TotalViews__data__metrics__text"><div class="TotalViews__data__metrics__label">Downloads</div></div></div><!----><div class="ImpactMetricsInfoPopover"><button aria-label="Open impact metrics info" class="ImpactMetricsInfoPopover__button"></button><div class="ImpactMetricsInfoPopover__tooltip"><button aria-label="Close impact metrics info" class="ImpactMetricsInfoPopover__tooltip__closeButton"></button><div class="ImpactMetricsInfoPopover__tooltip__text"> Citation numbers are available from Dimensions </div></div></div></div><div class="TotalViews__viewImpactLink"><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--chevronRight Link--right" aria-label="View article impact" href="http://loop-impact.frontiersin.org/impact/article/1652378#totalviews/views" target="_blank" data-event="customLink-link-a_viewArticleImpact"><span>View article impact</span></a></span></div><div class="TotalViews__altmetric"><div data-badge-popover="bottom" data-badge-type="donut" data-doi="10.3389/fneur.2025.1652378" data-condensed="true" data-link-target="new" class="altmetric-embed"></div><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--chevronRight Link--right" aria-label="View altmetric score" href="https://www.altmetric.com/details/doi/10.3389/fneur.2025.1652378" target="_blank" data-event="customLink-link-a_viewAltmetricScore"><span>View altmetric score</span></a></span></div></div><div class="ArticleDetailsShare"><p class="ArticleDetailsShare__title">Share on</p><ul class="ArticleDetailsShare__list"><!--[--><li class="ArticleDetailsShare__item"><a href="https://www.twitter.com/share?url=https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1652378/full" target="_blank" class="ArticleDetailsShare__link--x ArticleDetailsShare__link" title="Share on X" aria-label="Share on X"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.linkedin.com/share?url=https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1652378/full" target="_blank" class="ArticleDetailsShare__link--linkedin ArticleDetailsShare__link" title="Share on Linkedin" aria-label="Share on Linkedin"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.facebook.com/sharer/sharer.php?u=https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1652378/full" target="_blank" class="ArticleDetailsShare__link--facebook ArticleDetailsShare__link" title="Share on Facebook" aria-label="Share on Facebook"></a></li><!--]--></ul></div><div class="ArticleDetailsEditors"><div class="ArticleDetailsEditors__editors"><div class="ArticleDetailsEditors__title">Edited by</div><!--[--><a href="https://loop.frontiersin.org/people/2991286/overview" data-event="editorInfo-a-drShrutiVerma" class="ArticleDetailsEditors__ediorInfo"><div class="Avatar Avatar--size-32 Avatar--text Avatar--grey"><!--[--><span class="notranslate">D</span><span class="notranslate">S</span><!--]--></div><div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate">Dr.  Shruti Verma</div><div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate"></div></div></a><!--]--></div></div><div class="ArticleDetailsEditors"><div class="ArticleDetailsEditors__editors"><div class="ArticleDetailsEditors__title">Reviewed by</div><!--[--><a href="https://loop.frontiersin.org/people/451799/overview" data-event="editorInfo-a-chunchenXiang" class="ArticleDetailsEditors__ediorInfo"><div class="Avatar Avatar--size-32 Avatar--text Avatar--grey"><!--[--><span class="notranslate">C</span><span class="notranslate">X</span><!--]--></div><div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate">Chunchen  Xiang</div><div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate"></div></div></a><!--]--></div></div><div class="ArticleDetailsGlossary ArticleDetailsGlossary--open"><button class="ArticleDetailsGlossary__header"><div class="ArticleDetailsGlossary__header__title">Table of contents</div><div class="ArticleDetailsGlossary__header__arrow"></div></button><div class="ArticleDetailsGlossary__content"><ul class="flyoutJournal"> <li><a href="#h1">Abstract</a></li> <li><a href="#h2">1 Introduction</a></li> <li><a href="#h3">2 Neuroimaging biomarkers</a></li> <li><a href="#h4">3 Fluid biomarkers</a></li> <li><a href="#h5">4 Genetic biomarkers</a></li> <li><a href="#h6">5 Digital biomarkers</a></li> <li><a href="#h7">6 Clinical and neuropsychological assessment</a></li> <li><a href="#h8">7 Multimodal integration models</a></li> <li><a href="#h9">8 Conclusion</a></li> <li><a href="#h10">Author contributions</a></li> <li><a href="#h11">Funding</a></li> <li><a href="#h12">Conflict of interest</a></li> <li><a href="#h13">Generative AI statement</a></li> <li><a href="#h14">Publisher&#x2019;s note</a></li> <li><a href="#h15">References</a></li> </ul></div></div><span></span><div class="ActionsDropDown"><button aria-label="Open dropdown" class="ActionsDropDown__button--typeOutline ActionsDropDown__button--iconQuote ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><span class="ActionsDropDown__button__label">Export citation</span></button><div class="ActionsDropDown__menuWrapper"><!----><ul class="ActionsDropDown__menu"><!--[--><li><a href="/journals/neurology/articles/10.3389/fneur.2025.1652378/endNote" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-endNote">EndNote</a></li><li><a href="/journals/neurology/articles/10.3389/fneur.2025.1652378/reference" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-referenceManager">Reference Manager</a></li><li><a href="/journals/neurology/articles/10.3389/fneur.2025.1652378/text" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-simpleTextFile">Simple Text file</a></li><li><a href="/journals/neurology/articles/10.3389/fneur.2025.1652378/bibTex" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-bibTex">BibTex</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div><div class="CheckForUpdates"><button data-target="crossmark" class="CheckForUpdates__link" data-event="checkForUpdates-btn-openModal"><img class="CheckForUpdates__link__img" src="/ap-2024/images/crossmark.svg" alt="Crossmark icon"><div class="CheckForUpdates__link__text">Check for updates</div></button></div><div class="AnnouncementCard"><p class="AnnouncementCard__title">Frontiers&#39; impact</p><article class="CardA"><div class="CardA__wrapper CardA__wrapper--vertical"><figure class="FrontiersImage CardA__img"><picture class="FrontiersImage"><!--[--><source srcset="https://images-provider.frontiersin.org/api/ipx/w=440&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media="(max-width: 563px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=320x400&amp;fit=outside&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media="(max-width: 1024px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=268x280&amp;fit=outside&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media="(max-width: 1441px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=366x408&amp;fit=outside&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media><source srcset="https://images-provider.frontiersin.org/api/ipx/s=366x408&amp;fit=outside&amp;f=jpg/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media><!--]--><img src="https://images-provider.frontiersin.org/api/ipx/s=366x408&amp;fit=outside&amp;f=jpg/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" class="is-inside-mask" alt loading="eager"></picture><!----></figure><div class="CardA__info"><!--[--><h2 class="CardA__title">Articles published with Frontiers have received 12 million total citations</h2><p class="CardA__text">Your research is the real superpower - learn how we maximise its impact through our leading community journals</p><br><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--small Link--icon Link--chevronRight Link--right" aria-label="Explore our impact metrics" href="https://www.frontiersin.org/about/impact" target="_self" data-event="customLink-linkType-a_exploreOurImpactMe"><span>Explore our impact metrics</span></a></span><!--]--></div></div></article></div><!----><!----></div><div><div class="Modal Modal--noFooter"><button aria-label="Close modal" class="Modal__overlay" data-event="modal-overlay-close"></button><div class="Modal__container"><div class="Modal__header"><p class="Modal__title">Supplementary Material</p><button aria-label="Close modal" class="Modal__close" data-event="modal-button-close"></button></div><div class="Modal__body"><!--[--><div class="SupplementalData"><ul class="SupplementalData__list"><!--[--><!--]--></ul></div><!--]--><!----></div><!----><!----></div></div></div><div><div class="FloatingButtons"><!----><div class="ActionsDropDown"><button aria-label="Open dropdown" class="ActionsDropDown__button--type ActionsDropDown__button--iconDownload ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><span class="ActionsDropDown__button__label">Download article</span></button><div class="ActionsDropDown__menuWrapper"><div class="ActionsDropDown__mobileTitle">Download</div><ul class="ActionsDropDown__menu"><!--[--><li><a href="/journals/neurology/articles/10.3389/fneur.2025.1652378/pdf" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-pdf">Download PDF</a></li><li><a href="http://www.readcube.com/articles/10.3389/fneur.2025.1652378" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-readCube">ReadCube</a></li><li><a href="/journals/neurology/articles/10.3389/fneur.2025.1652378/epub" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-epub">epub</a></li><li><a href="/journals/neurology/articles/10.3389/fneur.2025.1652378/xml" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-nlmXml">XML</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div><!----></div></div></div></aside></div><div class=""><!----></div><!--]--></div><!----><footer class="Footer"><div class="Footer__wrapper"><div class="Footer__sections"><ul class="Accordion"><!--[--><!--[--><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Guidelines</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://www.frontiersin.org/guidelines/author-guidelines" target="_self" data-event="footer-block_0-a_authorGuidelines">Author guidelines</a></li><li><a href="https://www.frontiersin.org/for-authors/author-services" target="_self" data-event="footer-block_0-a_servicesForAuthors">Services for authors</a></li><li><a href="https://www.frontiersin.org/guidelines/policies-and-publication-ethics" target="_self" data-event="footer-block_0-a_policiesAndPublicationE">Policies and publication ethics</a></li><li><a href="https://www.frontiersin.org/guidelines/editor-guidelines" target="_self" data-event="footer-block_0-a_editorGuidelines">Editor guidelines</a></li><li><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="footer-block_0-a_feePolicy">Fee policy</a></li><!--]--></ul><!--]--></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Explore</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://www.frontiersin.org/articles" target="_self" data-event="footer-block_1-a_articles">Articles</a></li><li><a href="https://www.frontiersin.org/research-topics" target="_self" data-event="footer-block_1-a_researchTopics">Research Topics </a></li><li><a href="https://www.frontiersin.org/journals" target="_self" data-event="footer-block_1-a_journals">Journals</a></li><li><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="footer-block_1-a_howWePublish">How we publish</a></li><!--]--></ul><!--]--></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Outreach</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://forum.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersForum">Frontiers Forum </a></li><li><a href="https://policylabs.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersPolicyLabs">Frontiers Policy Labs </a></li><li><a href="https://kids.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersForYoungMinds">Frontiers for Young Minds</a></li><li><a href="https://www.frontiersin.org/about/frontiers-planet-prize" target="_self" data-event="footer-block_2-a_frontiersPlanetPrize">Frontiers Planet Prize</a></li><!--]--></ul><!--]--></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Connect</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://helpcenter.frontiersin.org" target="_blank" data-event="footer-block_3-a_helpCenter">Help center</a></li><li><a href="https://subscription-management.frontiersin.org/emails/preferences#block0" target="_blank" data-event="footer-block_3-a_emailsAndAlerts">Emails and alerts </a></li><li><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="footer-block_3-a_contactUs">Contact us </a></li><li><a href="https://www.frontiersin.org/submission/submit" target="_self" data-event="footer-block_3-a_submit">Submit</a></li><li><a href="https://careers.frontiersin.org/" target="_blank" data-event="footer-block_3-a_careerOpportunities">Career opportunities</a></li><!--]--></ul><!--]--></div></li><!--]--><!--]--></ul><div class="Footer__socialLinks"><div class="Footer__socialLinks__title">Follow us</div><!--[--><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--facebook Link--right" aria-label="Frontiers Facebook" href="https://www.facebook.com/Frontiersin" target="_blank" data-event="footer-facebook-a_true"><span></span></a></span><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--twitter Link--right" aria-label="Frontiers Twitter" href="https://twitter.com/frontiersin" target="_blank" data-event="footer-twitter-a_true"><span></span></a></span><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--linkedin Link--right" aria-label="Frontiers LinkedIn" href="https://www.linkedin.com/company/frontiers" target="_blank" data-event="footer-linkedIn-a_true"><span></span></a></span><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--instagram Link--right" aria-label="Frontiers Instagram" href="https://www.instagram.com/frontiersin_" target="_blank" data-event="footer-instagram-a_true"><span></span></a></span><!--]--></div></div><div class="Footer__copyright"><div><span>Â© 2025 Frontiers Media S.A. All rights reserved</span></div><div><a href="https://www.frontiersin.org/legal/privacy-policy" target="_blank">Privacy policy</a><span>Â |Â </span><a href="https://www.frontiersin.org/legal/terms-and-conditions" target="_blank">Terms and conditions</a></div></div></div></footer><div class="SnackbarWrapper"><div class="SnackbarManager"><!--[--><!--]--></div></div></div><noscript><iframe
            src="https://tag-manager.frontiersin.org/ns.html?id=GTM-M322FV2&gtm_auth=owVbWxfaJr21yQv1fe1cAQ&gtm_preview=env-1&gtm_cookies_win=x"
            height="0"
            width="0"
            style="display: none; visibility: hidden">
          </iframe></noscript><!--]--></div><div id="teleports"></div><script type="application/json" id="__NUXT_DATA__" data-ssr="true">[["ShallowReactive",1],{"data":2,"state":4,"once":10,"_errors":11,"serverRendered":13,"path":14,"pinia":15},["ShallowReactive",3],{},["Reactive",5],{"$ssite-config":6},{"env":7,"name":8,"url":9},"production","Frontiers articles","https://article-pages-2024.frontiersin.org/",["Set"],["ShallowReactive",12],{},true,"/journals/neurology/articles/10.3389/fneur.2025.1652378/full",["Reactive",16],{"main":17,"user":579,"article":580,"articleHub":851,"mainHeader":855},{"ibar":18,"footer":296,"newsletterComponent":-1,"snackbarItem":378,"toggleShowSnackbar":379,"contentfulJournal":380,"graphJournal":480,"settingsFeaturesSwitchers":484,"templateToggleBanner":485,"tenantConfig":544},{"tenantLogo":19,"journalLogo":19,"aboutUs":20,"submitUrl":113,"showSubmitButton":13,"journal":114,"sectionTerm":227,"aboutJournal":228,"mainLinks":277,"journalLinks":284,"helpCenterLink":293},"",[21,38,47,71,87],{"title":22,"links":23},"Who we are",[24,29,32,35],{"text":25,"url":26,"target":27,"ariaLabel":28},"Mission and values","https://www.frontiersin.org/about/mission","_self",null,{"text":30,"url":31,"target":27,"ariaLabel":28},"History","https://www.frontiersin.org/about/history",{"text":33,"url":34,"target":27,"ariaLabel":28},"Leadership","https://www.frontiersin.org/about/leadership",{"text":36,"url":37,"target":27,"ariaLabel":28},"Awards","https://www.frontiersin.org/about/awards",{"title":39,"links":40},"Impact and progress",[41,44],{"text":42,"url":43,"target":27,"ariaLabel":28},"Frontiers' impact","https://www.frontiersin.org/about/impact",{"text":45,"url":46,"target":27,"ariaLabel":28},"Our annual reports","https://www.frontiersin.org/about/annual-reports",{"title":48,"links":49},"Publishing model",[50,53,56,59,62,65,68],{"text":51,"url":52,"target":27,"ariaLabel":28},"How we publish","https://www.frontiersin.org/about/how-we-publish",{"text":54,"url":55,"target":27,"ariaLabel":28},"Open access","https://www.frontiersin.org/about/open-access",{"text":57,"url":58,"target":27,"ariaLabel":28},"Peer review","https://www.frontiersin.org/about/peer-review",{"text":60,"url":61,"target":27,"ariaLabel":28},"Research integrity","https://www.frontiersin.org/about/research-integrity",{"text":63,"url":64,"target":27,"ariaLabel":28},"Research Topics","https://www.frontiersin.org/about/research-topics",{"text":66,"url":67,"target":27,"ariaLabel":28},"FAIRÂ² Data Management","https://www.frontiersin.org/about/fair-data-management",{"text":69,"url":70,"target":27,"ariaLabel":28},"Fee policy","https://www.frontiersin.org/about/fee-policy",{"title":72,"links":73},"Services",[74,78,81,84],{"text":75,"url":76,"target":77,"ariaLabel":28},"Societies","https://publishingpartnerships.frontiersin.org/","_blank",{"text":79,"url":80,"target":27,"ariaLabel":28},"National consortia","https://www.frontiersin.org/open-access-agreements/consortia",{"text":82,"url":83,"target":27,"ariaLabel":28},"Institutional partnerships","https://www.frontiersin.org/about/open-access-agreements",{"text":85,"url":86,"target":27,"ariaLabel":28},"Collaborators","https://www.frontiersin.org/about/collaborators",{"title":88,"links":89},"More from Frontiers",[90,94,97,101,105,109],{"text":91,"url":92,"target":77,"ariaLabel":93},"Frontiers Forum","https://forum.frontiersin.org/","this link will take you to the Frontiers Forum website",{"text":95,"url":96,"target":27,"ariaLabel":28},"Frontiers Planet Prize","https://www.frontiersin.org/about/frontiers-planet-prize",{"text":98,"url":99,"target":77,"ariaLabel":100},"Press office","https://pressoffice.frontiersin.org/","this link will take you to the Frontiers press office website",{"text":102,"url":103,"target":27,"ariaLabel":104},"Sustainability","https://www.frontiersin.org/about/sustainability","link to information about Frontiers' sustainability",{"text":106,"url":107,"target":77,"ariaLabel":108},"Career opportunities","https://careers.frontiersin.org/","this link will take you to the Frontiers careers website",{"text":110,"url":111,"target":27,"ariaLabel":112},"Contact us","https://www.frontiersin.org/about/contact","this link will take you to the help pages to contact our support team","https://www.frontiersin.org/submission/submit?domainid=2&fieldid=54&specialtyid=0&entitytype=2&entityid=141",{"id":115,"name":116,"slug":117,"sections":118},141,"Frontiers in Neurology","neurology",[119,123,127,131,135,139,143,147,151,155,159,163,167,171,175,179,183,187,191,195,199,203,207,211,215,219,223],{"id":120,"name":121,"slug":122},156,"Applied Neuroimaging","applied-neuroimaging",{"id":124,"name":125,"slug":126},3712,"Artificial Intelligence in Neurology","artificial-intelligence-in-neurology",{"id":128,"name":129,"slug":130},3023,"Autonomic Disorders","autonomic-disorders",{"id":132,"name":133,"slug":134},3740,"Cognitive and Behavioral Neurology","cognitive-and-behavioral-neurology",{"id":136,"name":137,"slug":138},1439,"Dementia and Neurodegenerative Diseases","dementia-and-neurodegenerative-diseases",{"id":140,"name":141,"slug":142},2038,"Diagnostic Neuropathology","diagnostic-neuropathology",{"id":144,"name":145,"slug":146},143,"Endovascular and Interventional Neurology","endovascular-and-interventional-neurology",{"id":148,"name":149,"slug":150},144,"Epilepsy","epilepsy",{"id":152,"name":153,"slug":154},1784,"Experimental Therapeutics","experimental-therapeutics",{"id":156,"name":157,"slug":158},153,"Headache and Neurogenic Pain","headache-and-neurogenic-pain",{"id":160,"name":161,"slug":162},145,"Movement Disorders","movement-disorders",{"id":164,"name":165,"slug":166},147,"Multiple Sclerosis and Neuroimmunology","multiple-sclerosis-and-neuroimmunology",{"id":168,"name":169,"slug":170},150,"Neuro-Oncology and Neurosurgical Oncology","neuro-oncology-and-neurosurgical-oncology",{"id":172,"name":173,"slug":174},154,"Neuro-Ophthalmology","neuro-ophthalmology",{"id":176,"name":177,"slug":178},155,"Neuro-Otology","neuro-otology",{"id":180,"name":181,"slug":182},159,"Neurocritical and Neurohospitalist Care","neurocritical-and-neurohospitalist-care",{"id":184,"name":185,"slug":186},1339,"Neuroepidemiology","neuroepidemiology",{"id":188,"name":189,"slug":190},160,"Neurogenetics","neurogenetics",{"id":192,"name":193,"slug":194},1334,"Neuroinfectious Diseases","neuroinfectious-diseases",{"id":196,"name":197,"slug":198},2345,"Neurological Biomarkers","neurological-biomarkers",{"id":200,"name":201,"slug":202},146,"Neuromuscular Disorders and Peripheral Neuropathies","neuromuscular-disorders-and-peripheral-neuropathies",{"id":204,"name":205,"slug":206},547,"Neurorehabilitation","neurorehabilitation",{"id":208,"name":209,"slug":210},3418,"Neurotechnology","neurotechnology",{"id":212,"name":213,"slug":214},163,"Neurotrauma","neurotrauma",{"id":216,"name":217,"slug":218},161,"Pediatric Neurology","pediatric-neurology",{"id":220,"name":221,"slug":222},151,"Sleep Disorders","sleep-disorders",{"id":224,"name":225,"slug":226},142,"Stroke","stroke","Sections",[229,253],{"title":230,"links":231},"Scope",[232,235,238,241,244,247,250],{"text":233,"url":234,"target":27,"ariaLabel":28},"Field chief editors","https://www.frontiersin.org/journals/neurology/about#about-editors",{"text":236,"url":237,"target":27,"ariaLabel":28},"Mission & scope","https://www.frontiersin.org/journals/neurology/about#about-scope",{"text":239,"url":240,"target":27,"ariaLabel":28},"Facts","https://www.frontiersin.org/journals/neurology/about#about-facts",{"text":242,"url":243,"target":27,"ariaLabel":28},"Journal sections","https://www.frontiersin.org/journals/neurology/about#about-submission",{"text":245,"url":246,"target":27,"ariaLabel":28},"Open access statement","https://www.frontiersin.org/journals/neurology/about#about-open",{"text":248,"url":249,"target":27,"ariaLabel":28},"Copyright statement","https://www.frontiersin.org/journals/neurology/about#copyright-statement",{"text":251,"url":252,"target":27,"ariaLabel":28},"Quality","https://www.frontiersin.org/journals/neurology/about#about-quality",{"title":254,"links":255},"For authors",[256,259,262,265,268,271,274],{"text":257,"url":258,"target":27,"ariaLabel":28},"Why submit?","https://www.frontiersin.org/journals/neurology/for-authors/why-submit",{"text":260,"url":261,"target":27,"ariaLabel":28},"Article types","https://www.frontiersin.org/journals/neurology/for-authors/article-types",{"text":263,"url":264,"target":27,"ariaLabel":28},"Author guidelines","https://www.frontiersin.org/journals/neurology/for-authors/author-guidelines",{"text":266,"url":267,"target":27,"ariaLabel":28},"Editor guidelines","https://www.frontiersin.org/journals/neurology/for-authors/editor-guidelines",{"text":269,"url":270,"target":27,"ariaLabel":28},"Publishing fees","https://www.frontiersin.org/journals/neurology/for-authors/publishing-fees",{"text":272,"url":273,"target":27,"ariaLabel":28},"Submission checklist","https://www.frontiersin.org/journals/neurology/for-authors/submission-checklist",{"text":275,"url":276,"target":27,"ariaLabel":28},"Contact editorial office","https://www.frontiersin.org/journals/neurology/for-authors/contact-editorial-office",[278,281],{"text":279,"url":280,"target":27,"ariaLabel":28},"All journals","https://www.frontiersin.org/journals",{"text":282,"url":283,"target":27,"ariaLabel":28},"All articles","https://www.frontiersin.org/articles",[285,288,290],{"text":286,"url":287,"target":27,"ariaLabel":28},"Articles","articles",{"text":63,"url":289,"target":27,"ariaLabel":28},"research-topics",{"text":291,"url":292,"target":27,"ariaLabel":28},"Editorial board","editors",{"text":294,"url":295,"target":77,"ariaLabel":294},"Help center","https://helpcenter.frontiersin.org",{"blocks":297,"socialLinks":351,"copyright":375,"termsAndConditionsUrl":376,"privacyPolicyUrl":377},[298,312,322,336],{"title":299,"links":300},"Guidelines",[301,303,306,309,311],{"text":263,"url":302,"target":27,"ariaLabel":28},"https://www.frontiersin.org/guidelines/author-guidelines",{"text":304,"url":305,"target":27,"ariaLabel":28},"Services for authors","https://www.frontiersin.org/for-authors/author-services",{"text":307,"url":308,"target":27,"ariaLabel":28},"Policies and publication ethics","https://www.frontiersin.org/guidelines/policies-and-publication-ethics",{"text":266,"url":310,"target":27,"ariaLabel":28},"https://www.frontiersin.org/guidelines/editor-guidelines",{"text":69,"url":70,"target":27,"ariaLabel":28},{"title":313,"links":314},"Explore",[315,316,319,321],{"text":286,"url":283,"target":27,"ariaLabel":28},{"text":317,"url":318,"target":27,"ariaLabel":28},"Research Topics ","https://www.frontiersin.org/research-topics",{"text":320,"url":280,"target":27,"ariaLabel":28},"Journals",{"text":51,"url":52,"target":27,"ariaLabel":28},{"title":323,"links":324},"Outreach",[325,328,331,335],{"text":326,"url":92,"target":77,"ariaLabel":327},"Frontiers Forum ","Frontiers Forum website",{"text":329,"url":330,"target":77,"ariaLabel":28},"Frontiers Policy Labs ","https://policylabs.frontiersin.org/",{"text":332,"url":333,"target":77,"ariaLabel":334},"Frontiers for Young Minds","https://kids.frontiersin.org/","Frontiers for Young Minds journal",{"text":95,"url":96,"target":27,"ariaLabel":28},{"title":337,"links":338},"Connect",[339,340,344,347,350],{"text":294,"url":295,"target":77,"ariaLabel":294},{"text":341,"url":342,"target":77,"ariaLabel":343},"Emails and alerts ","https://subscription-management.frontiersin.org/emails/preferences#block0","Subscribe to Frontiers emails",{"text":345,"url":111,"target":27,"ariaLabel":346},"Contact us ","Subscribe to newsletter",{"text":348,"url":349,"target":27,"ariaLabel":28},"Submit","https://www.frontiersin.org/submission/submit",{"text":106,"url":107,"target":77,"ariaLabel":28},[352,360,365,370],{"link":353,"type":356,"color":357,"icon":358,"size":359,"hiddenText":13},{"text":354,"url":355,"target":77,"ariaLabel":354},"Frontiers Facebook","https://www.facebook.com/Frontiersin","Link","Grey","Facebook","Medium",{"link":361,"type":356,"color":357,"icon":364,"size":359,"hiddenText":13},{"text":362,"url":363,"target":77,"ariaLabel":28},"Frontiers Twitter","https://twitter.com/frontiersin","Twitter",{"link":366,"type":356,"color":357,"icon":369,"size":359,"hiddenText":13},{"text":367,"url":368,"target":77,"ariaLabel":28},"Frontiers LinkedIn","https://www.linkedin.com/company/frontiers","LinkedIn",{"link":371,"type":356,"color":357,"icon":374,"size":359,"hiddenText":13},{"text":372,"url":373,"target":77,"ariaLabel":28},"Frontiers Instagram","https://www.instagram.com/frontiersin_","Instagram","Frontiers Media S.A. All rights reserved","https://www.frontiersin.org/legal/terms-and-conditions","https://www.frontiersin.org/legal/privacy-policy",{},false,{"__typename":381,"identifier":115,"name":116,"slug":117,"banner":382,"description":473,"mission":474,"palette":475,"impactFactor":476,"citeScore":477,"citations":478,"showTagline":28,"twitter":479},"Journal",[383],{"id":384,"src":385,"name":386,"tags":387,"type":432,"width":433,"height":434,"idHash":435,"archive":436,"brandId":437,"limited":436,"fileSize":438,"isPublic":439,"original":440,"copyright":19,"extension":441,"thumbnails":443,"dateCreated":451,"description":452,"orientation":453,"userCreated":454,"watermarked":436,"dateModified":451,"datePublished":455,"ecsArchiveFiles":456,"propertyOptions":457,"property_Channel":462,"property_Sub-Type":464,"property_Asset_Type":466,"activeOriginalFocusPoint":468,"property_Office_Department":471},"D315ADB2-2967-48B6-BE3B61009343D69E","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/D315ADB2-2967-48B6-BE3B61009343D69E/webimage-810A1E19-163C-4FD0-BFD3D50A4721B642.png","FNEUR_Main Visual_Cyan_Website",[388,389,390,391,392,393,394,395,396,397,398,399,400,401,402,403,404,405,406,407,408,409,410,411,412,413,414,415,416,417,418,419,420,421,422,423,424,425,426,427,428,429,117,430,431],"professional","device","medical","close up","technology","wires","brain waves","record","digital","selective focus","laboratory","brain","health","electrodes","computer","examination","electroencephalography","scan","study","oncology","examine","electroencephalogram","neurosurgery","science","doctor","diagnose","magnetic","patient","modern","electroencephalograph","equipment","office","healthcare","scanning","instrument","eeg","hospital","ct","technician","medicine","ultrasound","radiology","diagnostic","lab","image",5052,3368,"62463d527f6ddd4d",0,"22C10171-81B3-4DA6-99342F272A32E8BB",5758943,1,"https://brand.frontiersin.org/m/62463d527f6ddd4d/original/FNEUR_Main-Visual_Cyan_Website.jpg",[442],"jpg",{"mini":444,"thul":445,"webimage":385,"Guidelines":446,"WebsiteJpg_XL":447,"WebsiteWebP_L":448,"WebsiteWebP_M":449,"WebsiteWebP_XL":450},"https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/D315ADB2-2967-48B6-BE3B61009343D69E/mini-A927C1B7-02F8-4D29-94320F509270457D.png","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/D315ADB2-2967-48B6-BE3B61009343D69E/thul-FCD9F16D-D1A9-4535-A7E4C140224266B9.png","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/D315ADB2-2967-48B6-BE3B61009343D69E/84855035-8C7E-4727-AB7CEC390287243C/Guidelines-FNEUR_Main Visual_Cyan_Website.png","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/D315ADB2-2967-48B6-BE3B61009343D69E/84855035-8C7E-4727-AB7CEC390287243C/WebsiteJpg_XL-FNEUR_Main Visual_Cyan_Website.jpg","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/D315ADB2-2967-48B6-BE3B61009343D69E/84855035-8C7E-4727-AB7CEC390287243C/WebsiteWebP_L-FNEUR_Main Visual_Cyan_Website.webp","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/D315ADB2-2967-48B6-BE3B61009343D69E/84855035-8C7E-4727-AB7CEC390287243C/WebsiteWebP_M-FNEUR_Main Visual_Cyan_Website.webp","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/D315ADB2-2967-48B6-BE3B61009343D69E/84855035-8C7E-4727-AB7CEC390287243C/WebsiteWebP_XL-FNEUR_Main Visual_Cyan_Website.webp","2022-06-27T10:00:23Z","Charming young woman undergoing electroencephalography; Shutterstock ID 695951221; purchase_order: Main Visual; job: ; client: ; other:","landscape","Caroline Sutter","2022-06-27T06:08:46Z",[],[458,459,460,461],"414FB2D4-2283-43FD-BE14E534ECA67928","6C18119B-14BD-4951-B437696F4357BD33","7C692885-DB25-4858-B1FB4FF47B241E9B","D88C0047-EC30-4506-A7DF28A4D765E1CF",[463],"frontiersin_org",[465],"Main_Visual",[467],"Photography",{"x":469,"y":470},2526,1684,[472],"Publishing","The world's most cited clinical neurology journal, exploring the diagnosis, causes, treatment, and public health aspects of neurological illnesses to improve patient care.","\u003Cp>Frontiers in Neurology is a multidisciplinary journal that addresses all areas of neurology to better understand, treat, and prevent neurological disorders. It is indexed in PubMed Central (PMC), Scopus, and the DOAJ.\u003C/p>\n\n\u003Cp>Led by Field Chief Editor Prof. Irene Litvan (University of California, San Diego, USA), Frontiers in Neurology welcomes submissions that explore the diagnosis, nature, causes, treatment, and public health aspects of neurological disorders.\u003C/p>\n\n\u003Cp>The journal covers a wide spectrum of basic, translational, and clinical research that help improve patient care, including but not limited to:\u003C/p>\n\n\u003Cul>\n  \u003Cli>artificial intelligence in neurology\u003C/li>\n  \u003Cli>applied neuroimaging\u003C/li>\n  \u003Cli>autonomic disorders\u003C/li>\n  \u003Cli>cognitive behavioural neurology\u003C/li>\n  \u003Cli>dementia and neurodegenerative diseases\u003C/li>\n  \u003Cli>diagnostic and forensic neuropathology\u003C/li>\n  \u003Cli>endovascular and interventional neurology\u003C/li>\n  \u003Cli>epilepsy\u003C/li>\n  \u003Cli>experimental therapeutics\u003C/li>\n  \u003Cli>headache and neurogenic pain\u003C/li>\n  \u003Cli>movement disorders\u003C/li>\n  \u003Cli>multiple sclerosis and neuroimmunology\u003C/li>\n  \u003Cli>neuro-oncology and neurosurgical oncology\u003C/li>\n  \u003Cli>neuro-ophthalmology\u003C/li>\n  \u003Cli>neuro-otology\u003C/li>\n  \u003Cli>neurocritical and neurohospitalist care\u003C/li>\n  \u003Cli>neuroepidemiology\u003C/li>\n  \u003Cli>neurogenetics\u003C/li>\n  \u003Cli>neuroinfectious diseases\u003C/li>\n  \u003Cli>neurological biomarkers\u003C/li>\n  \u003Cli>neuromuscular disorders and peripheral neuropathies\u003C/li>\n  \u003Cli>neurorehabilitation\u003C/li>\n  \u003Cli>neurotechnology\u003C/li>\n  \u003Cli>neurotrauma\u003C/li>\n  \u003Cli>pediatric neurology\u003C/li>\n  \u003Cli>sleep disorders\u003C/li>\n  \u003Cli>stroke\u003C/li>\n\u003C/ul>\n\n\u003Cp>In particular, the journal welcomes submissions that support and advance the UNâ€™s \u003Ca href=https://globalgoals.org/goals/>Sustainable Development Goals\u003C/a> (SDGs), notably \u003Ca href=https://globalgoals.org/goals/3-good-health-and-well-being/>SDG 3: Good Health and Well-Being\u003C/a>.\u003C/p>\n\n\u003Cp>Manuscripts that focus solely on surgical techniques, clinical trials, or case reports are not suitable for publication in this journal. Studies that do not provide significant insight into the neurological basis of disease or disorder, or those that do not contribute to the understanding of the fundamental mechanisms of neurology, diagnosis and treatment of neurological disorders are not appropriate for this journal.\u003C/p>\n\n\u003Cp>The journal no longer accepts papers concerning simple bibliometric studies. Authors are still welcome to submit Systematic Reviews using publicly available data, but these must adhere to the \u003Ca href=https://www.prisma-statement.org/>PRISMA guidelines\u003C/a> and have a conclusion related to neurological research. Studies without this primary focus will be transferred to a more applicable journal.\u003C/p>\n\n\u003Cp>Frontiersâ€™ journals require that manuscripts primarily comprising computational studies of public data, such as NHANES or Mendelian Randomization studies, must include appropriate validation. Please refer to the \u003Ca href=\"https://www.frontiersin.org/guidelines/policies-and-publication-ethics#standards-for-research-methodology:~:text=complaints%20and%20allegations.-,Standards%20for%20research%20methodology,-Experiments\">Frontiers Standards for research methodology policy\u003C/a> for more information. Manuscripts not adhering to these standards will not be considered.\u003Cp>\n\n\u003Cp>Frontiers in Neurology is committed to advancing developments in the field of neurology by communicating scientific knowledge to researchers, academics, clinicians and the public worldwide, to enable the scientific breakthroughs of the future.\u003C/p>","cyan","3.4","4.8","273537","@FrontNeurol",{"id":115,"name":116,"slug":117,"abbreviation":481,"isOnline":13,"isOpenForSubmissions":13,"citeScore":482,"impactFactor":483},"fneur",5.2,2.8,{"displayTitlePillLabels":13,"displayRelatedArticlesBox":13,"showEditors":13,"showReviewers":13,"showLoopImpactLink":13,"enableFigshare":379,"useXmlImages":13},{"isPublic":13,"allowCompanyUsers":379,"whiteListEmails":486,"enableAllJournals":13,"whiteListJournals":508},[487,488,489,490,491,492,493,494,495,492,496,497,498,499,500,501,502,503,504,505,506,507],"Y2FybG9zLmxvcmNhQGZyb250aWVyc2luLm9yZw==","ZGFuaWVsLmx1ekBmcm9udGllcnNpbi5vcmc=","bGF1cmEudGVuYUBmcm9udGllcnNpbi5vcmc=","cmFmYWVsLnJpYW5jaG9AZnJvbnRpZXJzaW4ub3Jn","amFtZXMuc21hbGxib25lQGZyb250aWVyc2luLm9yZw==","ZnJhbi5tb3Jlbm9AZnJvbnRpZXJzaW4ub3Jn","c2FtdWVsLmZlcm5hbmRlekBmcm9udGllcnNpbi5vcmc=","YmFyYmFyYS5jYXJjYW5naXVAZnJvbnRpZXJzaW4ub3Jn","aXZhbi5zYW50YW1hcmlhQGZyb250aWVyc2luLm9yZw==","aHVlLnRyYW5AZnJvbnRpZXJzaW4ub3Jn","Z29uY2Fsby52YXJnYXNAZnJvbnRpZXJzaW4ub3Jn","bHVjaWUuc2VubkBmcm9udGllcnNpbi5vcmc=","bG9ybi5mcmFzZXJAZnJvbnRpZXJzaW4ub3Jn","ZWxzYS5jYXJyb25AZnJvbnRpZXJzaW4ub3Jn","bWFhcnRlbi52YW5kaWpja0Bmcm9udGllcnNpbi5vcmc=","YmluZGh1LmtyaXNobmFuQGZyb250aWVyc2luLm9yZw==","bWF0dGhldy5hdHR3YXRlcnNAZnJvbnRpZXJzaW4ub3Jn","Z2l1bGlhLnZhbHNlY2NoaUBmcm9udGllcnNpbi5vcmc=","ZmFiaWFuLmRlbGxhbW9ydGVAZnJvbnRpZXJzaW4ub3Jn","dmlqYXlhbi5wcEBwaXRzb2x1dGlvbnMuY29t","Z3VpbGxhdW1lLnNldXJhdEBmcm9udGllcnNpbi5vcmc=",[509,510,511,512,513,514,439,515,516,517,518,519,520,521,522,523,524,525,526,527,528,529,115,530,531,532,533,534,535,536,537,538,539,540,541,542,543],2232,1729,2357,2456,2176,2333,1843,602,106,616,310,657,3123,1468,2137,628,1566,2726,2086,1490,451,1335,2655,1238,604,698,1547,176,1440,403,1239,755,2136,609,1534,{"spaceId":439,"name":439,"availableJournalPages":545,"announcement":549},[287,292,289,546,547,548],"volumes","about","community-reviewers",{"__typename":550,"sys":551,"preHeader":42,"title":553,"description":554,"image":555,"link":577},"Announcement",{"id":552},"5ITtnTtQgAzPPGH6rX0AlM","Articles published with Frontiers have received 12 million total citations","Your research is the real superpower - learn how we maximise its impact through our leading community journals",[556],{"archive":436,"brandId":437,"copyright":28,"dateCreated":557,"dateModified":558,"datePublished":559,"description":28,"extension":560,"fileSize":562,"height":563,"id":564,"isPublic":436,"limited":436,"name":565,"orientation":453,"original":28,"thumbnails":566,"type":432,"watermarked":436,"width":573,"videoPreviewURLs":574,"tags":575,"textMetaproperties":576,"src":567},"2025-06-18T12:58:01Z","2025-06-18T14:15:34Z","2025-06-18T12:57:32Z",[561],"png",1365026,920,"7C5269C4-3C83-4591-951A74D15B95DAEA","Impact metrics banner for article pages",{"webimage":567,"thul":568,"mini":569,"WebsiteWebP_L":570,"WebsiteWebP_M":571,"Guidelines":572},"https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/m/59ee6275cb9a849c/thul-Impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/m/59ee6275cb9a849c/mini-Impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/WebsiteWebP_L/Impact-metrics-banner-for-article-pages.webp","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/WebsiteWebP_M/Impact-metrics-banner-for-article-pages.webp","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/Guidelines/Impact-metrics-banner-for-article-pages.png",1600,[],[],[],{"text":578,"url":43,"target":27,"ariaLabel":28},"Explore our impact metrics",{"loggedUserInfo":-1},{"currentArticle":581,"isPreviewPage":379,"hasSupplementalData":379,"showCrossmarkWidget":13,"articleTemplate":718,"currentArticlePageMetaInfo":719,"xmlParsedArticleContent":-1,"xmlParsingError":-1},{"id":582,"doi":583,"title":584,"acceptanceDate":585,"receptionDate":586,"publicationDate":587,"lastModifiedDate":588,"isPublished":13,"abstract":589,"researchTopic":590,"articleType":596,"stage":599,"keywords":601,"authors":607,"editors":661,"reviewers":669,"journal":677,"section":685,"impactMetrics":687,"volume":690,"articleVolume":691,"relatedArticles":692,"isPublishedV2":13,"contents":693,"files":697,"htmlZipFileName":717},1652378,"10.3389/fneur.2025.1652378","Research progress of multimodal biomarkers in the early diagnosis of mild cognitive impairment in Parkinsonâ€™s disease","2025-08-01T14:42:50.000Z","2025-06-23T13:26:38.000Z","2025-08-29T00:00:00.000Z","2025-10-12T02:04:21.699Z","Parkinsonâ€™s disease (PD), as a common neurodegenerative disorder, its associated mild cognitive impairment (PD-mild cognitive impairment, PD-MCI) is a key prodromal stage in the progression to PD-dementia (PDD). Cognitive dysfunction seriously affects the quality of life of patients. Early diagnosis of PD-MCI is crucial for the prognosis of the disease. At present, traditional clinical diagnosis mainly relies on neuropsychological tests, but it has limitations such as low sensitivity and being easily interfered by subjective factors. It is difficult to achieve early and accurate identification of PD-MCI, which greatly affects the intervention timing and prognosis of the disease. This article summarizes the research progress of multimodal biomarkers in the early diagnosis of PD-MCI, mainly including the comprehensive application of neuroimaging biomarkers, humoral biomarkers, genetic and molecular biomarkers, digital biomarkers, and clinical assessment, providing new theoretical basis and technical paths for promoting the early diagnosis of PD-MCI. It is of great clinical significance and social value to assist in the formulation of individualized intervention strategies, delay the progression of diseases to dementia, improve the quality of life of patients, and reduce the medical burden on families and society.",{"id":591,"title":592,"articlesCount":593,"isMagazinePage":379,"slug":594,"isOpenForSubmission":13,"views":595},71456,"Identification of Neurological Biomarkers for Neurodegenerative Disorders",4,"identification-of-neurological-biomarkers-for-neurodegenerative-disorders",5726,{"id":597,"name":598},99,"Mini Review",{"id":600,"name":19},18,[602,603,604,605,606],"review","early diagnosis","machine learning algorithm","multimodal biomarkers","Parkinsonâ€™s disease-mild cognitive impairment",[608,619,625,633,640,647,654],{"id":609,"firstName":610,"middleName":19,"lastName":611,"givenNames":612,"isCorresponding":379,"isProfilePublic":13,"userId":609,"email":-1,"affiliations":613},2023989,"Huiping","Guo","Huiping ",[614,617],{"organizationName":615,"countryName":616,"cityName":19,"stateName":19,"zipCode":19},"Department of Encephalopathy, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine","China",{"organizationName":618,"countryName":616,"cityName":19,"stateName":19,"zipCode":19},"The First Clinical Medical College, Henan University of Chinese Medicine",{"id":436,"firstName":620,"middleName":19,"lastName":621,"givenNames":622,"isCorresponding":379,"isProfilePublic":379,"userId":436,"email":-1,"affiliations":623},"Xiaoming","Shen","Xiaoming ",[624],{"organizationName":615,"countryName":616,"cityName":19,"stateName":19,"zipCode":19},{"id":626,"firstName":627,"middleName":19,"lastName":628,"givenNames":629,"isCorresponding":379,"isProfilePublic":13,"userId":626,"email":-1,"affiliations":630},1249698,"Mengke","Lyu","Mengke ",[631,632],{"organizationName":615,"countryName":616,"cityName":19,"stateName":19,"zipCode":19},{"organizationName":618,"countryName":616,"cityName":19,"stateName":19,"zipCode":19},{"id":436,"firstName":634,"middleName":19,"lastName":635,"givenNames":636,"isCorresponding":379,"isProfilePublic":379,"userId":436,"email":-1,"affiliations":637},"Guangsheng","Zhou","Guangsheng ",[638,639],{"organizationName":615,"countryName":616,"cityName":19,"stateName":19,"zipCode":19},{"organizationName":618,"countryName":616,"cityName":19,"stateName":19,"zipCode":19},{"id":436,"firstName":641,"middleName":19,"lastName":642,"givenNames":643,"isCorresponding":379,"isProfilePublic":379,"userId":436,"email":-1,"affiliations":644},"Chongchong","Chen","Chongchong ",[645,646],{"organizationName":615,"countryName":616,"cityName":19,"stateName":19,"zipCode":19},{"organizationName":618,"countryName":616,"cityName":19,"stateName":19,"zipCode":19},{"id":436,"firstName":648,"middleName":19,"lastName":649,"givenNames":650,"isCorresponding":379,"isProfilePublic":379,"userId":436,"email":-1,"affiliations":651},"Baofu","Xing","Baofu ",[652,653],{"organizationName":615,"countryName":616,"cityName":19,"stateName":19,"zipCode":19},{"organizationName":618,"countryName":616,"cityName":19,"stateName":19,"zipCode":19},{"id":436,"firstName":655,"middleName":19,"lastName":656,"givenNames":657,"isCorresponding":379,"isProfilePublic":379,"userId":436,"email":-1,"affiliations":658},"Yanming","Xie","Yanming ",[659],{"organizationName":660,"countryName":616,"cityName":19,"stateName":19,"zipCode":19},"Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences",[662],{"id":663,"firstName":664,"middleName":19,"lastName":665,"givenNames":666,"isCorresponding":379,"isProfilePublic":13,"userId":663,"email":-1,"affiliations":667},2991286,"Dr.","Shruti Verma","Dr. ",[668],{"organizationName":19,"countryName":19,"cityName":19,"stateName":19,"zipCode":19},[670],{"id":671,"firstName":672,"middleName":19,"lastName":673,"givenNames":674,"isCorresponding":379,"isProfilePublic":13,"userId":671,"email":-1,"affiliations":675},451799,"Chunchen","Xiang","Chunchen ",[676],{"organizationName":19,"countryName":19,"cityName":19,"stateName":19,"zipCode":19},{"id":115,"slug":117,"name":116,"shortName":678,"electronicISSN":679,"field":680,"specialtyId":28,"journalSectionPaths":683},"Front. Neurol.","1664-2295",{"id":681,"domainId":682},54,2,[684],{"section":685},{"id":196,"name":197,"slug":198,"specialtyId":686},2717,{"views":688,"downloads":689,"citations":436},2261,348,16,"Volume 16 - 2025",[],{"titleHtml":694,"fullTextHtml":695,"menuHtml":696},"Research progress of multimodal biomarkers in the early diagnosis of mild cognitive impairment in Parkinson&#x2019;s disease","\u003Cdiv class=\"JournalAbstract\"> \u003Ca id=\"h1\" name=\"h1\">\u003C/a>\n \u003Cdiv class=\"authors\">\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/2023989\" class=\"user-id-2023989\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/2023989/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Huiping Guo,\">Huiping Guo\u003C/a>\u003Csup>1,2\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Xiaoming Shen&#xA;\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Xiaoming Shen\u003Csup>1\u003C/sup>\u003Csup>&#x0002A;\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/1249698\" class=\"user-id-1249698\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/1249698/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Mengke Lyu,\">Mengke Lyu\u003C/a>\u003Csup>1,2\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Guangsheng Zhou,\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Guangsheng Zhou\u003Csup>1,2\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Chongchong Chen,\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Chongchong Chen\u003Csup>1,2\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Baofu Xing,\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Baofu Xing\u003Csup>1,2\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Yanming Xie\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Yanming Xie\u003Csup>3\u003C/sup>\u003C/span>\u003C/div> \u003Cul class=\"notes\"> \u003Cli>\u003Cspan>\u003Csup>1\u003C/sup>\u003C/span>Department of Encephalopathy, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, China\u003C/li> \u003Cli>\u003Cspan>\u003Csup>2\u003C/sup>\u003C/span>The First Clinical Medical College, Henan University of Chinese Medicine, Zhengzhou, China\u003C/li> \u003Cli>\u003Cspan>\u003Csup>3\u003C/sup>\u003C/span>Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China\u003C/li> \u003C/ul>\n\u003Cp>Parkinson&#x2019;s disease (PD), as a common neurodegenerative disorder, its associated mild cognitive impairment (PD-mild cognitive impairment, PD-MCI) is a key prodromal stage in the progression to PD-dementia (PDD). Cognitive dysfunction seriously affects the quality of life of patients. Early diagnosis of PD-MCI is crucial for the prognosis of the disease. At present, traditional clinical diagnosis mainly relies on neuropsychological tests, but it has limitations such as low sensitivity and being easily interfered by subjective factors. It is difficult to achieve early and accurate identification of PD-MCI, which greatly affects the intervention timing and prognosis of the disease. This article summarizes the research progress of multimodal biomarkers in the early diagnosis of PD-MCI, mainly including the comprehensive application of neuroimaging biomarkers, humoral biomarkers, genetic and molecular biomarkers, digital biomarkers, and clinical assessment, providing new theoretical basis and technical paths for promoting the early diagnosis of PD-MCI. It is of great clinical significance and social value to assist in the formulation of individualized intervention strategies, delay the progression of diseases to dementia, improve the quality of life of patients, and reduce the medical burden on families and society.\u003C/p> \u003Cdiv class=\"clear\">\u003C/div> \u003C/div> \u003Cdiv class=\"JournalFullText\"> \u003Ca id=\"h2\" name=\"h2\">\u003C/a>\n\u003Ch2>1 Introduction\u003C/h2>\n\u003Cp class=\"mb0\">Mild cognitive impairment (PD-mild cognitive impairment, PD-MCI) in Parkinson&#x2019;s disease is the prodromal stage of PD-dementia (PDD), and its diagnosis and treatment are crucial for improving the prognosis of patients. Relevant epidemiological research shows that over 80% of PD patients have cognitive function changes, and approximately 30% of them will eventually develop into PDD (\u003Ca href=\"#ref1\">1\u003C/a>). Between 20 and 33% of patients have PD-MCI at the time of diagnosis of PD, and as many as 57% of PD patients develop PD-MCI successively within 5&#x202F;years after the first diagnosis (\u003Ca href=\"#ref2\">2\u003C/a>, \u003Ca href=\"#ref3\">3\u003C/a>). In recent years, with the rapid development of big data, artificial intelligence and machine learning technologies, the application of multimodal biomarkers has increasingly gained favor in clinical research, providing powerful tools for the early diagnosis and prognosis of diseases. By aggregating and integrating multi-dimensional data such as neuroimaging, humoral biomarkers, genetics, digital phenotypes, and clinical assessment tools, the pathophysiological changes of PD-MCI can be reflected from different perspectives, providing support for conducting high-quality clinical research and precise diagnosis and treatment. The realization of precise identification of risk factors for PD-MCI, early intervention of the disease and improvement of prognosis provides evidence-based medical evidence, which is conducive to the formulation of effective prevention and treatment strategies in clinical practice. This article reviews the application of multimodal biomarkers in the diagnosis of PD-MCI, explores their different roles in clinical diagnosis, and looks forward to their potential value in the assessment of PD-MCI, aiming to provide a more comprehensive diagnostic strategy for clinical practice and offer references for future research directions (\u003Ca href=\"#fig1\">Figure 1\u003C/a>).\u003C/p>\n\u003Cdiv class=\"DottedLine\">\u003C/div> \u003Cdiv class=\"Imageheaders\">Figure 1\u003C/div> \u003Cdiv class=\"FigureDesc\">\u003Ca href=\"https://www.frontiersin.org/files/Articles/1652378/fneur-16-1652378-HTML/image_m/fneur-16-1652378-g001.jpg\" name=\"figure1\" target=\"_blank\">\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/1652378/fneur-16-1652378-HTML/image_m/fneur-16-1652378-g001.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/1652378/fneur-16-1652378-HTML/image_m/fneur-16-1652378-g001.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/1652378/fneur-16-1652378-HTML/image_m/fneur-16-1652378-g001.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/1652378/fneur-16-1652378-HTML/image_m/fneur-16-1652378-g001.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/1652378/fneur-16-1652378-HTML/image_m/fneur-16-1652378-g001.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/1652378/fneur-16-1652378-HTML/image_m/fneur-16-1652378-g001.jpg\" alt=\"Flowchart illustrating the multimodal biomarker classification for early prediction of PD-MCI. It includes categories: neuroimaging, body fluid, genetics and molecular, digital, and clinical assessment. Each category lists specific methods and associated factors like gray/white matter, blood markers, gene mutations, speech analysis, and clinical scales.\" id=\"fig1\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\n\u003Cp>\u003Cb>Figure 1\u003C/b>. Classification and techniques of multimodal biomarkers.\u003C/p>\u003C/div> \u003Cdiv class=\"clear\">\u003C/div> \u003Cdiv class=\"DottedLine\">\u003C/div> \u003Ca id=\"h3\" name=\"h3\">\u003C/a>\n\u003Ch2>2 Neuroimaging biomarkers\u003C/h2>\n\u003Cp class=\"mb0\">Imaging plays a crucial role in the early diagnosis of PD-MCI (Parkinson&#x2019;s Disease with Mild Cognitive Impairment). Through imaging techniques such as Structural Magnetic Resonance Imaging (sMRI), Functional Magnetic Resonance Imaging (fMRI), Single Photon Emission Computed Tomography (SPECT), and Positron Emission Tomography (PET), researchers can identify structural and functional changes associated with PD-MCI. For instance, MRI can reveal atrophy in brain regions related to motor control, while PET is used to detect changes in dopamine transporter activity in the brain. These imaging biomarkers are not only helpful for early diagnosis but also provide key evidence for monitoring disease progression. Studies have shown that imaging-related indicators, such as changes in the basal ganglia, are closely correlated with the severity of clinical symptoms, making imaging an important tool for assessing PD-MCI patients (\u003Ca href=\"#ref4\">4\u003C/a>).\u003C/p>\n\u003Ch3>2.1 Structural magnetic resonance imaging\u003C/h3>\n\u003Cp class=\"mb0\">Structural Magnetic Resonance Imaging (sMRI), utilizing surface-based morphometry (SBM) techniques, quantifies parameters such as cortical thickness, surface area, volume, and curvature, revealing the characteristic gray matter atrophy and white matter damage in PD-MCI patients. Changes in these parameters are closely related to dysfunction in specific cognitive domains, as reflected by abnormal striatal volume alterations in PD-MCI patients. A multicenter study found that cortical thickness in the frontal lobe (dorsolateral prefrontal cortex, DLPFC) and parietal lobe (inferior parietal cortex) of PD-MCI patients was significantly reduced compared to healthy controls, with the degree of atrophy positively correlating with declines in executive function (e.g., Stroop test) and working memory scores (\u003Ca href=\"#ref5\">5\u003C/a>). A longitudinal cohort study showed that volume reduction in the temporal lobe (parahippocampal gyrus, entorhinal cortex) independently predicts episodic memory impairment in PD-MCI patients, with an atrophy rate 1.5 times faster than in PD patients without cognitive impairment (\u003Ca href=\"#ref6\">6\u003C/a>). Compared to early PD patients without MCI, the PD-MCI group exhibited more pronounced white matter microstructural abnormalities. sMRI evidence indicated widespread reductions in white matter fiber tract integrity, along with significantly increased volumes of white matter hyperintensity lesions in periventricular and deep brain regions. Moreover, expansion of white matter hyperintensities in the left frontal and temporal lobes was significantly associated with worsening performance on free recall tests, suggesting that white matter damage in specific brain regions may underlie PD-MCI pathology (\u003Ca href=\"#ref7\">7\u003C/a>&#x2013;\u003Ca href=\"#ref10\">10\u003C/a>).\u003C/p>\n\u003Ch3>2.2 Functional magnetic resonance imaging\u003C/h3>\n\u003Cp class=\"mb0\">Resting-state fMRI studies have shown (\u003Ca href=\"#ref11\">11\u003C/a>) that PD-MCI patients exhibit significant weakening in the functional connectivity (FC) of the default mode network (DMN) between the hippocampus-inferior frontal gyrus, posterior cingulate cortex-posterior parietal lobe, anterior temporal lobe-inferior frontal gyrus, and middle frontal gyrus-middle temporal gyrus. Compared to controls, PD-MCI patients show markedly reduced bilateral prefrontal cortex intra-FC, characterized by decreased connectivity strength between the caudate nucleus and precuneus (\u003Ca href=\"#ref12\">12\u003C/a>). Besides widespread FC reduction, studies have reported abnormal increases in FC between the midbrain-posterior cingulate cortex and left hippocampus-right cerebellar hemisphere in PD-MCI patients (\u003Ca href=\"#ref13\">13\u003C/a>, \u003Ca href=\"#ref14\">14\u003C/a>). Apart from FC, local consistency (ReHo) values within the DMN positively correlate with cognitive function in PD and continuously decline with disease progression (\u003Ca href=\"#ref15\">15\u003C/a>). The dynamic FC changes in the DMN, frontoparietal network (FPN), and salience network are more sensitive than structural imaging, with continuous alterations in the salience network showing the strongest association with PD cognitive impairment (PD-CI). Multiple task-based fMRI studies have found (\u003Ca href=\"#ref16\">16\u003C/a>, \u003Ca href=\"#ref17\">17\u003C/a>) that during working memory tasks, PD-MCI patients exhibit significantly reduced activation in bilateral caudate nuclei, right putamen, and dorsolateral/ventrolateral prefrontal cortex, indicating dopaminergic-cortical circuit dysfunction. Additionally, cerebellar functional activity is generally weakened, suggesting damage to cerebello-cortical pathways or their involvement in cognitive regulation.\u003C/p>\n\u003Ch3>2.3 Dopaminergic system imaging\u003C/h3>\n\u003Cp class=\"mb0\">Dopamine transporter (DAT) single-photon emission computed tomography (SPECT) demonstrates early dopaminergic dysfunction and its association with cognitive impairment in PD-MCI patients by detecting dopaminergic nerve terminal density in the striatum. A multicenter study showed that DAT binding in the caudate and posterior putamen of PD-MCI patients was 30&#x2013;40% lower than that of healthy controls, with caudate DAT loss significantly correlated with executive functions (such as Stroop test) and working memory (such as digit span test) scores (\u003Ca href=\"#ref18\">18\u003C/a>). The B&#x000E4;ckman research team, through longitudinal DAT-SPECT tracking, found that PD patients with an annual striatal DAT binding decline rate exceeding 5% had a 3.2-fold increased risk of progression to MCI within 3&#x202F;years, indicating that DAT loss could serve as an early predictive biomarker of cognitive decline (\u003Ca href=\"#ref19\">19\u003C/a>). Serotonin (5-HT) positron emission tomography (PET) utilizes tracers (e.g., [11C] DASB, [18F]altanserin) to visualize serotonin transporter (SERT) or receptor distribution, revealing abnormalities in the raphe 5-HT system and its association with attention and emotional regulation deficits in PD-MCI. Studies show that compared to healthy controls, PD-MCI patients exhibit a 45% decrease in raphe SERT binding, which is positively correlated with Conners&#x2019; Continuous Performance Test (CPT) scores. Reduced 5-HT projections from the raphe to the prefrontal cortex may impair attentional control (\u003Ca href=\"#ref20\">20\u003C/a>). Smith et al.&#x2019;s longitudinal 5-HT PET study indicated that PD patients with an annual raphe SERT binding decline exceeding 8% have a 2.5-fold increased risk of developing MCI within 2&#x202F;years (\u003Ca href=\"#ref21\">21\u003C/a>). The Ballanger team, using the [18F] MPPF tracer, demonstrated elevated 5-HT1A receptor binding in the anterior cingulate cortex of PD-MCI patients, which is associated with depressive symptoms (e.g., BDI scores) and anxiety, suggesting that compensatory receptor upregulation might exacerbate mood disorders (\u003Ca href=\"#ref22\">22\u003C/a>).\u003C/p>\n\u003Ch3>2.4 Metabolism and molecular imaging\u003C/h3>\n\u003Cp class=\"mb0\">Fluorodeoxyglucose positron emission tomography (FDG-PET) reveals the distinctive metabolic patterns of PD-MCI (Parkinson&#x2019;s Disease Mild Cognitive Impairment) patients by measuring cerebral glucose metabolism rate, which is associated with impairments in specific cognitive domains. Huang et al.&#x2019;s study demonstrated significantly reduced glucose metabolism in the prefrontal cortex (especially the dorsolateral prefrontal cortex, DLPFC) and the inferior parietal lobule in PD-MCI patients, with the degree of metabolic decline positively correlating with executive function scores (e.g., Stroop test, Digit Symbol Substitution Test) (\u003Ca href=\"#ref23\">23\u003C/a>). Tau positron emission tomography (Tau-PET), employing specific tracers such as [18F]AV-1451 and [18F]MK-6240, visualizes tau protein deposits, illustrating the spatial characteristics of tau pathology in PD-MCI and their relationship to cognitive decline. Sch&#x000F6;ll et al. found that tau deposition in the midbrain positively correlates with dopaminergic neuron loss assessed by DaT-SPECT, suggesting the involvement of tau pathology in degeneration of the nigrostriatal pathway (\u003Ca href=\"#ref24\">24\u003C/a>). Ossenkoppele et al. proposed that tau deposition in PD-MCI primarily occurs in the midbrain and limbic system, whereas in Alzheimer&#x2019;s disease (AD) it is predominantly distributed in the temporoparietal lobes and neocortex, supporting specificity in pathological distribution (\u003Ca href=\"#ref25\">25\u003C/a>).\u003C/p> \u003Ca id=\"h4\" name=\"h4\">\u003C/a>\n\u003Ch2>3 Fluid biomarkers\u003C/h2>\n\u003Cp class=\"mb0\">Fluid biomarkers are crucial for the early identification of PD-MCI. Specific biochemical substances detected in blood and cerebrospinal fluid, such as neuron-specific enolase (NSE) and neurofilament light chain (NfL), are considered closely related to the degree of neuronal damage and stages of disease progression. The detection of these biochemical markers not only aids in identifying early PD-MCI patients but also serves to monitor disease progression and evaluate therapeutic efficacy (\u003Ca href=\"#ref26\">26\u003C/a>). Due to their diversity and sensitivity, biochemical biomarkers hold broad application potential in clinical practice. Research on biomarkers continues to advance, and novel biomarkers, such as changes in \u003Cmath id=\"M1\">\n\u003Cmi>&#x03B1;\u003C/mi>\n\u003C/math>\n-synuclein and tau protein, have been confirmed to be associated with PD-MCI, offering new avenues for early clinical diagnosis (\u003Ca href=\"#ref27\">27\u003C/a>).\u003C/p>\n\u003Ch3>3.1 Cerebrospinal fluid\u003C/h3>\n\u003Cp class=\"mb0\">In patients with PD-MCI, changes in cerebrospinal fluid (CSF) \u003Cmath id=\"M2\">\n\u003Cmi>&#x03B1;\u003C/mi>\n\u003C/math>\n-synuclein levels reflect the association between pathological progression and cognitive impairment. Numerous studies have shown that total \u003Cmath id=\"M3\">\n\u003Cmi>&#x03B1;\u003C/mi>\n\u003C/math>\n-synuclein levels in the CSF of PD-MCI patients are significantly lower than those in healthy controls and PD patients without cognitive impairment. Kang et al. found that decreased CSF \u003Cmath id=\"M4\">\n\u003Cmi>&#x03B1;\u003C/mi>\n\u003C/math>\n-synuclein levels in PD-MCI patients are related to midbrain atrophy and weakened functional connectivity of the default mode network (DMN), suggesting it may serve as a surrogate marker for neuronal loss (\u003Ca href=\"#ref28\">28\u003C/a>). Parnetti et al.&#x2019;s review indicates that reduced CSF \u003Cmath id=\"M5\">\n\u003Cmi mathvariant=\"normal\">&#x03B1;\u003C/mi>\n\u003C/math>\n-synuclein is associated with degenerative changes in the frontostriatal pathway in PD-MCI patients, possibly affecting executive function through synaptic dysfunction (\u003Ca href=\"#ref29\">29\u003C/a>). Unlike total \u003Cmath id=\"M6\">\n\u003Cmi mathvariant=\"normal\">&#x03B1;\u003C/mi>\n\u003C/math>\n-synuclein, its oligomeric form (oligomeric \u003Cmath id=\"M7\">\n\u003Cmi>&#x03B1;\u003C/mi>\n\u003C/math>\n-syn) is significantly elevated in PD-MCI patients and correlates with cognitive deterioration. Shahnawaz et al. developed a novel detection method and found that CSF oligomeric \u003Cmath id=\"M8\">\n\u003Cmi mathvariant=\"normal\">&#x03B1;\u003C/mi>\n\u003C/math>\n-syn levels in PD-MCI patients are three times higher than those in healthy controls and negatively correlated with Montreal Cognitive Assessment (MoCA) scores (\u003Ca href=\"#ref30\">30\u003C/a>). Abnormal phosphorylation of Tau protein (such as p-tau181, p-tau231) is a typical marker of Alzheimer&#x2019;s disease (AD), and elevated CSF Tau levels are also observed in PD-MCI patients; however, its pathological distribution and clinical significance differ from those in AD-MCI. Alves et al. found that CSF p-tau181 levels in PD-MCI patients are significantly higher than in PD patients without cognitive impairment, but the increase is less pronounced compared to AD-MCI patients and lacks strong correlation with hippocampal atrophy, suggesting that Tau pathology in PD-MCI may be confined to subcortical regions (such as the brainstem and limbic system) (\u003Ca href=\"#ref31\">31\u003C/a>). Hall et al. demonstrated through proteomic analysis that the Tau phosphorylation patterns (such as p-tau231) in PD-MCI patients differ from those in AD-MCI and may contribute to synaptic toxicity formation together with \u003Cmath id=\"M9\">\n\u003Cmi mathvariant=\"normal\">&#x03B1;\u003C/mi>\n\u003C/math>\n-synuclein (\u003Ca href=\"#ref32\">32\u003C/a>).\u003C/p>\n\u003Ch3>3.2 Blood\u003C/h3>\n\u003Cp class=\"mb15\">The levels of &#x03B1;-synuclein and synaptic proteins such as GAP43 and SNAP25 in blood exosomes change and can serve as non-invasive biomarkers. Abnormal oligomers of &#x03B1;-synuclein can spread between neurons via exosomes, accelerating pathological propagation. Stuendl et al. observed a significant increase of &#x03B1;-synuclein oligomers in the blood exosomes of PD-MCI patients, which positively correlated with oligomer concentrations in cerebrospinal fluid (CSF), indicating it can replace CSF testing (\u003Ca href=\"#ref33\">33\u003C/a>). Shi et al. used single molecule array (Simoa) technology to show that exosomal &#x03B1;-synuclein oligomer levels were significantly associated with reduced executive function scores (e.g., Stroop test) in PD-MCI patients (\u003Ca href=\"#ref34\">34\u003C/a>). Mechanistic studies by Chung et al. demonstrated that exosome-mediated &#x03B1;-synuclein propagation triggers microglial inflammatory responses, leading to synaptic loss in the frontal cortex and consequent cognitive impairment (\u003Ca href=\"#ref35\">35\u003C/a>). Growth-associated protein 43 (GAP43) and synaptosomal-associated protein 25 (SNAP25) are key proteins for synaptic plasticity and neurotransmitter release; changes in their exosomal levels reflect synaptic integrity. Svenningsson et al. reported a 40% decrease in GAP43 content in blood exosomes of PD-MCI patients compared to healthy controls, correlating with hippocampal volume reduction (\u003Ca href=\"#ref36\">36\u003C/a>). Bacioglu et al. found significantly reduced exosomal SNAP25 in PD-MCI patients, associated with weakened functional connectivity in the default mode network (DMN), indicating decreased synaptic transmission efficiency (\u003Ca href=\"#ref37\">37\u003C/a>). Chen et al., combining exosomal proteomics with structural MRI, identified that GAP43/SNAP25 levels and frontal cortex thickness together predict the risk of PD-MCI progressing to dementia (\u003Ca href=\"#ref38\">38\u003C/a>).\u003C/p>\n\u003Cp class=\"mb0\">Neurofilament Light Chain (NfL) is a cytoskeletal protein released following neuronal axonal damage. Elevated plasma \u003Cmath id=\"M10\">\n\u003Cmi>NfL\u003C/mi>\n\u003C/math> levels reflect the activity of neurodegeneration. Backstrm and colleagues, after a 5-year follow-up, found that initial plasma NfL levels in PD-MCI patients were higher than in PD patients without cognitive impairment, and \u003Cmath id=\"M11\">\n\u003Cmi>NfL\u003C/mi>\n\u003C/math> for each increase of \u003Cmath id=\"M12\">\n\u003Cmn>10\u003C/mn>\n\u003Cmspace width=\"0.25em\">\u003C/mspace>\n\u003Cmi>pg\u003C/mi>\n\u003Cmo>/\u003C/mo>\n\u003Cmi>mL\u003C/mi>\n\u003C/math>\n, the risk of dementia conversion increased 2.3-fold (\u003Ca href=\"#ref39\">39\u003C/a>). Byrne et al. demonstrated that combining plasma NfL with midbrain atrophy MRI can predict the rate of cognitive decline in PD-MCI patients (\u003Ca href=\"#ref40\">40\u003C/a>). The rate of white matter atrophy and ventricular enlargement are also considered key early predictive factors for MCI, further indicating that plasma NfL combined with midbrain atrophy MRI has potential in predicting the rate of cognitive decline in PD-MCI patients. Hansson et al. through autopsy research, found that plasma \u003Cmath id=\"M13\">\n\u003Cmi>NfL\u003C/mi>\n\u003C/math> levels positively correlate with the degree of nigral dopaminergic neuron loss and \u003Cmath id=\"M14\">\n\u003Cmi mathvariant=\"normal\">&#x03B1;\u003C/mi>\n\u003C/math>\n-synuclein pathological burden in the brains of \u003Cmath id=\"M15\">\n\u003Cmi>PD\u003C/mi>\n\u003C/math>\n-\n\u003Cmath id=\"M16\">\n\u003Cmi>MCI\u003C/mi>\n\u003C/math> patients (\u003Ca href=\"#ref41\">41\u003C/a>).\u003C/p>\n\u003Ch3>3.3 Saliva/urine\u003C/h3>\n\u003Cp class=\"mb0\">The amount of salivary &#x03B1;-synuclein is positively correlated with its concentration in CSF (cerebrospinal fluid), demonstrating potential screening value. Vivacqua et al. showed that the content of \u003Cmath id=\"M17\">\n\u003Cmi mathvariant=\"normal\">&#x03B1;\u003C/mi>\n\u003C/math>\n-synuclein oligomers in the saliva of PD (Parkinson&#x2019;s disease) patients is significantly positively correlated with its concentration in CSF, and that PD-MCI (Parkinson&#x2019;s disease with mild cognitive impairment) patients have higher salivary oligomer levels than PD patients without cognitive impairment (\u003Ca href=\"#ref42\">42\u003C/a>). Stewart et al. used ultrasensitive single molecule detection technology (Simoa) to prove that the total &#x03B1;-synuclein level in saliva highly matches the total \u003Cmath id=\"M18\">\n\u003Cmi mathvariant=\"normal\">&#x03B1;\u003C/mi>\n\u003C/math>\n-synuclein concentration in CSF, and that salivary \u003Cmath id=\"M19\">\n\u003Cmi mathvariant=\"normal\">&#x03B1;\u003C/mi>\n\u003C/math>\n-synuclein is reduced by approximately 30% in PD-MCI patients compared to healthy controls (\u003Ca href=\"#ref43\">43\u003C/a>). Kang et al.&#x2019;s longitudinal cohort study showed that PD patients with high baseline saliva \u003Cmath id=\"M20\">\n\u003Cmi mathvariant=\"normal\">&#x03B1;\u003C/mi>\n\u003C/math>\n-synuclein levels are more likely to develop MCI within 2&#x202F;years, demonstrating its predictive role (\u003Ca href=\"#ref44\">44\u003C/a>). In PD-MCI patients, oxidative stress participates in cognitive decline by damaging neurons and synaptic function; elevated urinary 8-hydroxy-2&#x2032;-deoxyguanosine (8-OHdG) levels can serve as a non-invasive pathological marker. A cross-sectional study reported that urinary 8-OHdG levels are approximately 2.5 times higher in PD-MCI patients than in healthy controls, and are significantly negatively correlated with Montreal Cognitive Assessment (MoCA) scores; patients with high 8-OHdG levels have lower executive function and memory scores (\u003Ca href=\"#ref45\">45\u003C/a>). A five-year cohort study showed that PD patients with baseline urinary 8-OHdG levels above the median have a 2.8-fold increased risk of progression to MCI, and the rate of increase in 8-OHdG levels positively correlates with the rate of cognitive decline (\u003Ca href=\"#ref46\">46\u003C/a>). At present, there are relatively few studies on saliva/urine biomarkers of PD-MCI. Subsequently, it is necessary to optimize the detection technology, standardize the research process, and deeply explore its value in the early diagnosis of the disease, disease monitoring and mechanism interpretation.\u003C/p>\n\u003Ch3>3.4 Skin/sweat\u003C/h3>\n\u003Cp class=\"mb0\">\n\u003Cmath id=\"M21\">\n\u003Cmi mathvariant=\"normal\">&#x03B1;\u003C/mi>\n\u003C/math>\n-synuclein abnormal deposition in cutaneous nerve endings and sweat glands is a core pathological feature of PD, and its quantitative detection provides a non-invasive method for early diagnosis of PD-MCI. Donadio et al. found through skin biopsy that the positivity rate of phosphorylated \u003Cmath id=\"M22\">\n\u003Cmi mathvariant=\"normal\">&#x03B1;\u003C/mi>\n\u003C/math>\n-synuclein (p-\n\u003Cmath id=\"M23\">\n\u003Cmi mathvariant=\"normal\">&#x03B1;\u003C/mi>\n\u003C/math>\n-syn) deposition in the epidermal small nerve fibers of PD patients reached 90%, and the deposition density in PD-MCI patients was significantly higher than that in PD patients without cognitive impairment. The deposition density was negatively correlated with the MoCA score, indicating its association with cognitive decline (\u003Ca href=\"#ref47\">47\u003C/a>). Gibbons et al. quantitatively analyzed \u003Cmath id=\"M24\">\n\u003Cmi mathvariant=\"normal\">&#x03B1;\u003C/mi>\n\u003C/math>\n-synuclein aggregates around sweat glands using confocal microscopy and found that the aggregate load in PD-MCI patients was three times that of healthy controls and positively correlated with CSF \u003Cmath id=\"M25\">\n\u003Cmi mathvariant=\"normal\">&#x03B1;\u003C/mi>\n\u003C/math>\n-synuclein oligomer levels (\u003Ca href=\"#ref48\">48\u003C/a>). Wang&#x2019;s team multicenter study showed that skin p-&#x03B1;-syn detection distinguished PD-MCI from healthy controls with an AUC of 0.92, outperforming traditional blood biomarkers such as NfL (\u003Ca href=\"#ref49\">49\u003C/a>).\u003C/p> \u003Ca id=\"h5\" name=\"h5\">\u003C/a>\n\u003Ch2>4 Genetic biomarkers\u003C/h2>\n\u003Ch3>4.1 Genetics\u003C/h3>\n\u003Cp class=\"mb0\">Cohort studies by Sidransky et al. showed that PD patients carrying the heterozygous GBA N370S mutation have a 2.8-fold increased risk of developing MCI compared to non-carriers, with L444P mutation carriers exhibiting an even higher risk (\u003Ca href=\"#ref50\">50\u003C/a>). Polymeropoulos et al. found that 80% of PD patients carrying the SNCA A53T mutation progressed to MCI within 3&#x202F;years after diagnosis, significantly higher than non-carriers (\u003Ca href=\"#ref51\">51\u003C/a>). Kiely et al. reported that the SNCA E46K mutation accelerates \u003Cmath id=\"M26\">\n\u003Cmi mathvariant=\"normal\">&#x03B1;\u003C/mi>\n\u003C/math>\n-synuclein fibril formation, which is associated with temporal cortical atrophy and memory impairment (\u003Ca href=\"#ref52\">52\u003C/a>). Irwin et al. found that PD-MCI patients carrying APOE \u003Cmath id=\"M27\">\n\u003Cmi>&#x03B5;\u003C/mi>\n\u003Cmn>4\u003C/mn>\n\u003C/math> exhibit significantly elevated cerebrospinal fluid p-tau181 levels, indicating aggravated tau pathology (\u003Ca href=\"#ref53\">53\u003C/a>). Zhang et al.&#x2019;s fMRI study showed that the Val/Val genotype weakens functional connectivity between the DLPFC and the striatum, exacerbating deficits in cognitive flexibility (\u003Ca href=\"#ref54\">54\u003C/a>).\u003C/p>\n\u003Ch3>4.2 Epigenetics\u003C/h3>\n\u003Cp class=\"mb0\">Abnormal methylation of genes such as HDAC4 and HOXC5 is present in the peripheral blood of PD-MCI patients and is associated with neuroinflammation and synaptic plasticity. Studies have found hypermethylation in the promoter region of HDAC4 in the peripheral blood of PD-MCI patients, leading to decreased expression, which is also linked to reduced synaptophysin in the frontal cortex. Low expression of HDAC4 impairs synaptic plasticity by inhibiting the BDNF (brain-derived neurotrophic factor) signaling pathway (\u003Ca href=\"#ref55\">55\u003C/a>). Another study using epigenome-wide association study (EWAS) showed hypomethylation in the gene body of HOXC5 in PD-MCI patients, resulting in increased expression. Overexpression of HOXC5 promotes peripheral monocytes to release IL-6 and TNF-\n\u003Cmath id=\"M28\">\n\u003Cmi mathvariant=\"normal\">&#x03B1;\u003C/mi>\n\u003C/math>\n, exacerbating blood&#x2013;brain barrier permeability and central inflammation (\u003Ca href=\"#ref56\">56\u003C/a>). Abnormal expression of miR-124 and miR-132 regulates tau phosphorylation and synaptic function. Relevant studies found a 50% reduction of miR-124 levels in the plasma of PD-MCI patients compared with controls, with a negative correlation between its expression and CSF p-tau181. Experimental evidence shows that overexpression of miR-124 can inhibit GSK-3&#x03B2; activity, thereby reducing \u003Cmath id=\"M29\">\n\u003Cmi>tau\u003C/mi>\n\u003C/math> phosphorylation (\u003Ca href=\"#ref57\">57\u003C/a>). Additionally, studies have found significantly reduced miR-132 levels in exosomes from PD-MCI patients, with its expression positively correlated with hippocampal volume and memory scores. Overexpression of miR-132 can rescue synaptic plasticity deficits (\u003Ca href=\"#ref58\">58\u003C/a>).\u003C/p> \u003Ca id=\"h6\" name=\"h6\">\u003C/a>\n\u003Ch2>5 Digital biomarkers\u003C/h2>\n\u003Cp class=\"mb0\">Digital biomarkers leverage technologies such as wearable devices, voice analysis, and cognitive task interactions to collect real-time, non-invasive physiological, behavioral, and environmental multidimensional data, greatly enhancing early diagnostic accuracy for PD-MCI. Research shows that digital features based on gait dynamics (such as stride variability) and micro-expression recognition can precisely capture neurodegenerative changes in the prodromal phase of PD-MCI (\u003Ca href=\"#ref59\">59\u003C/a>). Moreover, smartphone applications (e.g., &#x201C;PD-Brain&#x201D;) can diagnose risks of hippocampal and prefrontal cortex functional decline by real-time monitoring of cognitive-motor dual tasks (\u003Ca href=\"#ref60\">60\u003C/a>). Longitudinal studies indicate that baseline speech articulation deficits in PD patients (e.g., prolonged consonant-vowel transition time) can predict the risk of developing MCI within 2 years, with sensitivity comparable to hippocampal volume reduction (\u003Ca href=\"#ref61\">61\u003C/a>). These technological advances overcome the subjective limitations of traditional neuropsychological scales, providing objective and dynamic quantitative tools for precise stratification and intervention in PD-MCI.\u003C/p> \u003Ca id=\"h7\" name=\"h7\">\u003C/a>\n\u003Ch2>6 Clinical and neuropsychological assessment\u003C/h2>\n\u003Cp class=\"mb0\">Clinical assessment indicators, as a key part of early diagnosis of PD-MCI (Parkinson&#x2019;s Disease Mild Cognitive Impairment), are typically implemented using standardized clinical evaluation tools. These tools include the Unified Parkinson&#x2019;s Disease Rating Scale (UPDRS), Montreal Cognitive Assessment (MoCA), and Stroop Color-Word Test, which effectively assess patients&#x2019; motor function and cognitive status. Research shows that clinical assessment indicators have significant correlations with imaging and biochemical biomarkers, providing critical information on disease progression. For example, integrating UPDRS scores with imaging results can more accurately diagnose patients&#x2019; disease progression and quality of life (\u003Ca href=\"#ref62\">62\u003C/a>). By combining clinical assessments with other biomarker information, physicians can develop personalized treatment plans better suited to patients&#x2019; needs to improve their quality of life.\u003C/p> \u003Ca id=\"h8\" name=\"h8\">\u003C/a>\n\u003Ch2>7 Multimodal integration models\u003C/h2>\n\u003Cp class=\"mb0\">The application of machine learning algorithms in the medical field is becoming increasingly widespread, especially in the early prediction of diseases. Common machine learning algorithms include categories such as Support Vector Machine (SVM), Random Forest (RF), Gradient Boosting Tree (GBM), and deep learning models. These algorithms identify biomarkers and potential therapeutic targets of PD-MCI by analyzing different dimensions of the data, and provide new ideas for the comprehensive diagnosis and personalized treatment of PD-MCI. As algorithms continue to be optimized and datasets become increasingly rich, the accuracy and reliability of early machine learning predictions are constantly improving. Machine learning helps identify PD-MCI patients by analyzing specific proteins or molecules in samples such as blood and cerebrospinal fluid. Zhang et al. constructed support vector machine (SVM), decision tree (DT), and logistic regression (LR) models based on multimodal markers of quantitative electroencephalogram (qEEG) and structural magnetic resonance imaging (sMRI). The study found that among 23 pairs of PD-MCI and non-dementia Parkinson&#x2019;s disease (PD-ND) patients matched by propensity scores, qEEG features are superior to sMRI features in terms of prediction accuracy and area under the curve (AUC). Among them, the theta wave in lead P3 of qEEG features has a significant impact on the classification model, suggesting that multimodal &#x201C;composite markers&#x201D; have potential value for individualized diagnosis of PD-MCI (\u003Ca href=\"#ref63\">63\u003C/a>). Zhu et al. integrated clinical features, plasma markers, functional connectivity of the default mode network and cortical thickness to construct a model and found that the plasma phosphorylated tau181 level and the ratio of phosphorylated tau181/&#x03B2;-amyloid protein 1&#x2013;42 in the PD-MCI group were significantly higher than those in the PD with normal cognition (PD-NC) group. Moreover, in terms of functional connectivity, the connection between the left posterior cingulate cortex and the left parahippocampal gyrus in the PD-MCI group was enhanced (\u003Ca href=\"#ref64\">64\u003C/a>). Andrew et al. found that by using support vector machine (SVM) to classify clinical data, T1-weighted magnetic resonance imaging (MRI), resting-state functional MRI (Rs-fMRI), and plasma nerve fiber light chain (NfL) and glial fibrillary acidic protein (GFAP) level data, the results showed that The classifier combining clinical data, Rs-fMRI and NfL biomarkers performed the best, highlighting the importance of multimodal data fusion in improving the predictive ability of PD-MCI (\u003Ca href=\"#ref65\">65\u003C/a>). A study analyzed the cognitive function assessment of MCI patients using machine learning algorithms. The results showed that a multimodal model integrating multi-source data biomarkers such as neuroimaging, humoral biomarkers, and clinical features demonstrated higher sensitivity and specificity in predicting cognitive decline in patients compared to single biomarkers or traditional diagnostic methods. It has laid a solid foundation for achieving precise and early diagnosis of PD-MCI and promoting the implementation of individualized intervention strategies (\u003Ca href=\"#ref66\">66\u003C/a>).\u003C/p> \u003Ca id=\"h9\" name=\"h9\">\u003C/a>\n\u003Ch2>8 Conclusion\u003C/h2>\n\u003Cp class=\"mb15\">PD-MCI is an intermediate transformation stage from normal cognition to PDD. As the duration of the disease increases, patients gradually lose their autonomy, increasing the mental and economic burden on society and families. To improve the prognosis of patients with PD-MCI, enhance the quality of life and reduce the social burden, the early identification, diagnosis and treatment of PD-MCI are of vital importance. However, there are still difficulties in the early and accurate identification of PD-MCI. This study integrates multi-dimensional data of multimodal biomarkers, including imaging biomarkers, humoral biomarkers, genetic and molecular biomarkers, digital biomarkers, and clinical evaluations. With the help of machine learning algorithms to mine potential disease patterns, it can more comprehensively assess the patient&#x2019;s condition and improve the sensitivity and specificity of early diagnosis of PD-MCI. Provide quantitative basis for individualized risk stratification.\u003C/p>\n\u003Cp class=\"mb0\">Although multimodal biomarkers have shown great potential in improving the accuracy, efficiency and personalization of the early diagnosis of PD-MCI, there are still many bottlenecks that need to be urgently broken through in their clinical transformation: (1) The cognitive barriers and trust deficits of clinicians toward emerging technologies stem from the insufficient update of interdisciplinary knowledge; (2) The update of clinical practice guidelines lags behind the progress of scientific research, and there is a lack of standardized procedures for interpreting multimodal data. (3) Insufficient allocation of interdisciplinary research resources has restricted the efficiency of large-scale cohort validation and technology transfer. Multimodal biomarkers still need to be further optimized and validated through clinical tests. Future research directions include: improving data quality on the basis of multimodal data fusion, constructing more generalized integrated models based on neurophysiological and pathological mechanisms, building larger-scale multi-center standardized databases, and promoting clinical transformation and precision diagnosis and treatment through industry-university-research collaboration. By continuously promoting the development of multimodal biomarkers in the diagnosis of PD-MCI, it is expected that in the future, through strengthening interdisciplinary cooperation, such as close collaboration among clinicians, data scientists and biomedical researchers, relying on large-scale cohort validation and standardized processes to promote the clinical application of multimodal biomarkers, more accurate diagnosis and more effective treatment can be provided for PD-MCI patients. In addition, with the continuous advancement of technology, the application of artificial intelligence and machine learning will also play a key role in this process. Utilizing artificial intelligence for multimodal data analysis and pattern recognition can accurately identify disease states and patient needs, providing support for the optimization of treatment plans. In conclusion, although there are many challenges at present, with the deepening of research and technological innovation, the application prospects of multimodal biomarkers in the diagnosis of PD-MCI will be very broad.\u003C/p> \u003Ca id=\"h10\" name=\"h10\">\u003C/a>\n\u003Ch2>Author contributions\u003C/h2>\n\u003Cp class=\"mb0\">HG: Funding acquisition, Writing &#x2013; original draft, Writing &#x2013; review &#x00026; editing. XS: Funding acquisition, Writing &#x2013; review &#x00026; editing. ML: Funding acquisition, Writing &#x2013; original draft. GZ: Funding acquisition, Writing &#x2013; original draft. CC: Funding acquisition, Writing &#x2013; original draft. BX: Funding acquisition, Writing &#x2013; original draft. YX: Funding acquisition, Writing &#x2013; original draft, Writing &#x2013; review &#x00026; editing.\u003C/p> \u003Ca id=\"h11\" name=\"h11\">\u003C/a>\n\u003Ch2>Funding\u003C/h2>\n\u003Cp class=\"mb0\">The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by the National Natural Science Foundation of China Project (81303011); Key Project jointly supported by the National Health Commission and Provincial Ministries (S BGJ202102187); Henan Province Key Scientific and Technological Tackling Project (242102311250); Henan Province &#x201C;Double First-Class&#x201D; Establishment Engineering Projects (No. HSRP-DFCTCM-2023-8-27, HSRP-DFCTCM-2023-8-44).\u003C/p> \u003Ca id=\"h12\" name=\"h12\">\u003C/a>\n\u003Ch2>Conflict of interest\u003C/h2>\n\u003Cp class=\"mb0\">The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.\u003C/p> \u003Ca id=\"h13\" name=\"h13\">\u003C/a>\n\u003Ch2>Generative AI statement\u003C/h2>\n\u003Cp class=\"mb15\">The authors declare that no Gen AI was used in the creation of this manuscript.\u003C/p>\n\u003Cp class=\"mb0\">Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.\u003C/p> \u003Ca id=\"h14\" name=\"h14\">\u003C/a>\n\u003Ch2>Publisher&#x2019;s note\u003C/h2>\n\u003Cp class=\"mb0\">All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.\u003C/p> \u003Ca id=\"h15\" name=\"h15\">\u003C/a>\n\u003Ch2>References\u003C/h2>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref1\" id=\"ref1\">\u003C/a>1. Monastero, R, Cicero, CE, Baschi, R, Dav&#x000EC;, M, Luca, A, Restivo, V, et al. Mild cogni-tive impairment in Parkinson's disease: the Parkinson's diseasecognitive study(PACOS). \u003Ci>J Neurol\u003C/i>. (2018) 265:1050&#x2013;8. doi: 10.1007/s00415-018-8800-4 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29478221\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1007/s00415-018-8800-4\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=R+Monastero&#x00026;author=CE+Cicero&#x00026;author=R+Baschi&#x00026;author=M+Dav&#x000EC;&#x00026;author=A+Luca&#x00026;author=V+Restivo&#x00026;publication_year=2018&#x00026;title=Mild+cogni-tive+impairment+in+Parkinson's+disease:+the+Parkinson's+diseasecognitive+study(PACOS)&#x00026;journal=J+Neurol&#x00026;volume=265&#x00026;pages=1050-8\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref2\" id=\"ref2\">\u003C/a>2. Lawson, RA, Yarnall, AJ, Duncan, GW, Breen, DP, Khoo, TK, Williams-Gray, CH, et al. Stability of mild cognitiveimpairment in newly diagnosed Parkinson's disease. \u003Ci>J Neurol Neurosurg Psychiatry\u003C/i>. (2017) 88:648&#x2013;52. doi: 10.1136/jnnp-2016-315099\u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1136/jnnp-2016-315099\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=RA+Lawson&#x00026;author=AJ+Yarnall&#x00026;author=GW+Duncan&#x00026;author=DP+Breen&#x00026;author=TK+Khoo&#x00026;author=CH+Williams-Gray&#x00026;publication_year=2017&#x00026;title=Stability+of+mild+cognitiveimpairment+in+newly+diagnosed+Parkinson's+disease&#x00026;journal=J+Neurol+Neurosurg+Psychiatry&#x00026;volume=88&#x00026;pages=648-52\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref3\" id=\"ref3\">\u003C/a>3. Goldman, JG, Vernaleo, &#x0412;A, Camicioli, R, Dahodwala, N, Dobkin, RD, Ellis, T, et al. Cognitive impairment inParkinson's disease:a report from a multidisciplinary symposium onunmet needs and future directions to maintain cognitive health. \u003Ci>NPJ Parkinsons Dis\u003C/i>. (2018) 4:19. doi: 10.1038/s41531-018-0055-3\u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1038/s41531-018-0055-3\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=JG+Goldman&#x00026;author=&#x0412;A+Vernaleo&#x00026;author=R+Camicioli&#x00026;author=N+Dahodwala&#x00026;author=RD+Dobkin&#x00026;author=T+Ellis&#x00026;publication_year=2018&#x00026;title=Cognitive+impairment+inParkinson's+disease:a+report+from+a+multidisciplinary+symposium+onunmet+needs+and+future+directions+to+maintain+cognitive+health&#x00026;journal=NPJ+Parkinsons+Dis&#x00026;volume=4&#x00026;pages=19\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref4\" id=\"ref4\">\u003C/a>4. Liang, J, Li, ZW, Sun, ZN, Bi, Y, Cheng, H, Zeng, T, et al. Latent space search based multimodal optimization with personalized edge-network biomarker for multi-purpose early disease prediction. \u003Ci>Brief Bioinform\u003C/i>. (2023) 24:bbad364. doi: 10.1093/bib/bbad364 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/37833844\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1093/bib/bbad364\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=J+Liang&#x00026;author=ZW+Li&#x00026;author=ZN+Sun&#x00026;author=Y+Bi&#x00026;author=H+Cheng&#x00026;author=T+Zeng&#x00026;publication_year=2023&#x00026;title=Latent+space+search+based+multimodal+optimization+with+personalized+edge-network+biomarker+for+multi-purpose+early+disease+prediction&#x00026;journal=Brief+Bioinform&#x00026;volume=24&#x00026;pages=bbad364\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref5\" id=\"ref5\">\u003C/a>5. Rong, S, Li, Y, Li, B, Nie, K, Zhang, P, Cai, T, et al. Meynert nucleus-related cortical thinning in Parkinson's disease with mild cognitive impairment. \u003Ci>Quant Imaging Med Surg\u003C/i>. (2021) 11:1554&#x2013;66. doi: 10.21037/qims-20-444 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/33816191\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.21037/qims-20-444\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=S+Rong&#x00026;author=Y+Li&#x00026;author=B+Li&#x00026;author=K+Nie&#x00026;author=P+Zhang&#x00026;author=T+Cai&#x00026;publication_year=2021&#x00026;title=Meynert+nucleus-related+cortical+thinning+in+Parkinson's+disease+with+mild+cognitive+impairment&#x00026;journal=Quant+Imaging+Med+Surg&#x00026;volume=11&#x00026;pages=1554-66\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref6\" id=\"ref6\">\u003C/a>6. Xu, H, Liu, Y, Wang, L, Zeng, X, Xu, Y, and Wang, Z. Role of hippocampal subfields in neurodegenerative disease progression analyzed with a multi-scale attention-based network. \u003Ci>Neuroimage Clin\u003C/i>. (2023) 38:103370. doi: 10.1016/j.nicl.2023.103370 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/36948139\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.nicl.2023.103370\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=H+Xu&#x00026;author=Y+Liu&#x00026;author=L+Wang&#x00026;author=X+Zeng&#x00026;author=Y+Xu&#x00026;author=Z+Wang&#x00026;publication_year=2023&#x00026;title=Role+of+hippocampal+subfields+in+neurodegenerative+disease+progression+analyzed+with+a+multi-scale+attention-based+network&#x00026;journal=Neuroimage+Clin&#x00026;volume=38&#x00026;pages=103370\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref7\" id=\"ref7\">\u003C/a>7. Choi, SA, Evidente, VG, Caviness, JN, Shill, HA, Sabbagh, MN, Connor, DJ, et al. Are there differences in cerebral white matter lesion burdens between Parkinson's disease patients with or without dementia? \u003Ci>Acta Neuropathol\u003C/i>. (2020) 119:147&#x2013;9. doi: 10.1007/s00401-009-0620-2\u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1007/s00401-009-0620-2\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=SA+Choi&#x00026;author=VG+Evidente&#x00026;author=JN+Caviness&#x00026;author=HA+Shill&#x00026;author=MN+Sabbagh&#x00026;author=DJ+Connor&#x00026;publication_year=2020&#x00026;title=Are+there+differences+in+cerebral+white+matter+lesion+burdens+between+Parkinson's+disease+patients+with+or+without+dementia?&#x00026;journal=Acta+Neuropathol&#x00026;volume=119&#x00026;pages=147-9\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref8\" id=\"ref8\">\u003C/a>8. Zhu, Y, Yang, B, Zhou, C, Gao, C, Hu, Y, Yin, WF, et al. Cortical atrophy is associated with cognitive impairment in Parkinson's disease: a combined analysis of cortical thickness and functional connectivity. \u003Ci>Brain Imaging Behav\u003C/i>. (2022) 16:2586&#x2013;600. doi: 10.1007/s11682-022-00714-w \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/36044168\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1007/s11682-022-00714-w\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=Y+Zhu&#x00026;author=B+Yang&#x00026;author=C+Zhou&#x00026;author=C+Gao&#x00026;author=Y+Hu&#x00026;author=WF+Yin&#x00026;publication_year=2022&#x00026;title=Cortical+atrophy+is+associated+with+cognitive+impairment+in+Parkinson's+disease:+a+combined+analysis+of+cortical+thickness+and+functional+connectivity&#x00026;journal=Brain+Imaging+Behav&#x00026;volume=16&#x00026;pages=2586-600\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref9\" id=\"ref9\">\u003C/a>9. Zhao, W, Cheng, B, Zhu, T, Cui, Y, Shen, Y, Fu, X, et al. Effects of white matter hyperintensity on cognitive function in PD patients: a meta-analysis. \u003Ci>Front Neurol\u003C/i>. (2023) 14:1203311. doi: 10.3389/fneur.2023.1203311 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/37621858\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3389/fneur.2023.1203311\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=W+Zhao&#x00026;author=B+Cheng&#x00026;author=T+Zhu&#x00026;author=Y+Cui&#x00026;author=Y+Shen&#x00026;author=X+Fu&#x00026;publication_year=2023&#x00026;title=Effects+of+white+matter+hyperintensity+on+cognitive+function+in+PD+patients:+a+meta-analysis&#x00026;journal=Front+Neurol&#x00026;volume=14&#x00026;pages=1203311\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref10\" id=\"ref10\">\u003C/a>10. Pu, W, Shen, X, Huang, M, Li, Z, Zeng, X, Wang, R, et al. Assessment of white matter lesions in Parkinson's disease: voxelbased analysis and tract-based spatial statistics analysis of Parkinson's disease with mild cognitive impairment. \u003Ci>Curr Neurovasc Res\u003C/i>. (2020) 17:480&#x2013;6. doi: 10.2174/1567202617666200901181842 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/32875986\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.2174/1567202617666200901181842\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=W+Pu&#x00026;author=X+Shen&#x00026;author=M+Huang&#x00026;author=Z+Li&#x00026;author=X+Zeng&#x00026;author=R+Wang&#x00026;publication_year=2020&#x00026;title=Assessment+of+white+matter+lesions+in+Parkinson's+disease:+voxelbased+analysis+and+tract-based+spatial+statistics+analysis+of+Parkinson's+disease+with+mild+cognitive+impairment&#x00026;journal=Curr+Neurovasc+Res&#x00026;volume=17&#x00026;pages=480-6\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref11\" id=\"ref11\">\u003C/a>11. Hou, Y, Yang, J, Luo, C, Song, W, Ou, R, Liu, W, et al. Dysfunction of the default mode network in drug-na&#x000EF;ve Parkinson's disease with mild cognitive impairments: a resting-state fMRI study. \u003Ci>Front Aging Neurosci\u003C/i>. (2016) 8:247. doi: 10.3389/fnagi.2016.00247 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/27833548\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3389/fnagi.2016.00247\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=Y+Hou&#x00026;author=J+Yang&#x00026;author=C+Luo&#x00026;author=W+Song&#x00026;author=R+Ou&#x00026;author=W+Liu&#x00026;publication_year=2016&#x00026;title=Dysfunction+of+the+default+mode+network+in+drug-na&#x000EF;ve+Parkinson's+disease+with+mild+cognitive+impairments:+a+resting-state+fMRI+study&#x00026;journal=Front+Aging+Neurosci&#x00026;volume=8&#x00026;pages=247\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref12\" id=\"ref12\">\u003C/a>12. Amboni, M, Tessitore, A, Esposito, F, Santangelo, G, Picillo, M, Vitale, C, et al. Restingstate functional connectivity associated with mild cognitive impairment in Parkinson's disease. \u003Ci>J Neurol\u003C/i>. (2015) 262:425&#x2013;34. doi: 10.1007/s00415-014-7591-5 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/25428532\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1007/s00415-014-7591-5\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=M+Amboni&#x00026;author=A+Tessitore&#x00026;author=F+Esposito&#x00026;author=G+Santangelo&#x00026;author=M+Picillo&#x00026;author=C+Vitale&#x00026;publication_year=2015&#x00026;title=Restingstate+functional+connectivity+associated+with+mild+cognitive+impairment+in+Parkinson's+disease&#x00026;journal=J+Neurol&#x00026;volume=262&#x00026;pages=425-34\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref13\" id=\"ref13\">\u003C/a>13. Owens-Walton, C, Jakabek, D, Power, BD, Walterfang, M, Hall, S, van Westen, D, et al. Structural and functional neuroimaging changes associated with cognitive impairment and dementia in Parkinson's disease. \u003Ci>Psychiatry Res Neuroimaging\u003C/i>. (2021) 312:111273. doi: 10.1016/j.pscychresns.2021.111273 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/33892387\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.pscychresns.2021.111273\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=C+Owens-Walton&#x00026;author=D+Jakabek&#x00026;author=BD+Power&#x00026;author=M+Walterfang&#x00026;author=S+Hall&#x00026;author=D+van+Westen&#x00026;publication_year=2021&#x00026;title=Structural+and+functional+neuroimaging+changes+associated+with+cognitive+impairment+and+dementia+in+Parkinson's+disease&#x00026;journal=Psychiatry+Res+Neuroimaging&#x00026;volume=312&#x00026;pages=111273\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref14\" id=\"ref14\">\u003C/a>14. Lang, S, Yoon, EJ, Kibreab, M, Kathol, I, Cheetham, J, Hammer, T, et al. Mild behavioral impairment in Parkinson's disease is associated with altered corticostriatal connectivity. \u003Ci>NeuroImage: Clinical\u003C/i>. (2020) 26:102252. doi: 10.1016/j.nicl.2020.102252 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/32279019\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.nicl.2020.102252\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=S+Lang&#x00026;author=EJ+Yoon&#x00026;author=M+Kibreab&#x00026;author=I+Kathol&#x00026;author=J+Cheetham&#x00026;author=T+Hammer&#x00026;publication_year=2020&#x00026;title=Mild+behavioral+impairment+in+Parkinson's+disease+is+associated+with+altered+corticostriatal+connectivity&#x00026;journal=NeuroImage:+Clinical&#x00026;volume=26&#x00026;pages=102252\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref15\" id=\"ref15\">\u003C/a>15. Guo, W, Jin, W, Li, N, Gao, J, Wang, J, Chang, Y, et al. Brain activity alterations in patients with Parkinson's disease with cognitive impairment based on resting-state functional MRI. \u003Ci>Neurosci Lett\u003C/i>. (2021) 747:135672. doi: 10.1016/j.neulet.2021.135672\u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1016/j.neulet.2021.135672\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=W+Guo&#x00026;author=W+Jin&#x00026;author=N+Li&#x00026;author=J+Gao&#x00026;author=J+Wang&#x00026;author=Y+Chang&#x00026;publication_year=2021&#x00026;title=Brain+activity+alterations+in+patients+with+Parkinson's+disease+with+cognitive+impairment+based+on+resting-state+functional+MRI&#x00026;journal=Neurosci+Lett&#x00026;volume=747&#x00026;pages=135672\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref16\" id=\"ref16\">\u003C/a>16. Ay, U, and G&#x000FC;rvit, IH. Alterations in large-scale intrinsic connectivity networks in the Parkinson's diseaseassociated cognitive impairment continuum: a systematic review. \u003Ci>Noro Psikiyatr Ars\u003C/i>. (2022) 59:S57&#x2013;66. doi: 10.29399/npa.28209 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/36578982\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.29399/npa.28209\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=U+Ay&#x00026;author=IH+G&#x000FC;rvit&#x00026;publication_year=2022&#x00026;title=Alterations+in+large-scale+intrinsic+connectivity+networks+in+the+Parkinson's+diseaseassociated+cognitive+impairment+continuum:+a+systematic+review&#x00026;journal=Noro+Psikiyatr+Ars&#x00026;volume=59&#x00026;pages=S57-66\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref17\" id=\"ref17\">\u003C/a>17. Putcha, D, Ross, RS, Cronin-Golomb, A, Janes, AC, and Stern, CE. Salience and default mode network coupling predicts cognition in aging and Parkinson's disease. \u003Ci>J Int Neuropsychol Soc\u003C/i>. (2016) 22:205&#x2013;15. doi: 10.1017/S1355617715000892 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/26888617\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1017/S1355617715000892\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=D+Putcha&#x00026;author=RS+Ross&#x00026;author=A+Cronin-Golomb&#x00026;author=AC+Janes&#x00026;author=CE+Stern&#x00026;publication_year=2016&#x00026;title=Salience+and+default+mode+network+coupling+predicts+cognition+in+aging+and+Parkinson's+disease&#x00026;journal=J+Int+Neuropsychol+Soc&#x00026;volume=22&#x00026;pages=205-15\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref18\" id=\"ref18\">\u003C/a>18. Demailly, A, Moreau, C, and Devos, D. Effectiveness of continuous dopaminergic therapies in Parkinson's disease: a review of L-DOPA pharmacokinetics/pharmacodynamics. \u003Ci>J Parkinsons Dis\u003C/i>. (2024) 14:925&#x2013;39. doi: 10.3233/JPD-230372 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/38848195\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3233/JPD-230372\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=A+Demailly&#x00026;author=C+Moreau&#x00026;author=D+Devos&#x00026;publication_year=2024&#x00026;title=Effectiveness+of+continuous+dopaminergic+therapies+in+Parkinson's+disease:+a+review+of+L-DOPA+pharmacokinetics/pharmacodynamics&#x00026;journal=J+Parkinsons+Dis&#x00026;volume=14&#x00026;pages=925-39\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref19\" id=\"ref19\">\u003C/a>19. Seo, S, Yoon, YJ, Lee, S, Lim, H, Choo, K, Kim, D, et al. Striatal dopamine transporter uptake predicts neuronal hypometabolism and visuospatial function in Parkinson's disease. \u003Ci>Eur J Nucl Med Mol Imaging\u003C/i>. (2025) 52:2307&#x2013;16. doi: 10.1007/s00259-025-07137-x \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/39951136\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1007/s00259-025-07137-x\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=S+Seo&#x00026;author=YJ+Yoon&#x00026;author=S+Lee&#x00026;author=H+Lim&#x00026;author=K+Choo&#x00026;author=D+Kim&#x00026;publication_year=2025&#x00026;title=Striatal+dopamine+transporter+uptake+predicts+neuronal+hypometabolism+and+visuospatial+function+in+Parkinson's+disease&#x00026;journal=Eur+J+Nucl+Med+Mol+Imaging&#x00026;volume=52&#x00026;pages=2307-16\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref20\" id=\"ref20\">\u003C/a>20. Lee, Y, Ha, S, Yoo, SW, Joo, HO, Ie, RY, and Joong-Seok, K. Decreased raphe connectivity preceding changes of raphe-regional perfusion and SERT expression in drug na&#x000EF;ve PD patients with depressive mood. \u003Ci>J Nucl Med\u003C/i>. (2022) 63:2948\u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"http://scholar.google.com/scholar_lookup?author=Y+Lee&#x00026;author=S+Ha&#x00026;author=SW+Yoo&#x00026;author=HO+Joo&#x00026;author=RY+Ie&#x00026;author=K+Joong-Seok&#x00026;publication_year=2022&#x00026;title=Decreased+raphe+connectivity+preceding+changes+of+raphe-regional+perfusion+and+SERT+expression+in+drug+na&#x000EF;ve+PD+patients+with+depressive+mood&#x00026;journal=J+Nucl+Med&#x00026;volume=63&#x00026;pages=2948\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref21\" id=\"ref21\">\u003C/a>21. Frouni, I, Kwan, C, Belliveau, S, and Huot, P. Cognition and serotonin in Parkinson's disease. \u003Ci>Prog Brain Res\u003C/i>. (2022) 269:373&#x2013;403. doi: 10.1016/bs.pbr.2022.01.013\u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1016/bs.pbr.2022.01.013\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=I+Frouni&#x00026;author=C+Kwan&#x00026;author=S+Belliveau&#x00026;author=P+Huot&#x00026;publication_year=2022&#x00026;title=Cognition+and+serotonin+in+Parkinson's+disease&#x00026;journal=Prog+Brain+Res&#x00026;volume=269&#x00026;pages=373-403\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref22\" id=\"ref22\">\u003C/a>22. Smith, GS, Kuwabara, H, Yan, H, Nassery, N, Yoon, M, Kamath, V, et al. Serotonin degeneration and amyloid-&#x03B2; deposition in mild cognitive impairment: relationship to cognitive deficits. \u003Ci>J Alzheimer's Dis\u003C/i>. (2023) 96:215&#x2013;27. doi: 10.3233/JAD-230570 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/37718818\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3233/JAD-230570\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=GS+Smith&#x00026;author=H+Kuwabara&#x00026;author=H+Yan&#x00026;author=N+Nassery&#x00026;author=M+Yoon&#x00026;author=V+Kamath&#x00026;publication_year=2023&#x00026;title=Serotonin+degeneration+and+amyloid-&#x03B2;+deposition+in+mild+cognitive+impairment:+relationship+to+cognitive+deficits&#x00026;journal=J+Alzheimer's+Dis&#x00026;volume=96&#x00026;pages=215-27\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref23\" id=\"ref23\">\u003C/a>23. Zhihui, S, Yinghua, L, Hongguang, Z, Yuyin, D, Xiaoxiao, D, Lulu, G, et al. Correlation analysis between 18F-fluorodeoxyglucose positron emission tomography and cognitive function in first diagnosed Parkinson&#x2019;s disease patients. \u003Ci>Front Neurol\u003C/i>. (2023) 14:1195576. doi: 10.3389/fneur.2023.1195576 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/37384283\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3389/fneur.2023.1195576\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=S+Zhihui&#x00026;author=L+Yinghua&#x00026;author=Z+Hongguang&#x00026;author=D+Yuyin&#x00026;author=D+Xiaoxiao&#x00026;author=G+Lulu&#x00026;publication_year=2023&#x00026;title=Correlation+analysis+between+18F-fluorodeoxyglucose+positron+emission+tomography+and+cognitive+function+in+first+diagnosed+Parkinson&#x2019;s+disease+patients&#x00026;journal=Front+Neurol&#x00026;volume=14&#x00026;pages=1195576\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref24\" id=\"ref24\">\u003C/a>24. Devignes, Q, Lopes, R, and Dujardin, K. Neuroimaging outcomes associated with mild cognitive impairment subtypes in Parkinson's disease: a systematic review. \u003Ci>Parkinsonism Relat Disord\u003C/i>. (2022) 95:122&#x2013;37. doi: 10.1016/j.parkreldis.2022.02.006 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/35249807\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.parkreldis.2022.02.006\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=Q+Devignes&#x00026;author=R+Lopes&#x00026;author=K+Dujardin&#x00026;publication_year=2022&#x00026;title=Neuroimaging+outcomes+associated+with+mild+cognitive+impairment+subtypes+in+Parkinson's+disease:+a+systematic+review&#x00026;journal=Parkinsonism+Relat+Disord&#x00026;volume=95&#x00026;pages=122-37\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref25\" id=\"ref25\">\u003C/a>25. Zhang, J, Jin, J, Su, D, Feng, T, and Zhao, H. Tau-PET imaging in Parkinson's disease: a systematic review and meta-analysis. \u003Ci>Front Neurol\u003C/i>. (2023) 14:1145939. doi: 10.3389/fneur.2023.1145939 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/37181568\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3389/fneur.2023.1145939\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=J+Zhang&#x00026;author=J+Jin&#x00026;author=D+Su&#x00026;author=T+Feng&#x00026;author=H+Zhao&#x00026;publication_year=2023&#x00026;title=Tau-PET+imaging+in+Parkinson's+disease:+a+systematic+review+and+meta-analysis&#x00026;journal=Front+Neurol&#x00026;volume=14&#x00026;pages=1145939\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref26\" id=\"ref26\">\u003C/a>26. Park, B, Kim, Y, Park, J, Choi, H, Kim, SE, Ryu, H, et al. Integrating biomarkers from virtual reality and magnetic resonance imaging for the early detection of mild cognitive impairment using a multimodal learning approach: validation study. \u003Ci>J Med Internet Res\u003C/i>. (2024) 26:e54538. doi: 10.2196/54538 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/38631021\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.2196/54538\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=B+Park&#x00026;author=Y+Kim&#x00026;author=J+Park&#x00026;author=H+Choi&#x00026;author=SE+Kim&#x00026;author=H+Ryu&#x00026;publication_year=2024&#x00026;title=Integrating+biomarkers+from+virtual+reality+and+magnetic+resonance+imaging+for+the+early+detection+of+mild+cognitive+impairment+using+a+multimodal+learning+approach:+validation+study&#x00026;journal=J+Med+Internet+Res&#x00026;volume=26&#x00026;pages=e54538\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref27\" id=\"ref27\">\u003C/a>27. Galper, J, Dean, NJ, Pickford, R, Lewis, SJG, Halliday, GM, Kim, WS, et al. Lipid pathway dysfunction is prevalent in patients with Parkinson's disease. \u003Ci>Brain\u003C/i>. (2022) 145:3472&#x2013;87. doi: 10.1093/brain/awac176 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/35551349\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1093/brain/awac176\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=J+Galper&#x00026;author=NJ+Dean&#x00026;author=R+Pickford&#x00026;author=SJG+Lewis&#x00026;author=GM+Halliday&#x00026;author=WS+Kim&#x00026;publication_year=2022&#x00026;title=Lipid+pathway+dysfunction+is+prevalent+in+patients+with+Parkinson's+disease&#x00026;journal=Brain&#x00026;volume=145&#x00026;pages=3472-87\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref28\" id=\"ref28\">\u003C/a>28. Fan, TS, Liu, SCH, and Wu, RM. Alpha-synuclein and cognitive decline in Parkinson disease. \u003Ci>Life\u003C/i>. (2021) 11:1239. doi: 10.3390/life11111239 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/34833115\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3390/life11111239\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=TS+Fan&#x00026;author=SCH+Liu&#x00026;author=RM+Wu&#x00026;publication_year=2021&#x00026;title=Alpha-synuclein+and+cognitive+decline+in+Parkinson+disease&#x00026;journal=Life&#x00026;volume=11&#x00026;pages=1239\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref29\" id=\"ref29\">\u003C/a>29. Papaliagkas, V, Kalinderi, K, Vareltzis, P, Moraitou, D, Papamitsou, T, and Chatzidimitriou, M. CSF biomarkers in the early diagnosis of mild cognitive impairment and Alzheimer&#x2019;s disease. \u003Ci>Int J Mol Sci\u003C/i>. (2023) 24:8976. doi: 10.3390/ijms24108976 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/37240322\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3390/ijms24108976\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=V+Papaliagkas&#x00026;author=K+Kalinderi&#x00026;author=P+Vareltzis&#x00026;author=D+Moraitou&#x00026;author=T+Papamitsou&#x00026;author=M+Chatzidimitriou&#x00026;publication_year=2023&#x00026;title=CSF+biomarkers+in+the+early+diagnosis+of+mild+cognitive+impairment+and+Alzheimer&#x2019;s+disease&#x00026;journal=Int+J+Mol+Sci&#x00026;volume=24&#x00026;pages=8976\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref30\" id=\"ref30\">\u003C/a>30. Brockmann, K, Lerche, S, Baiardi, S, Rossi, M, Wurster, I, Quadalti, C, et al. CSF &#x03B1;-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson&#x2019;s disease. \u003Ci>NPJ Parkinsons Dis\u003C/i>. (2024) 10:24. doi: 10.1038/s41531-023-00627-5 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/38242875\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/s41531-023-00627-5\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=K+Brockmann&#x00026;author=S+Lerche&#x00026;author=S+Baiardi&#x00026;author=M+Rossi&#x00026;author=I+Wurster&#x00026;author=C+Quadalti&#x00026;publication_year=2024&#x00026;title=CSF+&#x03B1;-synuclein+seed+amplification+kinetic+profiles+are+associated+with+cognitive+decline+in+Parkinson&#x2019;s+disease&#x00026;journal=NPJ+Parkinsons+Dis&#x00026;volume=10&#x00026;pages=24\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref31\" id=\"ref31\">\u003C/a>31. van der Gaag, BL, Deshayes, NAC, Breve, JJP, Bol, JGJM, Jonker, AJ, Hoozemans, JJM, et al. Distinct tau and alpha-synuclein molecular signatures in Alzheimer&#x2019;s disease with and without Lewy bodies and Parkinson&#x2019;s disease with dementia. \u003Ci>Acta Neuropathol\u003C/i>. (2024) 147:14. doi: 10.1007/s00401-023-02657-y \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/38198008\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1007/s00401-023-02657-y\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=BL+van+der+Gaag&#x00026;author=NAC+Deshayes&#x00026;author=JJP+Breve&#x00026;author=JGJM+Bol&#x00026;author=AJ+Jonker&#x00026;author=JJM+Hoozemans&#x00026;publication_year=2024&#x00026;title=Distinct+tau+and+alpha-synuclein+molecular+signatures+in+Alzheimer&#x2019;s+disease+with+and+without+Lewy+bodies+and+Parkinson&#x2019;s+disease+with+dementia&#x00026;journal=Acta+Neuropathol&#x00026;volume=147&#x00026;pages=14\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref32\" id=\"ref32\">\u003C/a>32. Zhang, N, Tang, C, Ma, Q, Wang, W, Shi, M, Zhou, X, et al. Comprehensive serum metabolic and proteomic characterization on cognitive dysfunction in Parkinson&#x2019;s disease. \u003Ci>Ann Transl Med\u003C/i>. (2021) 9:559&#x2013;9. doi: 10.21037/atm-20-4583 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/33987257\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.21037/atm-20-4583\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=N+Zhang&#x00026;author=C+Tang&#x00026;author=Q+Ma&#x00026;author=W+Wang&#x00026;author=M+Shi&#x00026;author=X+Zhou&#x00026;publication_year=2021&#x00026;title=Comprehensive+serum+metabolic+and+proteomic+characterization+on+cognitive+dysfunction+in+Parkinson&#x2019;s+disease&#x00026;journal=Ann+Transl+Med&#x00026;volume=9&#x00026;pages=559-9\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref33\" id=\"ref33\">\u003C/a>33. Chung, CC, Chan, L, Chen, JH, Chung, C&#x2010;C, Chen, J&#x2010;H, Bamodu, OA, et al. Plasma extracellular vesicles tau and &#x03B2;-amyloid as biomarkers of cognitive dysfunction of Parkinson's disease. \u003Ci>FASEB J\u003C/i>. (2021) 35:e21895. doi: 10.1096/fj.202100787R \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/34478572\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1096/fj.202100787R\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=CC+Chung&#x00026;author=L+Chan&#x00026;author=JH+Chen&#x00026;author=C&#x2010;C+Chung&#x00026;author=J&#x2010;H+Chen&#x00026;author=OA+Bamodu&#x00026;publication_year=2021&#x00026;title=Plasma+extracellular+vesicles+tau+and+&#x03B2;-amyloid+as+biomarkers+of+cognitive+dysfunction+of+Parkinson's+disease&#x00026;journal=FASEB+J&#x00026;volume=35&#x00026;pages=e21895\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref34\" id=\"ref34\">\u003C/a>34. Yan, YQ, Pu, JL, Zheng, R, Yan, Y&#x2010;Q, Pu, J&#x2010;L, Fang, Y, et al. Different patterns of exosomal &#x03B1;-synuclein between Parkinson's disease and probable rapid eye movement sleep behavior disorder. \u003Ci>Eur J Neurol\u003C/i>. (2022) 29:3590&#x2013;9. doi: 10.1111/ene.15537\u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1111/ene.15537\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=YQ+Yan&#x00026;author=JL+Pu&#x00026;author=R+Zheng&#x00026;author=Y&#x2010;Q+Yan&#x00026;author=J&#x2010;L+Pu&#x00026;author=Y+Fang&#x00026;publication_year=2022&#x00026;title=Different+patterns+of+exosomal+&#x03B1;-synuclein+between+Parkinson's+disease+and+probable+rapid+eye+movement+sleep+behavior+disorder&#x00026;journal=Eur+J+Neurol&#x00026;volume=29&#x00026;pages=3590-9\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref35\" id=\"ref35\">\u003C/a>35. Dai, M, Yan, L, Yu, H, Chen, C, and Xie, Y. TNFRSF10B is involved in motor dysfunction in Parkinson's disease by regulating exosomal &#x03B1;-synuclein secretion from microglia. \u003Ci>J Chem Neuroanat\u003C/i>. (2023) 129:102249. doi: 10.1016/j.jchemneu.2023.102249\u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1016/j.jchemneu.2023.102249\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=M+Dai&#x00026;author=L+Yan&#x00026;author=H+Yu&#x00026;author=C+Chen&#x00026;author=Y+Xie&#x00026;publication_year=2023&#x00026;title=TNFRSF10B+is+involved+in+motor+dysfunction+in+Parkinson's+disease+by+regulating+exosomal+&#x03B1;-synuclein+secretion+from+microglia&#x00026;journal=J+Chem+Neuroanat&#x00026;volume=129&#x00026;pages=102249\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref36\" id=\"ref36\">\u003C/a>36. Chen, J, Liang, C, Wang, F, Zhu, Y, Zhu, L, Chen, J, et al. Potential biofluid markers for cognitive impairment in Parkinson&#x2019;s disease. \u003Ci>Neural Regen Res\u003C/i>. (2025) 21:281&#x2013;95. doi: 10.4103/NRR.NRR-D-24-00592\u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.4103/NRR.NRR-D-24-00592\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=J+Chen&#x00026;author=C+Liang&#x00026;author=F+Wang&#x00026;author=Y+Zhu&#x00026;author=L+Zhu&#x00026;author=J+Chen&#x00026;publication_year=2025&#x00026;title=Potential+biofluid+markers+for+cognitive+impairment+in+Parkinson&#x2019;s+disease&#x00026;journal=Neural+Regen+Res&#x00026;volume=21&#x00026;pages=281-95\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref37\" id=\"ref37\">\u003C/a>37. Wang, W, Gao, W, Zhang, L, Xia, Z, and Zhao, B. SNAP25 ameliorates postoperative cognitive dysfunction by facilitating PINK1-dependent mitophagy and impeding caspase-3/GSDME-dependent pyroptosis. \u003Ci>Exp Neurol\u003C/i>. (2023) 367:114463. doi: 10.1016/j.expneurol.2023.114463 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/37295545\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.expneurol.2023.114463\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=W+Wang&#x00026;author=W+Gao&#x00026;author=L+Zhang&#x00026;author=Z+Xia&#x00026;author=B+Zhao&#x00026;publication_year=2023&#x00026;title=SNAP25+ameliorates+postoperative+cognitive+dysfunction+by+facilitating+PINK1-dependent+mitophagy+and+impeding+caspase-3/GSDME-dependent+pyroptosis&#x00026;journal=Exp+Neurol&#x00026;volume=367&#x00026;pages=114463\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref38\" id=\"ref38\">\u003C/a>38. Badr, MY, Amer, RA, Kotait, MA, Shoeib, SM, and Reda, AM. Role of multimodal advanced biomarkers as potential predictors of cognitive and psychiatric aspects of Parkinson's disease. \u003Ci>Egypt J Neurol Psychiatr Neurosurg\u003C/i>. (2023) 59:58. doi: 10.1186/s41983-023-00662-2\u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1186/s41983-023-00662-2\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=MY+Badr&#x00026;author=RA+Amer&#x00026;author=MA+Kotait&#x00026;author=SM+Shoeib&#x00026;author=AM+Reda&#x00026;publication_year=2023&#x00026;title=Role+of+multimodal+advanced+biomarkers+as+potential+predictors+of+cognitive+and+psychiatric+aspects+of+Parkinson's+disease&#x00026;journal=Egypt+J+Neurol+Psychiatr+Neurosurg&#x00026;volume=59&#x00026;pages=58\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref39\" id=\"ref39\">\u003C/a>39. Tang, Y, Han, L, Li, S, Hu, T, Xu, Z, Fan, Y, et al. Plasma GFAP in Parkinson&#x2019;s disease with cognitive impairment and its potential to predict conversion to dementia. \u003Ci>NPJ Parkinsons Dis\u003C/i>. (2023) 9:23. doi: 10.1038/s41531-023-00447-7 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/36759508\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/s41531-023-00447-7\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=Y+Tang&#x00026;author=L+Han&#x00026;author=S+Li&#x00026;author=T+Hu&#x00026;author=Z+Xu&#x00026;author=Y+Fan&#x00026;publication_year=2023&#x00026;title=Plasma+GFAP+in+Parkinson&#x2019;s+disease+with+cognitive+impairment+and+its+potential+to+predict+conversion+to+dementia&#x00026;journal=NPJ+Parkinsons+Dis&#x00026;volume=9&#x00026;pages=23\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref40\" id=\"ref40\">\u003C/a>40. Mohammadi, R, Ng, SYE, Tan, JY, Ng, ASL, Deng, X, Choi, X, et al. Machine learning for early detection of cognitive decline in Parkinson's disease using multimodal biomarker and clinical data. \u003Ci>Biomedicine\u003C/i>. (2024) 12:2758. doi: 10.3390/biomedicines12122758 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/39767666\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3390/biomedicines12122758\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=R+Mohammadi&#x00026;author=SYE+Ng&#x00026;author=JY+Tan&#x00026;author=ASL+Ng&#x00026;author=X+Deng&#x00026;author=X+Choi&#x00026;publication_year=2024&#x00026;title=Machine+learning+for+early+detection+of+cognitive+decline+in+Parkinson's+disease+using+multimodal+biomarker+and+clinical+data&#x00026;journal=Biomedicine&#x00026;volume=12&#x00026;pages=2758\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref41\" id=\"ref41\">\u003C/a>41. Lin, YS, Lee, WJ, Wang, SJ, and Fuh, JL. Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease. \u003Ci>Sci Rep\u003C/i>. (2018) 8:17368. doi: 10.1038/s41598-018-35766-w \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/30478269\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/s41598-018-35766-w\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=YS+Lin&#x00026;author=WJ+Lee&#x00026;author=SJ+Wang&#x00026;author=JL+Fuh&#x00026;publication_year=2018&#x00026;title=Levels+of+plasma+neurofilament+light+chain+and+cognitive+function+in+patients+with+Alzheimer+or+Parkinson+disease&#x00026;journal=Sci+Rep&#x00026;volume=8&#x00026;pages=17368\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref42\" id=\"ref42\">\u003C/a>42. Pawlik, P, and B&#x0142;ochowiak, K. The role of salivary biomarkers in the early diagnosis of Alzheimer&#x2019;s disease and Parkinson&#x2019;s disease. \u003Ci>Diagnostics\u003C/i>. (2021) 11:371. doi: 10.3390/diagnostics11020371 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/33671562\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3390/diagnostics11020371\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=P+Pawlik&#x00026;author=K+B&#x0142;ochowiak&#x00026;publication_year=2021&#x00026;title=The+role+of+salivary+biomarkers+in+the+early+diagnosis+of+Alzheimer&#x2019;s+disease+and+Parkinson&#x2019;s+disease&#x00026;journal=Diagnostics&#x00026;volume=11&#x00026;pages=371\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref43\" id=\"ref43\">\u003C/a>43. Kharel, S, Ojha, R, Bist, A, Joshi, SP, Rauniyar, R, and Yadav, JK. Salivary alpha-synuclein as a potential fluid biomarker in Parkinson's disease: a systematic review and meta-analysis. \u003Ci>Aging Med\u003C/i>. (2022) 5:53&#x2013;62. doi: 10.1002/agm2.12192 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/35309157\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1002/agm2.12192\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=S+Kharel&#x00026;author=R+Ojha&#x00026;author=A+Bist&#x00026;author=SP+Joshi&#x00026;author=R+Rauniyar&#x00026;author=JK+Yadav&#x00026;publication_year=2022&#x00026;title=Salivary+alpha-synuclein+as+a+potential+fluid+biomarker+in+Parkinson's+disease:+a+systematic+review+and+meta-analysis&#x00026;journal=Aging+Med&#x00026;volume=5&#x00026;pages=53-62\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref44\" id=\"ref44\">\u003C/a>44. Muddaloor, P, Farinango, M, Ansary, A, Dakka, A, Nazir, Z, Shamim, H, et al. Prospect of alpha-Synuclein (A-Syn) isolation from saliva as a promising diagnostic biomarker alternative in Parkinson's disease (PD): a systematic review. \u003Ci>Cureus\u003C/i>. (2022) 14:e29880. doi: 10.7759/cureus.29880 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/36348879\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.7759/cureus.29880\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=P+Muddaloor&#x00026;author=M+Farinango&#x00026;author=A+Ansary&#x00026;author=A+Dakka&#x00026;author=Z+Nazir&#x00026;author=H+Shamim&#x00026;publication_year=2022&#x00026;title=Prospect+of+alpha-Synuclein+(A-Syn)+isolation+from+saliva+as+a+promising+diagnostic+biomarker+alternative+in+Parkinson's+disease+(PD):+a+systematic+review&#x00026;journal=Cureus&#x00026;volume=14&#x00026;pages=e29880\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref45\" id=\"ref45\">\u003C/a>45. Ouyang, Q, Xu, L, Zhang, Y, Huang, L, Li, L, and Yu, M. Nonlinear relationship between homocysteine and mild cognitive impairment in early Parkinson&#x2019;s disease: a cross-sectional study. \u003Ci>Neuropsychiatr Dis Treat\u003C/i>. (2024) 20:913&#x2013;21. doi: 10.2147/NDT.S460938 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/38707522\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.2147/NDT.S460938\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=Q+Ouyang&#x00026;author=L+Xu&#x00026;author=Y+Zhang&#x00026;author=L+Huang&#x00026;author=L+Li&#x00026;author=M+Yu&#x00026;publication_year=2024&#x00026;title=Nonlinear+relationship+between+homocysteine+and+mild+cognitive+impairment+in+early+Parkinson&#x2019;s+disease:+a+cross-sectional+study&#x00026;journal=Neuropsychiatr+Dis+Treat&#x00026;volume=20&#x00026;pages=913-21\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref46\" id=\"ref46\">\u003C/a>46. Margiana, R, Hammid, AT, Ahmad, I, Alsaikhan, F, Jalil, AT, Tursunbaev, F, et al. Current progress in aptasensor for ultra-low level monitoring of Parkinson&#x2019;s disease biomarkers. \u003Ci>Crit Rev Anal Chem\u003C/i>. (2024) 54:617&#x2013;32. doi: 10.1080/10408347.2022.2091920\u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1080/10408347.2022.2091920\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=R+Margiana&#x00026;author=AT+Hammid&#x00026;author=I+Ahmad&#x00026;author=F+Alsaikhan&#x00026;author=AT+Jalil&#x00026;author=F+Tursunbaev&#x00026;publication_year=2024&#x00026;title=Current+progress+in+aptasensor+for+ultra-low+level+monitoring+of+Parkinson&#x2019;s+disease+biomarkers&#x00026;journal=Crit+Rev+Anal+Chem&#x00026;volume=54&#x00026;pages=617-32\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref47\" id=\"ref47\">\u003C/a>47. Wang, Z, Becker, K, Donadio, V, Siedlak, S, Yuan, J, Rezaee, M, et al. Skin &#x03B1;-synuclein aggregation seeding activity as a novel biomarker for Parkinson disease. \u003Ci>JAMA Neurol\u003C/i>. (2021) 78:120. doi: 10.1001/jamaneurol.2020.3311\u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1001/jamaneurol.2020.3311\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=Z+Wang&#x00026;author=K+Becker&#x00026;author=V+Donadio&#x00026;author=S+Siedlak&#x00026;author=J+Yuan&#x00026;author=M+Rezaee&#x00026;publication_year=2021&#x00026;title=Skin+&#x03B1;-synuclein+aggregation+seeding+activity+as+a+novel+biomarker+for+Parkinson+disease&#x00026;journal=JAMA+Neurol&#x00026;volume=78&#x00026;pages=120\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref48\" id=\"ref48\">\u003C/a>48. Majbour, N, Aasly, J, Abdi, I, Ghanem, S, Erskine, D, van de Berg, W, et al. Disease-associated &#x03B1;-synuclein aggregates as biomarkers of Parkinson disease clinical stage. \u003Ci>Neurology\u003C/i>. (2022) 99:e2417&#x2013;27. doi: 10.1212/WNL.0000000000201199 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/36096686\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1212/WNL.0000000000201199\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=N+Majbour&#x00026;author=J+Aasly&#x00026;author=I+Abdi&#x00026;author=S+Ghanem&#x00026;author=D+Erskine&#x00026;author=W+van+de+Berg&#x00026;publication_year=2022&#x00026;title=Disease-associated+&#x03B1;-synuclein+aggregates+as+biomarkers+of+Parkinson+disease+clinical+stage&#x00026;journal=Neurology&#x00026;volume=99&#x00026;pages=e2417-27\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref49\" id=\"ref49\">\u003C/a>49. Zhao, Y, Luan, M, Liu, J, Wang, Q, Deng, J, Wang, Z, et al. Skin &#x03B1;-synuclein assays in diagnosing Parkinson's disease: a systematic review and meta-analysis. \u003Ci>J Neurol\u003C/i>. (2025) 272:326. doi: 10.1007/s00415-025-12978-5\u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1007/s00415-025-12978-5\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=Y+Zhao&#x00026;author=M+Luan&#x00026;author=J+Liu&#x00026;author=Q+Wang&#x00026;author=J+Deng&#x00026;author=Z+Wang&#x00026;publication_year=2025&#x00026;title=Skin+&#x03B1;-synuclein+assays+in+diagnosing+Parkinson's+disease:+a+systematic+review+and+meta-analysis&#x00026;journal=J+Neurol&#x00026;volume=272&#x00026;pages=326\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref50\" id=\"ref50\">\u003C/a>50. Ren, J, Zhou, G, Wang, Y, Zhang, R, Guo, Z, Zhou, H, et al. Association of \u003Ci>GBA\u003C/i> genotype with motor and cognitive decline in Chinese Parkinson&#x2019;s disease patients. \u003Ci>Front Aging Neurosci\u003C/i>. (2023) 15:1091919. doi: 10.3389/fnagi.2023.1091919 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/36845659\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3389/fnagi.2023.1091919\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=J+Ren&#x00026;author=G+Zhou&#x00026;author=Y+Wang&#x00026;author=R+Zhang&#x00026;author=Z+Guo&#x00026;author=H+Zhou&#x00026;publication_year=2023&#x00026;title=Association+of+GBA+genotype+with+motor+and+cognitive+decline+in+Chinese+Parkinson&#x2019;s+disease+patients&#x00026;journal=Front+Aging+Neurosci&#x00026;volume=15&#x00026;pages=1091919\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref51\" id=\"ref51\">\u003C/a>51. Ramezani, M, Mouches, P, Yoon, E, Rajashekar, D, Ruskey, JA, Leveille, E, et al. Investigating the relationship between the SNCA gene and cognitive abilities in idiopathic Parkinson&#x2019;s disease using machine learning. \u003Ci>Sci Rep\u003C/i>. (2021) 11:4917. doi: 10.1038/s41598-021-84316-4 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/33649398\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/s41598-021-84316-4\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=M+Ramezani&#x00026;author=P+Mouches&#x00026;author=E+Yoon&#x00026;author=D+Rajashekar&#x00026;author=JA+Ruskey&#x00026;author=E+Leveille&#x00026;publication_year=2021&#x00026;title=Investigating+the+relationship+between+the+SNCA+gene+and+cognitive+abilities+in+idiopathic+Parkinson&#x2019;s+disease+using+machine+learning&#x00026;journal=Sci+Rep&#x00026;volume=11&#x00026;pages=4917\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref52\" id=\"ref52\">\u003C/a>52. Zhao, K, Li, Y, Liu, Z, Long, H, Zhao, C, Luo, F, et al. Parkinson's disease associated mutation E46K of &#x03B1;-synuclein triggers the formation of a distinct fibril structure. \u003Ci>Nat Commun\u003C/i>. (2020) 11:2643. doi: 10.1038/s41467-020-16386-3 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/32457390\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1038/s41467-020-16386-3\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=K+Zhao&#x00026;author=Y+Li&#x00026;author=Z+Liu&#x00026;author=H+Long&#x00026;author=C+Zhao&#x00026;author=F+Luo&#x00026;publication_year=2020&#x00026;title=Parkinson's+disease+associated+mutation+E46K+of+&#x03B1;-synuclein+triggers+the+formation+of+a+distinct+fibril+structure&#x00026;journal=Nat+Commun&#x00026;volume=11&#x00026;pages=2643\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref53\" id=\"ref53\">\u003C/a>53. Weigand, AJ, Ortiz, G, Walker, KS, Galasko, DR, Bondi, MW, and Thomas, KR. APOE differentially moderates cerebrospinal fluid and plasma phosphorylated tau181 associations with multi-domain cognition. \u003Ci>Neurobiol Aging\u003C/i>. (2023) 125:1&#x2013;8. doi: 10.1016/j.neurobiolaging.2022.10.016 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/36780762\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1016/j.neurobiolaging.2022.10.016\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=AJ+Weigand&#x00026;author=G+Ortiz&#x00026;author=KS+Walker&#x00026;author=DR+Galasko&#x00026;author=MW+Bondi&#x00026;author=KR+Thomas&#x00026;publication_year=2023&#x00026;title=APOE+differentially+moderates+cerebrospinal+fluid+and+plasma+phosphorylated+tau181+associations+with+multi-domain+cognition&#x00026;journal=Neurobiol+Aging&#x00026;volume=125&#x00026;pages=1-8\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref54\" id=\"ref54\">\u003C/a>54. Gordon, EM, Devaney, JM, Bean, S, and Vaidya, CJ. Resting-state striato-frontal functional connectivity is sensitive to DAT1 genotype and predicts executive function. \u003Ci>Cereb Cortex\u003C/i>. (2015) 25:336&#x2013;45. doi: 10.1093/cercor/bht229 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/23968837\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1093/cercor/bht229\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=EM+Gordon&#x00026;author=JM+Devaney&#x00026;author=S+Bean&#x00026;author=CJ+Vaidya&#x00026;publication_year=2015&#x00026;title=Resting-state+striato-frontal+functional+connectivity+is+sensitive+to+DAT1+genotype+and+predicts+executive+function&#x00026;journal=Cereb+Cortex&#x00026;volume=25&#x00026;pages=336-45\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref55\" id=\"ref55\">\u003C/a>55. Hasani, F, Ahmadi, P, Masrour, M, Khamaki, S, Rahmati, R, and Surguchov, A. Epigenetic alterations of cognition functions in Parkinson's disease (2024). doi: 10.20944/preprints202406.0981.v1,\u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.20944/preprints202406.0981.v1\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=F+Hasani&#x00026;author=P+Ahmadi&#x00026;author=M+Masrour&#x00026;author=S+Khamaki&#x00026;author=R+Rahmati&#x00026;author=A+Surguchov&#x00026;publication_year=2024&#x00026;title=Epigenetic+alterations+of+cognition+functions+in+Parkinson's+disease&#x00026;\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref56\" id=\"ref56\">\u003C/a>56. Zhang, Y, and Shen, S. Epigenome-wide DNA methylation analysis of late-stage mild cognitive impairment. \u003Ci>Front Cell Dev Biol\u003C/i>. (2024) 12:1276288. doi: 10.3389/fcell.2024.1276288 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/38298218\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3389/fcell.2024.1276288\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=Y+Zhang&#x00026;author=S+Shen&#x00026;publication_year=2024&#x00026;title=Epigenome-wide+DNA+methylation+analysis+of+late-stage+mild+cognitive+impairment&#x00026;journal=Front+Cell+Dev+Biol&#x00026;volume=12&#x00026;pages=1276288\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref57\" id=\"ref57\">\u003C/a>57. Jim&#x000E9;nez-Ram&#x000ED;rez, IA, and Casta&#x000F1;o, E. Non-coding RNAs in the pathogenesis of Alzheimer&#x2019;s disease: &#x03B2;-amyloid aggregation, tau phosphorylation and neuroinflammation. \u003Ci>Mol Biol Rep\u003C/i>. (2025) 52:183. doi: 10.1007/s11033-025-10284-x \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/39890684\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1007/s11033-025-10284-x\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=IA+Jim&#x000E9;nez-Ram&#x000ED;rez&#x00026;author=E+Casta&#x000F1;o&#x00026;publication_year=2025&#x00026;title=Non-coding+RNAs+in+the+pathogenesis+of+Alzheimer&#x2019;s+disease:+&#x03B2;-amyloid+aggregation+tau+phosphorylation+and+neuroinflammation&#x00026;journal=Mol+Biol+Rep&#x00026;volume=52&#x00026;pages=183\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref58\" id=\"ref58\">\u003C/a>58. Arya, R, Haque, AKMA, Shakya, H, Billah, MM, Parvin, A, Rahman, M-M, et al. Parkinson&#x2019;s disease: biomarkers for diagnosis and disease progression. \u003Ci>Int J Mol Sci\u003C/i>. (2024) 25:12379. doi: 10.3390/ijms252212379 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/39596444\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3390/ijms252212379\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=R+Arya&#x00026;author=AKMA+Haque&#x00026;author=H+Shakya&#x00026;author=MM+Billah&#x00026;author=A+Parvin&#x00026;author=M-M+Rahman&#x00026;publication_year=2024&#x00026;title=Parkinson&#x2019;s+disease:+biomarkers+for+diagnosis+and+disease+progression&#x00026;journal=Int+J+Mol+Sci&#x00026;volume=25&#x00026;pages=12379\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref59\" id=\"ref59\">\u003C/a>59. Geritz, J, Welzel, J, Hansen, C, Maetzler, C, Hobert, MA, Elshehabi, M, et al. Cognitive parameters can predict change of walking performance in advanced Parkinson's disease - chances and limits of early rehabilitation. \u003Ci>Front Aging Neurosci\u003C/i>. (2022) 14:1070093. doi: 10.3389/fnagi.2022.1070093 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/36620765\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.3389/fnagi.2022.1070093\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=J+Geritz&#x00026;author=J+Welzel&#x00026;author=C+Hansen&#x00026;author=C+Maetzler&#x00026;author=MA+Hobert&#x00026;author=M+Elshehabi&#x00026;publication_year=2022&#x00026;title=Cognitive+parameters+can+predict+change+of+walking+performance+in+advanced+Parkinson's+disease+-+chances+and+limits+of+early+rehabilitation&#x00026;journal=Front+Aging+Neurosci&#x00026;volume=14&#x00026;pages=1070093\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref60\" id=\"ref60\">\u003C/a>60. Berron, D, Olsson, E, Andersson, F, Janelidze, S, Tideman, P, D&#x000FC;zel, E, et al. Remote and unsupervised digital memory assessments can reliably detect cognitive impairment in Alzheimer's disease. \u003Ci>Alzheimers Dement\u003C/i>. (2024) 20:4775&#x2013;91. doi: 10.1002/alz.13919 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/38867417\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1002/alz.13919\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=D+Berron&#x00026;author=E+Olsson&#x00026;author=F+Andersson&#x00026;author=S+Janelidze&#x00026;author=P+Tideman&#x00026;author=E+D&#x000FC;zel&#x00026;publication_year=2024&#x00026;title=Remote+and+unsupervised+digital+memory+assessments+can+reliably+detect+cognitive+impairment+in+Alzheimer's+disease&#x00026;journal=Alzheimers+Dement&#x00026;volume=20&#x00026;pages=4775-91\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref61\" id=\"ref61\">\u003C/a>61. Park, SY, and Schott, N. Which motor-cognitive abilities underlie the digital trail-making test? Decomposing various test scores to detect cognitive impairment in Parkinson's disease-pilot study. \u003Ci>Appl Neuropsychol Adult\u003C/i>. (2025) 32:60&#x2013;74. doi: 10.1080/23279095.2022.2147837 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/36412487\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1080/23279095.2022.2147837\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=SY+Park&#x00026;author=N+Schott&#x00026;publication_year=2025&#x00026;title=Which+motor-cognitive+abilities+underlie+the+digital+trail-making+test?+Decomposing+various+test+scores+to+detect+cognitive+impairment+in+Parkinson's+disease-pilot+study&#x00026;journal=Appl+Neuropsychol+Adult&#x00026;volume=32&#x00026;pages=60-74\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref62\" id=\"ref62\">\u003C/a>62. Klotz, LV, Casjens, S, Johnen, G, Taeger, D, Brik, A, Eichhorn, F, et al. Combination of calretinin, MALAT1, and GAS5 as a potential prognostic biomarker to predict disease progression in surgically treated mesothelioma patients. \u003Ci>Lung Cancer\u003C/i>. (2024) 192:107802. doi: 10.1016/j.lungcan.2024.107802\u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1016/j.lungcan.2024.107802\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=LV+Klotz&#x00026;author=S+Casjens&#x00026;author=G+Johnen&#x00026;author=D+Taeger&#x00026;author=A+Brik&#x00026;author=F+Eichhorn&#x00026;publication_year=2024&#x00026;title=Combination+of+calretinin+MALAT1+and+GAS5+as+a+potential+prognostic+biomarker+to+predict+disease+progression+in+surgically+treated+mesothelioma+patients&#x00026;journal=Lung+Cancer&#x00026;volume=192&#x00026;pages=107802\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref63\" id=\"ref63\">\u003C/a>63. Zhang, J, Gao, Y, He, X, Feng, S, Hu, J, Zhang, Q, et al. Identifying Parkinson's disease with mild cognitive impairment by using combined MR imaging and electroencephalogram. \u003Ci>Eur Radiol\u003C/i>. (2021) 31:7386&#x2013;94. doi: 10.1007/s00330-020-07575-1 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/33389038\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1007/s00330-020-07575-1\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=J+Zhang&#x00026;author=Y+Gao&#x00026;author=X+He&#x00026;author=S+Feng&#x00026;author=J+Hu&#x00026;author=Q+Zhang&#x00026;publication_year=2021&#x00026;title=Identifying+Parkinson's+disease+with+mild+cognitive+impairment+by+using+combined+MR+imaging+and+electroencephalogram&#x00026;journal=Eur+Radiol&#x00026;volume=31&#x00026;pages=7386-94\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref64\" id=\"ref64\">\u003C/a>64. Zhu, Y, Wang, F, Ning, P, Zhu, Y, Zhang, L, Li, K, et al. Multimodal neuroimaging-based prediction of Parkinson&#x2019;s disease with mild cognitive impairment using machine learning technique. \u003Ci>npj Parkinson's Dis\u003C/i>. (2024) 10:218. doi: 10.1038/s41531-024-00828-6\u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1038/s41531-024-00828-6\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=Y+Zhu&#x00026;author=F+Wang&#x00026;author=P+Ning&#x00026;author=Y+Zhu&#x00026;author=L+Zhang&#x00026;author=K+Li&#x00026;publication_year=2024&#x00026;title=Multimodal+neuroimaging-based+prediction+of+Parkinson&#x2019;s+disease+with+mild+cognitive+impairment+using+machine+learning+technique&#x00026;journal=npj+Parkinson's+Dis&#x00026;volume=10&#x00026;pages=218\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\" style=\"margin-bottom:0.5em;\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref65\" id=\"ref65\">\u003C/a>65. Cirincione, A, Lynch, K, Bennett, J, Choupan, J, Varghese, B, Sheikh-Bahaei, N, et al. Prediction of future dementia among patients with mild cognitive impairment (MCI) by integrating multimodal clinical data. \u003Ci>Heliyon\u003C/i>. (2024) 10:&#x2013;e36728. doi: 10.1016/j.heliyon.2024.e36728\u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://doi.org/10.1016/j.heliyon.2024.e36728\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=A+Cirincione&#x00026;author=K+Lynch&#x00026;author=J+Bennett&#x00026;author=J+Choupan&#x00026;author=B+Varghese&#x00026;author=N+Sheikh-Bahaei&#x00026;publication_year=2024&#x00026;title=Prediction+of+future+dementia+among+patients+with+mild+cognitive+impairment+(MCI)+by+integrating+multimodal+clinical+data&#x00026;journal=Heliyon&#x00026;volume=10&#x00026;pages=e36728\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003Cdiv class=\"References\">\n\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"ref66\" id=\"ref66\">\u003C/a>66. Sato, M, Kobayashi, T, Soroida, Y, Tanaka, T, Nakatsuka, T, Nakagawa, H, et al. Development of novel deep multimodal representation learning-based model for the differentiation of liver tumors on B-mode ultrasound images. \u003Ci>J Gastroenterol Hepatol\u003C/i>. (2022) 37:678&#x2013;84. doi: 10.1111/jgh.15763 \u003C/p>\n\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/34911147\" target=\"_blank\">PubMed Abstract\u003C/a> | \u003Ca href=\"https://doi.org/10.1111/jgh.15763\" target=\"_blank\">Crossref Full Text\u003C/a> | \u003Ca href=\"http://scholar.google.com/scholar_lookup?author=M+Sato&#x00026;author=T+Kobayashi&#x00026;author=Y+Soroida&#x00026;author=T+Tanaka&#x00026;author=T+Nakatsuka&#x00026;author=H+Nakagawa&#x00026;publication_year=2022&#x00026;title=Development+of+novel+deep+multimodal+representation+learning-based+model+for+the+differentiation+of+liver+tumors+on+B-mode+ultrasound+images&#x00026;journal=J+Gastroenterol+Hepatol&#x00026;volume=37&#x00026;pages=678-84\" target=\"_blank\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\n\u003C/div> \u003Cdiv class=\"thinLineM20\">\u003C/div> \u003Cdiv class=\"AbstractSummary\">\n\u003Cp>\u003Cspan>Keywords:\u003C/span> Parkinson&#x2019;s disease-mild cognitive impairment, multimodal biomarkers, early diagnosis, machine learning algorithm, review\u003C/p>\n\u003Cp>\u003Cspan>Citation:\u003C/span> Guo H, Shen X, Lyu M, Zhou G, Chen C, Xing B and Xie Y (2025) Research progress of multimodal biomarkers in the early diagnosis of mild cognitive impairment in Parkinson&#x2019;s disease. \u003Ci>Front. Neurol\u003C/i>. 16:1652378. doi: 10.3389/fneur.2025.1652378\u003C/p>\n\u003Cp class=\"timestamps\">\u003Cspan>Received:\u003C/span> 23 June 2025; \u003Cspan>Accepted:\u003C/span> 01 August 2025;\u003Cbr> \u003Cspan>Published:\u003C/span> 29 August 2025.\u003C/p> \u003Cdiv>\n\u003Cp>Edited by:\u003C/p> \u003Ca href=\"https://loop.frontiersin.org/people/2991286/overview\">Shruti Verma\u003C/a>, Symbiosis International University, India\u003C/div> \u003Cdiv>\n\u003Cp>Reviewed by:\u003C/p> \u003Ca href=\"https://loop.frontiersin.org/people/451799/overview\">Chunchen Xiang\u003C/a>, Capital Medical University, China\u003C/div>\n\u003Cp>\u003Cspan>Copyright\u003C/span> &#x000A9; 2025 Guo, Shen, Lyu, Zhou, Chen, Xing and Xie. This is an open-access article distributed under the terms of the \u003Ca rel=\"license\" href=\"http://creativecommons.org/licenses/by/4.0/\" target=\"_blank\">Creative Commons Attribution License (CC BY)\u003C/a>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.\u003C/p>\n\u003Cp>\u003Cspan>&#x0002A;Correspondence:\u003C/span> Xiaoming Shen, \u003Ca id=\"encmail\">c3htZG9jQDE2My5jb20=\u003C/a>\u003C/p> \u003Cdiv class=\"clear\">\u003C/div> \u003C/div>","\u003Cul class=\"flyoutJournal\"> \u003Cli>\u003Ca href=\"#h1\">Abstract\u003C/a>\u003C/li> \u003Cli>\u003Ca href=\"#h2\">1 Introduction\u003C/a>\u003C/li> \u003Cli>\u003Ca href=\"#h3\">2 Neuroimaging biomarkers\u003C/a>\u003C/li> \u003Cli>\u003Ca href=\"#h4\">3 Fluid biomarkers\u003C/a>\u003C/li> \u003Cli>\u003Ca href=\"#h5\">4 Genetic biomarkers\u003C/a>\u003C/li> \u003Cli>\u003Ca href=\"#h6\">5 Digital biomarkers\u003C/a>\u003C/li> \u003Cli>\u003Ca href=\"#h7\">6 Clinical and neuropsychological assessment\u003C/a>\u003C/li> \u003Cli>\u003Ca href=\"#h8\">7 Multimodal integration models\u003C/a>\u003C/li> \u003Cli>\u003Ca href=\"#h9\">8 Conclusion\u003C/a>\u003C/li> \u003Cli>\u003Ca href=\"#h10\">Author contributions\u003C/a>\u003C/li> \u003Cli>\u003Ca href=\"#h11\">Funding\u003C/a>\u003C/li> \u003Cli>\u003Ca href=\"#h12\">Conflict of interest\u003C/a>\u003C/li> \u003Cli>\u003Ca href=\"#h13\">Generative AI statement\u003C/a>\u003C/li> \u003Cli>\u003Ca href=\"#h14\">Publisher&#x2019;s note\u003C/a>\u003C/li> \u003Cli>\u003Ca href=\"#h15\">References\u003C/a>\u003C/li> \u003C/ul>",[698,704,710],{"name":699,"fileServerPackageEntryId":19,"fileServerId":700,"fileServerVersionNumber":439,"type":701},"EPUB.epub","1652378/epub",{"code":702,"name":703},"EPUB","epub",{"name":705,"fileServerPackageEntryId":19,"fileServerId":706,"fileServerVersionNumber":439,"type":707},"Publishers-Proof.pdf","1652378/publishers-proof",{"code":708,"name":709},"PDF","pdf",{"name":711,"fileServerPackageEntryId":712,"fileServerId":713,"fileServerVersionNumber":439,"type":714},"fneur-16-1652378.xml","fneur-16-1652378/fneur-16-1652378.xml","1652378/xml",{"code":715,"name":716},"NLM_XML","xml","fneur-16-1652378-HTML","v3",{"title":720,"link":721,"meta":725,"script":839},"Frontiers | Research progress of multimodal biomarkers in the early diagnosis of mild cognitive impairment in Parkinsonâ€™s disease",[722],{"rel":723,"href":724},"canonical","https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1652378/full",[726,729,732,734,737,741,744,748,751,754,757,759,761,763,765,767,770,773,775,778,780,782,785,788,791,794,797,801,805,808,810,813,815,818,820,823,825,828,830,833,836],{"hid":727,"property":727,"name":727,"content":728},"description","Parkinsonâ€™s disease (PD), as a common neurodegenerative disorder, its associated mild cognitive impairment (PD-mild cognitive impairment, PD-MCI) is a key pr...",{"hid":730,"property":730,"name":731,"content":720},"og:title","title",{"hid":733,"property":733,"name":727,"content":728},"og:description",{"hid":735,"name":735,"content":736},"keywords","review,early diagnosis,machine learning algorithm,multimodal biomarkers,Parkinsonâ€™s disease-mild cognitive impairment",{"hid":738,"property":738,"name":739,"content":740},"og:site_name","site_name","Frontiers",{"hid":742,"property":742,"name":432,"content":743},"og:image","https://images-provider.frontiersin.org/api/ipx/w=1200&f=png/https://www.frontiersin.org/files/Articles/1652378/fneur-16-1652378-HTML/image_m/fneur-16-1652378-g001.jpg",{"hid":745,"property":745,"name":746,"content":747},"og:type","type","article",{"hid":749,"property":749,"name":750,"content":724},"og:url","url",{"hid":752,"name":752,"content":753},"twitter:card","summary_large_image",{"hid":755,"name":755,"content":756},"citation_volume","16",{"hid":758,"name":758,"content":116},"citation_journal_title",{"hid":760,"name":760,"content":740},"citation_publisher",{"hid":762,"name":762,"content":678},"citation_journal_abbrev",{"hid":764,"name":764,"content":679},"citation_issn",{"hid":766,"name":766,"content":583},"citation_doi",{"hid":768,"name":768,"content":769},"citation_firstpage","1652378",{"hid":771,"name":771,"content":772},"citation_language","English",{"hid":774,"name":774,"content":584},"citation_title",{"hid":776,"name":776,"content":777},"citation_keywords","review; early diagnosis; machine learning algorithm; multimodal biomarkers; Parkinsonâ€™s disease-mild cognitive impairment",{"hid":779,"name":779,"content":589},"citation_abstract",{"hid":781,"name":781,"content":598},"citation_article_type",{"hid":783,"name":783,"content":784},"citation_pdf_url","https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1652378/pdf",{"hid":786,"name":786,"content":787},"citation_xml_url","https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1652378/xml",{"hid":789,"name":789,"content":790},"citation_fulltext_world_readable","yes",{"hid":792,"name":792,"content":793},"citation_online_date","2025/08/01",{"hid":795,"name":795,"content":796},"citation_publication_date","2025/08/29",{"hid":798,"name":799,"content":800},"citation_author_0","citation_author","Guo, Huiping ",{"hid":802,"name":803,"content":804},"citation_author_institution_0","citation_author_institution","Department of Encephalopathy, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, China",{"hid":806,"name":799,"content":807},"citation_author_1","Shen, Xiaoming ",{"hid":809,"name":803,"content":804},"citation_author_institution_1",{"hid":811,"name":799,"content":812},"citation_author_2","Lyu, Mengke ",{"hid":814,"name":803,"content":804},"citation_author_institution_2",{"hid":816,"name":799,"content":817},"citation_author_3","Zhou, Guangsheng ",{"hid":819,"name":803,"content":804},"citation_author_institution_3",{"hid":821,"name":799,"content":822},"citation_author_4","Chen, Chongchong ",{"hid":824,"name":803,"content":804},"citation_author_institution_4",{"hid":826,"name":799,"content":827},"citation_author_5","Xing, Baofu ",{"hid":829,"name":803,"content":804},"citation_author_institution_5",{"hid":831,"name":799,"content":832},"citation_author_6","Xie, Yanming ",{"hid":834,"name":803,"content":835},"citation_author_institution_6","Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, China",{"hid":837,"name":837,"content":838},"dc.identifier","doi:10.3389/fneur.2025.1652378",[840,843,845,847,849],{"src":841,"body":13,"type":842,"async":13},"https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6","text/javascript",{"src":844,"body":13,"type":842,"async":13},"https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-MML-AM_CHTML",{"src":846,"body":13,"type":842,"async":13},"https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-f0bc9b243ff5677d05460c1eb71834ca998946d764eb3bc244ab4b18ba50d21e.js",{"src":848,"body":13,"type":842,"async":13},"https://api.altmetric.com/v1/doi/10.3389/fneur.2025.1652378?callback=_altmetric.embed_callback&domain=www.frontiersin.org&key=3c130976ca2b8f2e88f8377633751ba1&cache_until=14-15",{"src":850,"body":13,"type":842,"async":13},"https://crossmark-cdn.crossref.org/widget/v2.0/widget.js",{"articleHubSlug":19,"articleHubPage":852,"articleHubArticlesList":853,"canJournalHasArticleHub":379,"articleDoiList":854},{},[],[],{"title":19,"image":-1,"breadcrumbs":856,"linksCollection":857,"metricsCollection":859},[],{"total":436,"items":858},[],{"total":436,"items":860},[]]</script>
<script>window.__NUXT__={};window.__NUXT__.config={public:{isDevMode:false,appName:"article-pages-2024",baseUrl:"https://www.frontiersin.org",domain:"frontiersin.org",loopUrl:"https://loop.frontiersin.org",ssMainDomain:"frontiersin.org",contentfulUrl:"https://graphql.contentful.com/content/v1/spaces",spaceId:1,spaceName:"Frontiers",liveSpaceId:1,tenantLogoUrl:"",frontiersGraphUrl:"https://apollo-federation-gateway.frontiersin.org",registrationApiUrl:"https://onboarding-ui.frontiersin.org",emailDigestApiUrl:"https://api-email-digest.frontiersin.org",journalFilesApiUrl:"https://files-journal-api.frontiersin.org",searchApiUrl:"https://search-api.frontiersin.org",productionForumApiUrl:"https://production-forum-api-v2.frontiersin.org",gtmServerUrl:"https://tag-manager.frontiersin.org",gtmId:"GTM-M322FV2",gtmAuth:"owVbWxfaJr21yQv1fe1cAQ",gtmPreview:"env-1",figsharePluginUrl:"https://widgets.figshare.com/static/figshare.js",figshareApiUrl:"https://api.figshare.com/v2/collections/search",figshareTimeout:3000,crossmarkPublishedDate:"2015/08/24",googleRecaptchaSiteKey:"6LdG3i0UAAAAAOC4qUh35ubHgJotEHp_STXHgr_v",googleRecaptchaKeyName:"FrontiersRecaptchaV2",faviconSize16:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_16-tenantFavicon-Frontiers.png",faviconSize32:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_32-tenantFavicon-Frontiers.png",faviconSize180:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_180-tenantFavicon-Frontiers.png",faviconSize192:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_192-tenantFavicon-Frontiers.png",faviconSize512:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_512-tenantFavicon-Frontiers.png",socialMediaImg:"https://brand.frontiersin.org/m/1c8bcb536c789e11/Guidelines-Frontiers_Logo_1200x628_1-91to1.png",linkedArticleCopyText:"'{\"articleTypeCopyText\":[{\"articleTypeId\":0,\"originalArticleCopyText\":\"Part of this article's content has been mentioned in:\",\"linkedArticleCopyText\":\"This article mentions parts of:\"},{\"articleTypeId\":122,\"originalArticleCopyText\":\"Parts of this article's content have been modified or rectified in:\",\"linkedArticleCopyText\":\"This article is an erratum on:\"},{\"articleTypeId\":129,\"originalArticleCopyText\":\"Parts of this article's content have been modified or rectified in:\",\"linkedArticleCopyText\":\"This article is an addendum to:\"},{\"articleTypeId\":128,\"originalArticleCopyText\":\"A correction has been applied to this article in:\",\"linkedArticleCopyText\":\"This article is a correction to:\"},{\"articleTypeId\":134,\"originalArticleCopyText\":\"A retraction of this article was approved in:\",\"linkedArticleCopyText\":\"This article is a retraction of:\"},{\"articleTypeId\":29,\"originalArticleCopyText\":\"A commentary has been posted on this article:\",\"linkedArticleCopyText\":\"This article is a commentary on:\"},{\"articleTypeId\":30,\"originalArticleCopyText\":\"A commentary has been posted on this article:\",\"linkedArticleCopyText\":\"This article is a commentary on:\"}],\"articleIdCopyText\":[]}'\n",acceptedArticleExcludedJournalIds:"'[2766,979]'\n",articleTypeConfigurableLabel:"\u003C\u003Carticle-type:uppercase>> article",settingsFeaturesSwitchers:"'{\"displayTitlePillLabels\":true,\"displayRelatedArticlesBox\":true,\"showEditors\":true,\"showReviewers\":true,\"showLoopImpactLink\":true,\"enableFigshare\":false,\"useXmlImages\":true}'\n",journalsWithArticleHub:"'{\"strings\":[\"science\"]}'\n",terminologySettings:"'{\"terms\":[{\"sequenceNumber\":1,\"key\":\"frontiers\",\"tenantTerm\":\"Frontiers\",\"frontiersDefaultTerm\":\"Frontiers\",\"category\":\"Customer\"},{\"sequenceNumber\":2,\"key\":\"submission_system\",\"tenantTerm\":\"submission system\",\"frontiersDefaultTerm\":\"submission system\",\"category\":\"Product\"},{\"sequenceNumber\":3,\"key\":\"public_pages\",\"tenantTerm\":\"public pages\",\"frontiersDefaultTerm\":\"public pages\",\"category\":\"Product\"},{\"sequenceNumber\":4,\"key\":\"my_frontiers\",\"tenantTerm\":\"my frontiers\",\"frontiersDefaultTerm\":\"my frontiers\",\"category\":\"Product\"},{\"sequenceNumber\":5,\"key\":\"digital_editorial_office\",\"tenantTerm\":\"digital editorial office\",\"frontiersDefaultTerm\":\"digital editorial office\",\"category\":\"Product\"},{\"sequenceNumber\":6,\"key\":\"deo\",\"tenantTerm\":\"DEO\",\"frontiersDefaultTerm\":\"DEO\",\"category\":\"Product\"},{\"sequenceNumber\":7,\"key\":\"digital_editorial_office_for_chiefs\",\"tenantTerm\":\"digital editorial office for chiefs\",\"frontiersDefaultTerm\":\"digital editorial office for chiefs\",\"category\":\"Product\"},{\"sequenceNumber\":8,\"key\":\"digital_editorial_office_for_eof\",\"tenantTerm\":\"digital editorial office for eof\",\"frontiersDefaultTerm\":\"digital editorial office for eof\",\"category\":\"Product\"},{\"sequenceNumber\":9,\"key\":\"editorial_office\",\"tenantTerm\":\"editorial office\",\"frontiersDefaultTerm\":\"editorial office\",\"category\":\"Product\"},{\"sequenceNumber\":10,\"key\":\"eof\",\"tenantTerm\":\"EOF\",\"frontiersDefaultTerm\":\"EOF\",\"category\":\"Product\"},{\"sequenceNumber\":11,\"key\":\"research_topic_management\",\"tenantTerm\":\"research topic management\",\"frontiersDefaultTerm\":\"research topic management\",\"category\":\"Product\"},{\"sequenceNumber\":12,\"key\":\"review_forum\",\"tenantTerm\":\"review forum\",\"frontiersDefaultTerm\":\"review forum\",\"category\":\"Product\"},{\"sequenceNumber\":13,\"key\":\"accounting_office\",\"tenantTerm\":\"accounting office\",\"frontiersDefaultTerm\":\"accounting office\",\"category\":\"Product\"},{\"sequenceNumber\":14,\"key\":\"aof\",\"tenantTerm\":\"AOF\",\"frontiersDefaultTerm\":\"AOF\",\"category\":\"Product\"},{\"sequenceNumber\":15,\"key\":\"publishing_office\",\"tenantTerm\":\"publishing office\",\"frontiersDefaultTerm\":\"publishing office\",\"category\":\"Product\"},{\"sequenceNumber\":16,\"key\":\"production_office\",\"tenantTerm\":\"production office forum\",\"frontiersDefaultTerm\":\"production office forum\",\"category\":\"Product\"},{\"sequenceNumber\":17,\"key\":\"pof\",\"tenantTerm\":\"POF\",\"frontiersDefaultTerm\":\"POF\",\"category\":\"Product\"},{\"sequenceNumber\":18,\"key\":\"book_office_forum\",\"tenantTerm\":\"book office forum\",\"frontiersDefaultTerm\":\"book office forum\",\"category\":\"Product\"},{\"sequenceNumber\":19,\"key\":\"bof\",\"tenantTerm\":\"BOF\",\"frontiersDefaultTerm\":\"BOF\",\"category\":\"Product\"},{\"sequenceNumber\":20,\"key\":\"aira\",\"tenantTerm\":\"AIRA\",\"frontiersDefaultTerm\":\"AIRA\",\"category\":\"Product\"},{\"sequenceNumber\":21,\"key\":\"editorial_board_management\",\"tenantTerm\":\"editorial board management\",\"frontiersDefaultTerm\":\"editorial board management\",\"category\":\"Product\"},{\"sequenceNumber\":22,\"key\":\"ebm\",\"tenantTerm\":\"EBM\",\"frontiersDefaultTerm\":\"EBM\",\"category\":\"Product\"},{\"sequenceNumber\":23,\"key\":\"domain\",\"tenantTerm\":\"domain\",\"frontiersDefaultTerm\":\"domain\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":24,\"key\":\"journal\",\"tenantTerm\":\"journal\",\"frontiersDefaultTerm\":\"journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":25,\"key\":\"section\",\"tenantTerm\":\"section\",\"frontiersDefaultTerm\":\"section\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":26,\"key\":\"domains\",\"tenantTerm\":\"domains\",\"frontiersDefaultTerm\":\"domains\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":27,\"key\":\"specialty_section\",\"tenantTerm\":\"specialty section\",\"frontiersDefaultTerm\":\"specialty section\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":28,\"key\":\"specialty_journal\",\"tenantTerm\":\"specialty journal\",\"frontiersDefaultTerm\":\"specialty journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":29,\"key\":\"journals\",\"tenantTerm\":\"journals\",\"frontiersDefaultTerm\":\"journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":30,\"key\":\"sections\",\"tenantTerm\":\"sections\",\"frontiersDefaultTerm\":\"sections\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":31,\"key\":\"specialty_sections\",\"tenantTerm\":\"specialty sections\",\"frontiersDefaultTerm\":\"specialty sections\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":32,\"key\":\"specialty_journals\",\"tenantTerm\":\"specialty journals\",\"frontiersDefaultTerm\":\"specialty journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":33,\"key\":\"manuscript\",\"tenantTerm\":\"manuscript\",\"frontiersDefaultTerm\":\"manuscript\",\"category\":\"Core\"},{\"sequenceNumber\":34,\"key\":\"manuscripts\",\"tenantTerm\":\"manuscripts\",\"frontiersDefaultTerm\":\"manuscripts\",\"category\":\"Core\"},{\"sequenceNumber\":35,\"key\":\"article\",\"tenantTerm\":\"article\",\"frontiersDefaultTerm\":\"article\",\"category\":\"Core\"},{\"sequenceNumber\":36,\"key\":\"articles\",\"tenantTerm\":\"articles\",\"frontiersDefaultTerm\":\"articles\",\"category\":\"Core\"},{\"sequenceNumber\":37,\"key\":\"article_type\",\"tenantTerm\":\"article type\",\"frontiersDefaultTerm\":\"article type\",\"category\":\"Core\"},{\"sequenceNumber\":38,\"key\":\"article_types\",\"tenantTerm\":\"article types\",\"frontiersDefaultTerm\":\"article types\",\"category\":\"Core\"},{\"sequenceNumber\":39,\"key\":\"author\",\"tenantTerm\":\"author\",\"frontiersDefaultTerm\":\"author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":40,\"key\":\"authors\",\"tenantTerm\":\"authors\",\"frontiersDefaultTerm\":\"authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":41,\"key\":\"authoring\",\"tenantTerm\":\"authoring\",\"frontiersDefaultTerm\":\"authoring\",\"category\":\"Core\"},{\"sequenceNumber\":42,\"key\":\"authored\",\"tenantTerm\":\"authored\",\"frontiersDefaultTerm\":\"authored\",\"category\":\"Core\"},{\"sequenceNumber\":43,\"key\":\"accept\",\"tenantTerm\":\"accept\",\"frontiersDefaultTerm\":\"accept\",\"category\":\"Process\"},{\"sequenceNumber\":44,\"key\":\"accepted\",\"tenantTerm\":\"accepted\",\"frontiersDefaultTerm\":\"accepted\",\"category\":\"Process\"},{\"sequenceNumber\":45,\"key\":\"assistant_field_chief_editor\",\"tenantTerm\":\"Assistant Field Chief Editor\",\"frontiersDefaultTerm\":\"Assistant Field Chief Editor\",\"description\":\"An editorial role on a Field Journal that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":46,\"key\":\"assistant_specialty_chief_editor\",\"tenantTerm\":\"Assistant Specialty Chief Editor\",\"frontiersDefaultTerm\":\"Assistant Specialty Chief Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":47,\"key\":\"assistant_specialty_chief_editors\",\"tenantTerm\":\"Assistant Specialty Chief Editors\",\"frontiersDefaultTerm\":\"Assistant Specialty Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":48,\"key\":\"associate_editor\",\"tenantTerm\":\"Associate Editor\",\"frontiersDefaultTerm\":\"Associate Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":49,\"key\":\"specialty_chief_editor\",\"tenantTerm\":\"Specialty Chief Editor\",\"frontiersDefaultTerm\":\"Specialty Chief Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":50,\"key\":\"specialty_chief_editors\",\"tenantTerm\":\"Specialty Chief Editors\",\"frontiersDefaultTerm\":\"Specialty Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":51,\"key\":\"chief_editor\",\"tenantTerm\":\"Chief Editor\",\"frontiersDefaultTerm\":\"Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":52,\"key\":\"chief_editors\",\"tenantTerm\":\"Chief Editors\",\"frontiersDefaultTerm\":\"Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":53,\"key\":\"call_for_participation\",\"tenantTerm\":\"call for participation\",\"frontiersDefaultTerm\":\"call for participation\",\"category\":\"Process\"},{\"sequenceNumber\":54,\"key\":\"citation\",\"tenantTerm\":\"citation\",\"frontiersDefaultTerm\":\"citation\",\"category\":\"Misc.\"},{\"sequenceNumber\":55,\"key\":\"citations\",\"tenantTerm\":\"citations\",\"frontiersDefaultTerm\":\"citations\",\"category\":\"Misc.\"},{\"sequenceNumber\":56,\"key\":\"contributor\",\"tenantTerm\":\"contributor\",\"frontiersDefaultTerm\":\"contributor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":57,\"key\":\"contributors\",\"tenantTerm\":\"contributors\",\"frontiersDefaultTerm\":\"contributors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":58,\"key\":\"corresponding_author\",\"tenantTerm\":\"corresponding author\",\"frontiersDefaultTerm\":\"corresponding author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":59,\"key\":\"corresponding_authors\",\"tenantTerm\":\"corresponding authors\",\"frontiersDefaultTerm\":\"corresponding authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":60,\"key\":\"decline\",\"tenantTerm\":\"decline\",\"frontiersDefaultTerm\":\"decline\",\"category\":\"Process\"},{\"sequenceNumber\":61,\"key\":\"declined\",\"tenantTerm\":\"declined\",\"frontiersDefaultTerm\":\"declined\",\"category\":\"Process\"},{\"sequenceNumber\":62,\"key\":\"reject\",\"tenantTerm\":\"reject\",\"frontiersDefaultTerm\":\"reject\",\"category\":\"Process\"},{\"sequenceNumber\":63,\"key\":\"rejected\",\"tenantTerm\":\"rejected\",\"frontiersDefaultTerm\":\"rejected\",\"category\":\"Process\"},{\"sequenceNumber\":64,\"key\":\"publish\",\"tenantTerm\":\"publish\",\"frontiersDefaultTerm\":\"publish\",\"category\":\"Core\"},{\"sequenceNumber\":65,\"key\":\"published\",\"tenantTerm\":\"published\",\"frontiersDefaultTerm\":\"published\",\"category\":\"Core\"},{\"sequenceNumber\":66,\"key\":\"publication\",\"tenantTerm\":\"publication\",\"frontiersDefaultTerm\":\"publication\",\"category\":\"Core\"},{\"sequenceNumber\":67,\"key\":\"peer_review\",\"tenantTerm\":\"peer review\",\"frontiersDefaultTerm\":\"peer review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":68,\"key\":\"peer_reviewed\",\"tenantTerm\":\"peer reviewed\",\"frontiersDefaultTerm\":\"peer reviewed\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":69,\"key\":\"initial_validation\",\"tenantTerm\":\"initial validation\",\"frontiersDefaultTerm\":\"initial validation\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":70,\"key\":\"editorial_assignment\",\"tenantTerm\":\"editorial assignment\",\"frontiersDefaultTerm\":\"editorial assignment\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":71,\"key\":\"independent_review\",\"tenantTerm\":\"independent review\",\"frontiersDefaultTerm\":\"independent review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":72,\"key\":\"interactive_review\",\"tenantTerm\":\"interactive review\",\"frontiersDefaultTerm\":\"interactive review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":73,\"key\":\"review\",\"tenantTerm\":\"review\",\"frontiersDefaultTerm\":\"review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":74,\"key\":\"reviewing\",\"tenantTerm\":\"reviewing\",\"frontiersDefaultTerm\":\"reviewing\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":75,\"key\":\"reviewer\",\"tenantTerm\":\"reviewer\",\"frontiersDefaultTerm\":\"reviewer\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":76,\"key\":\"reviewers\",\"tenantTerm\":\"reviewers\",\"frontiersDefaultTerm\":\"reviewers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":77,\"key\":\"review_finalized\",\"tenantTerm\":\"review finalized\",\"frontiersDefaultTerm\":\"review finalized\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":78,\"key\":\"final_decision\",\"tenantTerm\":\"final decision\",\"frontiersDefaultTerm\":\"final decision\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":79,\"key\":\"final_validation\",\"tenantTerm\":\"final validation\",\"frontiersDefaultTerm\":\"final validation\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":80,\"key\":\"ae_accept_manuscript\",\"tenantTerm\":\"recommend to accept manuscript\",\"frontiersDefaultTerm\":\"accept manuscript\",\"category\":\"Process\"},{\"sequenceNumber\":81,\"key\":\"fee\",\"tenantTerm\":\"fee\",\"frontiersDefaultTerm\":\"fee\",\"category\":\"Accounting\"},{\"sequenceNumber\":82,\"key\":\"fees\",\"tenantTerm\":\"fees\",\"frontiersDefaultTerm\":\"fees\",\"category\":\"Accounting\"},{\"sequenceNumber\":83,\"key\":\"guest_associate_editor\",\"tenantTerm\":\"Guest Associate Editor\",\"frontiersDefaultTerm\":\"Guest Associate Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":84,\"key\":\"guest_associate_editors\",\"tenantTerm\":\"Guest Associate Editors\",\"frontiersDefaultTerm\":\"Guest Associate Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":85,\"key\":\"in_review\",\"tenantTerm\":\"in review\",\"frontiersDefaultTerm\":\"in review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":86,\"key\":\"institutional_member\",\"tenantTerm\":\"institutional partner\",\"frontiersDefaultTerm\":\"institutional partner\",\"category\":\"Accounting\"},{\"sequenceNumber\":87,\"key\":\"institutional_membership\",\"tenantTerm\":\"institutional partnership\",\"frontiersDefaultTerm\":\"institutional partnership\",\"category\":\"Accounting\"},{\"sequenceNumber\":88,\"key\":\"article_processing_charge\",\"tenantTerm\":\"article processing charge\",\"frontiersDefaultTerm\":\"article processing charge\",\"category\":\"Accounting\"},{\"sequenceNumber\":89,\"key\":\"article_processing_charges\",\"tenantTerm\":\"article processing charges\",\"frontiersDefaultTerm\":\"article processing charges\",\"category\":\"Accounting\"},{\"sequenceNumber\":90,\"key\":\"apcs\",\"tenantTerm\":\"APCs\",\"frontiersDefaultTerm\":\"APCs\",\"category\":\"Accounting\"},{\"sequenceNumber\":91,\"key\":\"apc\",\"tenantTerm\":\"APC\",\"frontiersDefaultTerm\":\"APC\",\"category\":\"Accounting\"},{\"sequenceNumber\":92,\"key\":\"received\",\"tenantTerm\":\"received\",\"frontiersDefaultTerm\":\"received\",\"description\":\"Date manuscript was received on.\",\"category\":\"Core\"},{\"sequenceNumber\":93,\"key\":\"transferred\",\"tenantTerm\":\"transferred\",\"frontiersDefaultTerm\":\"transferred\",\"category\":\"Core\"},{\"sequenceNumber\":94,\"key\":\"transfer\",\"tenantTerm\":\"transfer\",\"frontiersDefaultTerm\":\"transfer\",\"category\":\"Core\"},{\"sequenceNumber\":95,\"key\":\"research_topic\",\"tenantTerm\":\"research topic\",\"frontiersDefaultTerm\":\"research topic\",\"category\":\"Core\"},{\"sequenceNumber\":96,\"key\":\"research_topics\",\"tenantTerm\":\"research topics\",\"frontiersDefaultTerm\":\"research topics\",\"category\":\"Core\"},{\"sequenceNumber\":97,\"key\":\"topic_editor\",\"tenantTerm\":\"Topic Editor\",\"frontiersDefaultTerm\":\"Topic Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":98,\"key\":\"review_editor\",\"tenantTerm\":\"Community Reviewer\",\"frontiersDefaultTerm\":\"Review Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":99,\"key\":\"title\",\"tenantTerm\":\"title\",\"frontiersDefaultTerm\":\"title\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":100,\"key\":\"running_title\",\"tenantTerm\":\"running title\",\"frontiersDefaultTerm\":\"running title\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":101,\"key\":\"submit\",\"tenantTerm\":\"submit\",\"frontiersDefaultTerm\":\"submit\",\"category\":\"Process\"},{\"sequenceNumber\":102,\"key\":\"submitted\",\"tenantTerm\":\"submitted\",\"frontiersDefaultTerm\":\"submitted\",\"category\":\"Process\"},{\"sequenceNumber\":103,\"key\":\"submitting\",\"tenantTerm\":\"submitting\",\"frontiersDefaultTerm\":\"submitting\",\"category\":\"Process\"},{\"sequenceNumber\":104,\"key\":\"t_e\",\"tenantTerm\":\"TE\",\"frontiersDefaultTerm\":\"TE\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":105,\"key\":\"topic\",\"tenantTerm\":\"topic\",\"frontiersDefaultTerm\":\"topic\",\"category\":\"Process\"},{\"sequenceNumber\":106,\"key\":\"topic_summary\",\"tenantTerm\":\"topic summary\",\"frontiersDefaultTerm\":\"topic summary\",\"category\":\"Process\"},{\"sequenceNumber\":107,\"key\":\"figure\",\"tenantTerm\":\"figure\",\"frontiersDefaultTerm\":\"figure\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":108,\"key\":\"figures\",\"tenantTerm\":\"figures\",\"frontiersDefaultTerm\":\"figures\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":109,\"key\":\"editorial_file\",\"tenantTerm\":\"editorial file\",\"frontiersDefaultTerm\":\"editorial file\",\"category\":\"Core\"},{\"sequenceNumber\":110,\"key\":\"editorial_files\",\"tenantTerm\":\"editorial files\",\"frontiersDefaultTerm\":\"editorial files\",\"category\":\"Core\"},{\"sequenceNumber\":111,\"key\":\"e_book\",\"tenantTerm\":\"e-book\",\"frontiersDefaultTerm\":\"e-book\",\"category\":\"Core\"},{\"sequenceNumber\":112,\"key\":\"organization\",\"tenantTerm\":\"organization\",\"frontiersDefaultTerm\":\"organization\",\"category\":\"Core\"},{\"sequenceNumber\":113,\"key\":\"institution\",\"tenantTerm\":\"institution\",\"frontiersDefaultTerm\":\"institution\",\"category\":\"Core\"},{\"sequenceNumber\":114,\"key\":\"reference\",\"tenantTerm\":\"reference\",\"frontiersDefaultTerm\":\"reference\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":115,\"key\":\"references\",\"tenantTerm\":\"references\",\"frontiersDefaultTerm\":\"references\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":116,\"key\":\"sce\",\"tenantTerm\":\"SCE\",\"frontiersDefaultTerm\":\"SCE\",\"description\":\"Abbreviation for Specialty Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":117,\"key\":\"submission\",\"tenantTerm\":\"submission\",\"frontiersDefaultTerm\":\"submission\",\"category\":\"Process\"},{\"sequenceNumber\":118,\"key\":\"submissions\",\"tenantTerm\":\"submissions\",\"frontiersDefaultTerm\":\"submissions\",\"category\":\"Process\"},{\"sequenceNumber\":119,\"key\":\"editing\",\"tenantTerm\":\"editing\",\"frontiersDefaultTerm\":\"editing\",\"category\":\"Process\"},{\"sequenceNumber\":120,\"key\":\"in_preparation\",\"tenantTerm\":\"in preparation\",\"frontiersDefaultTerm\":\"in preparation\",\"category\":\"Process\"},{\"sequenceNumber\":121,\"key\":\"country_region\",\"tenantTerm\":\"country/region\",\"frontiersDefaultTerm\":\"country/region\",\"description\":\"Because of political issues, some of the country listings are actually classified as `regions` and we need to include this. However other clients may not want to do this.\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":122,\"key\":\"countries_regions\",\"tenantTerm\":\"countries/regions\",\"frontiersDefaultTerm\":\"countries/regions\",\"description\":\"Because of political issues, some of the country listings are actually classified as `regions` and we need to include this. However other clients may not want to do this.\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":123,\"key\":\"specialty\",\"tenantTerm\":\"specialty\",\"frontiersDefaultTerm\":\"specialty\",\"category\":\"Core\"},{\"sequenceNumber\":124,\"key\":\"specialties\",\"tenantTerm\":\"specialties\",\"frontiersDefaultTerm\":\"specialties\",\"category\":\"Core\"},{\"sequenceNumber\":125,\"key\":\"associate_editors\",\"tenantTerm\":\"Associate Editors\",\"frontiersDefaultTerm\":\"Associate Editors\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":126,\"key\":\"reviewed\",\"tenantTerm\":\"reviewed\",\"frontiersDefaultTerm\":\"reviewed\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":127,\"key\":\"institutional_members\",\"tenantTerm\":\"institutional partners\",\"frontiersDefaultTerm\":\"institutional partners\",\"category\":\"Accounting\"},{\"sequenceNumber\":128,\"key\":\"institutional_memberships\",\"tenantTerm\":\"institutional partnerships\",\"frontiersDefaultTerm\":\"institutional partnerships\",\"category\":\"Accounting\"},{\"sequenceNumber\":129,\"key\":\"assistant_field_chief_editors\",\"tenantTerm\":\"Assistant Field Chief Editors\",\"frontiersDefaultTerm\":\"Assistant Field Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":130,\"key\":\"publications\",\"tenantTerm\":\"publications\",\"frontiersDefaultTerm\":\"publications\",\"category\":\"Process\"},{\"sequenceNumber\":131,\"key\":\"ae_accepted\",\"tenantTerm\":\"recommended acceptance\",\"frontiersDefaultTerm\":\"accepted\",\"category\":\"Process\"},{\"sequenceNumber\":132,\"key\":\"field_journal\",\"tenantTerm\":\"field journal\",\"frontiersDefaultTerm\":\"field journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":133,\"key\":\"field_journals\",\"tenantTerm\":\"field journals\",\"frontiersDefaultTerm\":\"field journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":134,\"key\":\"program_manager\",\"tenantTerm\":\"program manager\",\"frontiersDefaultTerm\":\"program manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":135,\"key\":\"journal_manager\",\"tenantTerm\":\"journal manager\",\"frontiersDefaultTerm\":\"journal manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":136,\"key\":\"journal_specialist\",\"tenantTerm\":\"journal specialist\",\"frontiersDefaultTerm\":\"journal specialist\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":137,\"key\":\"program_managers\",\"tenantTerm\":\"program managers\",\"frontiersDefaultTerm\":\"program managers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":138,\"key\":\"journal_managers\",\"tenantTerm\":\"journal managers\",\"frontiersDefaultTerm\":\"journal managers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":139,\"key\":\"journal_specialists\",\"tenantTerm\":\"journal specialists\",\"frontiersDefaultTerm\":\"journal specialists\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":140,\"key\":\"cover_letter\",\"tenantTerm\":\"manuscript contribution to the field\",\"frontiersDefaultTerm\":\"manuscript contribution to the field\",\"category\":\"Process\"},{\"sequenceNumber\":141,\"key\":\"ae_accepted_manuscript\",\"tenantTerm\":\"recommended to accept manuscript\",\"frontiersDefaultTerm\":\"accepted manuscript\",\"category\":\"Process\"},{\"sequenceNumber\":142,\"key\":\"recommend_for_rejection\",\"tenantTerm\":\"recommend for rejection\",\"frontiersDefaultTerm\":\"recommend for rejection\",\"category\":\"Process\"},{\"sequenceNumber\":143,\"key\":\"recommended_for_rejection\",\"tenantTerm\":\"recommended for rejection\",\"frontiersDefaultTerm\":\"recommended for rejection\",\"category\":\"Process\"},{\"sequenceNumber\":144,\"key\":\"ae\",\"tenantTerm\":\"AE\",\"frontiersDefaultTerm\":\"AE\",\"description\":\"Associate Editor - board member\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":145,\"key\":\"re\",\"tenantTerm\":\"RE\",\"frontiersDefaultTerm\":\"RE\",\"description\":\"Review Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":146,\"key\":\"rev\",\"tenantTerm\":\"REV\",\"frontiersDefaultTerm\":\"REV\",\"description\":\"Reviewer\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":147,\"key\":\"aut\",\"tenantTerm\":\"AUT\",\"frontiersDefaultTerm\":\"AUT\",\"description\":\"Author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":148,\"key\":\"coraut\",\"tenantTerm\":\"CORAUT\",\"frontiersDefaultTerm\":\"CORAUT\",\"description\":\"Corresponding author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":149,\"key\":\"saut\",\"tenantTerm\":\"SAUT\",\"frontiersDefaultTerm\":\"SAUT\",\"description\":\"Submitting author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":150,\"key\":\"coaut\",\"tenantTerm\":\"COAUT\",\"frontiersDefaultTerm\":\"COAUT\",\"description\":\"co-author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":151,\"key\":\"tsof\",\"tenantTerm\":\"TSOF\",\"frontiersDefaultTerm\":\"TSOF\",\"description\":\"Typesetter\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":152,\"key\":\"typesetting_office\",\"tenantTerm\":\"typesetting office\",\"frontiersDefaultTerm\":\"typesetting office\",\"category\":\"Product\"},{\"sequenceNumber\":153,\"key\":\"config\",\"tenantTerm\":\"CONFIG\",\"frontiersDefaultTerm\":\"CONFIG\",\"description\":\"Configuration office role\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":154,\"key\":\"jm\",\"tenantTerm\":\"JM\",\"frontiersDefaultTerm\":\"JM\",\"description\":\"Journal Manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":155,\"key\":\"rte\",\"tenantTerm\":\"RTE\",\"frontiersDefaultTerm\":\"RTE\",\"description\":\"Research topic editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":156,\"key\":\"organizations\",\"tenantTerm\":\"organizations\",\"frontiersDefaultTerm\":\"organizations\",\"category\":\"Core\"},{\"sequenceNumber\":157,\"key\":\"publishing\",\"tenantTerm\":\"publishing\",\"frontiersDefaultTerm\":\"publishing\",\"category\":\"Core\"},{\"sequenceNumber\":158,\"key\":\"acceptance\",\"tenantTerm\":\"acceptance\",\"frontiersDefaultTerm\":\"acceptance\",\"category\":\"Process\"},{\"sequenceNumber\":159,\"key\":\"preferred_associate_editor\",\"tenantTerm\":\"preferred associate editor\",\"frontiersDefaultTerm\":\"preferred associate editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":160,\"key\":\"topic_editors\",\"tenantTerm\":\"Topic Editors\",\"frontiersDefaultTerm\":\"Topic Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":161,\"key\":\"institutions\",\"tenantTerm\":\"institutions\",\"frontiersDefaultTerm\":\"institutions\",\"category\":\"Core\"},{\"sequenceNumber\":162,\"key\":\"author(s)\",\"tenantTerm\":\"author(s)\",\"frontiersDefaultTerm\":\"author(s)\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":163,\"key\":\"figure(s)\",\"tenantTerm\":\"figure(s)\",\"frontiersDefaultTerm\":\"figure(s)\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":164,\"key\":\"co-authors\",\"tenantTerm\":\"co-authors\",\"frontiersDefaultTerm\":\"co-authors\",\"description\":\"co-authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":165,\"key\":\"editorial_board_members\",\"tenantTerm\":\"editorial board members\",\"frontiersDefaultTerm\":\"editorial board members\",\"description\":\"editorial board members\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":166,\"key\":\"editorial_board\",\"tenantTerm\":\"editorial board\",\"frontiersDefaultTerm\":\"editorial board\",\"description\":\"editorial board\",\"category\":\"Product\"},{\"sequenceNumber\":167,\"key\":\"co-authorship\",\"tenantTerm\":\"co-authorship\",\"frontiersDefaultTerm\":\"co-authorship\",\"description\":\"co-authorship\",\"category\":\"Misc.\"},{\"sequenceNumber\":168,\"key\":\"role_id_1\",\"tenantTerm\":\"registration office\",\"frontiersDefaultTerm\":\"registration office\",\"category\":\"User Role\"},{\"sequenceNumber\":169,\"key\":\"role_id_2\",\"tenantTerm\":\"editorial office\",\"frontiersDefaultTerm\":\"editorial office\",\"category\":\"User Role\"},{\"sequenceNumber\":170,\"key\":\"role_id_7\",\"tenantTerm\":\"field chief editor\",\"frontiersDefaultTerm\":\"field chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":171,\"key\":\"role_id_8\",\"tenantTerm\":\"assistant field chief editor\",\"frontiersDefaultTerm\":\"assistant field chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":172,\"key\":\"role_id_9\",\"tenantTerm\":\"specialty chief editor\",\"frontiersDefaultTerm\":\"specialty chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":173,\"key\":\"role_id_10\",\"tenantTerm\":\"assistant specialty chief editor\",\"frontiersDefaultTerm\":\"assistant specialty chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":174,\"key\":\"role_id_11\",\"tenantTerm\":\"associate editor\",\"frontiersDefaultTerm\":\"associate editor\",\"category\":\"User Role\"},{\"sequenceNumber\":175,\"key\":\"role_id_12\",\"tenantTerm\":\"guest associate editor\",\"frontiersDefaultTerm\":\"guest associate editor\",\"category\":\"User Role\"},{\"sequenceNumber\":176,\"key\":\"role_id_13\",\"tenantTerm\":\"review editor\",\"frontiersDefaultTerm\":\"review editor\",\"category\":\"User Role\"},{\"sequenceNumber\":177,\"key\":\"role_id_14\",\"tenantTerm\":\"reviewer\",\"frontiersDefaultTerm\":\"reviewer\",\"category\":\"User Role\"},{\"sequenceNumber\":178,\"key\":\"role_id_15\",\"tenantTerm\":\"author\",\"frontiersDefaultTerm\":\"author\",\"category\":\"User Role\"},{\"sequenceNumber\":179,\"key\":\"role_id_16\",\"tenantTerm\":\"corresponding author\",\"frontiersDefaultTerm\":\"corresponding author\",\"category\":\"User Role\"},{\"sequenceNumber\":180,\"key\":\"role_id_17\",\"tenantTerm\":\"submitting author\",\"frontiersDefaultTerm\":\"submitting author\",\"category\":\"User Role\"},{\"sequenceNumber\":181,\"key\":\"role_id_18\",\"tenantTerm\":\"co-author\",\"frontiersDefaultTerm\":\"co-author\",\"category\":\"User Role\"},{\"sequenceNumber\":182,\"key\":\"role_id_20\",\"tenantTerm\":\"production office\",\"frontiersDefaultTerm\":\"production office\",\"category\":\"User Role\"},{\"sequenceNumber\":183,\"key\":\"role_id_22\",\"tenantTerm\":\"typesetting office (typesetter)\",\"frontiersDefaultTerm\":\"typesetting office (typesetter)\",\"category\":\"User Role\"},{\"sequenceNumber\":184,\"key\":\"role_id_24\",\"tenantTerm\":\"registered user\",\"frontiersDefaultTerm\":\"registered user\",\"category\":\"User Role\"},{\"sequenceNumber\":185,\"key\":\"role_id_35\",\"tenantTerm\":\"job office\",\"frontiersDefaultTerm\":\"job office\",\"category\":\"User Role\"},{\"sequenceNumber\":186,\"key\":\"role_id_41\",\"tenantTerm\":\"special event administrator\",\"frontiersDefaultTerm\":\"special event administrator\",\"category\":\"User Role\"},{\"sequenceNumber\":187,\"key\":\"role_id_42\",\"tenantTerm\":\"special event reviewer\",\"frontiersDefaultTerm\":\"special event reviewer\",\"category\":\"User Role\"},{\"sequenceNumber\":188,\"key\":\"role_id_43\",\"tenantTerm\":\"submit abstract\",\"frontiersDefaultTerm\":\"submit abstract\",\"category\":\"User Role\"},{\"sequenceNumber\":189,\"key\":\"role_id_52\",\"tenantTerm\":\"events office\",\"frontiersDefaultTerm\":\"events office\",\"category\":\"User Role\"},{\"sequenceNumber\":190,\"key\":\"role_id_53\",\"tenantTerm\":\"event administrator\",\"frontiersDefaultTerm\":\"event administrator\",\"category\":\"User Role\"},{\"sequenceNumber\":191,\"key\":\"role_id_89\",\"tenantTerm\":\"content management office\",\"frontiersDefaultTerm\":\"content management office\",\"category\":\"User Role\"},{\"sequenceNumber\":192,\"key\":\"role_id_98\",\"tenantTerm\":\"accounting office\",\"frontiersDefaultTerm\":\"accounting office\",\"category\":\"User Role\"},{\"sequenceNumber\":193,\"key\":\"role_id_99\",\"tenantTerm\":\"projects\",\"frontiersDefaultTerm\":\"projects\",\"category\":\"User Role\"},{\"sequenceNumber\":194,\"key\":\"role_id_103\",\"tenantTerm\":\"configuration office\",\"frontiersDefaultTerm\":\"configuration office\",\"category\":\"User Role\"},{\"sequenceNumber\":195,\"key\":\"role_id_104\",\"tenantTerm\":\"beta user\",\"frontiersDefaultTerm\":\"beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":196,\"key\":\"role_id_106\",\"tenantTerm\":\"wfconf\",\"frontiersDefaultTerm\":\"wfconf\",\"category\":\"User Role\"},{\"sequenceNumber\":197,\"key\":\"role_id_107\",\"tenantTerm\":\"rt management beta user\",\"frontiersDefaultTerm\":\"rt management beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":198,\"key\":\"role_id_108\",\"tenantTerm\":\"deo beta user\",\"frontiersDefaultTerm\":\"deo beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":199,\"key\":\"role_id_109\",\"tenantTerm\":\"search beta user\",\"frontiersDefaultTerm\":\"search beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":200,\"key\":\"role_id_110\",\"tenantTerm\":\"journal manager\",\"frontiersDefaultTerm\":\"journal manager\",\"category\":\"User Role\"},{\"sequenceNumber\":201,\"key\":\"role_id_111\",\"tenantTerm\":\"myfrontiers beta user\",\"frontiersDefaultTerm\":\"myfrontiers beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":202,\"key\":\"role_id_21\",\"tenantTerm\":\"copy editor\",\"frontiersDefaultTerm\":\"copy editor\",\"category\":\"User Role\"},{\"sequenceNumber\":203,\"key\":\"role_id_1_abr\",\"tenantTerm\":\"ROF\",\"frontiersDefaultTerm\":\"ROF\",\"category\":\"User Role\"},{\"sequenceNumber\":204,\"key\":\"role_id_2_abr\",\"tenantTerm\":\"EOF\",\"frontiersDefaultTerm\":\"EOF\",\"category\":\"User Role\"},{\"sequenceNumber\":205,\"key\":\"role_id_7_abr\",\"tenantTerm\":\"FCE\",\"frontiersDefaultTerm\":\"FCE\",\"category\":\"User Role\"},{\"sequenceNumber\":206,\"key\":\"role_id_8_abr\",\"tenantTerm\":\"AFCE\",\"frontiersDefaultTerm\":\"AFCE\",\"category\":\"User Role\"},{\"sequenceNumber\":207,\"key\":\"role_id_9_abr\",\"tenantTerm\":\"SCE\",\"frontiersDefaultTerm\":\"SCE\",\"category\":\"User Role\"},{\"sequenceNumber\":208,\"key\":\"role_id_10_abr\",\"tenantTerm\":\"ASCE\",\"frontiersDefaultTerm\":\"ASCE\",\"category\":\"User Role\"},{\"sequenceNumber\":209,\"key\":\"role_id_11_abr\",\"tenantTerm\":\"AE\",\"frontiersDefaultTerm\":\"AE\",\"category\":\"User Role\"},{\"sequenceNumber\":210,\"key\":\"role_id_12_abr\",\"tenantTerm\":\"GAE\",\"frontiersDefaultTerm\":\"GAE\",\"category\":\"User Role\"},{\"sequenceNumber\":211,\"key\":\"role_id_13_abr\",\"tenantTerm\":\"RE\",\"frontiersDefaultTerm\":\"RE\",\"category\":\"User Role\"},{\"sequenceNumber\":212,\"key\":\"role_id_14_abr\",\"tenantTerm\":\"REV\",\"frontiersDefaultTerm\":\"REV\",\"category\":\"User Role\"},{\"sequenceNumber\":213,\"key\":\"role_id_15_abr\",\"tenantTerm\":\"AUT\",\"frontiersDefaultTerm\":\"AUT\",\"category\":\"User Role\"},{\"sequenceNumber\":214,\"key\":\"role_id_16_abr\",\"tenantTerm\":\"CORAUT\",\"frontiersDefaultTerm\":\"CORAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":215,\"key\":\"role_id_17_abr\",\"tenantTerm\":\"SAUT\",\"frontiersDefaultTerm\":\"SAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":216,\"key\":\"role_id_18_abr\",\"tenantTerm\":\"COAUT\",\"frontiersDefaultTerm\":\"COAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":217,\"key\":\"role_id_20_abr\",\"tenantTerm\":\"POF\",\"frontiersDefaultTerm\":\"POF\",\"category\":\"User Role\"},{\"sequenceNumber\":218,\"key\":\"role_id_22_abr\",\"tenantTerm\":\"TSOF\",\"frontiersDefaultTerm\":\"TSOF\",\"category\":\"User Role\"},{\"sequenceNumber\":219,\"key\":\"role_id_24_abr\",\"tenantTerm\":\"RU\",\"frontiersDefaultTerm\":\"RU\",\"category\":\"User Role\"},{\"sequenceNumber\":220,\"key\":\"role_id_35_abr\",\"tenantTerm\":\"JOF\",\"frontiersDefaultTerm\":\"JOF\",\"category\":\"User Role\"},{\"sequenceNumber\":221,\"key\":\"role_id_41_abr\",\"tenantTerm\":\"SE-ADM\",\"frontiersDefaultTerm\":\"SE-ADM\",\"category\":\"User Role\"},{\"sequenceNumber\":222,\"key\":\"role_id_42_abr\",\"tenantTerm\":\"SE-REV\",\"frontiersDefaultTerm\":\"SE-REV\",\"category\":\"User Role\"},{\"sequenceNumber\":223,\"key\":\"role_id_43_abr\",\"tenantTerm\":\"SE-AUT\",\"frontiersDefaultTerm\":\"SE-AUT\",\"category\":\"User Role\"},{\"sequenceNumber\":224,\"key\":\"role_id_52_abr\",\"tenantTerm\":\"EVOF\",\"frontiersDefaultTerm\":\"EVOF\",\"category\":\"User Role\"},{\"sequenceNumber\":225,\"key\":\"role_id_53_abr\",\"tenantTerm\":\"EV-ADM\",\"frontiersDefaultTerm\":\"EV-ADM\",\"category\":\"User Role\"},{\"sequenceNumber\":226,\"key\":\"role_id_89_abr\",\"tenantTerm\":\"COMOF\",\"frontiersDefaultTerm\":\"COMOF\",\"category\":\"User Role\"},{\"sequenceNumber\":227,\"key\":\"role_id_98_abr\",\"tenantTerm\":\"AOF\",\"frontiersDefaultTerm\":\"AOF\",\"category\":\"User Role\"},{\"sequenceNumber\":228,\"key\":\"role_id_99_abr\",\"tenantTerm\":\"Projects\",\"frontiersDefaultTerm\":\"Projects\",\"category\":\"User Role\"},{\"sequenceNumber\":229,\"key\":\"role_id_103_abr\",\"tenantTerm\":\"CONFIG\",\"frontiersDefaultTerm\":\"CONFIG\",\"category\":\"User Role\"},{\"sequenceNumber\":230,\"key\":\"role_id_104_abr\",\"tenantTerm\":\"BETA\",\"frontiersDefaultTerm\":\"BETA\",\"category\":\"User Role\"},{\"sequenceNumber\":231,\"key\":\"role_id_106_abr\",\"tenantTerm\":\"WFCONF\",\"frontiersDefaultTerm\":\"WFCONF\",\"category\":\"User Role\"},{\"sequenceNumber\":232,\"key\":\"role_id_107_abr\",\"tenantTerm\":\"RTBETA\",\"frontiersDefaultTerm\":\"RTBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":233,\"key\":\"role_id_108_abr\",\"tenantTerm\":\"DEOBETA\",\"frontiersDefaultTerm\":\"DEOBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":234,\"key\":\"role_id_109_abr\",\"tenantTerm\":\"SEARCHBETA\",\"frontiersDefaultTerm\":\"SEARCHBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":235,\"key\":\"role_id_110_abr\",\"tenantTerm\":\"JM\",\"frontiersDefaultTerm\":\"JM\",\"category\":\"User Role\"},{\"sequenceNumber\":236,\"key\":\"role_id_111_abr\",\"tenantTerm\":\"MFBETA\",\"frontiersDefaultTerm\":\"MFBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":237,\"key\":\"role_id_21_abr\",\"tenantTerm\":\"COPED\",\"frontiersDefaultTerm\":\"COPED\",\"category\":\"User Role\"},{\"sequenceNumber\":238,\"key\":\"reviewer_editorial_board\",\"tenantTerm\":\"editorial board\",\"frontiersDefaultTerm\":\"editorial board\",\"description\":\"This is the label for the review editorial board\",\"category\":\"Label\"},{\"sequenceNumber\":239,\"key\":\"field_chief_editor\",\"tenantTerm\":\"Field Chief Editor\",\"frontiersDefaultTerm\":\"Field Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":240,\"key\":\"field_chief_editors\",\"tenantTerm\":\"Field Chief Editors\",\"frontiersDefaultTerm\":\"Field Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":241,\"key\":\"editor\",\"tenantTerm\":\"editor\",\"frontiersDefaultTerm\":\"editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":242,\"key\":\"editors\",\"tenantTerm\":\"editors\",\"frontiersDefaultTerm\":\"editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":243,\"key\":\"board\",\"tenantTerm\":\"board\",\"frontiersDefaultTerm\":\"board\",\"category\":\"Label\"},{\"sequenceNumber\":244,\"key\":\"boards\",\"tenantTerm\":\"boards\",\"frontiersDefaultTerm\":\"boards\",\"category\":\"Label\"},{\"sequenceNumber\":245,\"key\":\"article_collection\",\"tenantTerm\":\"article collection\",\"frontiersDefaultTerm\":\"article collection\",\"category\":\"Label\"},{\"sequenceNumber\":246,\"key\":\"article_collections\",\"tenantTerm\":\"article collections\",\"frontiersDefaultTerm\":\"article collections\",\"category\":\"Label\"},{\"sequenceNumber\":247,\"key\":\"handling_editor\",\"tenantTerm\":\"handling editor\",\"frontiersDefaultTerm\":\"associate editor\",\"description\":\"This terminology key is for the person assigned to edit a manuscript. It is a label for the temporary handling editor assignment.\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":248,\"key\":\"handling_editors\",\"tenantTerm\":\"handling editors\",\"frontiersDefaultTerm\":\"associate editors\",\"description\":\"This terminology key is for the person assigned to edit a manuscript. It is a label for the temporary handling editor assignment.\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":249,\"key\":\"ae_accept\",\"tenantTerm\":\"recommend acceptance\",\"frontiersDefaultTerm\":\"accept\",\"category\":\"Process\"},{\"sequenceNumber\":250,\"key\":\"rtm\",\"tenantTerm\":\"RTM\",\"frontiersDefaultTerm\":\"RTM\",\"category\":\"Product\"},{\"sequenceNumber\":251,\"key\":\"frontiers_media_sa\",\"tenantTerm\":\"Frontiers Media S.A\",\"frontiersDefaultTerm\":\"Frontiers Media S.A\",\"category\":\"Customer\"},{\"sequenceNumber\":252,\"key\":\"review_editors\",\"tenantTerm\":\"Community Reviewers\",\"frontiersDefaultTerm\":\"Review Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":253,\"key\":\"journal_card_chief_editor\",\"tenantTerm\":\"Chief Editor\",\"frontiersDefaultTerm\":\"Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":254,\"key\":\"journal_card_chief_editors\",\"tenantTerm\":\"Chief Editors\",\"frontiersDefaultTerm\":\"Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":255,\"key\":\"call_for_papers\",\"tenantTerm\":\"Call for papers\",\"frontiersDefaultTerm\":\"Call for papers\",\"category\":\"Label\"},{\"sequenceNumber\":256,\"key\":\"calls_for_papers\",\"tenantTerm\":\"Calls for papers\",\"frontiersDefaultTerm\":\"Calls for papers\",\"category\":\"Label\"},{\"sequenceNumber\":257,\"key\":\"supervising_editor\",\"tenantTerm\":\"Supervising Editor\",\"frontiersDefaultTerm\":\"Supervising Editor\",\"description\":\"A Chief or Assistant Chief editor who is assigned to a manuscript to supervise.\",\"category\":\"Role\",\"externalKey\":\"supervising_editor\"},{\"sequenceNumber\":258,\"key\":\"supervising_editors\",\"tenantTerm\":\"Supervising Editors\",\"frontiersDefaultTerm\":\"Supervising Editors\",\"description\":\"A Chief or Assistant Chief editor who is assigned to a manuscript to supervise.\",\"category\":\"Role\",\"externalKey\":\"supervising_editors\"},{\"sequenceNumber\":259,\"key\":\"reviewer_endorse\",\"tenantTerm\":\"endorse\",\"frontiersDefaultTerm\":\"endorse\",\"category\":\"Label\"},{\"sequenceNumber\":260,\"key\":\"reviewer_endorsed\",\"tenantTerm\":\"endorsed\",\"frontiersDefaultTerm\":\"endorsed\",\"category\":\"Label\"},{\"sequenceNumber\":261,\"key\":\"reviewer_endorse_publication\",\"tenantTerm\":\"endorse publication\",\"frontiersDefaultTerm\":\"endorse publication\",\"category\":\"Label\"},{\"sequenceNumber\":262,\"key\":\"reviewer_endorsed_publication\",\"tenantTerm\":\"endorsed publication\",\"frontiersDefaultTerm\":\"endorsed publication\",\"category\":\"Label\"},{\"sequenceNumber\":263,\"key\":\"editor_role\",\"tenantTerm\":\"editor role\",\"frontiersDefaultTerm\":\"Editor Role\",\"category\":\"Label\"},{\"sequenceNumber\":264,\"key\":\"editor_roles\",\"tenantTerm\":\"editor roles\",\"frontiersDefaultTerm\":\"Editor Roles\",\"category\":\"Label\"},{\"sequenceNumber\":265,\"key\":\"editorial_role\",\"tenantTerm\":\"editorial role\",\"frontiersDefaultTerm\":\"Editorial Role\",\"category\":\"Label\"},{\"sequenceNumber\":266,\"key\":\"editorial_roles\",\"tenantTerm\":\"editorial roles\",\"frontiersDefaultTerm\":\"Editorial Roles\",\"category\":\"Label\"},{\"sequenceNumber\":267,\"key\":\"call_for_paper\",\"tenantTerm\":\"Call for paper\",\"frontiersDefaultTerm\":\"Call for paper\",\"category\":\"Label\"},{\"sequenceNumber\":268,\"key\":\"research_topic_abstract\",\"tenantTerm\":\"manuscript summary\",\"frontiersDefaultTerm\":\"manuscript summary\",\"category\":\"Process\"},{\"sequenceNumber\":269,\"key\":\"research_topic_abstracts\",\"tenantTerm\":\"manuscript summaries\",\"frontiersDefaultTerm\":\"manuscript summaries\",\"category\":\"Process\"},{\"sequenceNumber\":270,\"key\":\"submissions_team_manager\",\"tenantTerm\":\"Journal Manager\",\"frontiersDefaultTerm\":\"Content Manager\",\"category\":\"Process\"},{\"sequenceNumber\":271,\"key\":\"submissions_team\",\"tenantTerm\":\"Journal Team\",\"frontiersDefaultTerm\":\"Content Team\",\"category\":\"Process\"},{\"sequenceNumber\":272,\"key\":\"topic_coordinator\",\"tenantTerm\":\"topic coordinator\",\"frontiersDefaultTerm\":\"topic coordinator\",\"category\":\"Process\"},{\"sequenceNumber\":273,\"key\":\"topic_coordinators\",\"tenantTerm\":\"topic coordinators\",\"frontiersDefaultTerm\":\"topic coordinators\",\"category\":\"Process\"},{\"sequenceNumber\":274,\"key\":\"frontiers_journal_team\",\"tenantTerm\":\"frontiers journal team\",\"frontiersDefaultTerm\":\"frontiers journal team\",\"category\":\"Label (Role)\"}]}'\n",impactGtmId:"GTM-NJF2ML9B",impactGtmAuth:"fYo-7NoDm9w37QgFMs03SA",impactGtmPreview:"env-1",impactGoogleMapsApiKey:"AIzaSyCTEhX2EU8PWfi86GW9FI00FTcyKk6Ifr8",qualtricsV4ToV3:"'{\"enabled\":true,\"interceptId\":\"SI_er0E2ze69Oz8Yn4\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",qualtricsUmux:"'{\"enabled\":false,\"interceptId\":\"SI_89fPHY3eTxQBwtU\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",qualtricsContinuousBrand:"'{\"enabled\":true,\"interceptId\":\"SI_9ZuT94UT81FcRh4\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",defaultArticleTemplate:"v3"},app:{baseURL:"/",buildId:"b9b23680-846c-4155-9f00-37c6bae31c9f",buildAssetsDir:"ap-2024/_nuxt",cdnURL:""}}</script>
<script src="https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6" type="text/javascript" async></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-MML-AM_CHTML" type="text/javascript" async></script>
<script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-f0bc9b243ff5677d05460c1eb71834ca998946d764eb3bc244ab4b18ba50d21e.js" type="text/javascript" async></script>
<script src="https://api.altmetric.com/v1/doi/10.3389/fneur.2025.1652378?callback=_altmetric.embed_callback&domain=www.frontiersin.org&key=3c130976ca2b8f2e88f8377633751ba1&cache_until=14-15" type="text/javascript" async></script>
<script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript" async></script></body></html>